data_2k50_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k50 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.313 0.101 . . . . 74.4 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.3 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 74.33 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 75.1 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.22 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.01 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.52 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.2 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.14 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.42 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 72.33 111.572 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.33 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.45 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.31 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.31 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.23 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.55 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.53 111.053 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 27' ' ' LYS . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.43 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 63.4 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.42 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HB3' HD13 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.41 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.53 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.42 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.838 177.397 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 113.985 0.354 . . . . 62.31 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.433 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.33 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.54 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.55 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.51 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 60.31 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.54 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.45 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 72.45 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.52 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.43 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.51 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.44 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.2 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.12 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.24 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.04 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.22 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 74.33 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.05 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.1 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.41 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.22 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.4 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.1 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.616 ' HZ2' ' HB2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.13 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.13 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.22 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.01 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.03 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.54 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.1 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.43 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG11 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.44 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.15 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.1 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.55 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.24 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.14 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 . . . . . 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.35 111.699 -179.221 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.32 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.185 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.2 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.1 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.13 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.01 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.33 112.717 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 74.34 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.11 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG11 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.24 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 72.12 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.33 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 74.23 112.862 -175.19 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 54.44 112.797 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.24 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.568 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.03 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.755 ' HB3' ' HZ3' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.11 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.2 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.44 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.41 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.23 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.24 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.41 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.02 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.22 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.12 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.54 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.51 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.32 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.42 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.31 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.42 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 74.4 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.53 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.13 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.33 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.42 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.12 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.24 109.895 176.182 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 N-CA-C 113.661 0.224 . . . . 54.25 113.661 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.13 112.248 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.31 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.23 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.54 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.34 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 75.33 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.21 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.24 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.24 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.54 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.4 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.32 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.41 110.852 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.21 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.43 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 73.22 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.31 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.2 113.802 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.22 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.21 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 73.42 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.53 112.559 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.41 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.34 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.3 112.39 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.41 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 74.21 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 72.1 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.32 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.31 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.34 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.34 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.13 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.44 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.34 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.43 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.24 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.34 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.21 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.43 110.403 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 63.02 112.119 -177.432 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.3 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.42 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.22 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 74.33 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.44 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.42 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.41 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.01 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.31 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.23 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.548 HG11 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.31 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.14 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.44 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.32 110.997 179.484 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.019 0.438 . . . . 73.53 111.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 75.55 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.542 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.21 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.33 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.42 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.22 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.21 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.33 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.4 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.03 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.33 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.3 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.45 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' HG21 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.23 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.45 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.442 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.31 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.04 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 65.01 111.495 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.33 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 74.53 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.14 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.2 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.33 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 113.791 0.276 . . . . 64.45 113.791 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.55 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.33 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.44 111.135 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.23 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 73.22 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.02 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.44 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.53 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.43 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.22 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.13 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.13 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.11 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.13 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 72.33 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 74.24 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.13 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.44 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.13 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.12 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.646 HD12 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.01 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.31 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.13 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.12 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.01 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.34 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.45 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.21 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 71.42 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.32 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 105' ' ' LEU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.22 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.4 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.31 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.44 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.22 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 71.31 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.31 110.502 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.22 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.15 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.4 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.44 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.1 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.15 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.2 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.24 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.31 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.646 HG13 HD12 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.34 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.45 112.377 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.669 0.271 . . . . 73.13 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.51 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.43 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.33 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.03 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.42 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.12 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.3 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.55 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.01 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 74.32 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 65.01 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 72.43 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.32 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.13 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HG2' HG21 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.14 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.22 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.21 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.32 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 HG12 HG11 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.22 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.05 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.23 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.31 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.02 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.11 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.421 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.03 110.783 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 114.053 0.381 . . . . 73.15 114.053 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.13 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.34 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.43 111.814 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.503 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.53 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.44 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.53 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.21 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.21 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.15 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 70.04 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.22 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.04 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.41 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.2 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.24 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.11 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 75.53 111.227 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 71.13 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.51 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.6 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.22 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.13 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.4 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.23 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.23 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.1 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.33 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.24 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.43 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.04 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 75.31 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.43 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.13 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.4 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.31 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.05 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 HG11 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.22 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.32 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.11 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.24 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.22 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 72.33 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.11 111.511 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.216 0.532 . . . . 74.03 111.782 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.424 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 64.21 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 73.33 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.41 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.53 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.55 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.14 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.43 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.11 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.647 HG13 HD12 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 61.23 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.23 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 71.02 111.507 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.472 HG23 HG22 ' A' ' 53' ' ' THR . 9.3 t . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 110.594 -0.15 . . . . 72.05 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 73.54 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.11 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 84' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.51 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.1 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.42 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.14 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.21 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.33 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 72.12 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.11 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 72.42 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.45 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.42 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.33 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.3 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HZ3' ' HB3' ' A' ' 27' ' ' LYS . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.43 112.072 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.55 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.44 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.43 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.674 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.42 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.22 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 73.12 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.42 111.29 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 113.826 0.291 . . . . 53.01 113.826 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.13 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.23 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.11 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.54 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.11 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.12 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.14 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.33 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.31 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.12 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.02 110.93 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.01 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.31 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.01 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.34 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 74.34 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 74.42 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.42 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 73.51 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.21 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.4 112.55 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.607 HD12 HG11 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.24 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.33 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.22 111.85 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.41 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 64.4 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.01 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 37.9 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.13 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.34 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.14 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.35 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 75.25 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.13 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.31 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 63.01 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.41 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.545 0.688 . . . . 70.22 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.22 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.43 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.3 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.32 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.02 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.11 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 73.33 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 73.21 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.35 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.55 111.666 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 78.4 mt . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.32 110.518 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.818 0.342 . . . . 75.34 111.387 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.452 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 72.25 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.13 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.23 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.14 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.11 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.34 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.22 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.13 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.12 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 73.51 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.42 111.42 165.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.22 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.24 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.03 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.449 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 74.41 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.2 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 HG12 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 72.25 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.53 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.13 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.21 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.43 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.21 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.31 109.827 175.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 CA-C-O 120.973 0.207 . . . . 41.43 113.179 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.02 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.31 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.15 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.03 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.13 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.51 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.3 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.43 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.55 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 73.55 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.05 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.33 111.244 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.02 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.34 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.24 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.12 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.13 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.12 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.34 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.14 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.22 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.14 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.53 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 74.35 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.43 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.738 ' HZ2' ' HB3' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.52 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.51 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.34 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.42 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.14 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 63.03 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.21 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG11 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.51 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.21 112.061 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.1 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 19' ' ' THR . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.24 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.45 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 74.23 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 4.2 mmp_? . . . . . 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 74.45 111.25 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.3 mttp . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.32 112.559 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.31 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.31 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.52 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.33 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.33 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.12 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.54 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 75.01 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 73.43 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.612 HG13 HD12 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.4 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 62.41 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.34 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.495 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 88.0 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.31 110.996 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.785 0.326 . . . . 72.12 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.44 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.12 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 73.11 112.796 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.41 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.54 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.3 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.15 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.04 110.829 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.32 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.55 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.4 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.3 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.13 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HG2' HG21 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.52 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.32 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.505 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.35 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.35 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 74.11 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.3 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.42 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.55 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 64.14 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 75.44 111.4 178.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 N-CA-C 113.362 0.105 . . . . 64.24 113.362 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.51 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.24 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 50.13 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.419 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.1 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.01 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.03 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.24 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.13 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.14 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 38.79 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.53 111.599 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 73.53 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.03 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.51 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.14 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.44 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.11 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.469 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.13 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 54.2 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.4 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.53 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.03 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.423 HD12 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.54 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.21 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 63.43 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 72.23 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.12 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.44 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.13 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.01 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.584 HG21 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.11 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.32 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.21 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.417 HG23 HG11 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.44 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.01 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.24 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.22 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.24 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.54 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.53 111.197 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.54 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.495 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.14 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 61.45 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.41 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.12 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.1 110.397 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.15 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.35 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.32 112.029 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.52 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.423 HG13 HD12 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.4 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.02 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.42 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.018 174.628 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.45 112.811 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.13 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 52.32 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.43 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.02 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 72.45 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 72.1 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.33 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 37.03 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.41 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.31 112.013 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.24 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.51 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.21 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.34 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.34 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.35 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 37.03 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.2 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.51 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 63.43 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.42 110.571 176.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.03 114.226 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.22 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.44 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 71.23 111.606 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.3 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.32 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.31 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.456 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.51 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.42 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.05 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.44 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.14 113.614 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 73.31 110.818 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.41 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.45 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.01 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.1 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.22 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.4 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.34 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.15 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.13 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.41 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.33 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 74.03 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.23 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.35 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.42 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.52 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.52 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.22 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.4 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.11 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.41 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.04 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.21 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.21 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.14 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.14 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.22 111.391 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.51 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 74.13 111.14 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.253 0.549 . . . . 63.44 111.852 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.31 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.1 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.12 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.14 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.54 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.22 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.1 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.21 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 74.2 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.42 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.14 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 78' ' ' ARG . 87.3 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.3 111.428 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.04 0.448 . . . . 75.2 111.532 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 63.21 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.41 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.3 113.111 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.02 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.35 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.32 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 37.5 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.04 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.3 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.03 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.12 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.24 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.44 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.2 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HG2' HG21 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.01 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 71.1 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.522 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.32 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.35 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.2 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.45 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.32 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.11 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.42 109.937 176.517 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.43 114.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.23 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.34 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.43 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.34 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.52 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.43 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 70.24 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.34 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.43 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 75.34 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.02 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.21 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.34 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.05 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 73.41 111.788 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.54 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.34 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.44 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.12 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.12 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.03 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.24 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.33 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.22 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HB3' ' HZ1' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.14 112.372 -176.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 65.02 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.23 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.31 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.34 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 37.5 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.2 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.12 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.21 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HD2' HD12 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.43 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 70.33 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.42 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 71.23 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.11 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.22 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.03 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 . . . . . 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.11 111.915 -178.571 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.436 0.636 . . . . 74.21 112.61 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.05 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 74.22 111.917 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.14 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.42 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.494 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.04 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.41 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.24 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 71.14 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.52 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.44 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.4 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt . . . . . 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 63.12 111.786 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.372 0.13 . . . . 55.32 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.23 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.02 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 70.12 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.53 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 70.52 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.3 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.13 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.24 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.21 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 64.32 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.53 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.55 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.24 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.33 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HG2' HG21 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.02 111.932 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.51 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.14 110.924 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.31 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.22 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 63.21 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.31 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.51 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 71.05 111.304 179.638 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 114.036 0.374 . . . . 36.81 114.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.12 112.35 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 72.32 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.33 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.35 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 54.54 111.319 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 42.31 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 HD11 HD21 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.31 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 72.04 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.53 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.11 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.54 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 74.53 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.02 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.04 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.41 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.32 113.911 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.32 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.11 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.22 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.34 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.3 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 52.41 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.41 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.32 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.22 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.43 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.51 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.4 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.33 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 74.15 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.32 110.9 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.54 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.22 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.2 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.43 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 60.12 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.437 ' HD3' ' O ' ' A' ' 13' ' ' LEU . 57.7 mttp . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.42 112.912 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.02 111.051 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.4 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.34 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.22 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.465 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.54 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.15 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.33 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 73.52 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.45 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.22 111.628 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.21 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.33 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.766 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.41 111.734 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.551 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.24 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 51.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.54 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.551 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.21 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.51 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.34 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.52 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.22 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.41 110.522 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 73.4 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.34 112.892 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.01 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.01 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.13 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.41 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.44 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.05 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.22 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.33 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.34 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.53 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.42 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.51 109.19 174.651 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.211 0 CA-C-O 120.883 0.157 . . . . 44.12 113.417 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.402 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.54 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.41 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 54.23 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.04 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.4 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 73.33 110.994 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.13 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 73.24 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.21 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.42 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 72.41 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.14 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.11 110.85 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 ' HB1' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.41 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.34 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 64.11 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.14 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.44 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.34 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.402 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 64.31 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.3 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 72.33 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.32 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.24 112.559 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.593 HD12 HG11 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.22 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.15 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.02 112.654 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.54 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.23 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.4 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.45 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.31 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.3 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.35 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 74.0 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.01 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 75.43 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.03 112.204 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.54 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.34 110.784 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 70.12 111.152 178.426 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.42 112.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 72.12 111.815 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.11 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 74.23 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.22 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.14 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 71.31 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 61.44 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.03 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.31 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 65.15 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.23 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -176.277 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 53' ' ' THR . 10.0 t . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 120.822 0.344 . . . . 61.12 111.298 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.42 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.41 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.42 112.227 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.54 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.33 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 71.22 112.757 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.45 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.04 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.34 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.45 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.02 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.53 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.53 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.34 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.533 ' HA ' HG21 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.34 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.23 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.52 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.483 HG21 HG23 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.13 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.43 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.32 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.52 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 73.33 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 72.12 112.014 -179.309 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 113.675 0.23 . . . . 73.1 113.675 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.409 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 65.21 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.4 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.14 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.12 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG23 HG21 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.43 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.2 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.4 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.2 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 64.11 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.568 HG22 HG23 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 73.54 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 37.59 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.22 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.31 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.42 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.54 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.11 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 74.04 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.34 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.13 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.31 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.32 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.31 111.094 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.52 112.046 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.1 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.34 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.41 112.145 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.14 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.35 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.03 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.45 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.43 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.33 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 HG21 HG13 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.34 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.23 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.12 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.51 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.04 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.21 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.12 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.425 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.21 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.41 110.956 179.297 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 76.6 mttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 121.053 0.454 . . . . 73.44 111.548 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.21 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.14 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.32 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.454 ' HA ' HG11 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 72.34 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 72.3 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.41 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.23 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.459 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.01 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.03 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.1 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.13 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.33 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 64.33 110.804 -179.465 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.701 0.286 . . . . 73.41 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.23 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.11 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.41 112.54 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.54 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.04 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.43 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.13 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.43 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.35 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.02 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.54 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.34 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.44 111.822 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.14 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.33 110.068 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.52 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 64.53 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.04 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.33 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.13 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.12 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 75.03 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.51 110.396 178.198 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 N-CA-C 113.916 0.327 . . . . 54.24 113.916 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 72.25 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.01 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.23 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.14 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.31 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.35 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.51 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.23 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.23 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.12 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 64.45 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 38.28 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.12 111.001 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.23 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.52 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 45.23 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 74.42 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 74.53 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 72.31 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.54 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.21 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.3 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.24 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 71.0 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.03 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.52 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.43 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.34 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.43 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 70.22 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.35 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.22 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 74.35 110.712 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.54 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 72.23 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 64.03 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.34 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.45 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.43 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.21 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.23 111.189 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.1 111.045 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.49 0.662 . . . . 74.0 112.153 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.32 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.31 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.14 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.33 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.5 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.04 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 71.11 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 63.22 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 74.31 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 75.33 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 36.5 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.44 111.301 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.596 0.236 . . . . 74.44 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.24 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.02 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.42 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.11 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.23 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.42 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.4 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.12 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.35 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 71.13 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HG2' HG21 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.21 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.43 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.12 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.33 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.3 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.33 111.267 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 74.32 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 55.45 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.42 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.21 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 72.23 111.201 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 114.01 0.364 . . . . 64.25 114.01 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.42 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.04 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.41 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.31 111.271 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.32 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 72.03 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.53 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.1 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.34 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.34 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.11 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 65.32 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.15 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.31 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.11 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.02 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 73.14 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.14 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.02 113.631 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.4 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.15 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 61.31 111.551 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.31 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 73.45 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.22 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.3 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.2 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.23 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.4 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.34 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.24 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 73.34 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.14 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 HG11 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.1 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.43 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.13 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.42 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.34 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 75.21 111.288 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.3 112.379 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.445 ' HZ1' ' HB2' ' A' ' 92' ' ' LYS . 9.6 mtmp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.44 111.212 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.442 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.11 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.45 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 74.32 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.34 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.432 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.22 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.45 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.31 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 67' ' ' LEU . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.01 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.24 111.598 -177.082 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.64 0.257 . . . . 75.42 111.013 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.32 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.3 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.13 113.296 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.21 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.55 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 72.24 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.22 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.3 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.23 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 74.33 111.537 169.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.428 ' OG1' ' HG3' ' A' ' 78' ' ' ARG . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 75.35 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.21 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 63.34 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.14 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.14 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.13 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 73.52 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.12 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.34 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.23 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.12 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.33 111.419 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 114.037 0.375 . . . . 51.14 114.037 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 70.44 111.355 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.23 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.4 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 71.23 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.05 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.13 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.34 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.13 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.23 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.11 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.44 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.43 110.804 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.41 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.31 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.02 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.33 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 74.13 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 64.13 113.565 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.53 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.41 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.13 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.51 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.529 HD12 HG11 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.24 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.42 113.038 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.42 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.12 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.01 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.14 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.04 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.43 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG23 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.11 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.34 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HD2' HD13 ' A' ' 105' ' ' LEU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 71.13 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.14 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.01 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.23 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.12 111.627 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 75.02 111.462 174.732 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 mttp . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.52 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 61.32 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 73.03 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.11 112.009 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.13 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.401 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 63.01 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.12 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD12 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.31 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD13 ' HD2' ' A' ' 78' ' ' ARG . 76.6 mt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.53 110.214 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.093 -0.706 . . . . 72.4 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 54.13 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.12 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.34 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.21 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.41 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.14 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.23 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.44 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.42 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 54.33 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.33 111.679 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.23 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.13 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.13 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.23 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.422 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 72.05 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.44 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 75.14 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.43 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 75.52 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 74.24 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 64.11 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 72.51 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.35 111.298 -179.384 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 38.63 114.769 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 75.15 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.02 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.34 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.54 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.53 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.04 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.3 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.04 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.54 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 75.52 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.34 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.43 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.52 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.23 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 62.23 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 74.53 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 61.23 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.02 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.05 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.12 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.33 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.22 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.14 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 72.33 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.15 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.11 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 75.43 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.31 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.44 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.44 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.34 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.31 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.21 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.14 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.45 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 HG11 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.45 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.12 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.51 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.21 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.24 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 74.45 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.1 111.092 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.45 112.054 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.23 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 72.22 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.3 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.12 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.532 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.54 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.43 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.24 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 52.23 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.43 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.478 HG11 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 72.13 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.21 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 74.32 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' HB2' HG12 ' A' ' 76' ' ' VAL . 58.9 mt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.33 111.432 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.661 0.267 . . . . 63.23 111.611 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.53 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.24 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.44 111.79 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.44 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.51 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.53 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.41 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 71.12 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.45 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.12 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.22 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 65.21 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.1 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.34 111.472 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.1 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.42 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 HG12 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 64.44 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.43 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 74.12 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 37.67 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.15 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.32 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.31 110.207 174.54 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 120.695 0.053 . . . . 75.34 113.026 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.403 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.12 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.41 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 74.24 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.401 HG12 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.33 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.32 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.43 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 63.12 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.52 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.23 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.31 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.31 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.43 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.45 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.34 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 73.32 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.53 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.14 111.435 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.52 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.54 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.42 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.31 112.262 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.51 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.13 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.15 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.44 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.24 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.13 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.31 113.369 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.02 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.14 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 HG22 HG11 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.12 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.33 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.13 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.21 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.24 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.787 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.33 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.42 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 74.32 111.506 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.502 ' HE3' ' HB2' ' A' ' 13' ' ' LEU . 36.3 mtmm . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.105 0.478 . . . . 63.11 111.306 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.52 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.12 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.23 112.011 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.43 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 63.05 112.934 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.21 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.22 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.02 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.24 110.438 173.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 74.51 111.433 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.499 HG11 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.01 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.23 112.557 -176.006 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.176 -0.305 . . . . 60.41 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.42 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.34 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.44 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.41 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.52 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.33 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.02 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 72.42 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.15 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 75.13 111.264 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.12 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.12 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 74.44 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.44 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.43 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.04 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.24 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.44 111.196 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.44 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 65.14 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.13 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.52 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.34 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.52 110.741 178.546 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 N-CA-C 113.119 0.008 . . . . 72.54 113.119 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.2 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.12 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.33 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.41 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.13 110.961 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.54 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.452 HG23 HG23 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.42 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.33 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.51 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.32 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 72.2 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.14 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 94' ' ' ALA . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.54 112.13 -172.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 72.44 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.53 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 74.21 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 74.42 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 72.42 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 73.21 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.41 112.943 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.1 111.518 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.33 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.31 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.24 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.33 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 74.44 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.54 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 74.01 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.14 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.13 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.496 HG21 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.23 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.52 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.24 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.41 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.42 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.14 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.43 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.34 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 73.13 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.52 111.488 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.11 113.15 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 71.14 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.15 111.24 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.04 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.44 111.698 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.45 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.32 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.54 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.32 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.11 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 67' ' ' LEU . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 64.31 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG11 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.01 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.34 110.679 179.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 120.54 0.209 . . . . 74.4 111.43 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.674 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 74.34 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.531 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.44 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.42 113.065 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.41 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.03 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.55 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.34 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.04 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.33 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.45 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.503 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 73.41 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.33 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.23 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.53 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG21 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.3 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.24 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.24 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.1 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.496 HG23 HG23 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.2 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 71.14 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 74.15 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.15 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.35 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.45 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.52 110.239 176.83 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 112.903 -0.079 . . . . 36.81 112.903 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.11 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 74.13 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.2 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.13 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.14 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.24 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 62.3 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.2 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.1 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.05 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.531 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.02 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.15 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.11 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.04 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.22 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 53.32 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.2 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.13 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.31 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 73.01 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.33 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.14 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.42 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.03 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.14 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 HD11 HG22 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.785 ' HB3' ' HZ1' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.4 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.14 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.24 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.44 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.44 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.21 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.32 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.01 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.41 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 HG13 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.43 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.03 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.44 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.45 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.33 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.14 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.44 112.238 -178.447 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.418 ' NZ ' ' O ' ' A' ' 13' ' ' LEU . 97.1 mttt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.12 112.538 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.04 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 62.44 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 74.43 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HA ' HG11 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.33 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.45 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 50.42 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.24 111.423 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.54 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.44 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.55 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.01 112.983 -171.661 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' HG23 ' A' ' 53' ' ' THR . 76.7 p . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.169 0.509 . . . . 75.13 111.476 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.14 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.23 112.235 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.55 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.04 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.13 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.44 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 60.34 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.45 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.32 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.42 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.22 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.34 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.542 ' HG2' HG21 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.41 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.35 110.706 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 70.21 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.1 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.41 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 65.42 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.44 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.34 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.12 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.31 110.736 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 71.21 111.723 179.573 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 CA-C-O 121.099 0.277 . . . . 43.12 113.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.476 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.31 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.55 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.53 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 61.14 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.42 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.01 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 62.35 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.01 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.43 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.41 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.409 HG23 ' HG1' ' A' ' 9' ' ' THR . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.51 112.758 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.41 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.11 110.818 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.33 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.12 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.44 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.33 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.13 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.427 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.04 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.13 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' HZ2' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.34 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.54 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.42 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HB2' ' HZ1' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.53 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.31 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.41 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 74.33 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.13 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.21 113.661 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.14 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.53 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.14 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.43 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 HG12 HG11 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.12 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 71.34 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.2 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 63.11 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.32 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.31 112.367 -176.542 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.4 mttp . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.561 0.696 . . . . 63.45 112.862 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.32 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.12 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.23 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.43 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.04 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 65.41 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.12 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 62.52 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD12 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 71.15 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.02 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 71.1 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.35 112.916 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.715 0.293 . . . . 74.04 111.502 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD2' ' HD3' ' A' ' 6' ' ' ARG . 24.3 pttm -78.02 145.92 70.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.296 -0.252 . . . . 73.44 110.546 172.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.19 141.13 49.76 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 123.385 2.723 . . . . 72.34 114.776 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.86 -32.78 67.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.77 -0.65 . . . . 72.33 112.047 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -71.13 -5.17 29.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.421 0.526 . . . . 73.33 112.421 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HD3' ' HD2' ' A' ' 2' ' ' LYS . 20.3 ttt180 -88.34 117.11 27.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.03 0.443 . . . . 74.22 111.477 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.5 ptm -111.2 102.67 11.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.282 0.563 . . . . 72.41 110.948 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.98 151.59 35.59 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.32 0.581 . . . . 75.52 112.328 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p -88.6 172.13 9.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.971 -0.559 . . . . 74.4 110.859 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.3 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 74.33 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 75.1 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.22 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.01 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.52 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.2 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.14 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.42 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 72.33 111.572 -174.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.33 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.45 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.31 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.31 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HG2' HG21 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.23 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.55 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.53 111.053 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.43 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG23 HG23 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 63.4 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.42 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HB3' HD13 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.41 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.53 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.42 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -140.92 153.84 45.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.838 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.8 m -85.7 104.79 15.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.911 0.386 . . . . 74.44 111.638 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -98.69 152.98 19.06 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.158 0.504 . . . . 74.32 111.785 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -81.47 -8.19 59.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.821 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -63.73 -16.52 61.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 111.873 0.323 . . . . 61.5 111.873 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.86 75.72 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.25 -0.5 . . . . 61.35 112.849 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -97.73 160.8 14.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 122.769 -0.254 . . . . 72.21 110.668 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.16 -35.29 69.37 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.461 0.541 . . . . 72.33 112.461 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.9 108.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.292 -0.48 . . . . 62.31 113.985 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.433 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.33 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.54 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.55 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.51 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 60.31 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.54 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.45 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 72.45 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.52 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.43 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.51 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.44 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.2 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.12 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.24 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.04 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.22 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 74.33 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.05 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.1 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.41 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.22 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.4 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.1 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.616 ' HB2' ' HZ2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.13 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.13 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.22 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.01 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.03 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.54 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.536 HG21 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.1 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.43 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG11 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.44 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.15 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.1 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.55 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.24 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.14 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -95.89 -66.52 0.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.35 111.699 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.49 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . 90.56 70.66 1.22 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.961 -0.638 . . . . 72.04 113.007 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.48 17.29 58.77 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.09 -0.576 . . . . 44.34 113.811 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -159.69 145.58 15.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.842 0.353 . . . . 75.2 111.531 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.23 80.89 0.14 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.245 -0.434 . . . . 70.22 112.877 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.93 -95.29 0.18 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.428 -0.415 . . . . 40.22 112.681 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.51 97.27 1.64 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.021 0.439 . . . . 75.13 111.504 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.416 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm -73.22 -172.82 1.18 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.32 112.028 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.49 ' HG2' ' H ' ' A' ' 86' ' ' GLY . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.185 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.2 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.435 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.1 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.13 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.01 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.33 112.717 -176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 74.34 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.11 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG11 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.24 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 72.12 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.33 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.497 HD21 HD21 ' A' ' 108' ' ' LEU . 67.2 mt -111.8 -163.78 0.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 74.23 112.862 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.799 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 13.5 t70 87.2 -66.64 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.416 1.486 . . . . 75.33 109.915 -167.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.799 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -78.79 85.31 1.87 Allowed 'Trans proline' 0 C--N 1.364 1.345 0 CA-C-N 120.752 1.304 . . . . 60.3 109.331 155.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.497 HD21 HD21 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -52.98 126.0 19.02 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.017 -0.538 . . . . 73.31 111.968 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -75.08 -62.56 1.51 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.368 -0.378 . . . . 75.11 111.493 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.735 -0.65 . . . . 74.3 112.123 -178.941 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.518 0.199 . . . . 61.44 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 56.22 91.14 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 112.072 0.397 . . . . 72.34 112.072 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.13 113.0 1.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.553 2.168 . . . . 61.42 112.92 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.45 -26.88 65.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.756 0.65 . . . . 65.04 112.756 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -75.72 75.67 2.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 73.0 111.521 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.56 116.32 9.24 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.961 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.1 mmt -84.76 95.32 8.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.0 0.429 . . . . 61.42 110.966 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.27 104.87 5.2 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.442 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -57.69 166.47 1.36 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 54.44 112.797 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.24 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.568 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.03 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.755 ' HZ3' ' HB3' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.11 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.2 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.44 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.41 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.23 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.24 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.41 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.02 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.22 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.12 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.54 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.51 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.32 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.42 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.31 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.42 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 74.4 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.53 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.13 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.33 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.42 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.12 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -142.39 160.21 40.71 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.24 109.895 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.5 m -85.11 104.56 15.12 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.772 -0.58 . . . . 72.33 111.171 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -92.53 -171.34 2.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.796 -0.638 . . . . 71.0 111.554 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -64.6 152.05 43.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.959 0.409 . . . . 72.23 111.875 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -39.69 115.18 0.49 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.394 0.887 . . . . 71.24 113.394 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.28 -52.13 0.75 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.943 -0.646 . . . . 42.03 113.931 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -110.56 160.02 17.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.245 0.545 . . . . 70.42 112.389 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -65.89 -49.07 69.37 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.752 -0.658 . . . . 64.02 112.32 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.65 108.85 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.222 -0.513 . . . . 54.25 113.661 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.13 112.248 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.448 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.31 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.23 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.54 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.517 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.34 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 75.33 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.21 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.24 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.24 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.54 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.4 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.32 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.41 110.852 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.21 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.43 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 73.22 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.31 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.2 113.802 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.22 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.21 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 73.42 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.53 112.559 177.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.514 HD12 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.41 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.34 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.3 112.39 -178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.41 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 74.21 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 72.1 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.32 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.31 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.34 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.34 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG21 HG11 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.13 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.44 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.548 HG12 HG11 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.34 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.43 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.24 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG11 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.34 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.21 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.43 110.403 177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -83.65 -19.57 35.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 63.02 112.119 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.45 85.74 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.798 -0.715 . . . . 60.5 113.065 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -71.44 118.38 7.19 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.291 -0.481 . . . . 61.33 112.88 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -68.98 -34.6 75.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.864 0.364 . . . . 70.33 111.575 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.06 68.3 2.87 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.311 -0.471 . . . . 62.35 113.675 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.38 -72.1 0.79 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.721 -0.276 . . . . 65.02 113.72 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -82.52 131.14 35.22 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.907 0.384 . . . . 74.24 111.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.517 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp -71.67 -176.28 1.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.3 110.623 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.42 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.22 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 74.33 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.44 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.42 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.41 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.01 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.31 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.23 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.548 HG11 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.31 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.14 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.425 HG11 HG21 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.44 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.617 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 66.1 mt -106.72 163.6 12.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.32 110.997 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.651 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.5 t70 74.72 -76.23 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.091 0.956 . . . . 74.21 111.131 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.651 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 28.4 Cg_endo -66.92 62.17 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 CA-C-N 122.343 1.872 . . . . 64.3 109.978 155.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.74 124.99 20.35 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.381 -1.281 . . . . 70.45 113.524 -166.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.42 -33.57 8.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.359 -0.382 . . . . 75.52 111.305 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 m170 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.82 -0.61 . . . . 65.32 111.814 -177.665 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.476 0.176 . . . . 73.34 111.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 37.2 mtmm -99.16 125.06 42.92 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 112.075 0.398 . . . . 54.41 112.075 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 16.7 Cg_exo -68.49 112.54 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.584 2.189 . . . . 75.52 112.529 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.8 129.29 36.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.982 0.42 . . . . 72.03 111.129 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -90.44 154.88 19.33 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.704 0.764 . . . . 74.22 112.756 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 ttm-85 -176.69 -67.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.929 -1.032 . . . . 74.31 109.739 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.3 mtm -78.6 70.7 4.98 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.628 0.727 . . . . 61.55 110.566 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.23 172.76 6.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.59 -0.732 . . . . 74.53 112.145 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -79.22 178.78 7.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.947 -0.569 . . . . 73.53 111.902 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 75.55 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.542 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.21 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.33 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.534 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.42 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.22 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.21 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.33 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.4 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.03 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.33 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.3 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.45 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.566 ' HG2' HG21 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.23 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.45 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.442 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.31 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.04 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 65.01 111.495 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.33 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 74.53 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.55 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.14 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.2 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.33 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.65 165.57 22.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.6 m -85.52 108.17 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.208 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -103.09 173.88 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.228 0.537 . . . . 72.43 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -94.87 -9.18 35.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.121 -0.49 . . . . 74.3 111.577 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 9.4 mmpt? -88.03 167.01 14.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.784 0.326 . . . . 73.21 111.0 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.63 35.66 1.39 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.294 -0.479 . . . . 70.33 113.9 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -127.2 160.63 30.67 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.154 0.502 . . . . 72.53 111.709 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.11 -48.32 82.2 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.939 -0.573 . . . . 62.33 112.07 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.67 102.71 0.18 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.317 -0.468 . . . . 64.45 113.791 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.55 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.33 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.44 111.135 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.23 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 73.22 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.02 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.44 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.53 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.43 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.22 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.13 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.13 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.11 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.408 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.13 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 72.33 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 74.24 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.13 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.44 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.13 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.12 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.646 HD12 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.01 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.31 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.13 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.12 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.01 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.34 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.45 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.21 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.566 HG21 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 71.42 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.32 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.484 ' HB2' HD12 ' A' ' 105' ' ' LEU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.22 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.4 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.31 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.44 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.22 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 71.31 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 73.34 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 -122.05 167.41 13.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.31 110.502 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.69 84.14 0.37 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.929 -0.653 . . . . 71.12 113.807 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.61 165.16 43.98 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.044 -0.598 . . . . 39.08 112.771 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -78.75 150.56 32.42 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.048 0.452 . . . . 73.52 111.288 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.52 14.84 12.05 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.39 -0.433 . . . . 54.45 113.228 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.68 -57.92 4.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.229 -0.51 . . . . 70.44 113.577 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 91' ' ' ARG . 69.1 mtt85 -70.09 122.96 20.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.079 0.466 . . . . 72.53 111.876 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -80.62 -178.55 6.8 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.22 111.566 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.15 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.4 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.408 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.44 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.1 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.15 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.2 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.24 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.31 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.646 HG13 HD12 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.34 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.482 ' HB ' ' HD2' ' A' ' 107' ' ' PRO . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.45 112.377 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt -99.85 -1.88 36.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.844 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 14.8 t70 -77.39 -55.87 1.26 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 109.514 -0.55 . . . . 72.45 109.514 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.844 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -87.24 72.66 3.07 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.22 1.947 . . . . 75.33 108.692 156.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -40.55 116.99 0.76 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.67 -1.15 . . . . 72.14 113.34 -166.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.543 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 33.1 tt0 -90.02 -52.2 5.08 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.517 -0.765 . . . . 73.23 110.681 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.543 ' HD2' ' HG2' ' A' ' 109' ' ' GLU . 26.4 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.788 -0.625 . . . . 71.12 112.101 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.627 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.323 -0.251 . . . . 72.23 110.323 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 50.4 pttt -118.02 87.66 29.12 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.536 0.569 . . . . 71.41 112.536 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.65 102.83 1.63 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.291 1.994 . . . . 72.23 111.126 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.31 137.9 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.173 0.511 . . . . 75.23 111.804 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -134.13 -4.46 2.74 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.068 -0.515 . . . . 74.42 111.886 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.655 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 1.1 mmp_? -117.44 -68.28 0.93 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.189 0.44 . . . . 74.2 112.189 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.0 ttp -83.64 112.63 20.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.944 0.402 . . . . 63.34 111.735 -176.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.44 173.7 8.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.453 0.644 . . . . 73.33 112.624 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -103.73 177.57 4.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.69 -0.686 . . . . 73.13 111.424 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.51 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.551 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.43 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.33 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.518 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.03 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.42 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.12 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.3 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.55 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.01 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 74.32 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 65.01 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 72.43 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.32 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.13 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HG2' HG21 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.14 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.22 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.512 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.21 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.32 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 HG12 HG11 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.22 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.05 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.23 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.31 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.431 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.02 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.11 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.421 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 -136.99 149.98 47.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.03 110.783 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -85.35 108.43 17.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.971 0.415 . . . . 73.33 111.715 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 t -108.69 151.37 26.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.035 0.445 . . . . 65.24 112.164 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.666 ' H ' ' HD3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.28 3.77 29.93 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.347 -0.388 . . . . 64.2 111.968 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -66.36 -27.7 68.08 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.965 0.412 . . . . 65.34 111.53 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.46 21.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.049 -0.596 . . . . 63.5 112.932 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.7 161.84 19.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.799 0.333 . . . . 74.3 111.222 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.07 -27.71 65.79 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 111.993 0.368 . . . . 71.22 111.993 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . 82.06 113.54 0.42 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.332 -0.461 . . . . 73.15 114.053 174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.13 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.34 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.43 111.814 -178.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.503 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.53 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.522 HG11 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.44 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.53 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.21 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.414 ' HB3' HD13 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.21 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.15 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 70.04 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.22 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.04 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.41 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.503 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.2 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.24 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.11 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 75.53 111.227 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 71.13 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.459 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.51 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.6 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.22 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.13 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.4 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.23 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.647 HD12 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.23 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.1 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.33 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.24 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.43 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.04 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 75.31 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.43 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.13 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.512 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.4 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.31 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.05 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 HG11 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.22 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.32 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.11 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.24 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.22 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 72.33 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.424 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 -91.36 -19.07 23.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.11 111.511 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.08 -15.22 62.85 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.795 0.678 . . . . 74.4 114.795 174.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 55.18 58.94 11.44 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 117.67 0.735 . . . . 60.41 113.237 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.89 98.23 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.039 0.447 . . . . 71.11 111.592 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.51 -12.65 5.17 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.447 -0.406 . . . . 74.21 113.498 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.0 -118.29 0.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.98 -0.629 . . . . 37.59 112.983 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -88.25 149.12 24.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.199 0.523 . . . . 74.41 111.471 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.431 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 38.6 mttm -73.72 168.63 18.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.733 -0.667 . . . . 74.03 111.782 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.424 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 64.21 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 73.33 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.41 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.53 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.6 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.55 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.14 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.43 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.11 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.647 HG13 HD12 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 61.23 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 73.13 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.23 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.608 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 80.1 mt -111.52 -178.22 3.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 71.02 111.507 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.59 -76.93 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.281 0 CA-C-O 118.579 -0.724 . . . . 72.43 111.038 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.608 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 32.9 Cg_exo -63.94 78.05 0.16 Allowed 'Trans proline' 0 C--N 1.364 1.376 0 CA-C-N 122.236 1.834 . . . . 75.5 110.349 155.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.19 118.36 6.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.999 0.74 . . . . 72.0 112.999 -169.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.88 -20.08 50.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.558 -0.746 . . . . 72.2 111.745 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.049 -0.501 . . . . 74.21 111.379 179.411 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.849 0.357 . . . . 75.41 111.626 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.462 ' HZ1' ' HB3' ' A' ' 2' ' ' LYS . 1.1 mmmp? -78.83 116.65 61.43 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.425 -0.352 . . . . 73.44 110.809 -178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.9 147.53 49.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.607 2.204 . . . . 72.33 113.94 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -104.3 -39.65 6.4 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.907 -0.588 . . . . 71.34 110.973 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -159.0 105.53 1.77 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 75.25 111.901 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -96.0 34.76 1.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.82 0.819 . . . . 71.34 110.522 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.9 ttm -149.01 22.91 0.96 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.67 0.748 . . . . 71.41 109.686 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.85 92.69 4.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.746 0.784 . . . . 62.25 112.088 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.472 HG23 HG22 ' A' ' 53' ' ' THR . 9.3 t -76.55 -169.62 1.29 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.467 -0.788 . . . . 72.05 110.594 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.49 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 73.54 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.539 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.11 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HB3' HG13 ' A' ' 84' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.51 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.1 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.42 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.14 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.21 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.33 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 72.12 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.11 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 72.42 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.45 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.42 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.33 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 71.3 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.43 112.072 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.55 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.44 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.43 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.674 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.42 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.22 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 73.12 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -151.4 168.37 25.06 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.42 111.29 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.4 m -85.41 115.97 23.46 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 74.32 111.672 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.5 t -107.7 -170.11 1.64 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.961 -0.563 . . . . 65.35 110.763 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -48.77 -72.01 0.06 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.163 0.431 . . . . 64.32 112.163 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.81 167.66 12.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.488 . . . . 71.14 112.319 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.37 -66.2 2.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.156 -0.475 . . . . 55.42 113.679 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -85.33 146.86 26.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 74.01 111.243 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.49 -16.33 61.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.899 0.703 . . . . 74.23 112.899 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.18 105.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.327 -0.464 . . . . 53.01 113.826 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.674 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.13 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.23 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.11 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.54 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.11 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.12 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.14 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.33 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.31 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.12 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.02 110.93 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.01 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.31 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.01 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.34 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 74.34 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 74.42 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.44 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.42 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 73.51 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.44 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.21 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.4 112.55 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.607 HD12 HG11 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.24 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.33 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.22 111.85 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.41 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 64.4 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.01 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 37.9 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.13 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.34 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.14 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.35 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 75.25 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.13 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.31 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 63.01 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.492 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.41 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -76.23 -53.4 8.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.88 -52.53 0.19 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.43 -1.367 . . . . 74.31 115.477 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.591 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 53.84 45.46 70.07 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 117.633 0.717 . . . . 63.1 111.718 -167.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -50.66 118.44 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.191 0.52 . . . . 73.35 112.233 -172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.92 -49.47 0.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.019 -0.537 . . . . 73.34 112.958 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.3 -105.71 0.66 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.679 -0.772 . . . . 75.24 113.591 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 51.7 mtm180 -88.77 123.25 33.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.062 0.458 . . . . 72.53 111.58 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.591 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 55.4 mttm -61.55 179.24 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.511 -0.768 . . . . 70.22 112.719 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.22 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.43 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.3 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.32 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.02 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.11 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 73.33 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.607 HG11 HD12 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 73.21 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.35 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.77 HG22 ' HG3' ' A' ' 109' ' ' GLU . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.55 111.666 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.467 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 78.4 mt -103.52 177.86 4.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.32 110.518 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.65 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 18.3 t70 86.21 -65.1 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.111 0.965 . . . . 73.23 109.07 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 15.4 Cg_exo -75.29 -149.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.263 1.309 . . . . 64.02 109.798 149.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.27 124.33 1.2 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.659 -0.651 . . . . 65.23 111.601 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.77 ' HG3' HG22 ' A' ' 104' ' ' VAL . 45.9 mt-10 -78.46 -52.33 8.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.264 0.468 . . . . 74.43 112.264 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 112.95 0.722 . . . . 74.24 112.95 -175.463 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.236 -0.283 . . . . 71.33 110.236 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mptp? -71.64 121.71 85.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 111.786 0.291 . . . . 74.04 111.786 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.6 98.58 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.643 2.229 . . . . 72.12 112.904 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.85 128.88 38.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.187 -0.461 . . . . 71.4 111.65 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.84 130.78 5.04 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.533 -0.303 . . . . 73.42 111.488 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.651 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 2.8 mmp_? -101.47 76.85 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.429 0.633 . . . . 72.22 111.176 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.64 90.66 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.909 -1.042 . . . . 75.44 109.654 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -114.73 135.59 53.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 74.31 111.196 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -72.9 167.6 20.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.381 -0.372 . . . . 75.34 111.387 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.452 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 72.25 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.525 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.13 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.23 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.14 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.11 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.34 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.22 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.13 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.12 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 73.51 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.42 111.42 165.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.22 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.24 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HG2' HG21 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.03 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.449 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 74.41 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.2 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.514 HG12 HG12 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 72.25 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.53 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.13 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.21 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.43 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.21 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.14 175.81 5.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.31 109.827 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -106.12 128.24 53.75 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.355 -0.216 . . . . 73.41 111.434 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.496 HG21 ' O ' ' A' ' 41' ' ' GLU . 14.5 p -83.28 172.77 12.21 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.443 0.639 . . . . 74.04 111.77 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -103.8 14.69 30.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.998 -0.546 . . . . 53.2 110.667 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -107.76 -69.12 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.14 0.422 . . . . 75.24 112.14 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.29 -55.81 0.02 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.188 -1.006 . . . . 74.13 114.072 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -85.43 162.94 18.78 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.072 0.397 . . . . 75.03 112.072 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 42' ' ' GLY . 9.4 pt-20 -43.18 -68.92 0.16 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.788 -0.642 . . . . 74.52 112.711 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.512 ' H ' ' HG3' ' A' ' 41' ' ' GLU . . . 102.95 135.6 8.78 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 121.305 -0.474 . . . . 41.43 113.179 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.02 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.31 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.15 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.03 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.514 HG12 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.13 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.51 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.3 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.43 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.55 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 73.55 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.05 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.33 111.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD21 ' HB1' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.02 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.34 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.24 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.12 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.13 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.12 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.411 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.34 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.14 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.22 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.14 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.53 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.612 HD12 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 74.35 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.43 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.738 ' HB3' ' HZ2' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.52 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.51 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.34 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.42 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.14 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 63.03 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.21 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HG11 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.51 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.21 112.061 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.1 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 19' ' ' THR . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.24 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.45 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 74.23 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.464 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 4.2 mmp_? -91.63 -73.5 0.54 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 74.45 111.25 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.26 83.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.452 -0.88 . . . . 64.13 113.795 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -72.44 114.16 4.78 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.165 -0.54 . . . . 40.2 112.426 175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -69.96 105.74 2.95 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.47 0.652 . . . . 74.52 111.851 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.91 40.8 0.23 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.111 -0.495 . . . . 62.51 113.244 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.95 -58.55 4.29 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.465 -0.398 . . . . 54.2 113.243 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.425 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 99.2 mtt180 -72.45 89.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.944 0.402 . . . . 74.23 111.715 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.3 mttp -65.45 -173.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.32 112.559 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.31 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.31 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.52 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.33 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.33 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.12 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.54 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 75.01 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 73.43 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.612 HG13 HD12 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.4 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 62.41 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.34 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.653 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 88.0 mt -110.13 173.61 6.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.31 110.996 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.8 OUTLIER 81.84 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.336 1.054 . . . . 54.42 111.237 -169.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.653 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 53.7 Cg_exo -59.39 67.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 CA-C-N 121.057 1.413 . . . . 74.41 109.04 148.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 129.61 40.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.802 -1.09 . . . . 62.35 113.291 -160.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.73 -58.76 1.97 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.528 -0.76 . . . . 75.25 110.593 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.928 -0.558 . . . . 74.5 111.883 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.796 0.331 . . . . 54.22 111.085 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -109.72 131.66 21.8 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.675 -0.239 . . . . 74.33 111.084 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.0 -173.05 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.894 2.396 . . . . 64.31 114.156 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -97.51 2.67 50.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 74.45 113.24 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.85 122.6 27.93 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.254 0.55 . . . . 74.44 111.871 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' HG2' HH11 ' A' ' 6' ' ' ARG . 10.0 tpt180 -154.13 107.56 2.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.762 -0.654 . . . . 74.14 111.143 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.1 mtt 56.06 29.16 14.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.898 0.333 . . . . 73.15 111.898 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 43.6 m-20 -64.32 139.22 58.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 38.79 111.667 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p -62.62 161.25 12.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.051 -0.522 . . . . 72.12 111.182 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.539 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.44 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.497 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.12 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 73.11 112.796 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.539 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.41 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.54 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.3 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.15 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.04 110.829 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.32 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.54 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.55 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.4 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.3 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.13 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HG2' HG21 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.52 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.32 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.505 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.35 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.35 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 74.11 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.3 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.42 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.55 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 64.14 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -144.3 164.49 30.63 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 75.44 111.4 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 m -84.8 124.65 31.82 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.226 -0.296 . . . . 74.32 111.627 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.4 p -102.6 147.09 27.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.764 0.316 . . . . 73.31 111.264 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.08 -22.19 64.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.137 0.494 . . . . 72.41 110.935 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.07 -26.73 62.29 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.152 -0.476 . . . . 61.24 111.752 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.22 4.1 50.67 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.175 -0.536 . . . . 63.4 113.573 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -92.37 161.15 14.78 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.393 -0.475 . . . . 73.2 111.631 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -44.17 -52.16 7.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.464 0.913 . . . . 72.53 113.464 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.88 115.49 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.098 -0.572 . . . . 64.24 113.362 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.469 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.51 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.487 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.24 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 50.13 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.419 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.1 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.442 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.01 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.03 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.24 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.13 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.14 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 38.79 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.443 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.53 111.599 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 73.53 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.419 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.03 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.51 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.14 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.502 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.44 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.11 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.469 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.13 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 54.2 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.4 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.53 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.03 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.423 HD12 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.54 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.21 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 63.43 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 72.23 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.12 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.44 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.13 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.01 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.584 HG21 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.11 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.32 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.21 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.417 HG23 HG11 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.44 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.01 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.24 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.22 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.24 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 HD11 HD11 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.54 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.495 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 -124.1 171.34 9.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.53 111.197 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.04 102.25 2.83 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.829 -0.623 . . . . 71.04 114.173 -173.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.67 93.31 1.57 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.176 -0.535 . . . . 71.14 112.215 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -55.0 -27.2 42.38 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 73.24 112.166 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.87 57.35 5.05 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.207 -0.52 . . . . 62.43 112.792 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.8 -85.27 0.66 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.353 -0.451 . . . . 70.31 113.334 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 95.6 mtt180 -68.08 125.25 25.75 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.965 0.357 . . . . 64.32 111.965 -177.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -68.17 -176.21 0.69 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.54 110.804 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.495 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.14 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.431 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 61.45 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.41 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.12 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.1 110.397 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.15 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.35 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.32 112.029 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.52 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.423 HG13 HD12 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.4 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.02 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.42 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.671 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 63.8 mt -111.76 166.41 11.21 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.018 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.501 ' HB3' ' CD ' ' A' ' 107' ' ' PRO . 21.1 t70 87.61 -67.96 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.28 1.032 . . . . 70.34 109.504 -166.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 46.2 Cg_endo -71.38 75.28 1.94 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 CA-C-N 121.12 1.436 . . . . 53.03 109.762 156.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -52.87 108.15 0.29 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.55 -0.75 . . . . 75.35 112.608 -167.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -90.07 -61.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.041 -0.527 . . . . 74.14 110.988 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 112.36 0.504 . . . . 74.42 112.36 -174.088 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.616 0.246 . . . . 73.4 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -81.72 141.66 48.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.777 -0.192 . . . . 65.53 111.221 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.67 123.41 12.87 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.721 2.281 . . . . 73.11 112.905 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.07 138.1 58.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.434 0.635 . . . . 75.1 112.351 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -116.3 128.52 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 74.4 110.889 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -169.67 118.83 0.63 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.828 -0.624 . . . . 72.03 110.634 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.425 ' HE2' ' HA ' ' A' ' 7' ' ' MET . 5.5 tpt 65.2 20.5 11.95 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.177 0.436 . . . . 73.32 112.177 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.52 129.36 34.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.691 -0.631 . . . . 72.13 111.185 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p -91.1 -177.82 5.0 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.45 112.811 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.13 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 52.32 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.43 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.02 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 72.45 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 72.1 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.33 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 37.03 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.41 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.31 112.013 -174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.24 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.51 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.456 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.21 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.34 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.34 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.35 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 37.03 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB3' HD13 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.2 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.51 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 63.43 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -148.22 156.73 42.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.42 110.571 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.5 m -85.08 118.61 24.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.038 0.447 . . . . 65.21 111.982 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -89.44 147.55 23.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.323 -0.399 . . . . 73.31 110.952 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 5.7 tpm_? -73.82 -26.25 60.51 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.916 0.389 . . . . 75.13 111.071 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.633 ' HB2' ' HZ3' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.08 -44.42 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.439 -0.346 . . . . 72.21 111.804 -179.63 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.46 16.92 1.45 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.542 -0.837 . . . . 41.44 114.662 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.49 158.46 15.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.59 0.695 . . . . 71.31 110.784 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.2 -31.9 70.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.218 0.451 . . . . 64.43 112.218 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.87 116.8 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.03 114.226 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.22 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.44 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 71.23 111.606 -177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.3 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.449 HG12 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.32 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.31 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.456 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.51 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.42 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.05 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.44 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.14 113.614 -177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.606 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 73.31 110.818 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.41 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.45 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.01 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.1 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.22 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.4 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.34 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.15 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.13 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.465 HD13 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.41 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.564 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.33 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 74.03 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.23 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.35 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.42 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.52 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.52 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.22 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.4 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.11 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.41 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.04 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.463 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.21 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 HG13 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.21 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.14 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.14 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.22 111.391 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.51 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -85.52 -72.5 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 74.13 111.14 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.55 89.57 0.16 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.601 -0.809 . . . . 53.13 113.751 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.93 108.25 2.48 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.004 -0.617 . . . . 37.03 112.21 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -62.37 96.48 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.256 0.55 . . . . 74.4 112.138 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.59 39.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.187 -0.53 . . . . 65.45 113.449 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.26 -69.84 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.398 -0.429 . . . . 52.33 113.071 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 74.9 mtm180 -67.99 101.09 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.168 0.509 . . . . 65.22 111.356 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -75.7 -170.62 1.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.916 -0.584 . . . . 63.44 111.852 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.31 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.1 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.12 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.14 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.54 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.22 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.1 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.21 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 74.2 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.42 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.14 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 87.3 mt -122.35 171.37 9.1 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.3 111.428 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 2.3 m-20 77.35 -71.61 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.092 0.957 . . . . 74.3 110.889 -169.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.636 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 50.2 Cg_exo -59.68 77.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.415 0 CA-C-N 121.633 1.619 . . . . 74.43 109.888 154.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.525 HD12 ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -63.72 103.34 0.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.327 -0.851 . . . . 72.34 112.933 -165.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -98.76 -7.0 28.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.591 -0.731 . . . . 64.13 111.774 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.525 ' H ' HD12 ' A' ' 108' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.33 0 N-CA-C 112.404 0.52 . . . . 74.31 112.404 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.744 0.306 . . . . 75.43 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -149.25 88.08 5.15 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 120.859 0.362 . . . . 52.54 111.381 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.77 120.44 7.71 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.433 2.089 . . . . 71.31 111.638 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 73.04 3.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.507 0.67 . . . . 72.2 110.453 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -86.56 85.57 7.31 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.856 -0.611 . . . . 73.25 111.69 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -106.34 123.16 47.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.977 0.418 . . . . 75.12 111.627 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mtm -128.13 83.52 2.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.228 -0.442 . . . . 62.53 109.997 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.413 ' HB2' ' CG ' ' A' ' 12' ' ' LYS . 38.8 m-20 -100.86 -171.49 2.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.528 0.68 . . . . 64.44 112.462 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p -79.8 -153.83 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.581 -0.736 . . . . 75.2 111.532 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 63.21 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.41 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' CG ' ' HB2' ' A' ' 8' ' ' ASP . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.3 113.111 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.02 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.35 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.32 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 37.5 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.04 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.3 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.03 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.12 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.24 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.44 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.2 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HG2' HG21 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.01 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 71.1 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.522 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 73.34 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.32 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.446 HG12 HG12 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.35 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.2 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.45 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.32 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.11 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -147.48 173.12 12.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.42 109.937 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.7 m -106.24 113.64 27.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.916 -0.49 . . . . 70.15 111.604 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -80.81 -178.89 7.02 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.117 -0.492 . . . . 71.15 111.494 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -84.52 -5.28 59.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.704 0.288 . . . . 75.23 111.626 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.37 174.76 6.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.688 0.28 . . . . 74.4 111.233 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.67 55.26 3.77 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 114.812 0.685 . . . . 53.43 114.812 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -128.37 152.9 47.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.301 -0.529 . . . . 71.3 111.364 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.88 -23.88 67.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.9 0.704 . . . . 75.43 112.9 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.66 108.59 0.02 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.43 114.378 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.23 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.34 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.43 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.34 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG12 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.52 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.43 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 70.24 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.34 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.43 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 75.34 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.02 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.579 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.21 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.34 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.05 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 73.41 111.788 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.54 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.34 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.44 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.494 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.12 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.12 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.03 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.24 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.33 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.22 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.671 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.14 112.372 -176.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 65.02 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.23 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.31 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.34 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 37.5 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.2 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.12 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.21 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' HD2' HD12 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.43 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.621 HG12 HG11 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 70.33 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.42 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 71.23 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.503 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.11 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.22 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.03 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -85.38 -74.54 0.4 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.11 111.915 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.3 89.96 0.08 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.276 -0.964 . . . . 53.55 113.65 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.93 105.84 2.7 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.308 -0.472 . . . . 73.3 112.336 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.06 118.43 6.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.021 0.438 . . . . 73.44 111.735 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 120.71 39.19 0.62 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.261 -0.495 . . . . 51.22 113.078 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.8 -61.27 4.54 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.452 -0.404 . . . . 53.32 113.444 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 23.1 mtm180 -75.24 89.54 2.55 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.136 0.493 . . . . 72.05 112.026 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -63.76 -176.88 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.791 -0.64 . . . . 74.21 112.61 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.05 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 74.22 111.917 -176.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.503 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.14 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.42 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.494 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.04 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.41 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.24 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 71.14 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.52 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.44 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.4 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt -109.39 -172.4 2.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 63.12 111.786 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.743 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 7.7 t70 99.65 -58.7 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 125.4 1.48 . . . . 71.22 110.326 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 72.2 Cg_endo -96.32 96.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.21 1.94 . . . . 70.01 111.205 160.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.84 109.36 3.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.482 0.919 . . . . 71.42 113.482 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.13 -11.62 24.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.149 -0.932 . . . . 72.21 111.662 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.922 -0.561 . . . . 74.34 112.002 -179.21 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.528 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.001 0.429 . . . . 65.24 111.428 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -172.56 93.1 0.39 Allowed Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 112.145 0.424 . . . . 74.1 112.145 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.52 105.69 1.06 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.429 2.086 . . . . 71.25 112.031 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -39.13 20.84 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.501 0.556 . . . . 54.33 112.501 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -94.03 151.05 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.133 0.492 . . . . 74.11 111.823 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -107.21 -12.84 15.29 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.964 -0.562 . . . . 74.13 111.458 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.725 ' SD ' ' HG2' ' A' ' 20' ' ' PRO . 12.5 mmt -100.25 116.71 32.87 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 111.859 0.318 . . . . 72.21 111.859 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -131.04 -174.9 3.51 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.53 0.567 . . . . 73.12 112.53 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m -117.12 172.38 7.32 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.078 -0.51 . . . . 55.32 111.084 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.611 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.23 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.02 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 70.12 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.462 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.53 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 70.52 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.3 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.13 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.24 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.21 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 64.32 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.725 ' HG2' ' SD ' ' A' ' 7' ' ' MET . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.53 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.55 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.24 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.33 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.547 ' HG2' HG21 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.02 111.932 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.51 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.14 110.924 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.31 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.22 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 63.21 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.31 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.51 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.61 157.97 44.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 71.05 111.304 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.6 m -85.52 105.93 16.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.045 0.45 . . . . 75.13 111.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -91.39 -171.59 2.99 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.402 . . . . 72.11 111.339 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -75.35 44.8 0.27 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 121.246 0.546 . . . . 63.05 111.238 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp 63.45 -165.02 0.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.202 0.601 . . . . 64.01 111.58 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.0 -62.39 4.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.637 -0.792 . . . . 36.81 112.217 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -115.92 161.5 18.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.999 0.428 . . . . 74.55 111.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.93 -39.88 93.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.412 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.5 107.16 2.51 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.465 -0.398 . . . . 36.81 114.036 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.12 112.35 175.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' O ' HD13 ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 72.32 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.33 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.35 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 54.54 111.319 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 42.31 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 HD11 HD21 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.31 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 72.04 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.53 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.11 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.54 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 74.53 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.02 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.04 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.533 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.41 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.32 113.911 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.32 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.11 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.22 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.34 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.3 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 52.41 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.41 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.32 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.22 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.43 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.51 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.4 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.547 HG21 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 42.14 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.33 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.533 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 74.15 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.32 110.9 -177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.54 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.22 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.2 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.43 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 60.12 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 30.5 mmm180 -99.39 4.76 46.4 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 97.7 -36.83 3.72 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.224 0.85 . . . . 74.22 115.224 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 56.18 91.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.922 0 CA-C-N 117.552 0.676 . . . . 52.03 112.678 -172.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -71.69 89.41 1.01 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.273 0.559 . . . . 73.01 111.031 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.976 -0.556 . . . . 73.44 112.858 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.76 -62.55 3.89 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.174 -0.536 . . . . 75.35 113.803 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -80.56 100.09 8.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.004 0.431 . . . . 74.44 111.73 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.555 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 57.7 mttp -61.28 173.89 0.79 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.42 112.912 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.02 111.051 -175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.4 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.34 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.459 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.22 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.465 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.54 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.15 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.33 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 73.52 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.45 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.22 111.628 178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.533 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.21 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.33 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.479 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt -102.51 -153.35 0.46 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.766 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.561 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 6.0 m-20 68.11 158.04 0.14 Allowed Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.464 -0.939 . . . . 61.15 108.464 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 9.7 Cg_exo 0.73 82.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.421 2.747 . . . . 73.23 113.269 -152.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.67 128.69 2.56 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.842 -1.527 . . . . 65.24 114.328 -161.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -81.74 -38.1 26.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.234 -0.894 . . . . 70.14 111.776 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.791 -0.623 . . . . 70.21 112.004 -179.073 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 tpp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.645 0.26 . . . . 74.41 111.651 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.791 ' HZ1' ' HB2' ' A' ' 2' ' ' LYS . 9.1 mtmp? -111.28 110.03 56.26 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.043 0.386 . . . . 72.5 112.043 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.43 116.97 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.767 2.311 . . . . 74.54 113.029 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -78.34 17.55 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.431 0.53 . . . . 74.33 112.431 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -87.62 105.83 17.61 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.047 0.451 . . . . 73.41 111.539 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -177.15 6.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.204 0.526 . . . . 72.52 111.848 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 20.9 ptp -150.41 98.46 2.66 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.918 -0.583 . . . . 73.01 110.912 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.407 ' HB2' ' H ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.82 -158.61 0.68 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.006 0.373 . . . . 54.24 112.006 -178.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.407 ' H ' ' HB2' ' A' ' 8' ' ' ASP . 7.9 t -124.65 179.69 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.41 111.734 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.551 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.24 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.547 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 51.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.54 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.551 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.21 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.51 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.34 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.52 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.22 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.41 110.522 176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 73.4 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.34 112.892 171.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.01 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.01 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.13 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.41 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.44 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.05 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.22 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.33 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.34 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.53 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.42 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -139.42 174.75 10.19 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.51 109.19 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -100.69 108.75 20.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.721 -0.612 . . . . 70.24 111.627 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -78.08 -172.04 2.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.371 -0.377 . . . . 74.11 111.592 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -53.72 -66.55 0.37 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.043 0.757 . . . . 74.42 113.043 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -167.57 148.85 5.5 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.296 0.569 . . . . 62.45 112.401 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.0 -64.67 2.35 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 116.069 -0.514 . . . . 38.1 112.596 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -84.58 161.51 20.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.889 0.376 . . . . 73.04 111.154 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.457 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 20.4 pt-20 -76.39 -56.71 4.38 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.644 -0.253 . . . . 72.4 110.862 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 97.76 106.93 2.53 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 121.464 -0.398 . . . . 44.12 113.417 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.402 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.54 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.41 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 54.23 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.04 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.4 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 73.33 110.994 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.13 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 73.24 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.21 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.42 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 72.41 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.14 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.11 110.85 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD21 ' HB1' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.41 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.34 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 64.11 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.14 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.44 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.34 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.402 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 64.31 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.3 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 72.33 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.32 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.24 112.559 177.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.593 HD12 HG11 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.22 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.15 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.02 112.654 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.54 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.23 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.4 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.45 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.31 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.3 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.495 HG21 HG11 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.35 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.539 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 74.0 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.01 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 75.43 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.03 112.204 178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.54 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.34 110.784 177.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -93.36 -37.47 11.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 70.12 111.152 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.0 61.96 6.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.273 -0.489 . . . . 73.43 113.278 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -71.14 140.21 30.71 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.156 -0.545 . . . . 52.22 113.406 -177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.17 96.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.134 0.492 . . . . 74.44 111.445 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.02 46.66 0.16 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.79 -0.641 . . . . 75.35 112.341 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 -77.46 0.64 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.416 -0.421 . . . . 71.33 112.799 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.596 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 48.8 mtm180 -93.77 139.88 30.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.987 0.423 . . . . 74.01 111.301 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.49 -177.39 4.69 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.42 112.323 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 72.12 111.815 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.482 ' HB1' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.11 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 74.23 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.22 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.14 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 71.31 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 61.44 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.03 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.31 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.593 HG11 HD12 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 65.15 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.539 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.495 HG11 HG21 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.23 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt -85.49 -15.6 42.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.818 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 26.8 t70 -71.21 -58.65 3.81 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 121.111 -0.236 . . . . 71.23 110.874 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.818 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 14.1 Cg_exo -72.18 -18.81 26.7 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.859 1.706 . . . . 73.54 111.07 167.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 tm? 72.08 111.49 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.868 -1.06 . . . . 74.4 113.305 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -70.58 0.53 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.593 -0.73 . . . . 73.24 110.339 168.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.78 -0.628 . . . . 75.32 111.305 175.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.711 0.291 . . . . 63.22 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -94.86 114.88 64.63 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.558 -0.292 . . . . 74.1 111.069 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 138.0 68.29 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.667 2.245 . . . . 72.22 113.038 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.75 66.66 2.71 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.186 0.439 . . . . 73.03 112.186 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -171.36 131.48 0.75 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.575 -0.284 . . . . 75.22 111.128 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 57.92 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.412 0.625 . . . . 64.55 111.708 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.4 ttp -173.4 58.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.798 0.809 . . . . 72.51 109.474 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 1.8 m-20 -86.38 164.37 17.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.467 -0.788 . . . . 73.03 112.3 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.568 HG23 HG22 ' A' ' 53' ' ' THR . 10.0 t -99.28 -178.93 4.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.88 -0.6 . . . . 61.12 111.298 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.42 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.41 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.42 112.227 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.54 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.33 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.515 ' HB3' ' HA3' ' A' ' 86' ' ' GLY . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 71.22 112.757 -174.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.45 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.04 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.34 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.45 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.02 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.53 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.53 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HG2' HG21 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.34 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.533 ' HA ' HG21 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.34 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.502 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.23 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.52 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.483 HG21 HG23 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.13 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.43 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.32 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.52 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 73.33 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -145.4 158.54 43.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 72.12 112.014 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.1 m -86.33 105.52 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.213 -0.449 . . . . 74.43 111.212 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -96.85 173.59 7.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.3 0.572 . . . . 73.11 111.732 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.39 0.43 47.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.307 0.575 . . . . 64.0 110.68 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.43 ' NZ ' ' HB3' ' A' ' 38' ' ' LYS . 6.0 mtpm? -94.52 13.42 24.06 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.992 0.738 . . . . 62.42 112.992 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.05 -28.19 2.94 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 115.087 0.795 . . . . 70.11 115.087 172.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -85.05 160.77 19.93 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.807 -0.82 . . . . 75.22 112.004 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -48.37 -39.43 22.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.413 0.894 . . . . 71.25 113.413 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.25 110.24 0.12 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.017 -0.611 . . . . 73.1 113.675 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.409 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 65.21 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.4 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.14 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.12 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG23 HG21 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.43 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.2 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.4 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.2 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 64.11 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.568 HG22 HG23 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 73.54 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 37.59 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.22 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.31 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.42 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.54 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.11 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 74.04 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.34 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.409 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.13 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.31 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.32 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.31 111.094 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.52 112.046 175.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.1 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.34 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.41 112.145 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.14 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.35 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.03 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.45 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.43 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.501 HG21 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.33 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 HG21 HG13 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.34 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.464 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.23 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.12 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.51 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.04 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.454 HG11 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.21 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.12 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.425 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.21 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -75.89 -49.29 18.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.41 110.956 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.73 ' HA2' ' HB3' ' A' ' 92' ' ' LYS . . . 58.47 65.05 3.77 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.991 -0.549 . . . . 62.43 114.169 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.43 -32.55 3.65 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.928 -0.654 . . . . 53.14 112.593 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -82.48 131.54 35.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.927 0.394 . . . . 75.14 111.67 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.53 82.07 0.21 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.149 -0.548 . . . . 55.14 112.562 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.74 -109.77 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 112.032 -0.427 . . . . 64.23 112.032 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -72.56 87.22 1.2 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.153 0.501 . . . . 74.11 110.773 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.73 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 76.6 mttt -66.9 179.68 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.841 -0.618 . . . . 73.44 111.548 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.21 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.425 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.14 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.32 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.454 ' HA ' HG11 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 72.34 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.425 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 72.3 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.41 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.23 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.459 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.01 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.03 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.1 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.13 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.499 HG13 HG21 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.33 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.7 -169.18 2.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 64.33 110.804 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.525 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 10.6 t70 70.52 140.39 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.348 -0.982 . . . . 73.15 108.348 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.525 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 21.3 Cg_exo -3.48 81.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 124.536 3.491 . . . . 72.22 114.752 -161.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.732 HD12 ' H ' ' A' ' 110' ' ' HIS . 2.0 tm? -63.14 140.06 58.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.084 -1.416 . . . . 73.23 111.943 -168.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -41.64 -46.52 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.074 0.768 . . . . 74.11 113.074 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.732 ' H ' HD12 ' A' ' 108' ' ' LEU . 23.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.799 -0.619 . . . . 74.53 111.342 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.837 0.351 . . . . 71.44 111.267 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -143.02 96.98 5.83 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.829 0.347 . . . . 70.0 111.054 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.52 131.48 2.91 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.759 2.306 . . . . 73.42 113.548 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.12 156.03 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.536 -0.302 . . . . 72.32 110.809 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -134.01 101.27 4.99 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.902 0.382 . . . . 62.22 111.992 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -154.32 80.3 1.11 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 73.12 110.433 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -172.65 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.48 0.657 . . . . 74.0 110.733 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 3.3 m-20 -70.01 161.94 29.1 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.208 1.188 . . . . 52.42 114.208 -170.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -104.5 178.83 4.45 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.169 -0.923 . . . . 73.41 111.07 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.484 HD13 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.23 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.11 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.41 112.54 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.54 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.04 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.43 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.13 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.43 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.35 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.02 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.54 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 HG23 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.34 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.44 111.822 -176.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.14 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.33 110.068 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.52 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 64.53 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.445 HG22 HG23 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.04 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.33 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.13 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.12 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 75.03 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -144.47 157.08 44.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.51 110.396 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.8 m -85.48 112.75 21.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.285 0.564 . . . . 74.14 111.657 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.1 t -89.75 -171.1 3.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.863 -0.608 . . . . 74.43 111.187 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.443 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.7 mtt-85 -56.35 -59.25 5.24 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.819 0.342 . . . . 74.54 111.572 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -178.11 156.45 1.02 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.155 -0.475 . . . . 73.05 111.189 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 -72.55 0.2 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.321 -0.466 . . . . 52.51 113.127 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -104.34 155.31 18.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.016 0.436 . . . . 72.34 111.348 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.51 -11.37 57.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.542 0.941 . . . . 75.04 113.542 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.03 122.36 0.08 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.432 -0.413 . . . . 54.24 113.916 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 72.25 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.01 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.23 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.14 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.31 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.35 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.51 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.23 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB3' HD13 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.23 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.12 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.412 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 64.45 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 38.28 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.521 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.12 111.001 175.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.23 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.52 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 45.23 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 74.42 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.488 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 74.53 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 72.31 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.453 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.54 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.21 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.468 ' HB3' HD13 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.3 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.24 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 HD12 HG12 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 71.0 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.03 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.52 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.43 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.34 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.43 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 70.22 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.35 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.22 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 74.35 110.712 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.54 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 72.23 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.467 ' HB ' HG23 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 64.03 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.34 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.45 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.43 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.21 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.23 111.189 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 -81.02 -42.48 21.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.1 111.045 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 59.41 50.11 71.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.198 0.439 . . . . 64.21 114.198 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.68 66.49 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.243 -0.979 . . . . 41.14 114.044 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -126.27 89.38 3.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.053 0.454 . . . . 75.1 110.476 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.36 -49.08 3.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.052 -0.594 . . . . 65.43 113.209 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.83 -43.71 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.232 -0.509 . . . . 60.43 112.91 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.521 ' NH1' ' HB2' ' A' ' 55' ' ' GLU . 88.7 mtt180 -88.78 172.28 9.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.661 0.743 . . . . 71.34 112.684 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.534 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 93.3 mttt -87.65 168.92 12.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.513 -0.767 . . . . 74.0 112.153 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.498 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.32 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.31 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.14 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.33 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.5 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.04 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 71.11 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 63.22 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.495 HG12 HD12 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 74.31 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 75.33 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.537 HD21 HD22 ' A' ' 108' ' ' LEU . 36.5 mt -99.76 -172.27 2.21 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.44 111.301 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.581 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER 64.73 155.78 0.12 Allowed Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.618 -0.882 . . . . 74.33 108.618 -166.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 6.3 Cg_exo -1.54 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.717 2.945 . . . . 75.21 113.669 -156.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.537 HD22 HD21 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -50.64 133.72 25.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.907 -1.497 . . . . 72.4 114.772 -162.158 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.88 -61.78 2.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.068 -0.969 . . . . 73.24 110.621 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 118.53 -0.748 . . . . 72.43 111.29 176.486 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.581 0.215 . . . . 72.33 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -142.46 105.79 5.51 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.237 0.541 . . . . 73.32 110.761 177.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -89.76 114.23 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.459 2.106 . . . . 73.12 113.302 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.85 113.73 20.68 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.248 0.547 . . . . 51.51 111.08 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -101.62 145.72 28.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.916 -0.584 . . . . 70.2 112.194 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' NH1' ' HD3' ' A' ' 20' ' ' PRO . 17.7 tpt85 72.52 26.03 2.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.411 0.684 . . . . 72.14 112.318 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 100.06 0.92 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.639 -0.504 . . . . 73.12 109.639 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -118.92 141.21 48.86 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.179 0.437 . . . . 62.05 112.179 -173.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p -77.69 169.83 17.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.495 -0.32 . . . . 74.44 110.908 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.24 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.02 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.42 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.11 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.23 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.42 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.4 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.52 ' HD3' ' NH1' ' A' ' 6' ' ' ARG . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.12 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 HG23 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.35 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 71.13 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.541 ' HG2' HG21 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.21 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.43 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.12 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HB3' ' HZ2' ' A' ' 27' ' ' LYS . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.33 111.425 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.3 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.33 111.267 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 74.32 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 55.45 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.42 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.21 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.03 165.43 34.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 72.23 111.201 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.2 m -85.14 133.31 34.21 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.937 0.398 . . . . 71.41 111.486 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.549 HG22 ' HB2' ' A' ' 40' ' ' ARG . 47.2 p -92.12 178.33 5.9 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.211 0.529 . . . . 74.41 112.111 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -92.12 9.58 32.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.49 0.552 . . . . 71.15 112.49 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 38' ' ' LYS . 5.1 tmmm? -142.31 -69.08 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.082 -0.386 . . . . 73.14 111.894 -177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.29 40.33 0.05 OUTLIER Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.739 -1.219 . . . . 74.23 114.691 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.549 ' HB2' HG22 ' A' ' 36' ' ' THR . 46.7 mtp85 -111.04 161.72 15.6 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.386 -0.479 . . . . 75.44 110.073 175.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -68.56 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.751 -0.38 . . . . 71.2 111.432 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 66.79 107.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.397 -0.365 . . . . 64.25 114.01 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.42 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.463 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.04 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.41 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.31 111.271 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.32 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 72.03 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.53 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.1 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.34 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.34 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.429 ' O ' HD13 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.11 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 65.32 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.15 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.31 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.11 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.02 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.554 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 73.14 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.14 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.02 113.631 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.4 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.15 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 61.31 111.551 177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.31 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD11 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 73.45 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.22 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.3 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.2 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.23 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.4 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.34 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.24 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 73.34 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.14 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.455 HG12 HG11 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.1 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.43 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.13 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.42 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.34 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 75.21 111.288 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.421 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 -97.78 7.99 45.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.3 112.379 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 85.78 -26.76 5.74 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 114.539 0.576 . . . . 62.3 114.539 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.33 64.29 3.86 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 117.386 0.593 . . . . 65.14 112.939 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -50.51 107.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.111 0.481 . . . . 64.33 112.073 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.15 -39.86 1.63 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.273 -0.489 . . . . 37.48 113.221 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.4 -67.99 0.1 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.87 -0.681 . . . . 64.24 113.298 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 58.2 mtt180 -79.45 112.11 16.38 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.787 -0.243 . . . . 71.25 111.343 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.511 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 9.6 mtmp? -58.11 155.48 11.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.44 111.212 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.11 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.45 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 74.32 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.34 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.432 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.22 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.45 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.31 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.464 HG13 HD11 ' A' ' 67' ' ' LEU . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.01 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.469 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 86.2 mt -123.49 -175.13 3.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.24 111.598 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.656 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 27.9 t70 80.04 -74.39 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.38 1.072 . . . . 73.11 110.343 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 10.6 Cg_exo -75.76 93.88 1.0 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 CA-C-N 121.812 1.683 . . . . 74.03 109.882 156.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.54 92.25 0.14 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.358 0.873 . . . . 75.11 113.358 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -68.22 -25.34 65.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.705 -1.134 . . . . 73.21 111.637 173.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 112.857 0.688 . . . . 74.33 112.857 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.958 0.408 . . . . 73.43 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -163.44 82.5 1.46 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.85 -0.426 . . . . 73.31 109.85 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -90.98 121.54 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.262 2.642 . . . . 75.33 112.814 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.07 81.09 5.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.229 0.538 . . . . 72.44 111.42 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -154.95 72.66 0.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.87 -0.605 . . . . 72.45 110.887 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -92.57 -158.87 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.073 -0.714 . . . . 74.15 109.073 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.484 ' HE2' ' OG1' ' A' ' 22' ' ' THR . 18.1 ptm -91.13 87.33 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.484 -0.562 . . . . 63.23 109.484 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.55 136.35 38.66 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.627 -0.715 . . . . 74.13 112.238 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -69.36 167.39 16.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.217 -0.447 . . . . 75.42 111.013 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.32 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.529 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.3 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.13 113.296 -177.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.21 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.55 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 72.24 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.22 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.3 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.23 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HG2' ' HB3' ' A' ' 7' ' ' MET . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 74.33 111.537 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.484 ' OG1' ' HE2' ' A' ' 7' ' ' MET . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 75.35 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.21 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.489 ' HG2' HG23 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 63.34 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.14 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.14 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.13 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 73.52 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.12 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.34 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.23 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.12 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.8 146.62 30.31 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.33 111.419 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.3 m -84.57 106.88 16.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.276 0.56 . . . . 63.22 112.159 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 t -97.61 149.09 22.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.156 -0.475 . . . . 74.15 111.156 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.27 1.65 27.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.489 -0.323 . . . . 70.41 111.861 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -73.66 -43.53 59.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.179 0.437 . . . . 75.01 112.179 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.03 -32.77 1.4 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.475 -0.869 . . . . 65.43 113.809 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.03 160.77 20.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.091 0.446 . . . . 72.33 111.181 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.41 -13.23 62.25 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.987 0.736 . . . . 63.41 112.987 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 70.18 123.49 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.506 -0.378 . . . . 51.14 114.037 175.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 70.44 111.355 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.492 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.23 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.4 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 71.23 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.05 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.13 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.34 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.13 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.23 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.11 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.44 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.43 110.804 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.41 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.31 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.02 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.33 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 74.13 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 72.31 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 64.13 113.565 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.53 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.41 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.13 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.51 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.529 HD12 HG11 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.24 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.42 113.038 -178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.42 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.12 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.01 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.14 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.04 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.43 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG23 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.11 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.34 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HD2' HD13 ' A' ' 105' ' ' LEU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 71.13 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.14 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.01 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.23 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.12 111.627 175.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -101.92 -31.75 10.54 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 75.02 111.462 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.75 94.52 0.29 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.882 -0.675 . . . . 42.33 113.454 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.37 120.73 22.99 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.117 -0.563 . . . . 64.1 112.392 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.04 -33.89 72.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.673 -0.31 . . . . 75.42 111.716 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.31 70.76 1.84 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.954 -0.641 . . . . 61.32 113.59 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 -77.36 1.27 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 113.929 0.332 . . . . 37.21 113.929 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -86.62 135.38 33.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.074 0.464 . . . . 73.32 112.195 -174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -72.34 -176.05 1.74 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.52 112.37 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 61.32 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 73.03 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.11 112.009 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.13 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 74.23 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.401 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 63.01 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.12 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.529 HG11 HD12 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.31 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.677 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 76.6 mt -115.75 164.7 13.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.53 110.214 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.6 t70 91.42 -60.79 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.62 1.168 . . . . 65.13 109.415 -168.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.677 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 38.3 Cg_endo -69.73 -138.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 N-CA-C 109.047 -1.174 . . . . 75.44 109.047 149.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -173.46 138.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.821 0.737 . . . . 75.11 111.972 171.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.56 -53.08 10.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.181 0.515 . . . . 71.22 110.871 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.534 -0.746 . . . . 75.2 112.08 176.008 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 112.151 0.426 . . . . 72.44 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -120.72 159.62 47.81 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 122.207 -0.308 . . . . 44.02 110.636 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.85 92.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.332 2.022 . . . . 51.24 113.465 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -89.86 107.94 19.41 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.369 0.605 . . . . 74.13 111.289 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -140.55 103.98 4.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.918 -0.583 . . . . 74.13 111.972 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.507 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 2.9 mmp_? -145.12 -179.43 6.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.055 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.2 mmm -87.07 134.84 33.46 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.243 0.544 . . . . 62.12 112.015 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.52 126.96 31.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.708 0.766 . . . . 73.55 112.895 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -133.94 161.42 34.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.488 -0.778 . . . . 72.4 109.093 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.565 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 54.13 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.12 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.34 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.21 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.41 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.14 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.23 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.44 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.42 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.532 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 54.33 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.33 111.679 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.23 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.13 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' HG2' HG21 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.13 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.23 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.422 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 72.05 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.44 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 75.14 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.43 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 75.52 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 74.24 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 64.11 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 72.51 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -122.98 153.41 39.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.35 111.298 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.3 m -84.94 122.94 29.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 73.0 111.41 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -108.48 168.45 9.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.013 0.435 . . . . 75.34 111.038 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 2.4 mpt_? -102.05 5.21 40.44 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.767 0.284 . . . . 72.54 111.767 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -90.93 -53.06 4.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.399 0.518 . . . . 73.4 112.399 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.9 -19.3 0.24 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.033 -1.079 . . . . 64.31 114.991 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -85.59 160.79 19.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 117.656 0.728 . . . . 71.44 111.345 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.89 -22.23 63.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.374 0.509 . . . . 72.43 112.374 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 74.74 123.54 0.12 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 38.63 114.769 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.408 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 75.15 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.02 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.34 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.54 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.53 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.04 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.3 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.04 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.54 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 75.52 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.34 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.43 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.52 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.23 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 62.23 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 74.53 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 61.23 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.02 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.05 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.12 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.33 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.22 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.14 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 72.33 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.15 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.11 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 75.43 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.31 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.44 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.44 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.34 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.31 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.51 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.21 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.14 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.45 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.478 HG12 HG11 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.45 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.12 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.51 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.21 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.24 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 74.45 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? -85.98 -52.89 5.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.1 111.092 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 93.27 104.13 1.65 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.153 -0.546 . . . . 44.55 113.689 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -56.79 118.9 13.02 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.977 -0.63 . . . . 72.2 111.735 173.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -54.71 112.79 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.205 0.446 . . . . 73.24 112.205 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.13 11.06 85.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.413 0.525 . . . . 61.43 114.413 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.51 -146.75 4.6 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.968 -0.634 . . . . 72.45 112.719 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -74.18 145.49 44.17 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.365 0.602 . . . . 74.21 110.853 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.405 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 65.4 mttm -81.09 174.32 11.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.45 112.054 -173.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.23 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 72.22 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.3 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.508 ' HA ' HG11 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.12 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.532 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.54 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.532 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.43 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.24 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 52.23 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.43 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.478 HG11 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 72.13 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.592 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.21 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 74.32 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.51 HD21 HD11 ' A' ' 108' ' ' LEU . 58.9 mt -105.53 -172.01 2.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.33 111.432 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.65 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.3 m-20 65.03 161.31 0.12 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.758 -0.83 . . . . 75.23 108.758 -167.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 11.2 Cg_exo 0.3 81.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.342 2.695 . . . . 72.05 113.185 -153.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.51 HD11 HD21 ' A' ' 105' ' ' LEU . 4.1 mm? -57.98 128.82 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.566 1.691 . . . . 63.11 115.566 -159.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.58 -22.13 62.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.17 -1.377 . . . . 62.53 111.084 169.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.402 -0.809 . . . . 74.44 111.354 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.812 0.339 . . . . 72.34 110.777 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -118.82 148.44 44.48 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.573 0.225 . . . . 74.52 111.204 -177.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.99 56.01 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.543 2.162 . . . . 61.42 111.049 168.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.89 107.68 10.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.932 -1.031 . . . . 62.44 112.339 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -167.43 130.83 1.75 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.972 -0.558 . . . . 74.52 110.831 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -173.92 151.91 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.546 -0.297 . . . . 73.22 110.664 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 71.9 mtm -55.09 99.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.507 0.558 . . . . 61.41 112.507 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -83.98 153.77 23.69 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.934 -0.576 . . . . 73.5 112.164 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -134.27 -163.87 1.43 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.942 -0.572 . . . . 63.23 111.611 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.497 HD13 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.53 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.24 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.44 111.79 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.502 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.44 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.51 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.53 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.41 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 71.12 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.45 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.12 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.22 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 65.21 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.1 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HG2' HG21 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.34 111.472 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.1 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.42 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.401 HG12 HG12 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 64.44 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.43 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 74.12 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 37.67 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.15 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.32 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -119.59 174.42 6.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.31 110.207 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 m -101.62 120.85 40.97 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.158 -0.338 . . . . 70.44 111.839 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -107.39 173.35 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.913 0.387 . . . . 63.03 110.77 172.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -89.15 -31.72 17.83 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.319 0.859 . . . . 74.35 113.319 -171.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 137.69 49.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.545 0.943 . . . . 73.22 113.545 -170.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.98 -72.24 1.1 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.624 -0.716 . . . . 37.67 114.409 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -95.54 162.79 13.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 14.8 pt-20 -64.28 -54.46 32.92 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.27 -0.877 . . . . 73.12 111.214 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 120.04 117.06 2.59 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.359 -0.382 . . . . 75.34 113.026 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.411 ' HZ1' ' CD ' ' A' ' 41' ' ' GLU . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.12 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.41 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 74.24 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.401 HG12 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.33 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.32 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.43 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 63.12 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' HD13 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.52 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.23 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.31 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.31 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.43 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.45 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.34 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 73.32 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.53 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.14 111.435 179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.52 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.54 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.42 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.31 112.262 -177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.51 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.13 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.15 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.44 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.24 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.13 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.31 113.369 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.02 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.538 HG21 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.14 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 HG22 HG11 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.12 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.33 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.13 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.21 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.24 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.787 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.33 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.41 HD11 HD11 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.42 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.409 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 -87.66 -22.65 24.56 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 74.32 111.506 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.22 -14.01 58.43 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.409 -0.424 . . . . 72.54 113.639 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 61.6 -138.97 46.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.371 -0.442 . . . . 63.41 113.517 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -139.07 99.5 3.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.241 0.46 . . . . 74.52 112.241 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 43.11 56.27 4.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.0 0.76 . . . . 37.67 115.0 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.64 -74.95 0.28 Allowed Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.966 -0.635 . . . . 75.44 112.66 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -94.78 124.43 38.82 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.443 -0.445 . . . . 72.33 110.961 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.545 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 36.3 mtmm -92.85 176.09 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.004 -0.544 . . . . 63.11 111.306 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.409 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.52 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.12 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.23 112.011 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.43 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 63.05 112.934 175.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.21 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.22 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.02 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.24 110.438 173.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 74.51 111.433 -176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.499 HG11 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.01 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -102.33 -3.3 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.23 112.557 -176.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.806 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.3 t70 -75.88 -53.11 2.48 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 110.47 -0.196 . . . . 74.43 110.47 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.806 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.9 Cg_endo -84.93 -12.63 7.08 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.312 2.008 . . . . 55.23 111.368 165.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.45 112.79 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.454 0.702 . . . . 63.42 111.764 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 5.7 mm-40 -94.1 -59.98 1.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.897 -0.592 . . . . 72.25 112.277 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.985 -0.531 . . . . 73.22 112.206 -178.696 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 112.167 0.432 . . . . 74.11 112.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -125.68 86.8 56.88 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 121.958 -0.464 . . . . 63.15 111.215 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.75 91.35 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.348 2.032 . . . . 75.13 112.643 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -70.15 83.71 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.759 0.79 . . . . 52.54 111.4 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.69 109.19 7.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.771 -0.65 . . . . 71.12 111.542 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 -117.87 -178.28 3.45 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.09 -0.504 . . . . 63.32 110.693 177.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.88 60.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 64.54 109.908 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.713 ' HB2' HG22 ' A' ' 19' ' ' THR . 59.7 m-20 -71.56 110.02 5.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.114 -0.494 . . . . 74.33 111.676 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -71.58 175.61 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.162 -0.472 . . . . 60.41 110.176 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.552 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.42 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.34 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.44 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.41 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.52 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.33 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.02 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 72.42 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.15 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.713 HG22 ' HB2' ' A' ' 8' ' ' ASP . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 75.13 111.264 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.12 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.12 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 74.44 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.44 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HG2' HG21 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG23 HG23 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.43 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.04 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.24 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.44 111.196 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.44 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 65.14 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.13 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.52 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.34 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -117.57 175.0 5.84 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.52 110.741 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -94.06 105.44 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.787 0.327 . . . . 74.43 111.551 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -81.86 -171.65 3.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.964 0.357 . . . . 73.3 111.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -60.05 -65.2 0.72 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.866 0.466 . . . . 74.52 112.229 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -162.36 150.12 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.541 0.571 . . . . 72.35 112.541 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.78 -67.51 3.2 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 116.362 -0.381 . . . . 62.33 113.115 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -85.95 161.94 18.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.098 0.475 . . . . 71.45 111.674 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.46 -60.89 2.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.925 -0.58 . . . . 73.4 111.014 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.75 119.54 4.14 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.589 -0.339 . . . . 72.54 113.119 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.2 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.12 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.33 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.41 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.13 110.961 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.54 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.452 HG23 HG23 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.42 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.33 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.51 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.32 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 72.2 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.14 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 94' ' ' ALA . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.54 112.13 -172.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 72.44 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.53 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.537 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 74.21 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 74.42 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 72.42 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 73.21 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.41 112.943 -178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.1 111.518 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.33 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HG11 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.31 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.24 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.33 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 74.44 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.54 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 74.01 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.14 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.13 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.496 HG21 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.23 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.504 HG22 HG11 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.52 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.24 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.49 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.41 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.42 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.14 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.43 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.34 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 73.13 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.504 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 -92.63 -17.47 24.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.52 111.488 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 61.45 4.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.344 -0.455 . . . . 38.42 113.703 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -55.59 123.76 31.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.381 -0.438 . . . . 40.21 113.087 177.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 134.83 47.3 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.017 0.437 . . . . 70.05 111.394 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.75 -4.98 5.45 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.231 -0.509 . . . . 72.33 113.066 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.81 -81.56 0.33 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.663 -0.303 . . . . 61.34 112.783 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -72.37 110.49 6.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.021 0.439 . . . . 75.51 110.681 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.39 -176.2 0.56 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.11 113.15 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 71.14 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.411 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.15 111.24 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.04 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.44 111.698 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.45 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.32 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.54 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.32 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.11 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.53 HG11 HD12 ' A' ' 67' ' ' LEU . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 64.31 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 74.3 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG11 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.01 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.659 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 51.8 mt -104.16 158.27 16.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.34 110.679 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.439 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 36.4 t70 89.06 -64.44 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.0 1.32 . . . . 65.44 110.893 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.659 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 19.4 Cg_endo -64.64 70.35 0.24 Allowed 'Trans proline' 0 C--N 1.364 1.385 0 CA-C-N 121.082 1.422 . . . . 75.04 109.494 155.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.518 HD13 ' H ' ' A' ' 110' ' ' HIS . 1.8 tm? -42.27 103.7 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.494 -1.23 . . . . 73.04 114.192 -161.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.63 73.34 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.633 -0.712 . . . . 73.1 109.473 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.518 ' H ' HD13 ' A' ' 108' ' ' LEU . 22.0 m-70 . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.501 -0.762 . . . . 65.24 112.591 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.999 0.428 . . . . 73.44 111.598 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -171.61 83.74 0.48 Allowed Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.297 -0.411 . . . . 74.41 110.13 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.53 90.48 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.764 2.309 . . . . 52.01 113.282 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -101.52 101.15 11.67 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.039 0.447 . . . . 73.22 111.815 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -133.65 171.65 13.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.66 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 6' ' ' ARG . 50.8 mtm180 64.25 23.32 13.07 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.935 0.398 . . . . 72.3 110.972 -171.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.46 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 46.7 ttm -104.26 105.94 16.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.212 -0.449 . . . . 54.42 111.447 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 3.2 p-10 -136.89 157.66 46.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 74.22 111.549 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.674 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m -94.97 173.52 7.54 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.184 -0.462 . . . . 74.4 111.43 -175.071 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.674 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 74.34 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.531 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.44 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 8' ' ' ASP . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.42 113.065 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.537 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.41 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.03 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.55 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.34 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.04 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.33 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.45 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.503 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 73.41 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.33 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.23 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.53 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HG2' HG21 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.3 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.24 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.24 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.1 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.496 HG23 HG23 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.2 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 71.14 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 74.15 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.15 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.35 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.45 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -135.73 148.96 49.03 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.52 110.239 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.6 m -85.11 112.01 20.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.09 0.471 . . . . 63.4 111.415 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -95.77 169.27 10.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.832 -0.622 . . . . 73.2 111.976 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -78.29 -9.16 59.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.88 -0.6 . . . . 74.1 111.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -93.66 165.24 12.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.233 -0.439 . . . . 71.21 110.609 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.92 7.96 6.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.227 -0.511 . . . . 74.24 113.817 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -87.54 156.78 19.36 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.463 -0.433 . . . . 74.43 111.252 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.91 -45.75 92.37 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.55 0.574 . . . . 72.23 112.55 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.78 106.37 0.63 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.291 -0.48 . . . . 36.81 112.903 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.11 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 74.13 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.2 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.13 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.14 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.24 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 62.3 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.2 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.1 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.05 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.531 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.02 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.15 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.11 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.04 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.22 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 53.32 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.2 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.13 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.31 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 73.01 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.33 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.14 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.42 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.03 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.14 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 HD11 HG22 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.785 ' HZ1' ' HB3' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.4 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.14 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.24 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.44 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.44 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.21 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.506 HG21 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.32 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.01 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.41 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.469 HG12 HG13 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.43 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.503 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.03 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.44 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.543 HG11 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.45 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.33 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.14 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -83.91 -65.85 0.96 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.44 112.238 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 178.62 -39.41 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.091 -1.052 . . . . 36.81 114.017 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.557 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 79.26 111.79 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.105 -0.569 . . . . 72.42 113.278 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -65.02 109.11 2.02 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.219 0.533 . . . . 75.23 111.594 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.85 -48.17 0.97 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.205 -0.521 . . . . 63.42 113.071 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.41 -40.8 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.683 -0.77 . . . . 42.11 113.443 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -71.9 97.43 1.83 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.028 0.442 . . . . 75.11 110.699 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.557 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 97.1 mttt -59.27 163.86 3.58 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.12 112.538 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.04 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.43 ' HB2' HD23 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 62.44 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 74.43 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.543 ' HA ' HG11 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.33 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.45 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 50.42 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.24 111.423 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.54 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.44 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.55 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt -136.79 178.43 7.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.01 112.983 -171.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.408 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 m-20 60.14 58.91 4.35 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.787 1.773 . . . . 75.21 115.787 168.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' A' ' 106' ' ' ASP . 76.6 Cg_endo -103.09 20.38 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.361 2.707 . . . . 71.21 110.044 157.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.35 135.13 44.56 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.114 -0.948 . . . . 53.33 111.288 -166.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.5 -60.7 2.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.094 0.776 . . . . 73.21 113.094 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.217 0 N-CA-C 114.062 1.134 . . . . 74.22 114.062 -171.09 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.495 0.188 . . . . 72.52 111.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.598 ' HD3' ' SD ' ' A' ' 7' ' ' MET . 28.3 mtpp 65.24 114.75 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 122.9 0.48 . . . . 74.4 111.969 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -45.84 115.87 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.542 2.828 . . . . 63.42 114.91 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 58.35 67.07 0.98 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.186 -0.915 . . . . 74.41 112.888 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -149.1 150.21 32.36 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.098 -0.501 . . . . 71.42 110.566 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -78.57 74.61 5.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.62 0.724 . . . . 73.15 111.502 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.598 ' SD ' ' HD3' ' A' ' 2' ' ' LYS . 80.9 mtp -126.85 40.32 3.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.101 -0.954 . . . . 74.35 108.896 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 62.5 m-20 -62.1 133.92 55.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.382 -1.281 . . . . 71.53 113.196 -171.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.409 ' HG1' HG23 ' A' ' 53' ' ' THR . 76.7 p -89.4 -178.17 5.53 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.595 -0.73 . . . . 75.13 111.476 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.14 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.23 112.235 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.55 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.04 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.13 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.44 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 60.34 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.45 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.32 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.42 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.22 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.34 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.542 ' HG2' HG21 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.41 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.35 110.706 177.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 70.21 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.1 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.41 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 65.42 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.44 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.34 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.12 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.31 110.736 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.511 ' HE1' ' HB ' ' A' ' 36' ' ' THR . 32.9 p90 -131.04 173.44 11.0 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 71.21 111.723 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.1 m -95.08 108.22 20.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.996 0.427 . . . . 53.31 111.889 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.511 ' HB ' ' HE1' ' A' ' 34' ' ' PHE . 10.5 t -116.63 -179.3 3.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.306 -0.407 . . . . 71.41 110.596 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER -63.3 133.1 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.901 -0.407 . . . . 75.32 109.901 176.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.547 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 3.2 mptp? -71.5 79.31 0.78 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.501 0.926 . . . . 75.1 113.501 -166.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.15 -45.67 0.18 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.348 -1.501 . . . . 50.44 109.348 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -124.05 158.67 31.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.829 -0.685 . . . . 75.12 109.749 167.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.43 -46.28 89.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.775 0.657 . . . . 72.44 112.775 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.78 115.99 2.35 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.901 -0.666 . . . . 43.12 113.759 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.476 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.31 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD11 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.55 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.53 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 61.14 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.42 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.477 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.01 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 62.35 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.01 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.43 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.41 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.409 HG23 ' HG1' ' A' ' 9' ' ' THR . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.51 112.758 178.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.41 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.11 110.818 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.33 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.12 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.44 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.33 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 74.32 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.476 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.13 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.427 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.04 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.456 ' CG1' ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.13 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' HZ2' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.34 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.479 HD12 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.54 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.42 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.589 ' HZ1' ' HB2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.53 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.31 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.41 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 74.33 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.13 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.21 113.661 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.14 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.542 HG21 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.53 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.14 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.43 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 HG12 HG11 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.12 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 71.34 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.2 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 63.11 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.32 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.5 mmm180 -90.57 -27.32 19.21 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.31 112.367 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.89 -29.76 3.48 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.169 -1.015 . . . . 53.34 114.915 173.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.48 92.38 0.02 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 117.299 0.55 . . . . 71.3 112.873 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.19 112.51 1.94 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.158 0.429 . . . . 73.33 112.158 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.8 44.31 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.139 -0.553 . . . . 60.43 114.48 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.52 -76.19 0.22 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.886 -0.673 . . . . 37.87 114.456 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.438 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 73.8 mtp85 -77.14 107.67 9.69 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.45 -0.441 . . . . 73.5 112.124 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.491 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 59.4 mttp -61.58 170.23 2.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.629 -0.714 . . . . 63.45 112.862 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.32 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.12 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.23 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.43 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.04 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 65.41 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.12 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 62.52 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.479 HG13 HD12 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 71.15 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.02 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 71.1 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt -104.46 -68.05 0.87 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.35 112.916 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 10.0 m-20 -91.77 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 115.857 1.799 . . . . 51.44 115.857 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 106' ' ' ASP . 26.0 Cg_exo -66.91 53.6 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.509 1.575 . . . . 72.13 110.924 164.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.5 HD12 ' N ' ' A' ' 110' ' ' HIS . 3.2 tm? -107.78 136.25 47.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.284 -0.871 . . . . 63.22 111.356 -164.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.3 -42.34 14.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.028 0.751 . . . . 75.3 113.028 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.5 ' N ' HD12 ' A' ' 108' ' ' LEU . 13.8 m-70 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.603 0.594 . . . . 75.31 112.603 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.313 0.101 . . . . 74.400000000000006 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.299999999999997 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 61.520000000000003 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 71.030000000000001 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.219999999999999 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.010000000000005 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.519999999999996 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.200000000000003 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.140000000000001 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.420000000000002 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 54.100000000000001 111.572 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.329999999999998 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.209999999999994 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.310000000000002 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.310000000000002 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HG2' HG22 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.230000000000004 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.549999999999997 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.530000000000001 111.053 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.430000000000007 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG23 HG22 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 54.030000000000001 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.420000000000002 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.409999999999997 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.530000000000001 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.420000000000002 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.040000000000006 110.838 177.397 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 113.985 0.354 . . . . 62.310000000000002 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.329999999999998 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.540000000000006 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.549999999999997 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.510000000000005 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 53.450000000000003 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.540000000000006 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.450000000000003 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 70.019999999999996 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.519999999999996 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.430000000000007 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.510000000000005 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.439999999999998 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.200000000000003 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.120000000000005 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.239999999999995 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.040000000000006 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.219999999999999 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 73.030000000000001 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.049999999999997 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.099999999999994 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.209999999999994 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.409999999999997 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.219999999999999 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.400000000000006 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.099999999999994 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.129999999999995 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.129999999999995 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.219999999999999 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.010000000000005 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.030000000000001 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.540000000000006 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.099999999999994 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.209999999999994 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.439999999999998 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.150000000000006 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.099999999999994 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.549999999999997 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.020000000000003 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.140000000000001 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 . . . . . 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.350000000000001 111.699 -179.221 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.319999999999993 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 111.185 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.200000000000003 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.099999999999994 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.130000000000003 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.010000000000005 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 99' ' ' ARG . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.329999999999998 112.717 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 41.350000000000001 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.239999999999995 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 65.219999999999999 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 71.099999999999994 112.862 -175.19 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 43.210000000000001 112.797 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.559 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.240000000000002 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.030000000000001 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.596 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.109999999999999 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.200000000000003 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.439999999999998 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.409999999999997 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.229999999999997 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.239999999999995 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.409999999999997 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.019999999999996 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.219999999999999 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.120000000000005 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.539999999999999 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.510000000000005 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.319999999999993 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.420000000000002 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.310000000000002 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.420000000000002 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 72.340000000000003 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.530000000000001 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.129999999999995 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.329999999999998 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.420000000000002 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.119999999999997 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.239999999999995 109.895 176.182 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 N-CA-C 113.661 0.224 . . . . 54.25 113.661 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.129999999999995 112.248 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.310000000000002 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.230000000000004 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.540000000000006 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 70.319999999999993 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.119999999999997 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.210000000000001 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.239999999999995 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.239999999999995 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.539999999999999 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.400000000000006 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.319999999999993 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 57' ' ' ARG . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.409999999999997 110.852 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.209999999999994 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.430000000000007 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 45.130000000000003 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.310000000000002 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.200000000000003 113.802 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.219999999999999 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.209999999999994 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 63.109999999999999 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.530000000000001 112.559 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.409999999999997 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.340000000000003 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.299999999999997 112.39 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.409999999999997 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 73.239999999999995 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 71.129999999999995 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.319999999999993 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.310000000000002 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.340000000000003 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.340000000000003 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.129999999999995 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.439999999999998 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.340000000000003 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.430000000000007 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.239999999999995 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.340000000000003 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.209999999999994 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 13' ' ' LEU . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.430000000000007 110.403 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 54.409999999999997 112.119 -177.432 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.299999999999997 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.420000000000002 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.219999999999999 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 63.119999999999997 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.420000000000002 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.409999999999997 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.010000000000005 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.310000000000002 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.230000000000004 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.310000000000002 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.140000000000001 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.439999999999998 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.319999999999993 110.997 179.484 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.019 0.438 . . . . 73.519999999999996 111.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 55.439999999999998 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.209999999999994 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.329999999999998 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.420000000000002 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.219999999999999 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.209999999999994 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.329999999999998 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.400000000000006 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.030000000000001 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.329999999999998 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.299999999999997 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.450000000000003 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.230000000000004 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.450000000000003 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.040000000000006 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 47' ' ' VAL . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 64.409999999999997 111.495 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.329999999999998 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 72.030000000000001 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.140000000000001 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.200000000000003 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.329999999999998 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 113.791 0.276 . . . . 64.450000000000003 113.791 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.549999999999997 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.329999999999998 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 28' ' ' ILE . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.439999999999998 111.135 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.230000000000004 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 63.219999999999999 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.019999999999996 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.439999999999998 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.530000000000001 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.430000000000007 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.129999999999995 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.109999999999999 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.129999999999995 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 71.230000000000004 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.510000000000005 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 70.519999999999996 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.129999999999995 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.439999999999998 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.129999999999995 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.655 HD13 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.010000000000005 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.310000000000002 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.129999999999995 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.119999999999997 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.010000000000005 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.400000000000006 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.340000000000003 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.450000000000003 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.209999999999994 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 61.450000000000003 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.319999999999993 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 103' ' ' GLU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.219999999999999 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.400000000000006 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.310000000000002 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.439999999999998 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.219999999999999 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 63.32 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.310000000000002 110.502 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.150000000000006 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.400000000000006 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.439999999999998 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.100000000000001 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.150000000000006 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.200000000000003 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.240000000000002 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.310000000000002 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.340000000000003 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.450000000000003 112.377 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.669 0.271 . . . . 73.129999999999995 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.510000000000005 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.582 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.430000000000007 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.329999999999998 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.030000000000001 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.420000000000002 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.120000000000005 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.299999999999997 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.549999999999997 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.009999999999998 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 54.039999999999999 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 64.430000000000007 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 64.239999999999995 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.319999999999993 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.130000000000003 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.140000000000001 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.219999999999999 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.209999999999994 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 26' ' ' MET . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.219999999999999 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.049999999999997 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.229999999999997 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.310000000000002 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.019999999999996 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.109999999999999 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.030000000000001 110.783 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 114.053 0.381 . . . . 73.150000000000006 114.053 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.130000000000003 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.340000000000003 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.430000000000007 111.814 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.506 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.530000000000001 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.530000000000001 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.210000000000001 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.210000000000001 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.150000000000006 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 65.019999999999996 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.219999999999999 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.040000000000006 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.409999999999997 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.200000000000003 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.239999999999995 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.109999999999999 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 71.409999999999997 111.227 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 54.020000000000003 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.508 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.510000000000005 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.129999999999995 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.400000000000006 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.229999999999997 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.633 HD13 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.230000000000004 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.099999999999994 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.329999999999998 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.239999999999995 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.319999999999993 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.040000000000006 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.430000000000007 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.129999999999995 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.399999999999999 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.310000000000002 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.049999999999997 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.219999999999999 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.319999999999993 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.109999999999999 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.239999999999995 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.219999999999999 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 51.020000000000003 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 111.511 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.216 0.532 . . . . 61.439999999999998 111.782 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 63.509999999999998 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.219999999999999 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 65.439999999999998 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.409999999999997 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.530000000000001 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.549999999999997 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.140000000000001 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.430000000000007 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.109999999999999 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 54.119999999999997 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 62.539999999999999 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.230000000000004 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 42.240000000000002 111.507 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 53' ' ' THR . 9.3 t . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 110.594 -0.15 . . . . 72.049999999999997 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.517 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 61.030000000000001 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.109999999999999 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.510000000000005 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.109999999999999 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.140000000000001 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.209999999999994 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.329999999999998 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 62.25 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.109999999999999 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 64.099999999999994 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.450000000000003 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.420000000000002 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.329999999999998 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 34.420000000000002 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.430000000000007 112.072 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.549999999999997 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.439999999999998 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.430000000000007 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.701 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.420000000000002 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.219999999999999 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 52.210000000000001 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.040000000000006 111.29 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 113.826 0.291 . . . . 53.009999999999998 113.826 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.129999999999995 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.229999999999997 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.109999999999999 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.539999999999999 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.109999999999999 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.120000000000005 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.140000000000001 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.329999999999998 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.400000000000006 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.119999999999997 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.019999999999996 110.93 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.010000000000005 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.310000000000002 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.010000000000005 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.340000000000003 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 65.150000000000006 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 73.239999999999995 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.230000000000004 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 72.430000000000007 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.400000000000006 112.55 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.239999999999995 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.329999999999998 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.219999999999999 111.85 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.409999999999997 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 62.219999999999999 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.319999999999993 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.010000000000005 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 23.32 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.129999999999995 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.340000000000003 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.140000000000001 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.349999999999994 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 72.439999999999998 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.130000000000003 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.310000000000002 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 62.340000000000003 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.439999999999998 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.409999999999997 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.545 0.688 . . . . 70.129999999999995 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.219999999999999 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.219999999999999 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.430000000000007 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.299999999999997 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.319999999999993 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.019999999999996 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 65.340000000000003 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.349999999999994 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.549999999999997 111.666 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 78.4 mt . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.319999999999993 110.518 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.818 0.342 . . . . 75.340000000000003 111.387 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 63.439999999999998 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.129999999999995 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.230000000000004 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.140000000000001 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.109999999999999 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.340000000000003 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.219999999999999 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.130000000000003 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.120000000000005 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 65.010000000000005 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.420000000000002 111.42 165.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.219999999999999 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.219999999999999 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.240000000000002 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.030000000000001 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 61.020000000000003 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.200000000000003 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 53.200000000000003 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.530000000000001 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.130000000000003 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.210000000000001 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.209999999999994 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.310000000000002 109.827 175.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 CA-C-O 120.973 0.207 . . . . 41.43 113.179 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.019999999999996 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.310000000000002 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.149999999999999 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.030000000000001 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.129999999999995 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.299999999999997 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.430000000000007 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.549999999999997 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 70.420000000000002 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.049999999999997 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.329999999999998 111.244 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.019999999999996 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.340000000000003 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.240000000000002 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.120000000000005 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.129999999999995 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.120000000000005 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.340000000000003 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.140000000000001 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.219999999999999 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.140000000000001 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.530000000000001 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD13 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 72.0 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.430000000000007 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.519999999999996 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.510000000000005 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.340000000000003 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.420000000000002 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.140000000000001 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 54.439999999999998 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.209999999999994 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.509999999999998 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.210000000000001 112.061 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.099999999999994 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 94' ' ' ALA . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.239999999999995 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.450000000000003 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 72.439999999999998 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 4.2 mmp_? . . . . . 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 73.340000000000003 111.25 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.3 mttp . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.319999999999993 112.559 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.310000000000002 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.310000000000002 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.519999999999996 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.329999999999998 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.329999999999998 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.119999999999997 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.040000000000006 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 41.149999999999999 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.623 HG13 HD13 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.400000000000006 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 51.039999999999999 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.340000000000003 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 88.0 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 110.996 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.785 0.326 . . . . 72.120000000000005 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.439999999999998 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.119999999999997 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 61.549999999999997 112.796 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.409999999999997 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.540000000000006 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.149999999999999 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.040000000000006 110.829 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.319999999999993 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.549999999999997 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.399999999999999 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.299999999999997 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.129999999999995 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.519999999999996 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.319999999999993 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.349999999999994 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.350000000000001 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 62.420000000000002 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.299999999999997 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.420000000000002 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.549999999999997 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 62.420000000000002 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.4 178.618 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 N-CA-C 113.362 0.105 . . . . 64.239999999999995 113.362 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.510000000000005 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.239999999999995 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 35.509999999999998 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.099999999999994 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.329999999999998 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.009999999999998 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.030000000000001 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.129999999999995 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.140000000000001 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 23.23 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.530000000000001 111.599 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 44.210000000000001 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.030000000000001 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.510000000000005 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.140000000000001 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.439999999999998 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.109999999999999 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.482 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.129999999999995 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 53.130000000000003 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.399999999999999 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.530000000000001 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.030000000000001 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD13 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.540000000000006 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.209999999999994 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 60.340000000000003 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 54.140000000000001 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.120000000000005 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.439999999999998 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.129999999999995 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.010000000000005 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.673 HG22 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.109999999999999 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.319999999999993 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.209999999999994 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.428 HG23 HG12 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.439999999999998 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.010000000000005 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.239999999999995 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.219999999999999 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.239999999999995 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.540000000000006 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.530000000000001 111.197 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.539999999999999 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.140000000000001 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 55.140000000000001 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.409999999999997 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.120000000000005 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.099999999999994 110.397 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.150000000000006 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.349999999999994 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.319999999999993 112.029 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.519999999999996 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.400000000000006 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.019999999999996 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.420000000000002 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.310000000000002 110.018 174.628 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.450000000000003 112.811 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.130000000000003 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 42.509999999999998 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.430000000000007 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.019999999999996 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 42.520000000000003 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 65.340000000000003 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.329999999999998 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 33.439999999999998 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.310000000000002 112.013 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.239999999999995 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.510000000000005 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.209999999999994 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.340000000000003 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.340000000000003 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.349999999999994 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 31.210000000000001 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.48 ' HB3' HD12 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.200000000000003 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.510000000000005 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 62.340000000000003 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.420000000000002 110.571 176.598 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.030000000000001 114.226 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.219999999999999 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.439999999999998 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 64.230000000000004 111.606 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.299999999999997 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.319999999999993 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.310000000000002 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.509999999999998 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.420000000000002 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.049999999999997 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.439999999999998 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.140000000000001 113.614 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 70.540000000000006 110.818 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.340000000000003 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.450000000000003 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.009999999999998 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.099999999999994 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.340000000000003 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.150000000000006 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.129999999999995 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.409999999999997 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.329999999999998 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 72.299999999999997 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.229999999999997 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.349999999999994 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.420000000000002 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.519999999999996 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.520000000000003 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.219999999999999 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.400000000000006 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.109999999999999 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.409999999999997 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.039999999999999 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.209999999999994 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.140000000000001 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.140000000000001 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' THR . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.219999999999999 111.391 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.509999999999998 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 73.409999999999997 111.14 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 38.2 mtmm . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.253 0.549 . . . . 63.439999999999998 111.852 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.310000000000002 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.119999999999997 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.140000000000001 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.540000000000006 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.219999999999999 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.099999999999994 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.209999999999994 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 71.430000000000007 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.420000000000002 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.140000000000001 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 78' ' ' ARG . 87.3 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.299999999999997 111.428 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.04 0.448 . . . . 75.200000000000003 111.532 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 55.530000000000001 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.409999999999997 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.299999999999997 113.111 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.019999999999996 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.349999999999994 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.319999999999993 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 35.100000000000001 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.039999999999999 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.299999999999997 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.030000000000001 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.120000000000005 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.439999999999998 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.200000000000003 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.010000000000005 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 70.329999999999998 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 54.240000000000002 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.319999999999993 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 HG13 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.349999999999994 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.200000000000003 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.450000000000003 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.319999999999993 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.109999999999999 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.420000000000002 109.937 176.517 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.430000000000007 114.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.230000000000004 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.340000000000003 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.430000000000007 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.340000000000003 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.477 HG13 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.520000000000003 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.430000000000007 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 60.240000000000002 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.340000000000003 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.219999999999999 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 70.439999999999998 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.020000000000003 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.209999999999994 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.140000000000001 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.049999999999997 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 95' ' ' HIS . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 72.439999999999998 111.788 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.540000000000006 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.340000000000003 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.518 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.439999999999998 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.119999999999997 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.120000000000005 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.030000000000001 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.239999999999995 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.329999999999998 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.219999999999999 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.140000000000001 112.372 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 54.130000000000003 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.230000000000004 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.340000000000003 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 31.41 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.200000000000003 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.120000000000005 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.209999999999994 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' HD11 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.430000000000007 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 65.010000000000005 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.420000000000002 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 61.420000000000002 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.109999999999999 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.219999999999999 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.030000000000001 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 . . . . . 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.109999999999999 111.915 -178.571 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.436 0.636 . . . . 74.209999999999994 112.61 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.049999999999997 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 64.310000000000002 111.917 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.140000000000001 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.420000000000002 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.039999999999999 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.409999999999997 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.109999999999999 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 64.319999999999993 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.519999999999996 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.439999999999998 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.400000000000006 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt . . . . . 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 51.329999999999998 111.786 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.372 0.13 . . . . 42.520000000000003 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.627 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.230000000000004 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.019999999999996 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 64.0 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.530000000000001 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 60.439999999999998 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.299999999999997 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.129999999999995 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.240000000000002 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.209999999999994 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 52.439999999999998 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.530000000000001 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.549999999999997 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.329999999999998 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 28' ' ' ILE . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.019999999999996 111.932 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.239999999999995 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 47' ' ' VAL . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.140000000000001 110.924 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.310000000000002 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.219999999999999 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 51.399999999999999 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.310000000000002 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.509999999999998 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 52.0 111.304 179.638 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 114.036 0.374 . . . . 24.32 114.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.120000000000005 112.35 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 61.329999999999998 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.329999999999998 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.349999999999994 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 28' ' ' ILE . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 52.149999999999999 111.319 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 40.030000000000001 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.439 HD11 HD23 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.010000000000005 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.310000000000002 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.518 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.130000000000003 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 51.439999999999998 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.530000000000001 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.109999999999999 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.540000000000006 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 72.430000000000007 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.019999999999996 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.349999999999994 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.039999999999999 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 71.230000000000004 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.319999999999993 113.911 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.319999999999993 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.109999999999999 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.219999999999999 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.340000000000003 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.299999999999997 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 44.130000000000003 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.409999999999997 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.319999999999993 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.219999999999999 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.430000000000007 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.509999999999998 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.399999999999999 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 22.530000000000001 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.329999999999998 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 73.430000000000007 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 102' ' ' VAL . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.319999999999993 110.9 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.540000000000006 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.219999999999999 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.200000000000003 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.430000000000007 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 54.119999999999997 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 30.5 mmm180 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 13' ' ' LEU . 57.7 mttp . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.420000000000002 112.912 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.019999999999996 111.051 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.400000000000006 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.340000000000003 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.219999999999999 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.539999999999999 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.150000000000006 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.329999999999998 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 65.230000000000004 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.450000000000003 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 79' ' ' ILE . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.219999999999999 111.628 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.210000000000001 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.329999999999998 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.766 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 HG21 ' A' ' 53' ' ' THR . 7.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.409999999999997 111.734 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.239999999999995 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 42.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.540000000000006 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.209999999999994 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.510000000000005 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.340000000000003 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.520000000000003 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.219999999999999 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.409999999999997 110.522 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 71.549999999999997 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.340000000000003 112.892 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.010000000000005 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.010000000000005 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.129999999999995 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.409999999999997 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.329999999999998 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.049999999999997 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.219999999999999 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.329999999999998 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.340000000000003 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.530000000000001 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.420000000000002 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.510000000000005 109.19 174.651 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.211 0 CA-C-O 120.883 0.157 . . . . 44.119999999999997 113.417 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.540000000000006 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.409999999999997 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 53.140000000000001 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.040000000000006 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.399999999999999 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 71.530000000000001 110.994 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.010000000000005 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 72.219999999999999 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.209999999999994 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.420000000000002 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 71.209999999999994 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.140000000000001 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.109999999999999 110.85 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.409999999999997 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.340000000000003 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 52.520000000000003 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.140000000000001 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.439999999999998 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.340000000000003 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.447 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 43.409999999999997 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.299999999999997 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 43.420000000000002 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.319999999999993 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.240000000000002 112.559 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.609 HD13 HG13 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.219999999999999 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.150000000000006 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.019999999999996 112.654 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.539999999999999 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.230000000000004 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 72' ' ' ARG . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.399999999999999 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.450000000000003 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.310000000000002 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.299999999999997 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.349999999999994 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 65.340000000000003 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.010000000000005 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 74.340000000000003 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.030000000000001 112.204 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.540000000000006 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.408 HD12 HD13 ' A' ' 13' ' ' LEU . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.340000000000003 110.784 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 64.049999999999997 111.152 178.426 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.420000000000002 112.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 71.349999999999994 111.815 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.109999999999999 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 72.010000000000005 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.219999999999999 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.140000000000001 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 62.340000000000003 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 60.450000000000003 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.030000000000001 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.310000000000002 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.609 HG13 HD13 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 54.340000000000003 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.299999999999997 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.209999999999994 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.340000000000003 112.593 -176.277 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 53' ' ' THR . 10.0 t . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 120.822 0.344 . . . . 61.119999999999997 111.298 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.420000000000002 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.409999999999997 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.420000000000002 112.227 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.540000000000006 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.329999999999998 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 44.509999999999998 112.757 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.450000000000003 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.040000000000006 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.340000000000003 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.450000000000003 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.020000000000003 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.430000000000007 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.530000000000001 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.340000000000003 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.340000000000003 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.5 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.230000000000004 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.519999999999996 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.130000000000003 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.430000000000007 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.319999999999993 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.520000000000003 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 60.340000000000003 112.014 -179.309 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 113.675 0.23 . . . . 73.099999999999994 113.675 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.471 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 62.229999999999997 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.400000000000006 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.140000000000001 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.120000000000005 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.430000000000007 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.200000000000003 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.400000000000006 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.200000000000003 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 62.149999999999999 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 60.329999999999998 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 21.23 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.219999999999999 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.420000000000002 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.540000000000006 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.109999999999999 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 65.099999999999994 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.319999999999993 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.471 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.129999999999995 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.310000000000002 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.319999999999993 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 62' ' ' THR . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.310000000000002 111.094 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 112.046 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.099999999999994 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.340000000000003 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.409999999999997 112.145 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.140000000000001 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.349999999999994 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.030000000000001 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.450000000000003 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.430000000000007 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.329999999999998 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 HG22 HG12 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.340000000000003 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.120000000000005 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.510000000000005 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.040000000000006 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.209999999999994 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.120000000000005 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.209999999999994 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.409999999999997 110.956 179.297 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 76.6 mttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 121.053 0.454 . . . . 73.439999999999998 111.548 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.210000000000001 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.140000000000001 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.319999999999993 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 65.200000000000003 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 53.439999999999998 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.409999999999997 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.230000000000004 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.030000000000001 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.099999999999994 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.129999999999995 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 63.219999999999999 110.804 -179.465 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.701 0.286 . . . . 73.409999999999997 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.230000000000004 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.109999999999999 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.409999999999997 112.54 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.540000000000006 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.040000000000006 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.430000000000007 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.129999999999995 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.430000000000007 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.349999999999994 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.019999999999996 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.540000000000006 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.340000000000003 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 105' ' ' LEU . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.439999999999998 111.822 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.140000000000001 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' HG21 ' A' ' 76' ' ' VAL . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.329999999999998 110.068 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 53.119999999999997 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.457 HG23 HG22 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.039999999999999 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.329999999999998 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.129999999999995 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.119999999999997 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 60.140000000000001 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.510000000000005 110.396 178.198 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 N-CA-C 113.916 0.327 . . . . 54.240000000000002 113.916 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 63.210000000000001 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.009999999999998 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.230000000000004 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.140000000000001 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG22 HG23 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.310000000000002 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.349999999999994 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.509999999999998 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.230000000000004 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.524 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.230000000000004 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.119999999999997 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 53.450000000000003 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 12.210000000000001 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.120000000000005 111.001 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.230000000000004 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.519999999999996 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 44.530000000000001 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 64.400000000000006 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 61.299999999999997 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 62.240000000000002 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.52 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.540000000000006 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.209999999999994 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.484 ' HB3' HD12 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.299999999999997 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 61.039999999999999 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.030000000000001 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.519999999999996 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.430000000000007 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.310000000000002 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 61.350000000000001 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.350000000000001 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.219999999999999 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.421 HG21 ' HE ' ' A' ' 24' ' ' ARG . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 73.140000000000001 110.712 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.539999999999999 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 54.030000000000001 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 62.340000000000003 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.340000000000003 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.450000000000003 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.430000000000007 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.209999999999994 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 21' ' ' VAL . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.230000000000004 111.189 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.099999999999994 111.045 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.49 0.662 . . . . 74.0 112.153 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.319999999999993 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.310000000000002 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.140000000000001 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.329999999999998 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.489 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.329999999999998 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.040000000000006 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.109999999999999 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 64.450000000000003 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 54.539999999999999 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 72.239999999999995 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 73.510000000000005 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 22' ' ' THR . 36.5 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.439999999999998 111.301 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.596 0.236 . . . . 74.439999999999998 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.230000000000004 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.607 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.019999999999996 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.420000000000002 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.109999999999999 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.229999999999997 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.420000000000002 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.400000000000006 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.120000000000005 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.350000000000001 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 63.409999999999997 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.209999999999994 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.430000000000007 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.120000000000005 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.329999999999998 111.425 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.299999999999997 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.329999999999998 111.267 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 71.030000000000001 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 53.229999999999997 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.420000000000002 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.209999999999994 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.201 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 114.01 0.364 . . . . 64.25 114.01 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.420000000000002 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.039999999999999 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.409999999999997 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.310000000000002 111.271 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.319999999999993 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 43.109999999999999 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.530000000000001 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.099999999999994 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.340000000000003 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.340000000000003 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.109999999999999 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 64.219999999999999 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.149999999999999 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.310000000000002 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.109999999999999 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.019999999999996 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 62.350000000000001 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.140000000000001 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.019999999999996 113.631 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.400000000000006 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.43 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.150000000000006 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 40.439999999999998 111.551 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.310000000000002 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 71.439999999999998 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.219999999999999 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.299999999999997 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.200000000000003 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.230000000000004 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.400000000000006 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.340000000000003 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.239999999999995 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 64.540000000000006 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.140000000000001 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.099999999999994 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.430000000000007 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.129999999999995 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.420000000000002 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.340000000000003 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 73.319999999999993 111.288 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.299999999999997 112.379 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.439999999999998 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.109999999999999 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.450000000000003 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.340000000000003 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.219999999999999 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.310000000000002 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 79' ' ' ILE . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.010000000000005 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.239999999999995 111.598 -177.082 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.64 0.257 . . . . 75.420000000000002 111.013 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.319999999999993 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.299999999999997 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.129999999999995 113.296 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.209999999999994 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.549999999999997 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.219999999999999 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.299999999999997 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.420000000000002 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.230000000000004 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 33.240000000000002 111.537 169.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 78' ' ' ARG . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 73.450000000000003 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.209999999999994 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 54.43 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.140000000000001 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 52.310000000000002 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.120000000000005 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.340000000000003 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.230000000000004 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.120000000000005 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.329999999999998 111.419 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 114.037 0.375 . . . . 51.140000000000001 114.037 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' H ' ' HB ' ' A' ' 62' ' ' THR . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 61.140000000000001 111.355 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.229999999999997 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.400000000000006 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 64.140000000000001 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.049999999999997 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.129999999999995 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.340000000000003 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.129999999999995 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.229999999999997 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.535 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.109999999999999 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.439999999999998 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.804 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.409999999999997 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.019999999999996 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.329999999999998 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 72.099999999999994 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 63.119999999999997 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 61.030000000000001 113.565 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.530000000000001 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.409999999999997 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.129999999999995 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.509999999999998 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.546 HD13 HG13 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.239999999999995 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.420000000000002 113.038 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.420000000000002 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.120000000000005 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.010000000000005 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.140000000000001 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.040000000000006 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.430000000000007 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.109999999999999 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.340000000000003 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.528 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 53.219999999999999 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.140000000000001 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.010000000000005 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.229999999999997 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 96' ' ' LEU . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.120000000000005 111.627 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 52.329999999999998 111.462 174.732 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 mttp . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.520000000000003 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 54.210000000000001 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 64.430000000000007 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.109999999999999 112.009 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.130000000000003 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 64.219999999999999 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.408 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 62.43 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.120000000000005 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.310000000000002 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 78' ' ' ARG . 76.6 mt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.530000000000001 110.214 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.093 -0.706 . . . . 72.400000000000006 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 45.200000000000003 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.120000000000005 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.340000000000003 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.209999999999994 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.409999999999997 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.140000000000001 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.230000000000004 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.439999999999998 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.420000000000002 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 53.399999999999999 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 79' ' ' ILE . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.329999999999998 111.679 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.230000000000004 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.129999999999995 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.129999999999995 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.230000000000004 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.423 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 71.209999999999994 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.439999999999998 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 71.510000000000005 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.430000000000007 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 70.010000000000005 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 72.329999999999998 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 63.509999999999998 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 71.230000000000004 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.349999999999994 111.298 -179.384 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 23.43 114.769 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.019999999999996 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.340000000000003 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.540000000000006 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.530000000000001 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.040000000000006 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.299999999999997 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.040000000000006 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.540000000000006 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 52.509999999999998 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.340000000000003 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.430000000000007 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.520000000000003 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.230000000000004 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 51.450000000000003 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 53.439999999999998 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 54.030000000000001 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.019999999999996 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.049999999999997 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.120000000000005 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.329999999999998 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.219999999999999 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.140000000000001 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 71.25 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.149999999999999 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.109999999999999 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 71.150000000000006 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.310000000000002 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.439999999999998 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.439999999999998 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.340000000000003 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.310000000000002 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.209999999999994 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.140000000000001 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.617 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.450000000000003 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.450000000000003 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.119999999999997 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.510000000000005 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.209999999999994 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 72.420000000000002 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.099999999999994 111.092 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.450000000000003 112.054 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.229999999999997 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 52.539999999999999 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.299999999999997 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.120000000000005 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.53 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.539999999999999 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.430000000000007 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.239999999999995 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 31.399999999999999 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.430000000000007 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 64.409999999999997 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.209999999999994 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 61.020000000000003 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 78' ' ' ARG . 58.9 mt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 111.432 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.661 0.267 . . . . 63.229999999999997 111.611 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.530000000000001 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.239999999999995 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.439999999999998 111.79 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.53 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.439999999999998 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.510000000000005 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.530000000000001 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.409999999999997 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 42.450000000000003 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.219999999999999 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.450000000000003 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.120000000000005 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.219999999999999 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 44.25 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.100000000000001 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.340000000000003 111.472 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.099999999999994 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG12 HG13 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 61.149999999999999 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.430000000000007 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 61.310000000000002 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 24.120000000000001 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.319999999999993 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.310000000000002 110.207 174.54 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 120.695 0.053 . . . . 75.340000000000003 113.026 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.478 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.120000000000005 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.409999999999997 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 72.510000000000005 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.329999999999998 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.319999999999993 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.430000000000007 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 52.420000000000002 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.520000000000003 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.230000000000004 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.310000000000002 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.310000000000002 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.430000000000007 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.450000000000003 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.340000000000003 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 61.210000000000001 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.519999999999996 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.530000000000001 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.140000000000001 111.435 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.519999999999996 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.539999999999999 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.420000000000002 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HB3' HG22 ' A' ' 102' ' ' VAL . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.310000000000002 112.262 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.509999999999998 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.129999999999995 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.150000000000006 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.439999999999998 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.239999999999995 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.129999999999995 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.310000000000002 113.369 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.019999999999996 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.140000000000001 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.120000000000005 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.329999999999998 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.210000000000001 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.239999999999995 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.787 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.329999999999998 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.420000000000002 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 73.150000000000006 111.506 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' A' ' 13' ' ' LEU . 36.3 mtmm . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.105 0.478 . . . . 63.109999999999999 111.306 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.140000000000001 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.120000000000005 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.230000000000004 112.011 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.430000000000007 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 53.310000000000002 112.934 175.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.219999999999999 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.019999999999996 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 67' ' ' LEU . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.239999999999995 110.438 173.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 65.310000000000002 111.433 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.010000000000005 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.230000000000004 112.557 -176.006 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.176 -0.305 . . . . 43.210000000000001 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.56 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.420000000000002 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.340000000000003 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.439999999999998 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.409999999999997 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.329999999999998 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.020000000000003 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 45.340000000000003 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.150000000000006 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 73.120000000000005 111.264 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.120000000000005 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.120000000000005 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 65.219999999999999 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.439999999999998 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG2' HG22 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.430000000000007 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.040000000000006 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.239999999999995 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 47' ' ' VAL . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.196 173.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.439999999999998 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 64.549999999999997 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.129999999999995 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.519999999999996 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.340000000000003 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.519999999999996 110.741 178.546 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 N-CA-C 113.119 0.008 . . . . 72.540000000000006 113.119 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.200000000000003 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.120000000000005 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.329999999999998 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.130000000000003 110.961 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.540000000000006 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 HG22 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.329999999999998 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.510000000000005 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.319999999999993 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 70.0 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.140000000000001 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.539999999999999 112.13 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 64.450000000000003 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.530000000000001 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 54.329999999999998 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 71.340000000000003 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 61.140000000000001 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 72.129999999999995 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.409999999999997 112.943 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.099999999999994 111.518 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.329999999999998 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.310000000000002 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.239999999999995 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.209999999999994 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.329999999999998 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 62.130000000000003 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.540000000000006 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 61.130000000000003 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.140000000000001 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.129999999999995 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.230000000000004 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.519999999999996 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.239999999999995 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.409999999999997 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.140000000000001 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.340000000000003 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.519999999999996 111.488 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.109999999999999 113.15 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 63.409999999999997 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 111.24 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.040000000000006 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 64' ' ' ASN . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.439999999999998 111.698 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.450000000000003 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.319999999999993 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.540000000000006 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.319999999999993 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.109999999999999 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG12 HG12 ' A' ' 79' ' ' ILE . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 62.020000000000003 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.010000000000005 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.340000000000003 110.679 179.484 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 120.54 0.209 . . . . 74.400000000000006 111.43 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 73.329999999999998 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.439999999999998 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.420000000000002 113.065 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.409999999999997 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.030000000000001 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.549999999999997 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.340000000000003 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.040000000000006 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.329999999999998 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.450000000000003 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 55.229999999999997 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.329999999999998 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.229999999999997 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.530000000000001 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.299999999999997 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.239999999999995 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.099999999999994 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.200000000000003 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 51.32 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 61.530000000000001 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.150000000000006 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.349999999999994 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.450000000000003 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.519999999999996 110.239 176.83 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 112.903 -0.079 . . . . 31.43 112.903 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.109999999999999 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 64.299999999999997 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.200000000000003 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.129999999999995 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.140000000000001 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.239999999999995 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 61.039999999999999 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.200000000000003 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.099999999999994 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.049999999999997 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.548 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.019999999999996 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.149999999999999 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 52.350000000000001 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.200000000000003 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.129999999999995 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.310000000000002 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 63.509999999999998 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.329999999999998 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.140000000000001 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.420000000000002 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.030000000000001 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.140000000000001 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' NZ ' ' HB3' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.400000000000006 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.140000000000001 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.239999999999995 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.439999999999998 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.439999999999998 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.209999999999994 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.319999999999993 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.010000000000005 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.409999999999997 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.030000000000001 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' SER . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.450000000000003 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.140000000000001 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.439999999999998 112.238 -178.447 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.119999999999997 112.538 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.040000000000006 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 72.25 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.329999999999998 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.450000000000003 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 41.299999999999997 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.239999999999995 111.423 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.539999999999999 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.439999999999998 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.549999999999997 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.009999999999998 112.983 -171.661 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.169 0.509 . . . . 75.129999999999995 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.140000000000001 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.230000000000004 112.235 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.549999999999997 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.040000000000006 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.129999999999995 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.439999999999998 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 31.399999999999999 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.450000000000003 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.319999999999993 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.420000000000002 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.219999999999999 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.340000000000003 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.409999999999997 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.349999999999994 110.706 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 53.210000000000001 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.099999999999994 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.409999999999997 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 64.5 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.439999999999998 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.340000000000003 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.120000000000005 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.310000000000002 110.736 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 61.210000000000001 111.723 179.573 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 CA-C-O 121.099 0.277 . . . . 43.119999999999997 113.759 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.310000000000002 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.549999999999997 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.530000000000001 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 55.299999999999997 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.420000000000002 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.010000000000005 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 53.049999999999997 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.010000000000005 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.430000000000007 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.409999999999997 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.510000000000005 112.758 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.409999999999997 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.109999999999999 110.818 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.329999999999998 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.439999999999998 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.329999999999998 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.310000000000002 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.506 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.129999999999995 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.040000000000006 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.129999999999995 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.340000000000003 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.540000000000006 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.420000000000002 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.530000000000001 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.310000000000002 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.409999999999997 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 65.519999999999996 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.129999999999995 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.209999999999994 113.661 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.140000000000001 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.530000000000001 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.140000000000001 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB2' HD11 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.430000000000007 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.120000000000005 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 62.100000000000001 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.200000000000003 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 62.219999999999999 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.030000000000001 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.319999999999993 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 85' ' ' ARG . 12.5 mmm180 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.310000000000002 112.367 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.4 mttp . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.561 0.696 . . . . 63.450000000000003 112.862 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.319999999999993 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.120000000000005 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.230000000000004 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.239999999999995 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.040000000000006 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 61.32 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.119999999999997 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 61.5 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.497 HG13 HD13 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 64.200000000000003 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.019999999999996 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 54.229999999999997 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.349999999999994 112.916 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.715 0.293 . . . . 74.040000000000006 111.502 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD2' ' HD3' ' A' ' 6' ' ' ARG . 24.3 pttm -78.02 145.92 70.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.296 -0.252 . . . . 73.439999999999998 110.546 172.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.19 141.13 49.76 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 123.385 2.723 . . . . 72.340000000000003 114.776 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.86 -32.78 67.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.77 -0.65 . . . . 72.329999999999998 112.047 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -71.13 -5.17 29.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.421 0.526 . . . . 73.329999999999998 112.421 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HD3' ' HD2' ' A' ' 2' ' ' LYS . 20.3 ttt180 -88.34 117.11 27.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.03 0.443 . . . . 74.219999999999999 111.477 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.5 ptm -111.2 102.67 11.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.282 0.563 . . . . 72.409999999999997 110.948 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.98 151.59 35.59 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.32 0.581 . . . . 63.299999999999997 112.328 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p -88.6 172.13 9.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.971 -0.559 . . . . 74.400000000000006 110.859 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.299999999999997 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 61.520000000000003 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 71.030000000000001 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.219999999999999 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.010000000000005 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.519999999999996 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.200000000000003 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.140000000000001 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.420000000000002 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 54.100000000000001 111.572 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.329999999999998 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.209999999999994 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.310000000000002 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.310000000000002 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HG2' HG22 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.230000000000004 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.549999999999997 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.530000000000001 111.053 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.430000000000007 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG23 HG22 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 54.030000000000001 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.420000000000002 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.409999999999997 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.530000000000001 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.420000000000002 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -140.92 153.84 45.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.040000000000006 110.838 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.8 m -85.7 104.79 15.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.911 0.386 . . . . 74.439999999999998 111.638 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -98.69 152.98 19.06 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.158 0.504 . . . . 74.319999999999993 111.785 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -81.47 -8.19 59.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.128 -0.487 . . . . 73.129999999999995 111.821 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -63.73 -16.52 61.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 111.873 0.323 . . . . 61.5 111.873 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.86 75.72 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.25 -0.5 . . . . 61.350000000000001 112.849 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -97.73 160.8 14.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 122.769 -0.254 . . . . 72.209999999999994 110.668 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.16 -35.29 69.37 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.461 0.541 . . . . 72.329999999999998 112.461 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.9 108.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.292 -0.48 . . . . 62.310000000000002 113.985 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.329999999999998 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.540000000000006 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.549999999999997 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.510000000000005 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 53.450000000000003 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.540000000000006 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.450000000000003 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 70.019999999999996 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.519999999999996 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.430000000000007 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.510000000000005 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.439999999999998 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.200000000000003 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.120000000000005 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.239999999999995 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.040000000000006 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.219999999999999 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 73.030000000000001 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.049999999999997 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.099999999999994 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.209999999999994 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.409999999999997 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.219999999999999 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.400000000000006 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.099999999999994 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.129999999999995 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.129999999999995 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.219999999999999 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.209999999999994 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.010000000000005 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.030000000000001 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.540000000000006 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.099999999999994 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.430000000000007 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.209999999999994 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.439999999999998 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.150000000000006 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.099999999999994 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.549999999999997 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.020000000000003 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.140000000000001 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -95.89 -66.52 0.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.350000000000001 111.699 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.569 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . 90.56 70.66 1.22 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.961 -0.638 . . . . 72.040000000000006 113.007 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.48 17.29 58.77 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.09 -0.576 . . . . 44.340000000000003 113.811 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -159.69 145.58 15.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.842 0.353 . . . . 72.209999999999994 111.531 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.23 80.89 0.14 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.245 -0.434 . . . . 70.219999999999999 112.877 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.93 -95.29 0.18 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.428 -0.415 . . . . 40.219999999999999 112.681 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.51 97.27 1.64 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.021 0.439 . . . . 75.129999999999995 111.504 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm -73.22 -172.82 1.18 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.319999999999993 112.028 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HG2' ' H ' ' A' ' 86' ' ' GLY . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 111.185 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.200000000000003 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.099999999999994 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.130000000000003 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.010000000000005 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 99' ' ' ARG . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.329999999999998 112.717 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 41.350000000000001 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.239999999999995 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 65.219999999999999 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.329999999999998 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.506 HD22 HD22 ' A' ' 108' ' ' LEU . 67.2 mt -111.8 -163.78 0.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 71.099999999999994 112.862 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.824 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 13.5 t70 87.2 -66.64 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.416 1.486 . . . . 75.329999999999998 109.915 -167.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.824 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -78.79 85.31 1.87 Allowed 'Trans proline' 0 C--N 1.364 1.345 0 CA-C-N 120.752 1.304 . . . . 60.299999999999997 109.331 155.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.506 HD22 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -52.98 126.0 19.02 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.017 -0.538 . . . . 73.310000000000002 111.968 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -75.08 -62.56 1.51 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.368 -0.378 . . . . 75.109999999999999 111.493 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.735 -0.65 . . . . 74.019999999999996 112.123 -178.941 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.518 0.199 . . . . 61.439999999999998 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 56.22 91.14 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 112.072 0.397 . . . . 72.340000000000003 112.072 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.13 113.0 1.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.553 2.168 . . . . 61.420000000000002 112.92 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.45 -26.88 65.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.756 0.65 . . . . 65.040000000000006 112.756 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -75.72 75.67 2.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.299999999999997 111.521 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.56 116.32 9.24 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.259 -0.428 . . . . 74.209999999999994 110.961 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.1 mmt -84.76 95.32 8.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.0 0.429 . . . . 61.420000000000002 110.966 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.27 104.87 5.2 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.442 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -57.69 166.47 1.36 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 43.210000000000001 112.797 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.559 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.240000000000002 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.030000000000001 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.596 ' NZ ' ' HB3' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.109999999999999 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.200000000000003 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.439999999999998 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.409999999999997 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.229999999999997 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.239999999999995 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.409999999999997 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.019999999999996 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.219999999999999 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.120000000000005 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.539999999999999 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.510000000000005 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.319999999999993 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.420000000000002 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.310000000000002 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.420000000000002 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 72.340000000000003 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.530000000000001 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.129999999999995 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.329999999999998 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.420000000000002 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.119999999999997 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -142.39 160.21 40.71 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.239999999999995 109.895 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.5 m -85.11 104.56 15.12 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.772 -0.58 . . . . 72.329999999999998 111.171 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -92.53 -171.34 2.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.796 -0.638 . . . . 70.209999999999994 111.554 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -64.6 152.05 43.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.959 0.409 . . . . 72.230000000000004 111.875 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -39.69 115.18 0.49 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.394 0.887 . . . . 71.239999999999995 113.394 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.28 -52.13 0.75 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.943 -0.646 . . . . 42.030000000000001 113.931 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -110.56 160.02 17.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.245 0.545 . . . . 70.420000000000002 112.389 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 41' ' ' GLU . 7.9 pt-20 -65.89 -49.07 69.37 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.752 -0.658 . . . . 64.019999999999996 112.32 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.65 108.85 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.222 -0.513 . . . . 54.25 113.661 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.129999999999995 112.248 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.310000000000002 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.230000000000004 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.540000000000006 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.340000000000003 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 70.319999999999993 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.119999999999997 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.210000000000001 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.239999999999995 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.239999999999995 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.539999999999999 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.400000000000006 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.319999999999993 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 57' ' ' ARG . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.409999999999997 110.852 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.209999999999994 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.430000000000007 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 45.130000000000003 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.310000000000002 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.200000000000003 113.802 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.219999999999999 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.209999999999994 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 63.109999999999999 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.530000000000001 112.559 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.409999999999997 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.340000000000003 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.299999999999997 112.39 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.409999999999997 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 73.239999999999995 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 71.129999999999995 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.319999999999993 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.310000000000002 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.340000000000003 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.340000000000003 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.129999999999995 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.439999999999998 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.340000000000003 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.430000000000007 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.239999999999995 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.340000000000003 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.209999999999994 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 13' ' ' LEU . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.430000000000007 110.403 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -83.65 -19.57 35.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 54.409999999999997 112.119 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.45 85.74 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.798 -0.715 . . . . 60.5 113.065 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -71.44 118.38 7.19 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.291 -0.481 . . . . 61.329999999999998 112.88 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -68.98 -34.6 75.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.864 0.364 . . . . 51.329999999999998 111.575 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.06 68.3 2.87 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.311 -0.471 . . . . 62.350000000000001 113.675 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.38 -72.1 0.79 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.721 -0.276 . . . . 65.019999999999996 113.72 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -82.52 131.14 35.22 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.907 0.384 . . . . 74.239999999999995 111.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp -71.67 -176.28 1.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.299999999999997 110.623 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.420000000000002 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.219999999999999 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 63.119999999999997 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.420000000000002 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.409999999999997 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.010000000000005 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.310000000000002 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.230000000000004 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.310000000000002 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.140000000000001 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.439999999999998 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 66.1 mt -106.72 163.6 12.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.319999999999993 110.997 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.679 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.5 t70 74.72 -76.23 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.091 0.956 . . . . 74.209999999999994 111.131 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 28.4 Cg_endo -66.92 62.17 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 CA-C-N 122.343 1.872 . . . . 64.299999999999997 109.978 155.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.74 124.99 20.35 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.381 -1.281 . . . . 70.450000000000003 113.524 -166.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.42 -33.57 8.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.359 -0.382 . . . . 75.519999999999996 111.305 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 m170 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.82 -0.61 . . . . 61.25 111.814 -177.665 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.476 0.176 . . . . 73.340000000000003 111.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 37.2 mtmm -99.16 125.06 42.92 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 112.075 0.398 . . . . 54.409999999999997 112.075 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 16.7 Cg_exo -68.49 112.54 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.584 2.189 . . . . 75.519999999999996 112.529 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.8 129.29 36.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.982 0.42 . . . . 72.030000000000001 111.129 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -90.44 154.88 19.33 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.704 0.764 . . . . 74.219999999999999 112.756 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 ttm-85 -176.69 -67.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.929 -1.032 . . . . 74.310000000000002 109.739 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.3 mtm -78.6 70.7 4.98 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.628 0.727 . . . . 61.549999999999997 110.566 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.23 172.76 6.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.59 -0.732 . . . . 51.310000000000002 112.145 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -79.22 178.78 7.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.947 -0.569 . . . . 73.519999999999996 111.902 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 55.439999999999998 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.209999999999994 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.329999999999998 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.420000000000002 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.219999999999999 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.209999999999994 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.329999999999998 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.400000000000006 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.030000000000001 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.329999999999998 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.299999999999997 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.450000000000003 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.230000000000004 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.450000000000003 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.310000000000002 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.040000000000006 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 47' ' ' VAL . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 64.409999999999997 111.495 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.329999999999998 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 72.030000000000001 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.140000000000001 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.200000000000003 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.329999999999998 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.65 165.57 22.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.6 m -85.52 108.17 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.412 -0.358 . . . . 75.239999999999995 111.208 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -103.09 173.88 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.228 0.537 . . . . 72.430000000000007 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.3 mtt180 -94.87 -9.18 35.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.121 -0.49 . . . . 74.299999999999997 111.577 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HA ' ' HE2' ' A' ' 38' ' ' LYS . 9.4 mmpt? -88.03 167.01 14.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.784 0.326 . . . . 73.209999999999994 111.0 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.63 35.66 1.39 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.294 -0.479 . . . . 70.329999999999998 113.9 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -127.2 160.63 30.67 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.154 0.502 . . . . 72.530000000000001 111.709 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.11 -48.32 82.2 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.939 -0.573 . . . . 62.329999999999998 112.07 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.67 102.71 0.18 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.317 -0.468 . . . . 64.450000000000003 113.791 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.549999999999997 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.239999999999995 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.329999999999998 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 28' ' ' ILE . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.439999999999998 111.135 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.230000000000004 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 63.219999999999999 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.019999999999996 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.439999999999998 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.530000000000001 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.430000000000007 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.219999999999999 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.129999999999995 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.129999999999995 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.319999999999993 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.109999999999999 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.129999999999995 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 71.230000000000004 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.510000000000005 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 70.519999999999996 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.129999999999995 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.439999999999998 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.129999999999995 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.655 HD13 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.010000000000005 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.310000000000002 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.129999999999995 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.119999999999997 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.010000000000005 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.400000000000006 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.340000000000003 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.450000000000003 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.209999999999994 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 61.450000000000003 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.319999999999993 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HB2' HD11 ' A' ' 105' ' ' LEU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.219999999999999 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.400000000000006 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.310000000000002 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.439999999999998 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.219999999999999 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 63.32 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 72.230000000000004 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 -122.05 167.41 13.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.310000000000002 110.502 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.69 84.14 0.37 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.929 -0.653 . . . . 71.120000000000005 113.807 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.61 165.16 43.98 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.044 -0.598 . . . . 33.329999999999998 112.771 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -78.75 150.56 32.42 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.048 0.452 . . . . 73.519999999999996 111.288 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.52 14.84 12.05 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.39 -0.433 . . . . 54.450000000000003 113.228 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.68 -57.92 4.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.229 -0.51 . . . . 70.439999999999998 113.577 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 91' ' ' ARG . 69.1 mtt85 -70.09 122.96 20.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.079 0.466 . . . . 72.530000000000001 111.876 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -80.62 -178.55 6.8 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.219999999999999 111.566 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.150000000000006 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.400000000000006 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.439999999999998 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.100000000000001 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.150000000000006 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.200000000000003 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.240000000000002 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.310000000000002 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.340000000000003 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' A' ' 107' ' ' PRO . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.450000000000003 112.377 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt -99.85 -1.88 36.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.868 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 14.8 t70 -77.39 -55.87 1.26 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 109.514 -0.55 . . . . 72.450000000000003 109.514 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -87.24 72.66 3.07 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.22 1.947 . . . . 75.329999999999998 108.692 156.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 108' ' ' LEU . 3.5 tm? -40.55 116.99 0.76 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.67 -1.15 . . . . 72.140000000000001 113.34 -166.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -90.02 -52.2 5.08 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.517 -0.765 . . . . 73.230000000000004 110.681 174.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 43.8 m80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.788 -0.625 . . . . 64.140000000000001 112.101 176.817 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.323 -0.251 . . . . 72.230000000000004 110.323 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 2' ' ' LYS . 50.4 pttt -118.02 87.66 29.12 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.536 0.569 . . . . 64.420000000000002 112.536 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.65 102.83 1.63 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.291 1.994 . . . . 72.230000000000004 111.126 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.31 137.9 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.173 0.511 . . . . 75.230000000000004 111.804 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -134.13 -4.46 2.74 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.068 -0.515 . . . . 53.450000000000003 111.886 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.684 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 1.1 mmp_? -117.44 -68.28 0.93 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.189 0.44 . . . . 74.200000000000003 112.189 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.0 ttp -83.64 112.63 20.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.944 0.402 . . . . 63.340000000000003 111.735 -176.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.44 173.7 8.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.453 0.644 . . . . 73.329999999999998 112.624 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -103.73 177.57 4.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.69 -0.686 . . . . 73.129999999999995 111.424 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.510000000000005 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.582 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.430000000000007 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.329999999999998 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.030000000000001 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.420000000000002 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.120000000000005 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.299999999999997 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.549999999999997 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.009999999999998 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 54.039999999999999 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 64.430000000000007 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 64.239999999999995 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.319999999999993 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.130000000000003 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.140000000000001 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.219999999999999 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.209999999999994 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 26' ' ' MET . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.219999999999999 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.049999999999997 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.229999999999997 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.310000000000002 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.019999999999996 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.109999999999999 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 -136.99 149.98 47.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.030000000000001 110.783 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -85.35 108.43 17.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.971 0.415 . . . . 73.329999999999998 111.715 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 t -108.69 151.37 26.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.035 0.445 . . . . 45.530000000000001 112.164 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.766 ' HD3' ' H ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.28 3.77 29.93 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.347 -0.388 . . . . 64.200000000000003 111.968 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -66.36 -27.7 68.08 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.965 0.412 . . . . 65.340000000000003 111.53 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.46 21.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.049 -0.596 . . . . 63.5 112.932 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.7 161.84 19.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.799 0.333 . . . . 74.299999999999997 111.222 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.07 -27.71 65.79 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 111.993 0.368 . . . . 71.219999999999999 111.993 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . 82.06 113.54 0.42 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.332 -0.461 . . . . 73.150000000000006 114.053 174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.130000000000003 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.340000000000003 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.430000000000007 111.814 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.506 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.530000000000001 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.530000000000001 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.340000000000003 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.210000000000001 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.210000000000001 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.150000000000006 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 65.019999999999996 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.219999999999999 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.040000000000006 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.409999999999997 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.200000000000003 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.239999999999995 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.109999999999999 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 71.409999999999997 111.227 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 54.020000000000003 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.508 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.510000000000005 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.129999999999995 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.400000000000006 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.229999999999997 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.633 HD13 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.230000000000004 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.099999999999994 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.329999999999998 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.239999999999995 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.319999999999993 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.040000000000006 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 73.120000000000005 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.430000000000007 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.129999999999995 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.399999999999999 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.310000000000002 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.049999999999997 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.219999999999999 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.319999999999993 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.109999999999999 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.239999999999995 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.219999999999999 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 51.020000000000003 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 -91.36 -19.07 23.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 111.511 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.08 -15.22 62.85 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.795 0.678 . . . . 74.400000000000006 114.795 174.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 55.18 58.94 11.44 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 117.67 0.735 . . . . 60.409999999999997 113.237 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.89 98.23 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.039 0.447 . . . . 71.109999999999999 111.592 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.51 -12.65 5.17 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.447 -0.406 . . . . 74.209999999999994 113.498 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.0 -118.29 0.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.98 -0.629 . . . . 22.100000000000001 112.983 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -88.25 149.12 24.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.199 0.523 . . . . 72.450000000000003 111.471 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 38.6 mttm -73.72 168.63 18.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.733 -0.667 . . . . 61.439999999999998 111.782 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 63.509999999999998 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.219999999999999 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 65.439999999999998 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.409999999999997 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.530000000000001 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.549999999999997 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.140000000000001 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.430000000000007 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.109999999999999 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 54.119999999999997 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 62.539999999999999 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.230000000000004 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 80.1 mt -111.52 -178.22 3.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 42.240000000000002 111.507 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.59 -76.93 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.281 0 CA-C-O 118.579 -0.724 . . . . 62.049999999999997 111.038 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 32.9 Cg_exo -63.94 78.05 0.16 Allowed 'Trans proline' 0 C--N 1.364 1.376 0 CA-C-N 122.236 1.834 . . . . 75.5 110.349 155.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.19 118.36 6.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.999 0.74 . . . . 72.0 112.999 -169.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.88 -20.08 50.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.558 -0.746 . . . . 72.200000000000003 111.745 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.049 -0.501 . . . . 74.209999999999994 111.379 179.411 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.849 0.357 . . . . 63.200000000000003 111.626 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -78.83 116.65 61.43 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.425 -0.352 . . . . 73.439999999999998 110.809 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.9 147.53 49.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.607 2.204 . . . . 72.329999999999998 113.94 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -104.3 -39.65 6.4 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.907 -0.588 . . . . 71.340000000000003 110.973 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -159.0 105.53 1.77 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 75.25 111.901 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -96.0 34.76 1.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.82 0.819 . . . . 71.340000000000003 110.522 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.9 ttm -149.01 22.91 0.96 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.67 0.748 . . . . 71.409999999999997 109.686 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.85 92.69 4.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.746 0.784 . . . . 62.25 112.088 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 53' ' ' THR . 9.3 t -76.55 -169.62 1.29 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.467 -0.788 . . . . 72.049999999999997 110.594 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 61.030000000000001 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.109999999999999 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.510000000000005 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.100000000000001 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.109999999999999 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.140000000000001 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.209999999999994 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.329999999999998 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 62.25 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.109999999999999 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 64.099999999999994 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.450000000000003 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.420000000000002 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.329999999999998 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 34.420000000000002 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.430000000000007 112.072 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.549999999999997 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.439999999999998 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.430000000000007 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.701 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.420000000000002 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.219999999999999 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 52.210000000000001 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -151.4 168.37 25.06 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.040000000000006 111.29 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.4 m -85.41 115.97 23.46 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 74.319999999999993 111.672 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.5 t -107.7 -170.11 1.64 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.961 -0.563 . . . . 65.349999999999994 110.763 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -48.77 -72.01 0.06 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.163 0.431 . . . . 64.319999999999993 112.163 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.81 167.66 12.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.488 . . . . 71.140000000000001 112.319 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.37 -66.2 2.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.156 -0.475 . . . . 55.420000000000002 113.679 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -85.33 146.86 26.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 74.010000000000005 111.243 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.49 -16.33 61.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.899 0.703 . . . . 74.230000000000004 112.899 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.18 105.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.327 -0.464 . . . . 53.009999999999998 113.826 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.129999999999995 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.229999999999997 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.109999999999999 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.539999999999999 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.109999999999999 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.120000000000005 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.140000000000001 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.329999999999998 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.310000000000002 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.400000000000006 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.119999999999997 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.019999999999996 110.93 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.010000000000005 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.310000000000002 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.010000000000005 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.340000000000003 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 65.150000000000006 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 73.239999999999995 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.230000000000004 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 72.430000000000007 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.209999999999994 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.400000000000006 112.55 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.239999999999995 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.329999999999998 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.219999999999999 111.85 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.409999999999997 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 62.219999999999999 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.319999999999993 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.010000000000005 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 23.32 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.129999999999995 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.340000000000003 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.140000000000001 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.349999999999994 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 72.439999999999998 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.130000000000003 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.310000000000002 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 62.340000000000003 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.439999999999998 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.409999999999997 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -76.23 -53.4 8.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.88 -52.53 0.19 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.43 -1.367 . . . . 74.310000000000002 115.477 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 53.84 45.46 70.07 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 117.633 0.717 . . . . 63.100000000000001 111.718 -167.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -50.66 118.44 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.191 0.52 . . . . 73.239999999999995 112.233 -172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.92 -49.47 0.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.019 -0.537 . . . . 73.340000000000003 112.958 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.3 -105.71 0.66 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.679 -0.772 . . . . 75.239999999999995 113.591 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 51.7 mtm180 -88.77 123.25 33.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.062 0.458 . . . . 72.530000000000001 111.58 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.628 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 55.4 mttm -61.55 179.24 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.511 -0.768 . . . . 70.129999999999995 112.719 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.219999999999999 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.219999999999999 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.430000000000007 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.299999999999997 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.319999999999993 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.019999999999996 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.109999999999999 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 65.340000000000003 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 64.109999999999999 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.349999999999994 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.779 HG22 ' HG3' ' A' ' 109' ' ' GLU . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.549999999999997 111.666 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 78.4 mt -103.52 177.86 4.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.319999999999993 110.518 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.677 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 18.3 t70 86.21 -65.1 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.111 0.965 . . . . 73.230000000000004 109.07 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 15.4 Cg_exo -75.29 -149.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.263 1.309 . . . . 64.019999999999996 109.798 149.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.27 124.33 1.2 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.659 -0.651 . . . . 65.230000000000004 111.601 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.779 ' HG3' HG22 ' A' ' 104' ' ' VAL . 45.9 mt-10 -78.46 -52.33 8.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.264 0.468 . . . . 73.129999999999995 112.264 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 112.95 0.722 . . . . 64.510000000000005 112.95 -175.463 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.236 -0.283 . . . . 71.329999999999998 110.236 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mptp? -71.64 121.71 85.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 111.786 0.291 . . . . 74.040000000000006 111.786 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.6 98.58 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.643 2.229 . . . . 72.120000000000005 112.904 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.85 128.88 38.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.187 -0.461 . . . . 71.400000000000006 111.65 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.84 130.78 5.04 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.533 -0.303 . . . . 73.420000000000002 111.488 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 2.8 mmp_? -101.47 76.85 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.429 0.633 . . . . 72.219999999999999 111.176 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.64 90.66 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.909 -1.042 . . . . 75.439999999999998 109.654 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -114.73 135.59 53.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 74.310000000000002 111.196 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -72.9 167.6 20.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.381 -0.372 . . . . 75.340000000000003 111.387 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 63.439999999999998 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.129999999999995 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.230000000000004 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.140000000000001 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.109999999999999 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.340000000000003 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.219999999999999 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.130000000000003 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.120000000000005 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 65.010000000000005 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.420000000000002 111.42 165.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.219999999999999 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.219999999999999 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.240000000000002 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.030000000000001 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 61.020000000000003 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.200000000000003 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 53.200000000000003 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.530000000000001 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.130000000000003 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.210000000000001 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.430000000000007 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.209999999999994 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.14 175.81 5.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.310000000000002 109.827 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -106.12 128.24 53.75 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.355 -0.216 . . . . 73.409999999999997 111.434 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 41' ' ' GLU . 14.5 p -83.28 172.77 12.21 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.443 0.639 . . . . 74.040000000000006 111.77 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -103.8 14.69 30.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.998 -0.546 . . . . 53.200000000000003 110.667 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -107.76 -69.12 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.14 0.422 . . . . 75.239999999999995 112.14 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.29 -55.81 0.02 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.188 -1.006 . . . . 74.129999999999995 114.072 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -85.43 162.94 18.78 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.072 0.397 . . . . 75.030000000000001 112.072 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 42' ' ' GLY . 9.4 pt-20 -43.18 -68.92 0.16 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.788 -0.642 . . . . 73.340000000000003 112.711 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' H ' ' HG3' ' A' ' 41' ' ' GLU . . . 102.95 135.6 8.78 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 121.305 -0.474 . . . . 41.43 113.179 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.019999999999996 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.310000000000002 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.149999999999999 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.030000000000001 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.129999999999995 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.509999999999998 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.299999999999997 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.430000000000007 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.549999999999997 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 70.420000000000002 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.049999999999997 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.329999999999998 111.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.019999999999996 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.340000000000003 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.240000000000002 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.120000000000005 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.129999999999995 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.120000000000005 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.340000000000003 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.140000000000001 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.219999999999999 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.140000000000001 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.530000000000001 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD13 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 72.0 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.430000000000007 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.519999999999996 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.510000000000005 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.340000000000003 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.420000000000002 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.140000000000001 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 54.439999999999998 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.209999999999994 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.509999999999998 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.210000000000001 112.061 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.099999999999994 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 94' ' ' ALA . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.239999999999995 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.450000000000003 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 72.439999999999998 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 85' ' ' ARG . 4.2 mmp_? -91.63 -73.5 0.54 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 73.340000000000003 111.25 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.26 83.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.452 -0.88 . . . . 64.129999999999995 113.795 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -72.44 114.16 4.78 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.165 -0.54 . . . . 40.200000000000003 112.426 175.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -69.96 105.74 2.95 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.47 0.652 . . . . 74.519999999999996 111.851 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.91 40.8 0.23 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.111 -0.495 . . . . 62.509999999999998 113.244 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.95 -58.55 4.29 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.465 -0.398 . . . . 54.200000000000003 113.243 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 99.2 mtt180 -72.45 89.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 111.715 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 53.3 mttp -65.45 -173.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.319999999999993 112.559 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.310000000000002 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.310000000000002 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.519999999999996 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.329999999999998 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.329999999999998 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.119999999999997 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.040000000000006 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 41.149999999999999 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 55.439999999999998 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.623 HG13 HD13 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.400000000000006 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 51.039999999999999 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.340000000000003 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.676 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 88.0 mt -110.13 173.61 6.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 110.996 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.8 OUTLIER 81.84 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.336 1.054 . . . . 54.420000000000002 111.237 -169.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 53.7 Cg_exo -59.39 67.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 CA-C-N 121.057 1.413 . . . . 74.409999999999997 109.04 148.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 129.61 40.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.802 -1.09 . . . . 62.100000000000001 113.291 -160.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.73 -58.76 1.97 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.528 -0.76 . . . . 75.25 110.593 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.928 -0.558 . . . . 74.5 111.883 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.796 0.331 . . . . 54.219999999999999 111.085 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -109.72 131.66 21.8 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.675 -0.239 . . . . 74.329999999999998 111.084 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.0 -173.05 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.894 2.396 . . . . 64.310000000000002 114.156 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -97.51 2.67 50.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 53.25 113.24 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.85 122.6 27.93 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.254 0.55 . . . . 74.439999999999998 111.871 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.434 ' HG2' HH11 ' A' ' 6' ' ' ARG . 10.0 tpt180 -154.13 107.56 2.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.762 -0.654 . . . . 74.140000000000001 111.143 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.1 mtt 56.06 29.16 14.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.898 0.333 . . . . 73.150000000000006 111.898 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 43.6 m-20 -64.32 139.22 58.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 35.299999999999997 111.667 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p -62.62 161.25 12.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.051 -0.522 . . . . 72.120000000000005 111.182 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.439999999999998 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.119999999999997 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 61.549999999999997 112.796 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.409999999999997 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.540000000000006 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.299999999999997 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.149999999999999 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.040000000000006 110.829 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.319999999999993 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.549999999999997 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.399999999999999 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.299999999999997 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.129999999999995 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.519999999999996 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.319999999999993 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.349999999999994 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.350000000000001 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 62.420000000000002 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.299999999999997 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.420000000000002 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.549999999999997 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 62.420000000000002 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -144.3 164.49 30.63 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 74.310000000000002 111.4 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 m -84.8 124.65 31.82 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.226 -0.296 . . . . 65.420000000000002 111.627 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.4 p -102.6 147.09 27.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.764 0.316 . . . . 73.310000000000002 111.264 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.08 -22.19 64.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.137 0.494 . . . . 72.409999999999997 110.935 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.07 -26.73 62.29 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.152 -0.476 . . . . 61.240000000000002 111.752 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.22 4.1 50.67 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.175 -0.536 . . . . 63.399999999999999 113.573 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -92.37 161.15 14.78 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.393 -0.475 . . . . 73.200000000000003 111.631 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -44.17 -52.16 7.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.464 0.913 . . . . 72.530000000000001 113.464 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.88 115.49 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.098 -0.572 . . . . 64.239999999999995 113.362 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.510000000000005 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.239999999999995 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 35.509999999999998 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.099999999999994 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.329999999999998 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.009999999999998 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.030000000000001 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.240000000000002 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.129999999999995 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.140000000000001 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 23.23 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.530000000000001 111.599 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 44.210000000000001 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.030000000000001 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.510000000000005 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.140000000000001 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.439999999999998 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.109999999999999 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.482 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.129999999999995 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 53.130000000000003 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.399999999999999 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.530000000000001 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.030000000000001 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD13 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.540000000000006 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.209999999999994 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 60.340000000000003 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 54.140000000000001 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.120000000000005 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.439999999999998 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.129999999999995 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.010000000000005 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.673 HG22 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.109999999999999 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.319999999999993 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.209999999999994 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.428 HG23 HG12 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.439999999999998 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.010000000000005 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.239999999999995 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.219999999999999 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.239999999999995 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.540000000000006 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 -124.1 171.34 9.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.530000000000001 111.197 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.04 102.25 2.83 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.829 -0.623 . . . . 71.040000000000006 114.173 -173.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -81.67 93.31 1.57 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.176 -0.535 . . . . 71.140000000000001 112.215 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -55.0 -27.2 42.38 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 72.510000000000005 112.166 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.87 57.35 5.05 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.207 -0.52 . . . . 62.43 112.792 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.8 -85.27 0.66 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.353 -0.451 . . . . 70.310000000000002 113.334 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 95.6 mtt180 -68.08 125.25 25.75 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.965 0.357 . . . . 64.319999999999993 111.965 -177.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 63.8 mttm -68.17 -176.21 0.69 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.539999999999999 110.804 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.140000000000001 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 55.140000000000001 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.409999999999997 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.120000000000005 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.099999999999994 110.397 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.150000000000006 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.349999999999994 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.319999999999993 112.029 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.519999999999996 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.400000000000006 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.019999999999996 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.420000000000002 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.682 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 63.8 mt -111.76 166.41 11.21 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.310000000000002 110.018 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' HB3' ' CD ' ' A' ' 107' ' ' PRO . 21.1 t70 87.61 -67.96 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.28 1.032 . . . . 63.130000000000003 109.504 -166.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 46.2 Cg_endo -71.38 75.28 1.94 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 CA-C-N 121.12 1.436 . . . . 53.030000000000001 109.762 156.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -52.87 108.15 0.29 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.55 -0.75 . . . . 75.349999999999994 112.608 -167.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -90.07 -61.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.041 -0.527 . . . . 62.210000000000001 110.988 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 19.7 m80 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 112.36 0.504 . . . . 70.340000000000003 112.36 -174.088 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.616 0.246 . . . . 73.400000000000006 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -81.72 141.66 48.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.777 -0.192 . . . . 65.530000000000001 111.221 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.67 123.41 12.87 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.721 2.281 . . . . 73.109999999999999 112.905 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.07 138.1 58.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.434 0.635 . . . . 72.409999999999997 112.351 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -116.3 128.52 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 74.400000000000006 110.889 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -169.67 118.83 0.63 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.828 -0.624 . . . . 72.030000000000001 110.634 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' MET . 5.5 tpt 65.2 20.5 11.95 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.177 0.436 . . . . 73.319999999999993 112.177 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.52 129.36 34.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.691 -0.631 . . . . 43.039999999999999 111.185 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p -91.1 -177.82 5.0 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.450000000000003 112.811 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.130000000000003 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 42.509999999999998 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.430000000000007 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.019999999999996 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 42.520000000000003 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 65.340000000000003 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.329999999999998 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 33.439999999999998 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.409999999999997 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.310000000000002 112.013 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.239999999999995 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.510000000000005 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.209999999999994 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.239999999999995 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.340000000000003 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.340000000000003 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.349999999999994 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 31.210000000000001 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.48 ' HB3' HD12 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.200000000000003 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.510000000000005 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 62.340000000000003 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -148.22 156.73 42.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.420000000000002 110.571 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.5 m -85.08 118.61 24.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.038 0.447 . . . . 65.209999999999994 111.982 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -89.44 147.55 23.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.323 -0.399 . . . . 73.310000000000002 110.952 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' HA ' ' NE ' ' A' ' 37' ' ' ARG . 5.7 tpm_? -73.82 -26.25 60.51 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.916 0.389 . . . . 75.129999999999995 111.071 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -44.42 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.439 -0.346 . . . . 72.209999999999994 111.804 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.46 16.92 1.45 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.542 -0.837 . . . . 41.439999999999998 114.662 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.49 158.46 15.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.59 0.695 . . . . 71.310000000000002 110.784 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.2 -31.9 70.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.218 0.451 . . . . 64.430000000000007 112.218 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.87 116.8 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.030000000000001 114.226 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.219999999999999 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.439999999999998 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 64.230000000000004 111.606 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.299999999999997 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.319999999999993 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.310000000000002 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.509999999999998 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.420000000000002 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.049999999999997 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.439999999999998 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.140000000000001 113.614 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 70.540000000000006 110.818 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.340000000000003 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.450000000000003 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.009999999999998 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.099999999999994 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.400000000000006 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.340000000000003 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.150000000000006 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.129999999999995 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.409999999999997 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.329999999999998 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 72.299999999999997 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.229999999999997 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.349999999999994 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.420000000000002 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.519999999999996 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.520000000000003 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.219999999999999 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.400000000000006 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.109999999999999 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.409999999999997 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.039999999999999 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.209999999999994 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.140000000000001 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.140000000000001 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' THR . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.219999999999999 111.391 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.509999999999998 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -85.52 -72.5 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 73.409999999999997 111.14 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.55 89.57 0.16 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.601 -0.809 . . . . 53.130000000000003 113.751 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.93 108.25 2.48 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.004 -0.617 . . . . 33.530000000000001 112.21 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -62.37 96.48 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.256 0.55 . . . . 74.400000000000006 112.138 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.59 39.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.187 -0.53 . . . . 65.450000000000003 113.449 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.26 -69.84 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.398 -0.429 . . . . 52.329999999999998 113.071 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 74.9 mtm180 -67.99 101.09 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.168 0.509 . . . . 65.219999999999999 111.356 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 38.2 mtmm -75.7 -170.62 1.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.916 -0.584 . . . . 63.439999999999998 111.852 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.310000000000002 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.099999999999994 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.119999999999997 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.140000000000001 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.540000000000006 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.219999999999999 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.099999999999994 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.209999999999994 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 71.430000000000007 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.420000000000002 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.140000000000001 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 87.3 mt -122.35 171.37 9.1 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.299999999999997 111.428 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 2.3 m-20 77.35 -71.61 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.092 0.957 . . . . 74.299999999999997 110.889 -169.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 50.2 Cg_exo -59.68 77.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.415 0 CA-C-N 121.633 1.619 . . . . 74.430000000000007 109.888 154.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -63.72 103.34 0.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.327 -0.851 . . . . 72.340000000000003 112.933 -165.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -98.76 -7.0 28.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.591 -0.731 . . . . 51.549999999999997 111.774 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.33 0 N-CA-C 112.404 0.52 . . . . 74.310000000000002 112.404 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.744 0.306 . . . . 75.430000000000007 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -149.25 88.08 5.15 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 120.859 0.362 . . . . 52.310000000000002 111.381 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.77 120.44 7.71 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.433 2.089 . . . . 71.310000000000002 111.638 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 73.04 3.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.507 0.67 . . . . 63.539999999999999 110.453 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -86.56 85.57 7.31 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.856 -0.611 . . . . 73.25 111.69 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -106.34 123.16 47.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.977 0.418 . . . . 75.120000000000005 111.627 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mtm -128.13 83.52 2.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 109.997 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' HB2' ' CG ' ' A' ' 12' ' ' LYS . 38.8 m-20 -100.86 -171.49 2.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.528 0.68 . . . . 64.439999999999998 112.462 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p -79.8 -153.83 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.581 -0.736 . . . . 75.200000000000003 111.532 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 55.530000000000001 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.409999999999997 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' CG ' ' HB2' ' A' ' 8' ' ' ASP . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.299999999999997 113.111 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.019999999999996 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.349999999999994 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.319999999999993 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 35.100000000000001 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.039999999999999 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.299999999999997 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.030000000000001 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.120000000000005 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.239999999999995 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.439999999999998 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.200000000000003 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.010000000000005 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 70.329999999999998 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 54.240000000000002 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.319999999999993 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 HG13 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.349999999999994 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.209999999999994 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.200000000000003 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.450000000000003 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.319999999999993 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.109999999999999 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -147.48 173.12 12.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.420000000000002 109.937 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.7 m -106.24 113.64 27.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.916 -0.49 . . . . 70.150000000000006 111.604 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -80.81 -178.89 7.02 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.117 -0.492 . . . . 71.150000000000006 111.494 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -84.52 -5.28 59.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.704 0.288 . . . . 75.230000000000004 111.626 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.37 174.76 6.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.688 0.28 . . . . 74.400000000000006 111.233 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.67 55.26 3.77 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 114.812 0.685 . . . . 53.43 114.812 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -128.37 152.9 47.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.301 -0.529 . . . . 71.299999999999997 111.364 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.88 -23.88 67.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.9 0.704 . . . . 75.430000000000007 112.9 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.66 108.59 0.02 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.430000000000007 114.378 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.230000000000004 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.340000000000003 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.430000000000007 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.340000000000003 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.477 HG13 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.520000000000003 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.430000000000007 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 60.240000000000002 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.340000000000003 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.219999999999999 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.430000000000007 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 70.439999999999998 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.020000000000003 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.591 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.209999999999994 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.140000000000001 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.049999999999997 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 95' ' ' HIS . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 72.439999999999998 111.788 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.540000000000006 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.340000000000003 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.518 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.439999999999998 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.119999999999997 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.120000000000005 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.030000000000001 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.239999999999995 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.329999999999998 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.219999999999999 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.140000000000001 112.372 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 54.130000000000003 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.230000000000004 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.310000000000002 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.340000000000003 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 31.41 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.200000000000003 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.120000000000005 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.209999999999994 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' HD11 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.430000000000007 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 65.010000000000005 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.420000000000002 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 61.420000000000002 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.109999999999999 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.219999999999999 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.030000000000001 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -85.38 -74.54 0.4 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.109999999999999 111.915 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.3 89.96 0.08 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.276 -0.964 . . . . 53.549999999999997 113.65 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -82.93 105.84 2.7 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.308 -0.472 . . . . 73.299999999999997 112.336 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.06 118.43 6.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.021 0.438 . . . . 73.439999999999998 111.735 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 120.71 39.19 0.62 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.261 -0.495 . . . . 51.219999999999999 113.078 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.8 -61.27 4.54 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.452 -0.404 . . . . 53.32 113.444 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.591 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 23.1 mtm180 -75.24 89.54 2.55 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.136 0.493 . . . . 72.049999999999997 112.026 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 59.6 mttp -63.76 -176.88 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.791 -0.64 . . . . 74.209999999999994 112.61 177.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.340000000000003 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.049999999999997 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 64.310000000000002 111.917 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.140000000000001 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.420000000000002 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.039999999999999 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.409999999999997 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.109999999999999 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 64.319999999999993 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.519999999999996 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.439999999999998 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.400000000000006 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt -109.39 -172.4 2.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 51.329999999999998 111.786 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.764 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 7.7 t70 99.65 -58.7 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 125.4 1.48 . . . . 71.219999999999999 110.326 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 72.2 Cg_endo -96.32 96.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.21 1.94 . . . . 70.010000000000005 111.205 160.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.84 109.36 3.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.482 0.919 . . . . 64.439999999999998 113.482 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.13 -11.62 24.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.149 -0.932 . . . . 72.209999999999994 111.662 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.922 -0.561 . . . . 74.040000000000006 112.002 -179.21 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.001 0.429 . . . . 65.239999999999995 111.428 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -172.56 93.1 0.39 Allowed Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 112.145 0.424 . . . . 74.099999999999994 112.145 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.52 105.69 1.06 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.429 2.086 . . . . 71.25 112.031 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -39.13 20.84 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.501 0.556 . . . . 54.329999999999998 112.501 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -94.03 151.05 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.133 0.492 . . . . 74.109999999999999 111.823 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -107.21 -12.84 15.29 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 111.458 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.738 ' SD ' ' HG2' ' A' ' 20' ' ' PRO . 12.5 mmt -100.25 116.71 32.87 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 111.859 0.318 . . . . 72.209999999999994 111.859 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -131.04 -174.9 3.51 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.53 0.567 . . . . 73.010000000000005 112.53 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m -117.12 172.38 7.32 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.078 -0.51 . . . . 42.520000000000003 111.084 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.627 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.230000000000004 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.019999999999996 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 64.0 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.530000000000001 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 60.439999999999998 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.299999999999997 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.129999999999995 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.240000000000002 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.209999999999994 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 52.439999999999998 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.738 ' HG2' ' SD ' ' A' ' 7' ' ' MET . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.530000000000001 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.549999999999997 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.240000000000002 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.329999999999998 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 28' ' ' ILE . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.019999999999996 111.932 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.510000000000005 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.239999999999995 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 47' ' ' VAL . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.140000000000001 110.924 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.310000000000002 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.219999999999999 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 51.399999999999999 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.310000000000002 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.509999999999998 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.61 157.97 44.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 52.0 111.304 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.6 m -85.52 105.93 16.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.045 0.45 . . . . 74.5 111.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -91.39 -171.59 2.99 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.402 . . . . 63.200000000000003 111.339 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 37' ' ' ARG . 7.4 tpt180 -75.35 44.8 0.27 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 121.246 0.546 . . . . 63.049999999999997 111.238 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp 63.45 -165.02 0.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.202 0.601 . . . . 64.010000000000005 111.58 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.0 -62.39 4.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.637 -0.792 . . . . 22.41 112.217 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -115.92 161.5 18.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.999 0.428 . . . . 74.549999999999997 111.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.93 -39.88 93.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 111.412 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.5 107.16 2.51 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.465 -0.398 . . . . 24.32 114.036 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.120000000000005 112.35 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 61.329999999999998 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.329999999999998 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.349999999999994 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 28' ' ' ILE . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 52.149999999999999 111.319 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 40.030000000000001 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.439 HD11 HD23 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.010000000000005 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.310000000000002 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.130000000000003 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 51.439999999999998 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.530000000000001 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.109999999999999 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.540000000000006 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 72.430000000000007 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.019999999999996 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.349999999999994 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.039999999999999 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 71.230000000000004 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.409999999999997 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.319999999999993 113.911 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.319999999999993 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.109999999999999 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.219999999999999 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.340000000000003 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.299999999999997 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 44.130000000000003 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.409999999999997 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.319999999999993 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.219999999999999 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.430000000000007 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.109999999999999 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.509999999999998 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.399999999999999 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 22.530000000000001 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.329999999999998 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 73.430000000000007 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 102' ' ' VAL . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.319999999999993 110.9 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.540000000000006 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.219999999999999 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.200000000000003 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.430000000000007 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 54.119999999999997 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 30.5 mmm180 -99.39 4.76 46.4 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 97.7 -36.83 3.72 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.224 0.85 . . . . 74.219999999999999 115.224 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 56.18 91.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.922 0 CA-C-N 117.552 0.676 . . . . 52.030000000000001 112.678 -172.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -71.69 89.41 1.01 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.273 0.559 . . . . 71.310000000000002 111.031 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.976 -0.556 . . . . 73.439999999999998 112.858 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.76 -62.55 3.89 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.174 -0.536 . . . . 75.349999999999994 113.803 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -80.56 100.09 8.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.004 0.431 . . . . 74.439999999999998 111.73 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 57.7 mttp -61.28 173.89 0.79 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.420000000000002 112.912 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.019999999999996 111.051 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.400000000000006 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.340000000000003 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.219999999999999 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.539999999999999 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.150000000000006 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.329999999999998 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 65.230000000000004 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.450000000000003 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 79' ' ' ILE . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.219999999999999 111.628 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.210000000000001 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.329999999999998 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt -102.51 -153.35 0.46 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.209999999999994 111.766 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 6.0 m-20 68.11 158.04 0.14 Allowed Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.464 -0.939 . . . . 61.149999999999999 108.464 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 9.7 Cg_exo 0.73 82.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.421 2.747 . . . . 73.230000000000004 113.269 -152.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.67 128.69 2.56 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.842 -1.527 . . . . 52.229999999999997 114.328 -161.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -81.74 -38.1 26.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.234 -0.894 . . . . 62.25 111.776 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.791 -0.623 . . . . 70.209999999999994 112.004 -179.073 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 tpp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.645 0.26 . . . . 74.409999999999997 111.651 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 9.1 mtmp? -111.28 110.03 56.26 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.043 0.386 . . . . 64.019999999999996 112.043 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.43 116.97 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.767 2.311 . . . . 74.540000000000006 113.029 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -78.34 17.55 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.431 0.53 . . . . 64.540000000000006 112.431 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -87.62 105.83 17.61 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.047 0.451 . . . . 73.409999999999997 111.539 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -177.15 6.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.204 0.526 . . . . 72.519999999999996 111.848 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 20.9 ptp -150.41 98.46 2.66 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.918 -0.583 . . . . 71.430000000000007 110.912 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -158.61 0.68 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.006 0.373 . . . . 54.240000000000002 112.006 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 HG21 ' A' ' 53' ' ' THR . 7.9 t -124.65 179.69 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.409999999999997 111.734 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.239999999999995 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 42.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.540000000000006 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.209999999999994 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.510000000000005 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.340000000000003 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.520000000000003 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.219999999999999 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.409999999999997 110.522 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 71.549999999999997 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.340000000000003 112.892 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.010000000000005 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.010000000000005 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.129999999999995 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.409999999999997 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.329999999999998 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.049999999999997 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.219999999999999 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.329999999999998 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.340000000000003 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.530000000000001 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.420000000000002 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -139.42 174.75 10.19 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.510000000000005 109.19 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -100.69 108.75 20.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.721 -0.612 . . . . 70.239999999999995 111.627 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -78.08 -172.04 2.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.371 -0.377 . . . . 74.109999999999999 111.592 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -53.72 -66.55 0.37 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.043 0.757 . . . . 74.420000000000002 113.043 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -167.57 148.85 5.5 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.296 0.569 . . . . 62.439999999999998 112.401 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.0 -64.67 2.35 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 116.069 -0.514 . . . . 30.140000000000001 112.596 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -84.58 161.51 20.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.889 0.376 . . . . 73.040000000000006 111.154 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 20.4 pt-20 -76.39 -56.71 4.38 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.644 -0.253 . . . . 72.400000000000006 110.862 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 97.76 106.93 2.53 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 121.464 -0.398 . . . . 44.119999999999997 113.417 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.540000000000006 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.409999999999997 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 53.140000000000001 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.040000000000006 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.399999999999999 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 71.530000000000001 110.994 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.010000000000005 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 72.219999999999999 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.209999999999994 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.420000000000002 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 71.209999999999994 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.140000000000001 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.636 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.109999999999999 110.85 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.409999999999997 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.340000000000003 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 52.520000000000003 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.140000000000001 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.439999999999998 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.340000000000003 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.447 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 43.409999999999997 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.299999999999997 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 43.420000000000002 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.319999999999993 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.240000000000002 112.559 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.609 HD13 HG13 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.219999999999999 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.150000000000006 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.019999999999996 112.654 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.539999999999999 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.230000000000004 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 72' ' ' ARG . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.399999999999999 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.450000000000003 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.310000000000002 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.299999999999997 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.349999999999994 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 65.340000000000003 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.010000000000005 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 74.340000000000003 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.030000000000001 112.204 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.540000000000006 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.408 HD12 HD13 ' A' ' 13' ' ' LEU . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.340000000000003 110.784 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -93.36 -37.47 11.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 64.049999999999997 111.152 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.0 61.96 6.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.273 -0.489 . . . . 73.430000000000007 113.278 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . -71.14 140.21 30.71 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.156 -0.545 . . . . 52.219999999999999 113.406 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.17 96.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.134 0.492 . . . . 74.439999999999998 111.445 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.02 46.66 0.16 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.79 -0.641 . . . . 75.349999999999994 112.341 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 -77.46 0.64 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.416 -0.421 . . . . 71.329999999999998 112.799 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.636 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 48.8 mtm180 -93.77 139.88 30.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.987 0.423 . . . . 74.010000000000005 111.301 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.49 -177.39 4.69 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.420000000000002 112.323 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 71.349999999999994 111.815 -176.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.109999999999999 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 72.010000000000005 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.219999999999999 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.140000000000001 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 62.340000000000003 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 60.450000000000003 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.030000000000001 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.310000000000002 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.609 HG13 HD13 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 54.340000000000003 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.299999999999997 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.209999999999994 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt -85.49 -15.6 42.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.340000000000003 112.593 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 26.8 t70 -71.21 -58.65 3.81 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 121.111 -0.236 . . . . 64.409999999999997 110.874 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 14.1 Cg_exo -72.18 -18.81 26.7 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.859 1.706 . . . . 53.539999999999999 111.07 167.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 tm? 72.08 111.49 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.868 -1.06 . . . . 74.400000000000006 113.305 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -70.58 0.53 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.593 -0.73 . . . . 73.239999999999995 110.339 168.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.78 -0.628 . . . . 75.319999999999993 111.305 175.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.711 0.291 . . . . 63.219999999999999 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -94.86 114.88 64.63 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.558 -0.292 . . . . 72.420000000000002 111.069 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 138.0 68.29 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.667 2.245 . . . . 72.219999999999999 113.038 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.75 66.66 2.71 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.186 0.439 . . . . 73.030000000000001 112.186 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -171.36 131.48 0.75 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.575 -0.284 . . . . 74.140000000000001 111.128 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 57.92 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.412 0.625 . . . . 64.549999999999997 111.708 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.4 ttp -173.4 58.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.798 0.809 . . . . 72.510000000000005 109.474 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 1.8 m-20 -86.38 164.37 17.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.467 -0.788 . . . . 73.030000000000001 112.3 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 53' ' ' THR . 10.0 t -99.28 -178.93 4.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.88 -0.6 . . . . 61.119999999999997 111.298 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.420000000000002 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.409999999999997 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.420000000000002 112.227 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.540000000000006 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.329999999999998 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.545 ' HB3' ' HA3' ' A' ' 86' ' ' GLY . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 44.509999999999998 112.757 -174.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.450000000000003 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.040000000000006 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.340000000000003 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.450000000000003 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.020000000000003 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.430000000000007 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.530000000000001 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.340000000000003 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.340000000000003 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.5 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.230000000000004 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.519999999999996 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.130000000000003 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.430000000000007 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.319999999999993 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.520000000000003 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.310000000000002 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 71.439999999999998 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -145.4 158.54 43.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 60.340000000000003 112.014 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.1 m -86.33 105.52 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.213 -0.449 . . . . 63.140000000000001 111.212 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -96.85 173.59 7.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.3 0.572 . . . . 73.109999999999999 111.732 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.39 0.43 47.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.307 0.575 . . . . 64.0 110.68 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' HB3' ' NZ ' ' A' ' 38' ' ' LYS . 6.0 mtpm? -94.52 13.42 24.06 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.992 0.738 . . . . 62.420000000000002 112.992 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.05 -28.19 2.94 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 115.087 0.795 . . . . 70.109999999999999 115.087 172.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -85.05 160.77 19.93 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.807 -0.82 . . . . 75.219999999999999 112.004 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -48.37 -39.43 22.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.413 0.894 . . . . 71.25 113.413 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.25 110.24 0.12 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.017 -0.611 . . . . 73.099999999999994 113.675 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 62.229999999999997 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.400000000000006 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.140000000000001 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.120000000000005 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.430000000000007 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.200000000000003 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.400000000000006 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.200000000000003 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 62.149999999999999 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 60.329999999999998 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 21.23 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.219999999999999 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.310000000000002 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.420000000000002 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.540000000000006 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.109999999999999 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 65.099999999999994 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.319999999999993 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.471 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.129999999999995 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.310000000000002 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.319999999999993 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 62' ' ' THR . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.310000000000002 111.094 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.519999999999996 112.046 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.099999999999994 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.340000000000003 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.409999999999997 112.145 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.140000000000001 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.349999999999994 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.030000000000001 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.239999999999995 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.450000000000003 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.430000000000007 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.329999999999998 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.531 HG22 HG12 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.340000000000003 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.230000000000004 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.120000000000005 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.510000000000005 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.040000000000006 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.209999999999994 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.120000000000005 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.209999999999994 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -75.89 -49.29 18.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.409999999999997 110.956 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.733 ' HA2' ' HB3' ' A' ' 92' ' ' LYS . . . 58.47 65.05 3.77 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.991 -0.549 . . . . 62.43 114.169 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.43 -32.55 3.65 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.928 -0.654 . . . . 53.140000000000001 112.593 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -82.48 131.54 35.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.927 0.394 . . . . 75.140000000000001 111.67 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.53 82.07 0.21 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.149 -0.548 . . . . 55.140000000000001 112.562 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.74 -109.77 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 112.032 -0.427 . . . . 64.230000000000004 112.032 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -72.56 87.22 1.2 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.153 0.501 . . . . 74.109999999999999 110.773 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.733 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 76.6 mttt -66.9 179.68 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.841 -0.618 . . . . 73.439999999999998 111.548 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.210000000000001 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.140000000000001 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.319999999999993 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 65.200000000000003 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 53.439999999999998 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.409999999999997 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.230000000000004 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.030000000000001 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.099999999999994 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.129999999999995 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.329999999999998 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.7 -169.18 2.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 63.219999999999999 110.804 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 10.6 t70 70.52 140.39 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.348 -0.982 . . . . 73.150000000000006 108.348 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 21.3 Cg_exo -3.48 81.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 124.536 3.491 . . . . 72.219999999999999 114.752 -161.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 110' ' ' HIS . 2.0 tm? -63.14 140.06 58.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.084 -1.416 . . . . 73.230000000000004 111.943 -168.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -41.64 -46.52 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.074 0.768 . . . . 74.109999999999999 113.074 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.772 ' H ' HD13 ' A' ' 108' ' ' LEU . 23.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.799 -0.619 . . . . 72.400000000000006 111.342 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.837 0.351 . . . . 71.439999999999998 111.267 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -143.02 96.98 5.83 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.829 0.347 . . . . 70.0 111.054 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.52 131.48 2.91 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.759 2.306 . . . . 73.420000000000002 113.548 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.12 156.03 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.536 -0.302 . . . . 72.319999999999993 110.809 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -134.01 101.27 4.99 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.902 0.382 . . . . 60.25 111.992 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -154.32 80.3 1.11 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 73.120000000000005 110.433 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -172.65 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.48 0.657 . . . . 74.0 110.733 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 3.3 m-20 -70.01 161.94 29.1 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.208 1.188 . . . . 52.420000000000002 114.208 -170.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -104.5 178.83 4.45 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.169 -0.923 . . . . 73.409999999999997 111.07 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.230000000000004 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.109999999999999 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.409999999999997 112.54 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.540000000000006 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.040000000000006 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.430000000000007 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.129999999999995 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.430000000000007 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.349999999999994 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.019999999999996 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.540000000000006 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.340000000000003 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 105' ' ' LEU . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.439999999999998 111.822 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.140000000000001 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' HG21 ' A' ' 76' ' ' VAL . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.329999999999998 110.068 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.519999999999996 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 53.119999999999997 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.457 HG23 HG22 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.039999999999999 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.329999999999998 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.129999999999995 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.119999999999997 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.340000000000003 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 60.140000000000001 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -144.47 157.08 44.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.510000000000005 110.396 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.8 m -85.48 112.75 21.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.285 0.564 . . . . 74.140000000000001 111.657 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.1 t -89.75 -171.1 3.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.863 -0.608 . . . . 72.150000000000006 111.187 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.7 mtt-85 -56.35 -59.25 5.24 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.819 0.342 . . . . 74.540000000000006 111.572 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -178.11 156.45 1.02 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 111.189 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 -72.55 0.2 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.321 -0.466 . . . . 52.509999999999998 113.127 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -104.34 155.31 18.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.016 0.436 . . . . 70.019999999999996 111.348 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.51 -11.37 57.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.542 0.941 . . . . 75.040000000000006 113.542 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.03 122.36 0.08 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.432 -0.413 . . . . 54.240000000000002 113.916 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 63.210000000000001 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.009999999999998 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.230000000000004 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.140000000000001 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG22 HG23 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.310000000000002 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.349999999999994 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.509999999999998 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.230000000000004 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.524 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.230000000000004 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.119999999999997 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 53.450000000000003 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 12.210000000000001 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.120000000000005 111.001 175.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.230000000000004 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.519999999999996 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 44.530000000000001 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 64.400000000000006 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 61.299999999999997 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 62.240000000000002 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.52 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.540000000000006 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.209999999999994 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.484 ' HB3' HD12 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.299999999999997 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.239999999999995 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 61.039999999999999 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.030000000000001 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.519999999999996 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.430000000000007 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.310000000000002 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.430000000000007 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 61.350000000000001 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.350000000000001 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.219999999999999 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.421 HG21 ' HE ' ' A' ' 24' ' ' ARG . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 73.140000000000001 110.712 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.539999999999999 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 54.030000000000001 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 62.340000000000003 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.340000000000003 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.450000000000003 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.430000000000007 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.209999999999994 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 21' ' ' VAL . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.230000000000004 111.189 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 -81.02 -42.48 21.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.099999999999994 111.045 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 59.41 50.11 71.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.198 0.439 . . . . 64.209999999999994 114.198 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.68 66.49 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.243 -0.979 . . . . 41.140000000000001 114.044 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -126.27 89.38 3.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.053 0.454 . . . . 75.099999999999994 110.476 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.36 -49.08 3.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.052 -0.594 . . . . 65.430000000000007 113.209 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.83 -43.71 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.232 -0.509 . . . . 60.43 112.91 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.529 ' NH1' ' HB2' ' A' ' 55' ' ' GLU . 88.7 mtt180 -88.78 172.28 9.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.661 0.743 . . . . 71.340000000000003 112.684 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 93.3 mttt -87.65 168.92 12.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.513 -0.767 . . . . 74.0 112.153 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.319999999999993 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.310000000000002 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.140000000000001 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.329999999999998 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.489 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.329999999999998 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.040000000000006 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.109999999999999 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 64.450000000000003 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 54.539999999999999 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 72.239999999999995 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 73.510000000000005 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 108' ' ' LEU . 36.5 mt -99.76 -172.27 2.21 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.439999999999998 111.301 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.589 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER 64.73 155.78 0.12 Allowed Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.618 -0.882 . . . . 74.329999999999998 108.618 -166.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 6.3 Cg_exo -1.54 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.717 2.945 . . . . 75.209999999999994 113.669 -156.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -50.64 133.72 25.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.907 -1.497 . . . . 72.400000000000006 114.772 -162.158 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.88 -61.78 2.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.068 -0.969 . . . . 73.239999999999995 110.621 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 118.53 -0.748 . . . . 72.430000000000007 111.29 176.486 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.581 0.215 . . . . 72.329999999999998 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HD3' ' H ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -142.46 105.79 5.51 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.237 0.541 . . . . 73.319999999999993 110.761 177.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -89.76 114.23 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.459 2.106 . . . . 73.120000000000005 113.302 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.85 113.73 20.68 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.248 0.547 . . . . 51.509999999999998 111.08 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -101.62 145.72 28.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.916 -0.584 . . . . 65.129999999999995 112.194 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.537 ' NH1' ' HD3' ' A' ' 20' ' ' PRO . 17.7 tpt85 72.52 26.03 2.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.411 0.684 . . . . 71.129999999999995 112.318 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 100.06 0.92 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.639 -0.504 . . . . 73.120000000000005 109.639 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -118.92 141.21 48.86 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.179 0.437 . . . . 62.049999999999997 112.179 -173.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p -77.69 169.83 17.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.495 -0.32 . . . . 74.439999999999998 110.908 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.230000000000004 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.607 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.239999999999995 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.019999999999996 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.420000000000002 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.109999999999999 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.229999999999997 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.420000000000002 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.400000000000006 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HD3' ' NH1' ' A' ' 6' ' ' ARG . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.120000000000005 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.350000000000001 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 63.409999999999997 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.209999999999994 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.430000000000007 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.120000000000005 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.329999999999998 111.425 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.299999999999997 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.329999999999998 111.267 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 71.030000000000001 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 53.229999999999997 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.420000000000002 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.209999999999994 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.03 165.43 34.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 71.329999999999998 111.201 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.2 m -85.14 133.31 34.21 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.937 0.398 . . . . 71.409999999999997 111.486 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 40' ' ' ARG . 47.2 p -92.12 178.33 5.9 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.211 0.529 . . . . 74.409999999999997 112.111 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -92.12 9.58 32.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.49 0.552 . . . . 71.150000000000006 112.49 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -142.31 -69.08 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.082 -0.386 . . . . 73.140000000000001 111.894 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.29 40.33 0.05 OUTLIER Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.739 -1.219 . . . . 74.230000000000004 114.691 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.588 ' HB2' HG21 ' A' ' 36' ' ' THR . 46.7 mtp85 -111.04 161.72 15.6 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.386 -0.479 . . . . 75.439999999999998 110.073 175.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -68.56 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.751 -0.38 . . . . 71.200000000000003 111.432 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 66.79 107.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.397 -0.365 . . . . 64.25 114.01 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.420000000000002 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.039999999999999 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.409999999999997 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.310000000000002 111.271 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.319999999999993 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 43.109999999999999 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.530000000000001 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.099999999999994 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.340000000000003 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.340000000000003 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.109999999999999 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 64.219999999999999 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.149999999999999 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.310000000000002 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.109999999999999 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.019999999999996 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 62.350000000000001 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.140000000000001 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.019999999999996 113.631 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.400000000000006 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.43 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.150000000000006 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 40.439999999999998 111.551 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.310000000000002 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 71.439999999999998 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.219999999999999 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.299999999999997 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.200000000000003 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.230000000000004 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.400000000000006 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.340000000000003 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.239999999999995 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 64.540000000000006 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.140000000000001 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.099999999999994 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.430000000000007 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.129999999999995 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.420000000000002 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.340000000000003 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 86' ' ' GLY . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 73.319999999999993 111.288 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 -97.78 7.99 45.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.299999999999997 112.379 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 84' ' ' ILE . . . 85.78 -26.76 5.74 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 114.539 0.576 . . . . 62.299999999999997 114.539 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.33 64.29 3.86 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 117.386 0.593 . . . . 65.140000000000001 112.939 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -50.51 107.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.111 0.481 . . . . 64.329999999999998 112.073 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.15 -39.86 1.63 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.273 -0.489 . . . . 24.550000000000001 113.221 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.4 -67.99 0.1 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.87 -0.681 . . . . 64.239999999999995 113.298 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 58.2 mtt180 -79.45 112.11 16.38 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.787 -0.243 . . . . 71.25 111.343 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 9.6 mtmp? -58.11 155.48 11.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.439999999999998 111.212 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.109999999999999 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.450000000000003 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 73.420000000000002 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.340000000000003 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.219999999999999 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.450000000000003 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.310000000000002 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 79' ' ' ILE . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.010000000000005 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.010000000000005 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 86.2 mt -123.49 -175.13 3.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.239999999999995 111.598 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 27.9 t70 80.04 -74.39 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.38 1.072 . . . . 73.109999999999999 110.343 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 10.6 Cg_exo -75.76 93.88 1.0 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 CA-C-N 121.812 1.683 . . . . 74.030000000000001 109.882 156.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.54 92.25 0.14 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.358 0.873 . . . . 54.340000000000003 113.358 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -68.22 -25.34 65.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.705 -1.134 . . . . 73.209999999999994 111.637 173.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 112.857 0.688 . . . . 74.329999999999998 112.857 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.958 0.408 . . . . 73.430000000000007 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -163.44 82.5 1.46 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.85 -0.426 . . . . 73.310000000000002 109.85 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -90.98 121.54 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.262 2.642 . . . . 75.329999999999998 112.814 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.07 81.09 5.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.229 0.538 . . . . 72.439999999999998 111.42 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -154.95 72.66 0.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.87 -0.605 . . . . 65.200000000000003 110.887 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -92.57 -158.87 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.073 -0.714 . . . . 74.150000000000006 109.073 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.498 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . 18.1 ptm -91.13 87.33 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.484 -0.562 . . . . 63.229999999999997 109.484 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.55 136.35 38.66 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.627 -0.715 . . . . 74.129999999999995 112.238 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -69.36 167.39 16.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.217 -0.447 . . . . 75.420000000000002 111.013 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.319999999999993 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.299999999999997 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.129999999999995 113.296 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.209999999999994 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.549999999999997 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 71.019999999999996 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.219999999999999 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.299999999999997 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.420000000000002 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.230000000000004 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HG2' ' HB3' ' A' ' 7' ' ' MET . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 33.240000000000002 111.537 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 78' ' ' ARG . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 73.450000000000003 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.209999999999994 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 54.43 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.140000000000001 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.140000000000001 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.129999999999995 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 52.310000000000002 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.120000000000005 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.340000000000003 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.230000000000004 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.120000000000005 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.8 146.62 30.31 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.329999999999998 111.419 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.3 m -84.57 106.88 16.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.276 0.56 . . . . 62.450000000000003 112.159 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 t -97.61 149.09 22.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.156 -0.475 . . . . 70.230000000000004 111.156 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.27 1.65 27.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.489 -0.323 . . . . 70.409999999999997 111.861 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -73.66 -43.53 59.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.179 0.437 . . . . 75.010000000000005 112.179 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.03 -32.77 1.4 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.475 -0.869 . . . . 65.430000000000007 113.809 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.03 160.77 20.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.091 0.446 . . . . 72.329999999999998 111.181 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 43' ' ' LYS . 13.0 pt-20 -69.41 -13.23 62.25 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.987 0.736 . . . . 63.409999999999997 112.987 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 70.18 123.49 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.506 -0.378 . . . . 51.140000000000001 114.037 175.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' H ' ' HB ' ' A' ' 62' ' ' THR . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 61.140000000000001 111.355 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.129999999999995 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.229999999999997 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.400000000000006 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 64.140000000000001 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.049999999999997 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.129999999999995 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.340000000000003 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.129999999999995 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.229999999999997 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.535 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.109999999999999 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.439999999999998 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.804 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.409999999999997 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.310000000000002 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.019999999999996 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.329999999999998 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 72.099999999999994 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 63.119999999999997 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 61.030000000000001 113.565 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.530000000000001 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.409999999999997 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.129999999999995 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.509999999999998 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.546 HD13 HG13 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.230000000000004 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.239999999999995 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.420000000000002 113.038 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.420000000000002 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.120000000000005 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.010000000000005 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.140000000000001 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.040000000000006 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.430000000000007 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.109999999999999 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.340000000000003 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 53.219999999999999 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.140000000000001 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.010000000000005 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.229999999999997 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 96' ' ' LEU . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.120000000000005 111.627 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -101.92 -31.75 10.54 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 52.329999999999998 111.462 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.75 94.52 0.29 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.882 -0.675 . . . . 42.329999999999998 113.454 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -62.37 120.73 22.99 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.117 -0.563 . . . . 64.099999999999994 112.392 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.04 -33.89 72.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.673 -0.31 . . . . 72.140000000000001 111.716 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.31 70.76 1.84 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.954 -0.641 . . . . 61.32 113.59 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 -77.36 1.27 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 113.929 0.332 . . . . 35.399999999999999 113.929 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 89.4 mtm180 -86.62 135.38 33.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.074 0.464 . . . . 73.319999999999993 112.195 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 52.3 mttp -72.34 -176.05 1.74 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.520000000000003 112.37 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 54.210000000000001 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 64.430000000000007 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.109999999999999 112.009 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.130000000000003 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 64.219999999999999 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.408 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 62.43 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.120000000000005 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.310000000000002 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 76.6 mt -115.75 164.7 13.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.530000000000001 110.214 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.6 t70 91.42 -60.79 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.62 1.168 . . . . 65.129999999999995 109.415 -168.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.685 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 38.3 Cg_endo -69.73 -138.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 N-CA-C 109.047 -1.174 . . . . 75.439999999999998 109.047 149.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -173.46 138.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.821 0.737 . . . . 75.109999999999999 111.972 171.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.56 -53.08 10.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.181 0.515 . . . . 71.219999999999999 110.871 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.534 -0.746 . . . . 75.200000000000003 112.08 176.008 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 112.151 0.426 . . . . 72.439999999999998 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -120.72 159.62 47.81 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 122.207 -0.308 . . . . 44.020000000000003 110.636 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.85 92.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.332 2.022 . . . . 51.240000000000002 113.465 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -89.86 107.94 19.41 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.369 0.605 . . . . 74.129999999999995 111.289 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -140.55 103.98 4.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.918 -0.583 . . . . 73.329999999999998 111.972 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.512 ' HA ' ' NE ' ' A' ' 6' ' ' ARG . 2.9 mmp_? -145.12 -179.43 6.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.238 -0.437 . . . . 71.340000000000003 111.055 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.2 mmm -87.07 134.84 33.46 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.243 0.544 . . . . 62.119999999999997 112.015 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.52 126.96 31.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.708 0.766 . . . . 73.549999999999997 112.895 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -133.94 161.42 34.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.488 -0.778 . . . . 72.400000000000006 109.093 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 45.200000000000003 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.120000000000005 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.340000000000003 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.209999999999994 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.409999999999997 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.140000000000001 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.230000000000004 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.439999999999998 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.420000000000002 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 53.399999999999999 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 79' ' ' ILE . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.329999999999998 111.679 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.230000000000004 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.129999999999995 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.129999999999995 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.230000000000004 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.423 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 71.209999999999994 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.439999999999998 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 71.510000000000005 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.430000000000007 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 70.010000000000005 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 72.329999999999998 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 63.509999999999998 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 71.230000000000004 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -122.98 153.41 39.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.349999999999994 111.298 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.3 m -84.94 122.94 29.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 65.099999999999994 111.41 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -108.48 168.45 9.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.013 0.435 . . . . 75.340000000000003 111.038 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.536 ' N ' ' HD2' ' A' ' 37' ' ' ARG . 2.4 mpt_? -102.05 5.21 40.44 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.767 0.284 . . . . 72.540000000000006 111.767 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -90.93 -53.06 4.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.399 0.518 . . . . 73.400000000000006 112.399 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.9 -19.3 0.24 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.033 -1.079 . . . . 64.310000000000002 114.991 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -85.59 160.79 19.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 117.656 0.728 . . . . 71.439999999999998 111.345 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.89 -22.23 63.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.374 0.509 . . . . 72.430000000000007 112.374 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 74.74 123.54 0.12 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 23.43 114.769 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 71.299999999999997 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.019999999999996 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.340000000000003 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.540000000000006 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.530000000000001 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.040000000000006 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.219999999999999 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.299999999999997 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.040000000000006 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.540000000000006 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 52.509999999999998 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.340000000000003 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.430000000000007 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.520000000000003 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.230000000000004 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 51.450000000000003 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 53.439999999999998 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 54.030000000000001 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.019999999999996 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.049999999999997 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.120000000000005 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.329999999999998 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.219999999999999 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.140000000000001 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 71.25 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.149999999999999 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.109999999999999 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 71.150000000000006 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.310000000000002 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.439999999999998 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.439999999999998 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.340000000000003 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.310000000000002 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.209999999999994 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.140000000000001 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.617 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.450000000000003 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.450000000000003 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.119999999999997 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.510000000000005 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.209999999999994 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.239999999999995 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 72.420000000000002 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? -85.98 -52.89 5.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.099999999999994 111.092 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 93.27 104.13 1.65 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.153 -0.546 . . . . 44.549999999999997 113.689 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -56.79 118.9 13.02 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.977 -0.63 . . . . 72.200000000000003 111.735 173.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -54.71 112.79 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.205 0.446 . . . . 73.239999999999995 112.205 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.13 11.06 85.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.413 0.525 . . . . 61.43 114.413 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.51 -146.75 4.6 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.968 -0.634 . . . . 72.450000000000003 112.719 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -74.18 145.49 44.17 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.365 0.602 . . . . 74.209999999999994 110.853 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 65.4 mttm -81.09 174.32 11.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.450000000000003 112.054 -173.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.229999999999997 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 52.539999999999999 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.299999999999997 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.120000000000005 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.53 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.539999999999999 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.430000000000007 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.239999999999995 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 31.399999999999999 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.430000000000007 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 64.409999999999997 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.209999999999994 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 61.020000000000003 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 108' ' ' LEU . 58.9 mt -105.53 -172.01 2.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.329999999999998 111.432 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.668 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.3 m-20 65.03 161.31 0.12 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.758 -0.83 . . . . 75.230000000000004 108.758 -167.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 11.2 Cg_exo 0.3 81.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.342 2.695 . . . . 63.399999999999999 113.185 -153.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 HD22 ' A' ' 105' ' ' LEU . 4.1 mm? -57.98 128.82 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.566 1.691 . . . . 63.109999999999999 115.566 -159.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.58 -22.13 62.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.17 -1.377 . . . . 62.530000000000001 111.084 169.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.402 -0.809 . . . . 74.439999999999998 111.354 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.812 0.339 . . . . 72.340000000000003 110.777 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -118.82 148.44 44.48 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.573 0.225 . . . . 74.519999999999996 111.204 -177.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.99 56.01 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.543 2.162 . . . . 61.420000000000002 111.049 168.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.89 107.68 10.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.932 -1.031 . . . . 62.439999999999998 112.339 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -167.43 130.83 1.75 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.972 -0.558 . . . . 74.519999999999996 110.831 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -173.92 151.91 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.546 -0.297 . . . . 73.219999999999999 110.664 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 71.9 mtm -55.09 99.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.507 0.558 . . . . 61.409999999999997 112.507 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 1.2 p30 -83.98 153.77 23.69 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.934 -0.576 . . . . 73.5 112.164 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -134.27 -163.87 1.43 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.942 -0.572 . . . . 63.229999999999997 111.611 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.530000000000001 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.239999999999995 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' ASP . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.439999999999998 111.79 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.439999999999998 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.510000000000005 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.530000000000001 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.409999999999997 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 42.450000000000003 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.219999999999999 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.450000000000003 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.120000000000005 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.219999999999999 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 44.25 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.100000000000001 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.340000000000003 111.472 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.099999999999994 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.420000000000002 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG12 HG13 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 61.149999999999999 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.430000000000007 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 61.310000000000002 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 24.120000000000001 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.149999999999999 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.319999999999993 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -119.59 174.42 6.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.310000000000002 110.207 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 m -101.62 120.85 40.97 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.158 -0.338 . . . . 70.439999999999998 111.839 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -107.39 173.35 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.913 0.387 . . . . 54.229999999999997 110.77 172.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -89.15 -31.72 17.83 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.319 0.859 . . . . 74.349999999999994 113.319 -171.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 137.69 49.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.545 0.943 . . . . 73.219999999999999 113.545 -170.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.98 -72.24 1.1 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.624 -0.716 . . . . 23.43 114.409 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -95.54 162.79 13.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.913 0.708 . . . . 64.120000000000005 112.913 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 14.8 pt-20 -64.28 -54.46 32.92 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.27 -0.877 . . . . 73.120000000000005 111.214 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 120.04 117.06 2.59 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.359 -0.382 . . . . 75.340000000000003 113.026 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.120000000000005 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.409999999999997 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 72.510000000000005 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.329999999999998 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.319999999999993 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.430000000000007 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 52.420000000000002 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.230000000000004 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.520000000000003 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.230000000000004 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.310000000000002 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.310000000000002 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.430000000000007 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.450000000000003 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.340000000000003 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 61.210000000000001 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.519999999999996 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.150000000000006 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.530000000000001 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.140000000000001 111.435 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.519999999999996 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.539999999999999 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.420000000000002 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HB3' HG22 ' A' ' 102' ' ' VAL . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.310000000000002 112.262 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.509999999999998 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.129999999999995 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.150000000000006 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.439999999999998 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.239999999999995 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.129999999999995 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.310000000000002 113.369 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.019999999999996 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.140000000000001 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.120000000000005 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.329999999999998 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.129999999999995 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.210000000000001 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.239999999999995 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.319999999999993 111.787 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.329999999999998 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.420000000000002 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 -87.66 -22.65 24.56 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 73.150000000000006 111.506 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.22 -14.01 58.43 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.409 -0.424 . . . . 72.540000000000006 113.639 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 61.6 -138.97 46.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.371 -0.442 . . . . 63.409999999999997 113.517 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -139.07 99.5 3.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.241 0.46 . . . . 74.109999999999999 112.241 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 43.11 56.27 4.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.0 0.76 . . . . 22.32 115.0 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.64 -74.95 0.28 Allowed Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.966 -0.635 . . . . 75.439999999999998 112.66 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -94.78 124.43 38.82 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.443 -0.445 . . . . 72.329999999999998 110.961 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 36.3 mtmm -92.85 176.09 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.004 -0.544 . . . . 63.109999999999999 111.306 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.140000000000001 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.409999999999997 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.120000000000005 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.230000000000004 112.011 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.430000000000007 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 53.310000000000002 112.934 175.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.209999999999994 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.219999999999999 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.019999999999996 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 67' ' ' LEU . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.239999999999995 110.438 173.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 65.310000000000002 111.433 -176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.010000000000005 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -102.33 -3.3 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.230000000000004 112.557 -176.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.816 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.3 t70 -75.88 -53.11 2.48 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 110.47 -0.196 . . . . 74.430000000000007 110.47 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.9 Cg_endo -84.93 -12.63 7.08 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.312 2.008 . . . . 55.229999999999997 111.368 165.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.45 112.79 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.454 0.702 . . . . 63.420000000000002 111.764 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 5.7 mm-40 -94.1 -59.98 1.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.897 -0.592 . . . . 72.25 112.277 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.6 m80 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.985 -0.531 . . . . 73.219999999999999 112.206 -178.696 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 112.167 0.432 . . . . 74.109999999999999 112.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -125.68 86.8 56.88 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 121.958 -0.464 . . . . 63.149999999999999 111.215 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.75 91.35 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.348 2.032 . . . . 75.129999999999995 112.643 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -70.15 83.71 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.759 0.79 . . . . 52.539999999999999 111.4 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.69 109.19 7.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.771 -0.65 . . . . 71.120000000000005 111.542 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 6' ' ' ARG . 16.4 mtm180 -117.87 -178.28 3.45 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.09 -0.504 . . . . 63.32 110.693 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.88 60.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 62.039999999999999 109.908 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.736 ' HB2' HG21 ' A' ' 19' ' ' THR . 59.7 m-20 -71.56 110.02 5.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.114 -0.494 . . . . 74.329999999999998 111.676 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -71.58 175.61 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.162 -0.472 . . . . 43.210000000000001 110.176 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.56 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.420000000000002 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.340000000000003 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.439999999999998 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.409999999999997 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.519999999999996 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.329999999999998 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.020000000000003 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 45.340000000000003 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.150000000000006 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.736 HG21 ' HB2' ' A' ' 8' ' ' ASP . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 73.120000000000005 111.264 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.120000000000005 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.120000000000005 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 65.219999999999999 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.439999999999998 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG2' HG22 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.430000000000007 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.040000000000006 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.239999999999995 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 47' ' ' VAL . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.439999999999998 111.196 173.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.439999999999998 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 64.549999999999997 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.129999999999995 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.519999999999996 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.340000000000003 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -117.57 175.0 5.84 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.519999999999996 110.741 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -94.06 105.44 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 111.551 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -81.86 -171.65 3.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.964 0.357 . . . . 73.299999999999997 111.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -60.05 -65.2 0.72 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.866 0.466 . . . . 74.519999999999996 112.229 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -162.36 150.12 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.541 0.571 . . . . 72.349999999999994 112.541 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.78 -67.51 3.2 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 116.362 -0.381 . . . . 62.329999999999998 113.115 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -85.95 161.94 18.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.098 0.475 . . . . 62.310000000000002 111.674 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.46 -60.89 2.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.925 -0.58 . . . . 72.140000000000001 111.014 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.75 119.54 4.14 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.589 -0.339 . . . . 72.540000000000006 113.119 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.200000000000003 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.120000000000005 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.329999999999998 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.130000000000003 110.961 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.540000000000006 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 HG22 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.420000000000002 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.329999999999998 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.510000000000005 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.319999999999993 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 70.0 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.140000000000001 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.539999999999999 112.13 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 64.450000000000003 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.530000000000001 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 54.329999999999998 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 71.340000000000003 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 61.140000000000001 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 72.129999999999995 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.409999999999997 112.943 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.099999999999994 111.518 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.329999999999998 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.310000000000002 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.239999999999995 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.209999999999994 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.329999999999998 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 62.130000000000003 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.540000000000006 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 61.130000000000003 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.140000000000001 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.129999999999995 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.230000000000004 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.519999999999996 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.239999999999995 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.409999999999997 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.420000000000002 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.140000000000001 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.430000000000007 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.340000000000003 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 71.450000000000003 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 -92.63 -17.47 24.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.519999999999996 111.488 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 61.45 4.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.344 -0.455 . . . . 34.119999999999997 113.703 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . -55.59 123.76 31.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.381 -0.438 . . . . 40.210000000000001 113.087 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 134.83 47.3 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.017 0.437 . . . . 70.049999999999997 111.394 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.75 -4.98 5.45 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.231 -0.509 . . . . 72.329999999999998 113.066 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.81 -81.56 0.33 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.663 -0.303 . . . . 61.340000000000003 112.783 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -72.37 110.49 6.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.021 0.439 . . . . 75.510000000000005 110.681 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.39 -176.2 0.56 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.109999999999999 113.15 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 63.409999999999997 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.150000000000006 111.24 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.040000000000006 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 64' ' ' ASN . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.439999999999998 111.698 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.450000000000003 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.319999999999993 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.540000000000006 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.319999999999993 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.109999999999999 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG12 HG12 ' A' ' 79' ' ' ILE . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 62.020000000000003 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 73.040000000000006 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.010000000000005 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.661 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 51.8 mt -104.16 158.27 16.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.340000000000003 110.679 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 36.4 t70 89.06 -64.44 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.0 1.32 . . . . 63.340000000000003 110.893 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 19.4 Cg_endo -64.64 70.35 0.24 Allowed 'Trans proline' 0 C--N 1.364 1.385 0 CA-C-N 121.082 1.422 . . . . 73.420000000000002 109.494 155.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 110' ' ' HIS . 1.8 tm? -42.27 103.7 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.494 -1.23 . . . . 73.040000000000006 114.192 -161.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.63 73.34 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.633 -0.712 . . . . 63.130000000000003 109.473 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.521 ' H ' HD13 ' A' ' 108' ' ' LEU . 22.0 m-70 . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.501 -0.762 . . . . 65.239999999999995 112.591 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.999 0.428 . . . . 73.439999999999998 111.598 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -171.61 83.74 0.48 Allowed Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.297 -0.411 . . . . 74.409999999999997 110.13 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.53 90.48 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.764 2.309 . . . . 52.009999999999998 113.282 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -101.52 101.15 11.67 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.039 0.447 . . . . 73.219999999999999 111.815 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -133.65 171.65 13.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.66 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 6' ' ' ARG . 50.8 mtm180 64.25 23.32 13.07 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.935 0.398 . . . . 72.030000000000001 110.972 -171.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.487 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 46.7 ttm -104.26 105.94 16.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.212 -0.449 . . . . 54.420000000000002 111.447 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 3.2 p-10 -136.89 157.66 46.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 74.219999999999999 111.549 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m -94.97 173.52 7.54 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 111.43 -175.071 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 73.329999999999998 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.439999999999998 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 8' ' ' ASP . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.420000000000002 113.065 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.409999999999997 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.030000000000001 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.549999999999997 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.340000000000003 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.040000000000006 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.329999999999998 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.450000000000003 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 55.229999999999997 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.329999999999998 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.229999999999997 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.530000000000001 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.299999999999997 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.239999999999995 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.240000000000002 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.099999999999994 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.200000000000003 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 51.32 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 61.530000000000001 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.150000000000006 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.349999999999994 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.450000000000003 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -135.73 148.96 49.03 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.519999999999996 110.239 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.6 m -85.11 112.01 20.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.09 0.471 . . . . 63.399999999999999 111.415 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -95.77 169.27 10.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.832 -0.622 . . . . 73.200000000000003 111.976 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -78.29 -9.16 59.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.88 -0.6 . . . . 74.099999999999994 111.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -93.66 165.24 12.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.233 -0.439 . . . . 71.209999999999994 110.609 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.92 7.96 6.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.227 -0.511 . . . . 74.239999999999995 113.817 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -87.54 156.78 19.36 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.463 -0.433 . . . . 74.430000000000007 111.252 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.91 -45.75 92.37 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.55 0.574 . . . . 72.230000000000004 112.55 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.78 106.37 0.63 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.291 -0.48 . . . . 31.43 112.903 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.109999999999999 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 64.299999999999997 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.200000000000003 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.129999999999995 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.140000000000001 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.239999999999995 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 61.039999999999999 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.200000000000003 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.099999999999994 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.049999999999997 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.548 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.019999999999996 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.149999999999999 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.109999999999999 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.219999999999999 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 52.350000000000001 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.200000000000003 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.129999999999995 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.310000000000002 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 63.509999999999998 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.329999999999998 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.140000000000001 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.420000000000002 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.030000000000001 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.140000000000001 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.200000000000003 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.400000000000006 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.140000000000001 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.239999999999995 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.439999999999998 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.439999999999998 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.209999999999994 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.319999999999993 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.010000000000005 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.409999999999997 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.030000000000001 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' SER . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.439999999999998 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.450000000000003 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.329999999999998 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.140000000000001 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -83.91 -65.85 0.96 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.439999999999998 112.238 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 178.62 -39.41 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.091 -1.052 . . . . 34.329999999999998 114.017 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 79.26 111.79 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.105 -0.569 . . . . 72.420000000000002 113.278 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -65.02 109.11 2.02 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.219 0.533 . . . . 75.230000000000004 111.594 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.85 -48.17 0.97 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.205 -0.521 . . . . 63.420000000000002 113.071 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.41 -40.8 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.683 -0.77 . . . . 42.109999999999999 113.443 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -71.9 97.43 1.83 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.028 0.442 . . . . 75.109999999999999 110.699 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 97.1 mttt -59.27 163.86 3.58 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.119999999999997 112.538 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.040000000000006 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 54.149999999999999 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 72.25 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.329999999999998 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.450000000000003 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 41.299999999999997 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.239999999999995 111.423 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.539999999999999 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.439999999999998 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.439999999999998 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.549999999999997 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt -136.79 178.43 7.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.009999999999998 112.983 -171.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 m-20 60.14 58.91 4.35 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.787 1.773 . . . . 75.209999999999994 115.787 168.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 106' ' ' ASP . 76.6 Cg_endo -103.09 20.38 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.361 2.707 . . . . 71.209999999999994 110.044 157.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.35 135.13 44.56 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.114 -0.948 . . . . 53.329999999999998 111.288 -166.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.5 -60.7 2.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.094 0.776 . . . . 73.209999999999994 113.094 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.217 0 N-CA-C 114.062 1.134 . . . . 74.219999999999999 114.062 -171.09 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.495 0.188 . . . . 72.519999999999996 111.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.605 ' HD3' ' SD ' ' A' ' 7' ' ' MET . 28.3 mtpp 65.24 114.75 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 122.9 0.48 . . . . 63.340000000000003 111.969 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -45.84 115.87 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.542 2.828 . . . . 62.310000000000002 114.91 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 58.35 67.07 0.98 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.186 -0.915 . . . . 74.409999999999997 112.888 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -149.1 150.21 32.36 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 110.566 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -78.57 74.61 5.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.62 0.724 . . . . 73.150000000000006 111.502 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 2' ' ' LYS . 80.9 mtp -126.85 40.32 3.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.101 -0.954 . . . . 51.149999999999999 108.896 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 62.5 m-20 -62.1 133.92 55.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.382 -1.281 . . . . 71.530000000000001 113.196 -171.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -89.4 -178.17 5.53 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.595 -0.73 . . . . 75.129999999999995 111.476 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.099999999999994 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.140000000000001 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.230000000000004 112.235 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.549999999999997 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.040000000000006 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.129999999999995 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.439999999999998 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 31.399999999999999 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.450000000000003 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.319999999999993 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.420000000000002 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.219999999999999 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.340000000000003 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.409999999999997 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.349999999999994 110.706 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 53.210000000000001 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.099999999999994 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.409999999999997 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 64.5 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.439999999999998 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.340000000000003 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.120000000000005 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.310000000000002 110.736 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HE1' ' HB ' ' A' ' 36' ' ' THR . 32.9 p90 -131.04 173.44 11.0 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 61.210000000000001 111.723 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.1 m -95.08 108.22 20.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.996 0.427 . . . . 52.539999999999999 111.889 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.518 ' HB ' ' HE1' ' A' ' 34' ' ' PHE . 10.5 t -116.63 -179.3 3.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.306 -0.407 . . . . 71.409999999999997 110.596 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER -63.3 133.1 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.901 -0.407 . . . . 75.319999999999993 109.901 176.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' N ' ' HD2' ' A' ' 38' ' ' LYS . 3.2 mptp? -71.5 79.31 0.78 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.501 0.926 . . . . 75.099999999999994 113.501 -166.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.15 -45.67 0.18 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.348 -1.501 . . . . 50.439999999999998 109.348 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -124.05 158.67 31.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.829 -0.685 . . . . 75.120000000000005 109.749 167.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.43 -46.28 89.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.775 0.657 . . . . 72.439999999999998 112.775 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.78 115.99 2.35 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.901 -0.666 . . . . 43.119999999999997 113.759 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.310000000000002 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.549999999999997 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.530000000000001 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 55.299999999999997 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.420000000000002 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.010000000000005 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 53.049999999999997 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.010000000000005 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.430000000000007 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.409999999999997 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.510000000000005 112.758 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.409999999999997 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 91' ' ' ARG . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.109999999999999 110.818 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.329999999999998 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.120000000000005 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.439999999999998 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.329999999999998 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 73.450000000000003 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.310000000000002 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.506 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.129999999999995 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.040000000000006 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.129999999999995 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.340000000000003 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.540000000000006 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.420000000000002 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.530000000000001 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.310000000000002 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.409999999999997 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 65.519999999999996 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.129999999999995 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.209999999999994 113.661 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.140000000000001 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.530000000000001 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.140000000000001 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB2' HD11 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.430000000000007 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.120000000000005 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 62.100000000000001 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.200000000000003 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 62.219999999999999 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.030000000000001 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.319999999999993 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 85' ' ' ARG . 12.5 mmm180 -90.57 -27.32 19.21 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.310000000000002 112.367 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.89 -29.76 3.48 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.169 -1.015 . . . . 53.340000000000003 114.915 173.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.48 92.38 0.02 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 117.299 0.55 . . . . 71.299999999999997 112.873 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.19 112.51 1.94 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.158 0.429 . . . . 50.130000000000003 112.158 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.8 44.31 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.139 -0.553 . . . . 60.43 114.48 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.52 -76.19 0.22 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.886 -0.673 . . . . 24.34 114.456 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 73.8 mtp85 -77.14 107.67 9.69 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.45 -0.441 . . . . 73.5 112.124 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 59.4 mttp -61.58 170.23 2.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.629 -0.714 . . . . 63.450000000000003 112.862 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.319999999999993 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.120000000000005 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.230000000000004 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.239999999999995 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.219999999999999 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.040000000000006 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 61.32 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.119999999999997 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 61.5 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.497 HG13 HD13 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 64.200000000000003 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.019999999999996 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 54.229999999999997 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt -104.46 -68.05 0.87 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.349999999999994 112.916 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 10.0 m-20 -91.77 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 115.857 1.799 . . . . 51.439999999999998 115.857 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 106' ' ' ASP . 26.0 Cg_exo -66.91 53.6 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.509 1.575 . . . . 72.129999999999995 110.924 164.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 110' ' ' HIS . 3.2 tm? -107.78 136.25 47.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.284 -0.871 . . . . 54.530000000000001 111.356 -164.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.3 -42.34 14.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.028 0.751 . . . . 75.299999999999997 113.028 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.486 ' N ' HD13 ' A' ' 108' ' ' LEU . 10.1 m80 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.603 0.594 . . . . 75.310000000000002 112.603 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p . . . . . 0 N--CA 1.471 0.598 0 CA-C-O 120.313 0.101 . . . . 74.4 110.859 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.3 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 61.52 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 71.03 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.22 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.01 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.52 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.2 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.14 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.42 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 54.1 111.572 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.33 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.21 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.31 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.31 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HG2' HG22 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.23 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.55 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.53 111.053 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.43 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.455 HG23 HG22 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 54.03 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.42 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.41 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.53 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.42 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.838 177.397 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 N-CA-C 113.985 0.354 . . . . 62.31 113.985 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.33 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.54 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.55 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.51 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 53.45 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.54 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.45 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 70.02 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.52 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.43 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.51 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.44 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.2 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.12 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.24 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.04 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.22 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 73.03 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.05 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.1 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.41 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.22 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.4 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.1 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.13 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.13 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.22 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.01 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.03 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.54 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.1 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.43 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.44 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.15 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.1 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.55 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.02 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.14 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 . . . . . 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.35 111.699 -179.221 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm . . . . . 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.32 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.185 -176.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.2 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.1 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.13 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.01 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 99' ' ' ARG . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.33 112.717 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 41.35 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.11 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.24 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 65.22 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.33 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 71.1 112.862 -175.19 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 43.21 112.797 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.559 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.24 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.03 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.11 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.2 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.44 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.41 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.23 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.24 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.41 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.02 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.22 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.12 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.54 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.51 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.32 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.42 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.31 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.42 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 72.34 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.53 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.13 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.33 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.42 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.12 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.24 109.895 176.182 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.959 0 N-CA-C 113.661 0.224 . . . . 54.25 113.661 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.13 112.248 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.31 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.23 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.54 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.34 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 70.32 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.21 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.24 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.24 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.54 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.4 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.32 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 57' ' ' ARG . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.41 110.852 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.21 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.43 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 45.13 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.31 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.2 113.802 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.22 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.21 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 63.11 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.53 112.559 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.41 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.34 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.3 112.39 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.41 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 73.24 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 71.13 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.32 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.31 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.34 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.34 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.13 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.44 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.34 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.43 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.24 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.34 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.21 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 13' ' ' LEU . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.43 110.403 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 54.41 112.119 -177.432 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.3 110.623 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.42 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.22 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 63.12 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.42 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.41 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.01 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.31 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.23 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.31 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.14 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.44 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 66.1 mt . . . . . 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.32 110.997 179.484 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 121.019 0.438 . . . . 73.52 111.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 55.44 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.21 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.33 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.42 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.22 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.21 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.33 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.4 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.03 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.33 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.3 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.45 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.23 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.45 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.31 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.04 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 47' ' ' VAL . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 64.41 111.495 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.33 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 72.03 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.14 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.2 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.33 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 . . . . . 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.993 0 N-CA-C 113.791 0.276 . . . . 64.45 113.791 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.55 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.33 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 28' ' ' ILE . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.44 111.135 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.23 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 63.22 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.02 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.44 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.53 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.43 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.22 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.13 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.13 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.11 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.13 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 71.23 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 70.52 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.13 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.44 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.13 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.12 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.655 HD13 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.01 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.31 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.13 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.12 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.01 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.34 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.45 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.21 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 61.45 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.32 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 103' ' ' GLU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.22 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.4 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.31 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.44 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.22 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 63.32 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.31 110.502 176.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.22 111.566 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.15 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.4 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.44 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.1 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.15 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.2 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.24 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.31 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.34 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.45 112.377 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt . . . . . 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.669 0.271 . . . . 73.13 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.51 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.582 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.43 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.33 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.03 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.42 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.12 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.3 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.55 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.01 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 54.04 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 64.43 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 64.24 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.32 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.13 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.14 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.22 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.21 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 26' ' ' MET . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.32 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.22 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.05 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.23 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.31 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.02 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.11 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.424 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 . . . . . 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.03 110.783 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . . . . . . 0 CA--C 1.529 0.927 0 N-CA-C 114.053 0.381 . . . . 73.15 114.053 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.508 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.13 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.34 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.43 111.814 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.506 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.53 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.44 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.53 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.21 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.21 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.15 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 65.02 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.22 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.04 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.41 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.2 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.24 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.11 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 71.41 111.227 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 54.02 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.508 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.51 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.22 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.13 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.4 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.23 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.633 HD13 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.23 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.1 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.33 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.24 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.32 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.04 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 73.12 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.43 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.13 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.4 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.31 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.05 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.22 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.32 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.11 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.24 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.22 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 51.02 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.11 111.511 175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 38.6 mttm . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 121.216 0.532 . . . . 61.44 111.782 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.43 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 63.51 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 65.44 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.41 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.53 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.55 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.14 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.43 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.11 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 54.12 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 62.54 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.23 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.1 mt . . . . . 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 42.24 111.507 -179.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 53' ' ' THR . 9.3 t . . . . . 0 CA--C 1.543 0.678 0 N-CA-C 110.594 -0.15 . . . . 72.05 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.517 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 61.03 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.11 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.51 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.1 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.11 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.14 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.21 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.33 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 62.25 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.11 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 64.1 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.45 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.42 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.33 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 34.42 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.43 112.072 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.55 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.44 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.43 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.701 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.42 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.22 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 52.21 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.04 111.29 179.064 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.999 0 N-CA-C 113.826 0.291 . . . . 53.01 113.826 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.13 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.23 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.11 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.54 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.11 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.12 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.14 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.33 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.31 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.12 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.02 110.93 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.01 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.31 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.01 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.34 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 65.15 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 73.24 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.23 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 72.43 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.21 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.4 112.55 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.24 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.33 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.22 111.85 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.41 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 62.22 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.01 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 23.32 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.13 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.34 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.14 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.35 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 72.44 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.13 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.31 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 62.34 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.41 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 55.4 mttm . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 121.545 0.688 . . . . 70.13 112.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.22 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.43 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.3 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.32 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.02 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.11 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 65.34 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 64.11 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.35 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.55 111.666 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.409 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 78.4 mt . . . . . 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.32 110.518 176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.818 0.342 . . . . 75.34 111.387 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 63.44 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.13 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.23 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.14 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.11 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.34 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.22 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.13 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.12 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 65.01 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.42 111.42 165.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.22 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.24 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.03 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 61.02 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.2 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 53.2 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.53 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.13 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.21 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.43 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.21 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 . . . . . 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.31 109.827 175.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 CA-C-O 120.973 0.207 . . . . 41.43 113.179 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.466 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.02 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.31 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.15 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.03 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.13 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.51 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.3 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.43 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.55 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 70.42 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.05 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.33 111.244 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.02 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.34 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.24 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.12 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.13 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.12 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.34 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.14 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.22 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.14 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.53 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.623 HD13 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 72.0 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.43 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.52 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.51 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.34 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.42 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.14 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 54.44 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.21 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.51 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.21 112.061 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.1 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 19' ' ' THR . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.24 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.45 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 72.44 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 4.2 mmp_? . . . . . 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 73.34 111.25 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 53.3 mttp . . . . . 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.32 112.559 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.31 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.31 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.52 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.33 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.33 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.12 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.04 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 41.15 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 55.44 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.623 HG13 HD13 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.4 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 51.04 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.34 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.502 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 88.0 mt . . . . . 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.31 110.996 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 120.785 0.326 . . . . 72.12 111.182 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.44 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.12 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 61.55 112.796 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.41 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.54 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.3 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.15 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' OE2' ' HE1' ' A' ' 97' ' ' MET . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.04 110.829 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.32 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.55 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.4 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.3 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.13 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.52 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.32 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.35 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.35 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 62.42 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.3 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.42 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.55 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 62.42 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 . . . . . 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 74.31 111.4 178.618 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.124 0 N-CA-C 113.362 0.105 . . . . 64.24 113.362 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.482 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.51 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.24 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 35.51 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.1 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.01 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.03 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.24 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.13 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.14 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 23.23 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.53 111.599 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 44.21 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.03 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.51 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.14 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.44 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.11 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.482 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.13 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 53.13 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.4 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.53 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.03 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD13 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.54 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.21 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 60.34 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 54.14 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.12 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.44 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.13 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.01 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.673 HG22 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.11 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.32 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.21 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.428 HG23 HG12 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.44 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.01 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.24 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.22 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.24 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.54 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 . . . . . 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.53 111.197 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 63.8 mttm . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.54 110.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.14 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 55.14 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.41 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.12 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.406 ' HE1' ' OE2' ' A' ' 18' ' ' GLU . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.1 110.397 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.15 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.35 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.32 112.029 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.52 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.4 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.02 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.42 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.018 174.628 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.45 112.811 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.13 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 42.51 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.43 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.02 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 42.52 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 65.34 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.33 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 33.44 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.41 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.31 112.013 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.24 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.51 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.21 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.34 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.34 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.35 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 31.21 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.48 ' HB3' HD12 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.2 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.51 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 62.34 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.42 110.571 176.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.03 114.226 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.22 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.44 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 64.23 111.606 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.3 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.32 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.31 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.51 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.42 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.05 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.44 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.14 113.614 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 70.54 110.818 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.34 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.45 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.01 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.1 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.22 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.4 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.34 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.15 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.13 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.41 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.33 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 72.3 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.23 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.35 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.42 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.52 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.52 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.22 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.4 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.11 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.41 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.04 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.21 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.21 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.14 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.14 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' THR . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.22 111.391 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.51 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 . . . . . 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 73.41 111.14 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 38.2 mtmm . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 121.253 0.549 . . . . 63.44 111.852 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.31 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.1 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.12 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.14 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.54 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.22 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.1 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.21 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 71.43 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.42 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.14 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD11 ' HB2' ' A' ' 78' ' ' ARG . 87.3 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.3 111.428 -178.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 121.04 0.448 . . . . 75.2 111.532 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 55.53 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.41 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.3 113.111 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.02 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.35 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.32 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 35.1 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.04 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.3 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.03 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.12 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.24 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.44 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.2 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.01 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 70.33 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 54.24 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.32 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 HG13 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.35 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.2 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.45 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.32 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.11 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 . . . . . 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.42 109.937 176.517 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.43 114.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.23 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.34 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.43 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.34 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.477 HG13 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.52 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.43 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 60.24 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.34 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.43 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 70.44 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.02 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.21 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.14 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.05 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 95' ' ' HIS . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 72.44 111.788 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.54 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.34 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.518 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.44 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.12 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.12 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.03 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.24 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.33 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.22 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.14 112.372 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 54.13 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.23 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.31 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.34 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 31.41 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.2 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.12 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.21 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' HD11 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.43 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 65.01 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.42 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 61.42 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.11 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.22 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.03 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 . . . . . 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.11 111.915 -178.571 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.6 mttp . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.436 0.636 . . . . 74.21 112.61 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.05 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 64.31 111.917 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.14 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.42 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.04 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.41 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.11 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 64.32 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.52 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.44 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.4 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt . . . . . 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 51.33 111.786 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.372 0.13 . . . . 42.52 111.084 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.627 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.23 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.02 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 64.0 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.53 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 60.44 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.3 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.13 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.24 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.21 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 52.44 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.53 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.55 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.24 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.33 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 28' ' ' ILE . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.02 111.932 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.51 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 47' ' ' VAL . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.14 110.924 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.31 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.22 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 51.4 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.31 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.51 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 52.0 111.304 179.638 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.03 0 N-CA-C 114.036 0.374 . . . . 24.32 114.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.12 112.35 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 61.33 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.33 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.35 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 28' ' ' ILE . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 52.15 111.319 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 40.03 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.439 HD11 HD23 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.31 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.518 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 51.44 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.53 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.11 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.54 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 72.43 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.02 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.04 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 71.23 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.41 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.32 113.911 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.32 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.11 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.22 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.34 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.3 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 44.13 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.41 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.32 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.22 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.43 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.51 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.4 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 22.53 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.33 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 102' ' ' VAL . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.32 110.9 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.54 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.22 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.2 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.43 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 54.12 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 30.5 mmm180 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 13' ' ' LEU . 57.7 mttp . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.42 112.912 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.02 111.051 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.4 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.34 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.22 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.54 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.15 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.33 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 65.23 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.45 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 79' ' ' ILE . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.22 111.628 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.21 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.33 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt . . . . . 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.766 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 HG21 ' A' ' 53' ' ' THR . 7.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.41 111.734 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.24 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 42.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.54 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.21 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.51 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.34 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.52 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.22 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.41 110.522 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 71.55 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.34 112.892 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.01 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.01 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.13 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.41 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.33 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.05 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.22 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.33 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.34 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.53 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.42 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.51 109.19 174.651 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.211 0 CA-C-O 120.883 0.157 . . . . 44.12 113.417 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.54 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.41 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 53.14 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.04 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.4 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 71.53 110.994 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.01 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 72.22 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.21 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.42 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 71.21 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.14 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.11 110.85 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.41 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.34 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 52.52 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.14 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.44 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.34 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.447 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 43.41 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.3 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 43.42 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.32 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.24 112.559 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.609 HD13 HG13 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.22 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.15 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.02 112.654 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.54 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.23 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 72' ' ' ARG . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.4 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.45 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.31 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.3 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.35 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 65.34 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.01 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 74.34 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.03 112.204 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.54 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.408 HD12 HD13 ' A' ' 13' ' ' LEU . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.34 110.784 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 64.05 111.152 178.426 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.42 112.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 71.35 111.815 -176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.11 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 72.01 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.22 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.14 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 62.34 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 60.45 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.03 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.31 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.609 HG13 HD13 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 54.34 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.21 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -176.277 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 53' ' ' THR . 10.0 t . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 120.822 0.344 . . . . 61.12 111.298 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.42 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.41 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.42 112.227 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.54 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.33 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 44.51 112.757 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.45 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.04 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.34 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.45 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.02 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.43 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.53 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.34 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.34 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.5 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.23 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.52 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.13 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.43 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.32 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.52 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 60.34 112.014 -179.309 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.946 0 N-CA-C 113.675 0.23 . . . . 73.1 113.675 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.471 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 62.23 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.4 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.14 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.12 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.43 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.2 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.4 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.2 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 62.15 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 60.33 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 21.23 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.22 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.31 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.42 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.54 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.11 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 65.1 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.32 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.471 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.13 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.31 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.32 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 62' ' ' THR . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.31 111.094 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.52 112.046 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.1 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.34 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.41 112.145 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.14 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.35 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.03 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.45 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.43 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.33 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 HG22 HG12 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.34 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.23 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.12 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.51 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.04 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.21 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.12 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.21 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 . . . . . 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.41 110.956 179.297 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 76.6 mttt . . . . . 0 CA--C 1.543 0.69 0 CA-C-O 121.053 0.454 . . . . 73.44 111.548 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.21 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.14 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.32 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 65.2 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 53.44 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.41 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.23 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.01 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.03 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.1 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.13 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.33 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt . . . . . 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.804 -179.465 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 N--CA 1.472 0.63 0 CA-C-O 120.701 0.286 . . . . 73.41 111.07 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.23 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.11 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.41 112.54 -177.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.54 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.04 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.43 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.13 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.43 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.35 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.02 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.54 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.34 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 105' ' ' LEU . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.44 111.822 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.14 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' HG21 ' A' ' 76' ' ' VAL . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.33 110.068 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.52 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 53.12 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.457 HG23 HG22 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.04 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.33 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.13 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.12 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 60.14 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 . . . . . 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.51 110.396 178.198 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.055 0 N-CA-C 113.916 0.327 . . . . 54.24 113.916 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 63.21 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.01 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.23 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.14 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG22 HG23 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.31 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.35 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.51 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.23 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.524 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.23 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.12 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 53.45 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 12.21 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.12 111.001 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.23 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.52 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 44.53 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 64.4 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 61.3 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 62.24 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.52 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.54 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.21 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.484 ' HB3' HD12 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.3 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.24 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 61.04 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.03 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.52 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.43 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.31 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.43 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 61.35 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.35 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.22 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.421 HG21 ' HE ' ' A' ' 24' ' ' ARG . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 73.14 110.712 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.54 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 54.03 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 62.34 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.34 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.45 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.43 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.21 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 21' ' ' VAL . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.23 111.189 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 . . . . . 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.1 111.045 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 121.49 0.662 . . . . 74.0 112.153 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.32 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.31 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.14 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.33 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.489 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.04 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 64.45 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 54.54 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 72.24 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 73.51 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.448 HD12 HG23 ' A' ' 22' ' ' THR . 36.5 mt . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.44 111.301 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.596 0.236 . . . . 74.44 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.607 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.24 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.02 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.42 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.11 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.23 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.42 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.4 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.12 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.35 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 63.41 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.21 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.43 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.12 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.33 111.425 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.3 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.33 111.267 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 71.03 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 53.23 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.42 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.21 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 71.33 111.201 -179.087 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.527 0.837 0 N-CA-C 114.01 0.364 . . . . 64.25 114.01 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.42 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.04 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.41 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.31 111.271 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.32 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 43.11 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.53 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.1 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.34 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.34 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.11 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 64.22 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.15 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.31 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.11 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.02 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 62.35 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.14 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.02 113.631 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.4 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.43 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.15 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 40.44 111.551 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.31 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 71.44 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.22 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.3 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.2 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.23 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.4 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.34 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.24 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 64.54 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.14 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.1 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.43 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.13 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.42 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.34 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 73.32 111.288 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.3 112.379 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.44 111.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.11 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.45 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 73.42 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.34 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.22 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.45 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.31 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 79' ' ' ILE . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.01 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.24 111.598 -177.082 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.64 0.257 . . . . 75.42 111.013 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.32 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.3 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.13 113.296 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.21 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.55 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 71.02 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.22 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.3 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.23 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 33.24 111.537 169.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 78' ' ' ARG . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 73.45 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.21 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 54.43 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.14 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.14 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.13 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 52.31 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.12 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.34 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.23 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.12 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 . . . . . 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.33 111.419 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.531 1.08 0 N-CA-C 114.037 0.375 . . . . 51.14 114.037 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.445 ' H ' ' HB ' ' A' ' 62' ' ' THR . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 61.14 111.355 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.23 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.4 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 64.14 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.05 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.13 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.34 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.13 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.23 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.535 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.11 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.44 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.43 110.804 175.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.41 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.31 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.02 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.33 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 72.1 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 63.12 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 61.03 113.565 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.53 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.41 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.13 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.51 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.546 HD13 HG13 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.24 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.42 113.038 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.42 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.12 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.01 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.14 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.04 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.43 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.11 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.34 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.528 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 53.22 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.14 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.01 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.23 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 96' ' ' LEU . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.12 111.627 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 52.33 111.462 174.732 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 52.3 mttp . . . . . 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.52 112.37 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 54.21 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 64.43 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.11 112.009 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.13 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 64.22 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.408 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 62.43 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.12 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.31 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HD2' ' A' ' 78' ' ' ARG . 76.6 mt . . . . . 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.53 110.214 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.093 -0.706 . . . . 72.4 109.093 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 45.2 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.12 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.34 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.21 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.41 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.14 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.23 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.44 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.42 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 53.4 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 79' ' ' ILE . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.33 111.679 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.23 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.13 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.13 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.23 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.423 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 71.21 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.44 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 71.51 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.43 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 70.01 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 72.33 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 63.51 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 71.23 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.35 111.298 -179.384 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . . . . . . 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 23.43 114.769 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.463 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 71.3 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.02 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.34 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.54 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.53 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.04 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.3 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.04 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.54 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 52.51 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.34 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.43 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.52 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.23 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 51.45 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 53.44 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 54.03 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.02 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.05 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.12 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.33 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.22 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.14 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 71.25 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.15 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.11 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 71.15 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.31 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.44 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.44 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.34 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.31 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.21 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.14 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.617 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.45 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.45 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.12 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.51 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.21 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.24 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 72.42 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.1 111.092 178.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.45 112.054 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.23 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 52.54 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.3 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.12 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.53 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.54 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.43 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.24 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 31.4 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.43 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 64.41 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.21 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 61.02 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.447 HD11 ' HB2' ' A' ' 78' ' ' ARG . 58.9 mt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.33 111.432 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 120.661 0.267 . . . . 63.23 111.611 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.53 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.24 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.44 111.79 -175.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.53 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.44 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.51 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.53 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.41 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 42.45 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.45 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.12 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.22 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 44.25 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.1 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.34 111.472 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.1 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.42 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.412 HG12 HG13 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 61.15 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.43 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 61.31 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 24.12 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.15 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.32 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 . . . . . 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.31 110.207 174.54 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.101 0 CA-C-O 120.695 0.053 . . . . 75.34 113.026 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.478 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.12 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.41 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 72.51 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.33 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.32 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.43 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 52.42 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.52 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.23 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.31 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.31 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.43 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.45 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.34 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 61.21 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.53 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.14 111.435 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.52 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.54 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.42 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HB3' HG22 ' A' ' 102' ' ' VAL . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.31 112.262 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.51 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.13 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.15 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.44 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.24 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.13 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.31 113.369 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.02 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.14 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.12 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.33 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.13 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.21 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.24 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.787 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.33 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.42 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 73.15 111.506 178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.53 ' HE3' ' HB2' ' A' ' 13' ' ' LEU . 36.3 mtmm . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.105 0.478 . . . . 63.11 111.306 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.14 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.12 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.23 112.011 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.43 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 53.31 112.934 175.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.21 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.22 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.02 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 67' ' ' LEU . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.24 110.438 173.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 65.31 111.433 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.01 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.23 112.557 -176.006 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 110.176 -0.305 . . . . 43.21 110.176 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.56 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.42 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.34 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.44 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.41 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.52 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.33 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.02 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 45.34 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.15 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.264 -175.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.12 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.12 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 65.22 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.44 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG2' HG22 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.43 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.04 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.24 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 47' ' ' VAL . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.44 111.196 173.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.44 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 64.55 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.13 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.52 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.34 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 . . . . . 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.52 110.741 178.546 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.091 0 N-CA-C 113.119 0.008 . . . . 72.54 113.119 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.496 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.2 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.12 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.33 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.41 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.13 110.961 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.54 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 HG22 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.42 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.33 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.51 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.32 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 70.0 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.14 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.54 112.13 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 64.45 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.53 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 54.33 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 71.34 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 61.14 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 72.13 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.41 112.943 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.1 111.518 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.33 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.31 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.24 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.33 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 62.13 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.54 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 61.13 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.14 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.13 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.23 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.52 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.24 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.41 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.42 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.14 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.43 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.34 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 71.45 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.52 111.488 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.11 113.15 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 63.41 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.15 111.24 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.04 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 64' ' ' ASN . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.44 111.698 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.45 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.32 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.54 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.32 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.11 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.538 HG12 HG12 ' A' ' 79' ' ' ILE . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 62.02 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.01 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.8 mt . . . . . 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.34 110.679 179.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m . . . . . 0 CA--C 1.549 0.935 0 CA-C-O 120.54 0.209 . . . . 74.4 111.43 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 73.33 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.44 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.42 113.065 -172.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.41 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.03 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.55 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.34 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.04 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.33 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.45 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 55.23 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.33 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.23 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.53 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.3 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.24 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.24 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.1 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.2 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 51.32 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 61.53 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.15 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.35 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.45 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 . . . . . 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.52 110.239 176.83 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.931 0 N-CA-C 112.903 -0.079 . . . . 31.43 112.903 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.11 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 64.3 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.2 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.13 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.14 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.24 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 61.04 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.2 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.1 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.05 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.548 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.02 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.15 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.11 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.04 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.22 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 52.35 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.2 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.13 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.31 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 63.51 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.33 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.14 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.42 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.03 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.14 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.4 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.14 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.24 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.44 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.44 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.21 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.32 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.01 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.41 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.43 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.03 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' SER . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.44 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.45 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.33 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.14 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.44 112.238 -178.447 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.12 112.538 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.04 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 54.15 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 72.25 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.33 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.45 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 41.3 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.24 111.423 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.54 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.44 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.55 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.01 112.983 -171.661 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p . . . . . 0 CA--C 1.534 0.357 0 CA-C-O 121.169 0.509 . . . . 75.13 111.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.14 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.23 112.235 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.55 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.04 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.13 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.44 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 31.4 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.45 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.32 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.42 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.22 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.34 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.41 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.35 110.706 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 53.21 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.1 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.41 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 64.5 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.44 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.34 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.12 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.31 110.736 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 32.9 p90 . . . . . 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 61.21 111.723 179.573 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.252 0 CA-C-O 121.099 0.277 . . . . 43.12 113.759 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.31 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.55 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.53 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 55.3 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.42 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.01 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 53.05 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.01 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.43 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.41 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.51 112.758 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.41 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.11 110.818 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.33 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.12 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.44 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.33 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 73.45 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.506 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.13 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.04 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.13 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.34 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.54 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.42 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.53 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.31 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.41 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 65.52 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.13 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.21 113.661 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.14 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.53 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.14 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB2' HD11 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.43 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.12 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 62.1 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.2 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 62.22 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.03 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.32 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 85' ' ' ARG . 12.5 mmm180 . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.31 112.367 -176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 59.4 mttp . . . . . 0 CA--C 1.539 0.535 0 CA-C-O 121.561 0.696 . . . . 63.45 112.862 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.32 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.12 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.23 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.24 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.04 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 61.32 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.12 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 61.5 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.497 HG13 HD13 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 64.2 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.02 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 54.23 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt . . . . . 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.35 112.916 -174.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.715 0.293 . . . . 74.04 111.502 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.485 ' HD2' ' HD3' ' A' ' 6' ' ' ARG . 24.3 pttm -78.02 145.92 70.58 Favored Pre-proline 0 CA--C 1.546 0.802 0 O-C-N 122.296 -0.252 . . . . 73.44 110.546 172.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -52.19 141.13 49.76 Favored 'Trans proline' 0 N--CA 1.484 0.955 0 C-N-CA 123.385 2.723 . . . . 72.34 114.776 -172.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -57.86 -32.78 67.99 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.77 -0.65 . . . . 72.33 112.047 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -71.13 -5.17 29.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.421 0.526 . . . . 73.33 112.421 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.485 ' HD3' ' HD2' ' A' ' 2' ' ' LYS . 20.3 ttt180 -88.34 117.11 27.03 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.03 0.443 . . . . 74.22 111.477 178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 18.5 ptm -111.2 102.67 11.08 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.282 0.563 . . . . 72.41 110.948 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -76.98 151.59 35.59 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.32 0.581 . . . . 63.3 112.328 -178.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.445 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 80.5 p -88.6 172.13 9.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.971 -0.559 . . . . 74.4 110.859 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 51' ' ' ASP . 47.2 mt -52.28 -41.95 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.498 0.555 . . . . 73.3 112.498 -176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 53' ' ' THR . 34.8 t -69.08 -27.57 65.74 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-O 120.928 0.394 . . . . 61.52 111.755 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -95.82 -9.39 31.68 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.472 0.545 . . . . 71.03 112.472 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 9' ' ' THR . 84.6 mt -54.12 123.84 13.89 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.196 0.522 . . . . 54.22 112.042 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -89.24 133.11 34.58 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.749 -0.66 . . . . 71.01 111.396 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.53 135.29 49.9 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.059 0.457 . . . . 75.52 111.125 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 82.98 2.56 90.67 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.398 -0.429 . . . . 62.2 112.927 -175.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.46 153.58 17.86 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.256 0.551 . . . . 70.14 112.257 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -110.6 109.12 19.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.013 -0.539 . . . . 74.42 109.974 176.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.402 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.2 t -151.74 152.5 30.38 Favored Pre-proline 0 N--CA 1.475 0.799 0 CA-C-N 116.581 -0.281 . . . . 54.1 111.572 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -74.75 149.52 38.08 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.247 1.965 . . . . 61.33 112.194 170.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.3 m -126.93 157.93 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.961 0.41 . . . . 73.21 112.027 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 m -141.14 141.13 34.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.555 -0.293 . . . . 74.31 111.174 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.24 167.47 38.67 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.759 -0.734 . . . . 72.31 113.773 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HG2' HG22 ' A' ' 76' ' ' VAL . 45.1 mtt180 -87.95 124.34 33.6 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 122.635 -0.332 . . . . 73.23 111.101 177.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.0 t -68.04 107.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-O 120.786 0.326 . . . . 63.55 111.599 -178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 54.6 ttp -88.07 -52.43 5.26 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 120.689 0.281 . . . . 74.53 111.053 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.0 mmmp? -132.73 143.56 49.7 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.902 0.382 . . . . 73.43 111.715 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.455 HG23 HG22 ' A' ' 47' ' ' VAL . 70.7 mt -123.1 129.82 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.163 -0.471 . . . . 74.33 110.707 175.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 69.3 m -109.25 145.18 36.33 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.776 0.322 . . . . 54.03 111.296 177.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.9 p -66.31 151.32 96.05 Favored Pre-proline 0 N--CA 1.469 0.488 0 CA-C-O 120.972 0.415 . . . . 74.42 111.767 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' HD12 ' A' ' 65' ' ' ILE . 19.3 Cg_endo -59.12 137.21 77.94 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.027 2.484 . . . . 72.41 113.882 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -94.55 118.84 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.719 -0.673 . . . . 75.53 109.731 173.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.7 m -86.58 138.63 31.54 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.314 0.487 . . . . 73.42 112.314 -173.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -140.92 153.84 45.85 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.198 -0.455 . . . . 73.04 110.838 177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.8 m -85.7 104.79 15.74 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.911 0.386 . . . . 74.44 111.638 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.5 t -98.69 152.98 19.06 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.158 0.504 . . . . 74.32 111.785 177.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -81.47 -8.19 59.69 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 116.128 -0.487 . . . . 73.13 111.821 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -63.73 -16.52 61.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 111.873 0.323 . . . . 61.5 111.873 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 89.02 3.86 75.72 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.25 -0.5 . . . . 61.35 112.849 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -97.73 160.8 14.09 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 122.769 -0.254 . . . . 72.21 110.668 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -57.16 -35.29 69.37 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.461 0.541 . . . . 72.33 112.461 -176.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.9 108.82 0.04 OUTLIER Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.292 -0.48 . . . . 62.31 113.985 173.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.47 ' H ' ' HB ' ' A' ' 62' ' ' THR . 88.3 mttt -149.37 155.26 40.19 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 122.358 -0.495 . . . . 65.33 112.271 -178.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.1 pp -141.49 127.96 20.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.831 -0.622 . . . . 73.54 110.187 173.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 59' ' ' VAL . . . -117.88 143.97 45.84 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.912 -0.492 . . . . 40.55 111.901 -176.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -107.96 111.6 23.78 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.92 0.391 . . . . 74.51 111.513 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG22 HG23 ' A' ' 28' ' ' ILE . 93.0 t -111.71 125.93 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.838 0.351 . . . . 53.45 110.754 176.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.7 mm -93.98 111.39 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.062 0.458 . . . . 71.54 111.811 -177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.9 pt -107.18 144.06 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.109 -0.496 . . . . 73.45 110.741 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.06 135.28 54.72 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.274 0.559 . . . . 70.02 112.405 -176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.52 ' HB3' HD12 ' A' ' 10' ' ' ILE . 20.0 t70 -126.53 167.07 16.12 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.581 -0.736 . . . . 75.52 110.025 175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.59 -30.77 55.47 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.886 0.374 . . . . 64.43 111.775 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 11' ' ' SER . 43.4 p -93.87 -1.77 54.35 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 113.346 0.869 . . . . 71.51 113.346 -175.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.28 15.7 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.065 -1.064 . . . . 75.0 114.177 -178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -102.37 140.84 36.11 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.656 0.382 . . . . 63.44 110.908 177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.4 tp -125.48 144.3 50.6 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.102 0.477 . . . . 75.2 111.891 -175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -98.38 104.86 16.93 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.258 -0.428 . . . . 74.12 111.478 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.33 127.61 34.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.79 0.329 . . . . 73.24 111.518 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 45' ' ' ALA . 57.2 t -105.22 110.27 30.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 121.041 0.448 . . . . 72.04 111.694 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -92.94 106.36 18.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.055 0.455 . . . . 63.22 111.43 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.7 m95 -77.16 164.05 26.0 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.862 -0.608 . . . . 73.03 112.022 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.47 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.1 t -36.86 -39.64 0.23 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.152 1.167 . . . . 71.05 114.152 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.8 mm-40 -75.52 -33.26 60.71 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.892 -0.505 . . . . 74.1 111.981 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -84.95 -10.29 57.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 31' ' ' PRO . 41.2 mm -53.31 -35.65 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 120.989 0.423 . . . . 71.41 111.434 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 26.0 pttm -63.51 -16.2 60.03 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.196 0.443 . . . . 74.22 112.196 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 83.9 mt -80.63 -19.5 45.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 120.763 0.316 . . . . 74.4 111.71 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -64.82 -17.39 64.19 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.064 0.394 . . . . 65.1 112.064 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.99 -5.27 59.02 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.67 0.271 . . . . 72.13 111.599 178.366 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -87.93 -41.84 12.9 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.122 0.786 . . . . 71.13 113.122 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -120.49 163.88 17.27 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.396 0.617 . . . . 70.22 112.417 -175.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 -111.43 163.7 13.73 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.94 -0.573 . . . . 72.21 111.592 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.95 78.4 0.9 Allowed 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 121.34 0.59 . . . . 70.01 110.479 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.97 -8.92 0.34 Allowed Glycine 0 CA--C 1.53 1.016 0 CA-C-N 116.114 -0.493 . . . . 55.03 113.323 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -88.01 175.79 7.61 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.164 0.507 . . . . 73.54 111.092 175.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.676 HG22 ' HG2' ' A' ' 24' ' ' ARG . 14.5 t -108.72 136.73 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 N-CA-C 110.129 -0.323 . . . . 74.1 110.129 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' GLU . 40.1 pt -134.57 147.21 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-O 121.596 0.712 . . . . 73.43 112.826 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -115.29 114.55 25.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.517 -0.765 . . . . 73.21 109.941 169.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.582 HG12 HG12 ' A' ' 102' ' ' VAL . 43.0 mt -96.39 123.67 48.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-N 116.292 -0.413 . . . . 64.44 110.849 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -99.7 140.76 33.44 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.024 0.379 . . . . 75.15 112.024 -176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 65.71 79.54 0.24 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.841 0.682 . . . . 74.1 112.841 176.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 96' ' ' LEU . 34.6 m -136.54 157.61 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 O-C-N 121.849 -0.532 . . . . 41.55 111.884 176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -105.6 121.59 44.29 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.059 -0.519 . . . . 54.02 111.268 177.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.9 mm -81.79 118.69 29.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.308 -0.405 . . . . 63.14 111.0 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -95.89 -66.52 0.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 O-C-N 122.038 -0.414 . . . . 61.35 111.699 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.569 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . 90.56 70.66 1.22 Allowed Glycine 0 CA--C 1.527 0.802 0 C-N-CA 120.961 -0.638 . . . . 72.04 113.007 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -93.48 17.29 58.77 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 121.09 -0.576 . . . . 44.34 113.811 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -159.69 145.58 15.88 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.842 0.353 . . . . 72.21 111.531 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -67.23 80.89 0.14 Allowed Glycine 0 CA--C 1.526 0.78 0 CA-C-N 116.245 -0.434 . . . . 70.22 112.877 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.93 -95.29 0.18 Allowed Glycine 0 CA--C 1.524 0.652 0 C-N-CA 121.428 -0.415 . . . . 40.22 112.681 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 -71.51 97.27 1.64 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.021 0.439 . . . . 75.13 111.504 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 31.4 mtmm -73.22 -172.82 1.18 Allowed 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.399 0.619 . . . . 75.32 112.028 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.569 ' HG2' ' H ' ' A' ' 86' ' ' GLY . 12.7 pt-20 -142.21 147.17 36.09 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.147 -0.479 . . . . 71.33 111.185 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -123.95 118.49 27.16 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.512 -0.313 . . . . 62.43 111.244 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -92.5 126.32 37.53 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.107 0.479 . . . . 73.2 111.87 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.439 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -84.56 162.79 19.69 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.533 0.683 . . . . 75.1 112.259 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.0 mtt -121.05 162.31 35.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 115.645 -0.707 . . . . 63.13 110.676 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -47.48 -39.62 28.94 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.4 2.066 . . . . 74.01 113.727 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 99' ' ' ARG . 49.0 mtm180 -87.86 1.68 53.36 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.717 0.636 . . . . 74.33 112.717 -176.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 18.8 m -76.64 124.79 28.17 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.701 0.286 . . . . 41.35 111.598 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.5 p -109.99 157.88 18.83 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.908 0.385 . . . . 75.11 111.277 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.582 HG12 HG12 ' A' ' 79' ' ' ILE . 35.0 m -124.16 139.7 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 65.24 111.123 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' ILE . 10.2 pt-20 -127.29 142.39 51.47 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.632 0.253 . . . . 65.22 111.376 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 22.8 m -86.89 118.38 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.288 0.566 . . . . 64.33 111.928 -178.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.506 HD22 HD22 ' A' ' 108' ' ' LEU . 67.2 mt -111.8 -163.78 0.87 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 112.862 0.69 . . . . 71.1 112.862 -175.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.824 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 13.5 t70 87.2 -66.64 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 125.416 1.486 . . . . 75.33 109.915 -167.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.824 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -78.79 85.31 1.87 Allowed 'Trans proline' 0 C--N 1.364 1.345 0 CA-C-N 120.752 1.304 . . . . 60.3 109.331 155.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.506 HD22 HD22 ' A' ' 105' ' ' LEU . 0.2 OUTLIER -52.98 126.0 19.02 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.017 -0.538 . . . . 73.31 111.968 -170.09 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -75.08 -62.56 1.51 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.368 -0.378 . . . . 75.11 111.493 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 25.6 m-70 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.735 -0.65 . . . . 74.02 112.123 -178.941 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.518 0.199 . . . . 61.44 111.118 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt 56.22 91.14 0.08 OUTLIER Pre-proline 0 N--CA 1.473 0.713 0 N-CA-C 112.072 0.397 . . . . 72.34 112.072 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.13 113.0 1.2 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.553 2.168 . . . . 61.42 112.92 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -59.45 -26.88 65.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.756 0.65 . . . . 65.04 112.756 -178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -75.72 75.67 2.69 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.057 0.456 . . . . 63.3 111.521 -175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -142.56 116.32 9.24 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.259 -0.428 . . . . 74.21 110.961 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 24.1 mmt -84.76 95.32 8.92 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.0 0.429 . . . . 61.42 110.966 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -74.27 104.87 5.2 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 116.27 -0.423 . . . . 72.25 110.442 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -57.69 166.47 1.36 Allowed 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 112.797 0.665 . . . . 43.21 112.797 -175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.559 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 35.5 mt -63.09 -37.91 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 112.531 0.567 . . . . 53.24 112.531 -173.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.602 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 29.9 t -55.0 -37.4 66.55 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.149 0.5 . . . . 44.03 110.357 172.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.596 ' HB3' ' NZ ' ' A' ' 12' ' ' LYS . 3.8 mmmp? -77.54 -84.13 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.728 -0.669 . . . . 65.11 111.716 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.559 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 90.3 mt 29.36 68.62 0.09 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.438 0.637 . . . . 71.2 111.981 -172.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -61.45 115.11 3.63 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.61 -0.723 . . . . 72.44 111.794 -173.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -47.85 135.66 11.89 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.744 -0.662 . . . . 73.41 112.696 -176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.49 -3.31 81.66 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 116.174 -0.466 . . . . 61.23 113.449 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -93.97 152.03 19.12 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 112.476 0.546 . . . . 64.24 112.476 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.35 110.11 20.42 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.852 -0.613 . . . . 73.41 109.988 175.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 t -150.68 153.07 33.42 Favored Pre-proline 0 N--CA 1.473 0.699 0 N-CA-C 111.86 0.319 . . . . 74.02 111.86 -174.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.98 144.37 47.34 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.051 1.834 . . . . 72.22 111.929 169.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.16 161.43 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 121.112 0.482 . . . . 73.12 111.735 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.1 m -145.57 140.84 27.71 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.385 0.274 . . . . 62.54 110.604 177.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -168.03 162.86 36.65 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.206 -0.997 . . . . 70.51 114.028 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -84.85 112.82 20.89 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 122.992 0.517 . . . . 70.32 110.68 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.8 t -61.75 107.48 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 121.156 0.503 . . . . 61.42 111.8 -174.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 55.1 ttp -97.41 -47.79 5.55 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.134 -0.484 . . . . 72.31 111.329 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 40.2 mmtm -130.34 140.27 50.64 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.804 0.335 . . . . 73.42 111.56 -179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 66.3 mt -124.8 112.81 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.899 0.38 . . . . 72.34 110.865 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.7 m -92.45 128.03 38.16 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.382 -0.372 . . . . 75.53 110.651 177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.5 m -59.45 151.67 58.98 Favored Pre-proline 0 N--CA 1.473 0.715 0 CA-C-N 116.352 -0.386 . . . . 71.13 112.007 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 65' ' ' ILE . 9.0 Cg_endo -49.59 119.91 5.21 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 123.038 2.492 . . . . 60.33 113.613 -177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -92.66 116.26 28.85 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.596 -0.729 . . . . 63.42 110.095 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.1 m -89.21 142.4 27.68 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.267 0.556 . . . . 55.12 112.393 -172.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -142.39 160.21 40.71 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.672 -0.695 . . . . 73.24 109.895 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.5 m -85.11 104.56 15.12 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.772 -0.58 . . . . 72.33 111.171 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.6 t -92.53 -171.34 2.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.796 -0.638 . . . . 70.21 111.554 -178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 -64.6 152.05 43.13 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 120.959 0.409 . . . . 72.23 111.875 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -39.69 115.18 0.49 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 113.394 0.887 . . . . 71.24 113.394 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.28 -52.13 0.75 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.943 -0.646 . . . . 42.03 113.931 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 60.7 mtt85 -110.56 160.02 17.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.245 0.545 . . . . 70.42 112.389 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.415 ' H ' ' HG2' ' A' ' 41' ' ' GLU . 7.9 pt-20 -65.89 -49.07 69.37 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.752 -0.658 . . . . 64.02 112.32 177.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.65 108.85 1.42 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.222 -0.513 . . . . 54.25 113.661 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.9 mttt -148.53 155.99 41.86 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.191 0.519 . . . . 72.13 112.248 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -148.82 135.03 19.29 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.52 -0.764 . . . . 73.31 109.92 173.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 144.9 46.29 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.075 -0.391 . . . . 71.23 111.899 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -106.62 110.89 23.22 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.794 0.331 . . . . 71.54 111.204 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.07 114.57 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 CA-C-O 120.976 0.417 . . . . 72.0 110.585 175.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 42.4 mm -92.74 107.35 18.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 121.213 0.53 . . . . 72.34 111.246 -176.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.4 pt -105.71 141.86 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.875 -0.602 . . . . 70.32 110.523 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -119.15 139.01 52.52 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.909 0.707 . . . . 61.12 112.909 -172.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.84 167.06 14.0 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.451 -0.795 . . . . 63.21 109.111 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -60.18 -22.64 63.17 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 120.859 0.361 . . . . 73.24 111.485 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.602 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 30.1 p -98.18 -3.93 36.56 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.805 0.668 . . . . 64.24 112.805 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.93 167.21 13.25 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.841 -0.695 . . . . 53.54 113.609 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 2.8 mp0 -103.35 163.7 12.1 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.068 0.461 . . . . 70.4 111.372 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 tp -137.15 142.34 42.22 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.374 -0.375 . . . . 72.32 111.547 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 57' ' ' ARG . 33.3 ttm-85 -95.19 100.5 12.29 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.406 -0.361 . . . . 73.41 110.852 175.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 112.29 19.92 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.751 0.31 . . . . 73.21 110.939 177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -93.41 108.04 19.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-O 121.211 0.529 . . . . 70.43 111.802 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.1 m-85 -92.61 104.02 16.36 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.043 -0.526 . . . . 45.13 110.895 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -71.51 162.18 29.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.082 -0.508 . . . . 74.31 111.619 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.428 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 5.2 t -39.02 -36.5 0.29 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 113.802 1.038 . . . . 74.2 113.802 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -71.19 -29.83 65.65 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 120.938 0.399 . . . . 70.22 111.946 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -96.95 1.81 50.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.078 0.77 . . . . 74.21 113.078 -177.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 31' ' ' PRO . 44.6 mm -55.8 -35.92 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 CA-C-O 120.906 0.384 . . . . 63.11 111.554 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 21.1 pttm -54.61 -25.35 25.99 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.559 0.578 . . . . 72.53 112.559 177.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.508 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -74.41 -23.75 59.0 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.178 0.436 . . . . 75.41 112.178 -177.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.02 -28.43 69.04 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.814 0.672 . . . . 72.34 112.814 -175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 23.0 pttp -81.0 -6.0 58.26 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.39 0.515 . . . . 71.3 112.39 -178.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -76.28 -42.59 45.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.912 0.386 . . . . 64.41 111.925 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -117.47 156.48 27.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.068 0.461 . . . . 73.24 111.781 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -116.81 157.78 25.01 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.123 0.487 . . . . 71.13 110.857 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -63.13 92.01 0.05 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.193 0.52 . . . . 73.32 111.245 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.55 -17.2 1.46 Allowed Glycine 0 CA--C 1.529 0.932 0 CA-C-N 116.072 -0.513 . . . . 61.31 113.297 -178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -82.58 -174.57 5.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.014 0.407 . . . . 70.34 111.541 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 60.8 t -122.5 123.92 69.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 122.392 0.277 . . . . 74.34 110.583 178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 104' ' ' VAL . 35.2 pt -120.44 147.53 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.263 0.838 . . . . 74.13 113.263 -174.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 40.4 ttm180 -114.77 114.41 25.55 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 115.014 -0.994 . . . . 75.44 110.073 172.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 102' ' ' VAL . 36.5 mt -97.87 128.95 48.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 120.701 0.286 . . . . 53.34 110.907 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -102.07 125.05 48.66 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.706 0.632 . . . . 74.43 112.706 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 66.95 90.03 0.1 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.769 0.827 . . . . 74.24 112.806 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 96' ' ' LEU . 24.8 m -139.52 160.13 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.96 0.41 . . . . 74.34 111.36 175.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -102.67 121.16 41.87 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.895 0.379 . . . . 74.21 111.332 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 13' ' ' LEU . 43.7 mm -80.94 108.98 14.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 116.435 -0.348 . . . . 71.43 110.403 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -83.65 -19.57 35.17 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.119 0.414 . . . . 54.41 112.119 -177.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 83.45 85.74 0.85 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 120.798 -0.715 . . . . 60.5 113.065 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.506 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -71.44 118.38 7.19 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.291 -0.481 . . . . 61.33 112.88 177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -68.98 -34.6 75.57 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.864 0.364 . . . . 51.33 111.575 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -78.06 68.3 2.87 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.311 -0.471 . . . . 62.35 113.675 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.38 -72.1 0.79 Allowed Glycine 0 CA--C 1.528 0.879 0 C-N-CA 121.721 -0.276 . . . . 65.02 113.72 176.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.6 mtt180 -82.52 131.14 35.22 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.907 0.384 . . . . 74.24 111.91 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.52 ' HE2' ' O ' ' A' ' 12' ' ' LYS . 50.1 mttp -71.67 -176.28 1.57 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.898 0.38 . . . . 75.3 110.623 176.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -151.87 141.55 21.82 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.198 0.523 . . . . 75.42 112.219 -176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -125.1 120.39 31.3 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.428 -0.805 . . . . 71.22 111.027 -178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -94.6 130.51 41.01 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.862 0.363 . . . . 63.12 111.445 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.457 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -84.15 170.02 14.23 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.426 0.631 . . . . 71.42 112.322 -176.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.4 mtt -125.46 153.49 72.42 Favored Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 115.683 -0.689 . . . . 65.41 110.502 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.33 -31.04 8.83 Favored 'Trans proline' 0 CA--C 1.546 1.08 0 C-N-CA 123.274 2.649 . . . . 64.5 115.334 -175.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 99' ' ' ARG . 27.7 mtm-85 -100.21 -13.52 18.87 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.006 -0.433 . . . . 65.01 111.945 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 40.2 m -64.14 131.68 48.2 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.049 0.452 . . . . 54.31 111.741 -178.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.1 p -112.51 166.5 11.26 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.286 0.565 . . . . 72.23 112.214 -177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 79' ' ' ILE . 32.9 m -124.32 148.36 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-N 115.86 -0.609 . . . . 73.31 110.613 175.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -137.56 124.83 21.76 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.99 0.424 . . . . 71.14 111.606 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG12 HG22 ' A' ' 77' ' ' ILE . 32.7 m -77.68 138.12 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.411 0.624 . . . . 74.44 112.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.604 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 66.1 mt -106.72 163.6 12.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.673 -0.694 . . . . 75.32 110.997 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.679 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.5 t70 74.72 -76.23 0.0 OUTLIER Pre-proline 0 CA--C 1.564 1.507 0 C-N-CA 124.091 0.956 . . . . 74.21 111.131 -174.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.679 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 28.4 Cg_endo -66.92 62.17 0.6 Allowed 'Trans proline' 0 C--N 1.373 1.827 0 CA-C-N 122.343 1.872 . . . . 64.3 109.978 155.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.74 124.99 20.35 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.381 -1.281 . . . . 70.45 113.524 -166.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -104.42 -33.57 8.56 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 116.359 -0.382 . . . . 75.52 111.305 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 m170 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.82 -0.61 . . . . 61.25 111.814 -177.665 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 111.476 0.176 . . . . 73.34 111.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 3' ' ' PRO . 37.2 mtmm -99.16 125.06 42.92 Favored Pre-proline 0 N--CA 1.474 0.766 0 N-CA-C 112.075 0.398 . . . . 54.41 112.075 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 16.7 Cg_exo -68.49 112.54 2.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.584 2.189 . . . . 75.52 112.529 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -75.8 129.29 36.8 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.982 0.42 . . . . 72.03 111.129 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 -90.44 154.88 19.33 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.704 0.764 . . . . 74.22 112.756 -175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 26.9 ttm-85 -176.69 -67.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.929 -1.032 . . . . 74.31 109.739 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 67.3 mtm -78.6 70.7 4.98 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.628 0.727 . . . . 61.55 110.566 177.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -114.23 172.76 6.81 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.59 -0.732 . . . . 51.31 112.145 -177.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.6 p -79.22 178.78 7.81 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.947 -0.569 . . . . 73.52 111.902 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.553 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.1 mt -58.81 -22.25 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 121.185 0.517 . . . . 55.44 112.0 -177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 78.6 p -66.37 -21.74 66.24 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.534 0.568 . . . . 73.21 112.534 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -113.32 4.64 16.49 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.75 0.648 . . . . 72.33 112.75 -177.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 75.5 mt -73.43 101.13 3.41 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.571 0.582 . . . . 73.0 112.571 -175.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.27 142.78 27.34 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.0 -0.545 . . . . 75.42 110.858 173.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.64 124.86 24.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.329 0.585 . . . . 52.22 111.461 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 108.7 -10.14 35.03 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-N 115.902 -0.59 . . . . 75.21 112.405 -175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.45 142.45 30.08 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.86 0.362 . . . . 70.33 111.911 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -102.8 107.37 18.21 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.116 0.484 . . . . 75.4 110.813 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -153.31 153.76 29.8 Favored Pre-proline 0 N--CA 1.471 0.605 0 N-CA-C 112.166 0.432 . . . . 72.03 112.166 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.6 145.63 47.38 Favored 'Trans proline' 0 CA--C 1.542 0.905 0 C-N-CA 122.036 1.824 . . . . 75.33 111.72 166.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.11 161.32 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 121.102 0.477 . . . . 72.5 111.731 -177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -140.14 147.45 40.2 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 116.313 -0.403 . . . . 61.3 111.322 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.95 165.46 35.0 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.556 -0.83 . . . . 71.45 113.951 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.61 ' HG2' HG22 ' A' ' 76' ' ' VAL . 65.6 mtm180 -88.79 114.16 25.11 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 122.865 0.466 . . . . 74.23 110.816 176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 88.1 t -62.92 110.24 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 111.842 0.312 . . . . 74.45 111.842 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.441 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.3 ttp -96.29 -55.37 2.97 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.674 0.273 . . . . 73.31 111.581 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HD3' ' O ' ' A' ' 26' ' ' MET . 74.7 mmtt -132.28 130.84 41.39 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.649 0.261 . . . . 73.04 111.251 -178.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG23 HG22 ' A' ' 47' ' ' VAL . 61.7 mt -110.64 115.6 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 120.827 0.346 . . . . 64.41 111.495 178.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.2 m -83.84 141.22 31.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.871 0.367 . . . . 73.33 110.912 175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.2 m -62.08 150.51 83.5 Favored Pre-proline 0 N--CA 1.471 0.595 0 CA-C-N 116.074 -0.512 . . . . 72.03 112.357 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HB2' ' HD3' ' A' ' 43' ' ' LYS . 48.8 Cg_endo -66.91 118.99 5.99 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.623 2.215 . . . . 72.14 112.628 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -93.66 125.49 38.3 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.491 -0.322 . . . . 74.2 111.288 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.7 m -89.76 138.17 31.71 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.855 0.36 . . . . 74.33 111.766 -177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.65 165.57 22.55 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.125 0.488 . . . . 71.5 111.232 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 38.6 m -85.52 108.17 17.8 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.208 178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.3 t -103.09 173.88 6.11 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 121.228 0.537 . . . . 72.43 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.3 mtt180 -94.87 -9.18 35.05 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.121 -0.49 . . . . 74.3 111.577 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.562 ' HE2' ' HA ' ' A' ' 38' ' ' LYS . 9.4 mmpt? -88.03 167.01 14.05 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.784 0.326 . . . . 73.21 111.0 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.63 35.66 1.39 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 121.294 -0.479 . . . . 70.33 113.9 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 32.3 mtt180 -127.2 160.63 30.67 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.154 0.502 . . . . 72.53 111.709 177.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -61.11 -48.32 82.2 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.939 -0.573 . . . . 62.33 112.07 176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.67 102.71 0.18 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 121.317 -0.468 . . . . 64.45 113.791 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 31' ' ' PRO . 50.6 mttp -124.31 163.17 22.23 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.351 -0.499 . . . . 72.55 112.117 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -144.74 137.18 26.31 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.087 -0.506 . . . . 74.24 110.44 173.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.483 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -121.76 154.71 36.58 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 121.991 -0.443 . . . . 54.33 111.997 -177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -123.3 111.04 15.94 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.893 0.378 . . . . 73.25 111.131 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG22 HG23 ' A' ' 28' ' ' ILE . 73.7 t -109.59 125.33 66.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.003 0.43 . . . . 72.44 111.135 178.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.9 mm -93.05 108.6 20.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.999 0.428 . . . . 73.23 110.806 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.0 pt -111.61 138.54 39.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 116.075 -0.511 . . . . 63.22 111.198 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.0 128.11 54.09 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.936 0.398 . . . . 71.02 111.504 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -117.82 165.43 13.66 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.684 0.278 . . . . 73.44 110.473 177.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.82 -24.24 49.62 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.34 0.496 . . . . 61.53 112.34 178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.543 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 56.5 p -100.95 4.4 42.53 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.876 0.695 . . . . 73.43 112.876 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.53 168.31 12.11 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 120.794 -0.717 . . . . 71.22 113.531 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -103.11 148.89 25.19 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.437 -0.449 . . . . 71.13 110.958 176.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.478 HD21 ' HB2' ' A' ' 94' ' ' ALA . 31.2 tp -139.67 151.06 45.62 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.186 0.517 . . . . 74.13 111.644 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -103.05 107.39 18.18 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.998 -0.546 . . . . 73.32 111.34 177.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.78 127.56 33.9 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.728 0.299 . . . . 62.11 111.774 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' O ' HD13 ' A' ' 96' ' ' LEU . 49.0 t -108.11 107.21 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 121.062 0.458 . . . . 73.13 111.345 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.483 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 42.7 m-85 -93.0 106.37 18.34 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.055 0.455 . . . . 71.23 111.581 -178.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -74.36 163.14 28.15 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.563 0.579 . . . . 75.51 112.563 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.462 HG23 ' HG2' ' A' ' 63' ' ' GLU . 2.8 t -37.14 -47.41 0.76 Allowed 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.735 1.383 . . . . 70.52 114.735 -174.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 62' ' ' THR . 10.6 mm-40 -77.52 -17.04 58.33 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.024 0.44 . . . . 74.13 111.949 -175.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -98.41 -4.79 33.94 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 112.109 0.411 . . . . 71.44 112.109 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 37.2 mm -54.09 -36.06 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-O 121.043 0.449 . . . . 64.13 111.337 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 64.7 pttt -56.14 -23.52 35.11 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.232 -0.44 . . . . 73.12 112.174 178.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.655 HD13 HG13 ' A' ' 102' ' ' VAL . 80.8 mt -76.2 -24.66 54.68 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 111.931 0.345 . . . . 74.01 111.931 -177.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.15 -41.29 75.18 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.167 0.432 . . . . 54.31 112.167 -177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -76.77 -6.77 53.64 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.76 0.652 . . . . 64.13 112.76 -177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -71.65 -28.76 63.98 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 122.08 -0.388 . . . . 54.12 111.734 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -126.36 170.18 12.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.155 0.502 . . . . 75.01 112.075 -177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.5 mtt85 -109.17 159.37 16.96 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 116.34 -0.391 . . . . 72.4 110.806 178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -68.6 89.59 0.37 Allowed 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.064 0.459 . . . . 72.34 110.017 174.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.34 -17.86 1.51 Allowed Glycine 0 CA--C 1.526 0.755 0 CA-C-N 116.083 -0.508 . . . . 64.45 112.802 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -81.75 146.96 29.69 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.467 0.651 . . . . 75.21 112.387 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.61 HG22 ' HG2' ' A' ' 24' ' ' ARG . 31.4 t -76.88 125.83 37.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-N 115.847 -0.615 . . . . 61.45 110.67 171.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.9 pt -126.98 157.35 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-O 121.34 0.591 . . . . 75.32 112.474 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.474 ' HB2' HD11 ' A' ' 105' ' ' LEU . 58.2 ttp180 -124.93 112.28 16.42 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.599 -0.728 . . . . 74.22 110.198 174.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.9 mt -87.45 127.41 40.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.471 -0.331 . . . . 70.4 110.367 178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -93.12 116.12 28.73 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.226 0.454 . . . . 72.31 112.226 -171.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 61.42 97.37 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.539 0.94 . . . . 72.44 113.539 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.1 m -133.52 167.65 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.04 -0.527 . . . . 72.22 111.218 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -108.16 122.1 46.21 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.317 -0.401 . . . . 63.32 110.382 173.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 46.5 mm -80.13 137.98 20.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.248 -0.433 . . . . 72.23 111.147 -178.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.544 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 34.5 mmt180 -122.05 167.41 13.16 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.921 0.391 . . . . 74.31 110.502 176.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.69 84.14 0.37 Allowed Glycine 0 CA--C 1.525 0.719 0 C-N-CA 120.929 -0.653 . . . . 71.12 113.807 -175.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.61 165.16 43.98 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.044 -0.598 . . . . 33.33 112.771 175.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -78.75 150.56 32.42 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.048 0.452 . . . . 73.52 111.288 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 110.52 14.84 12.05 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 121.39 -0.433 . . . . 54.45 113.228 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.68 -57.92 4.49 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 121.229 -0.51 . . . . 70.44 113.577 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 91' ' ' ARG . 69.1 mtt85 -70.09 122.96 20.41 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.079 0.466 . . . . 72.53 111.876 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -80.62 -178.55 6.8 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.16 0.505 . . . . 72.22 111.566 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.544 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 9.7 pt-20 -136.96 156.07 48.92 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.326 -0.397 . . . . 73.13 110.912 -177.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.478 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -128.99 116.09 18.81 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.729 0.299 . . . . 75.15 111.489 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -95.43 128.44 42.29 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.132 0.491 . . . . 75.4 111.718 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 59' ' ' VAL . 10.4 mp -82.86 -178.37 7.08 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.685 0.755 . . . . 74.44 112.314 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 39.2 mtt -133.8 158.97 74.21 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.418 -0.81 . . . . 63.1 110.191 -178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -54.1 -18.37 13.44 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 122.291 1.994 . . . . 72.15 113.345 177.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 84.5 mtt180 -99.83 -12.98 19.42 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.046 0.387 . . . . 74.2 112.046 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 45.3 m -70.32 127.76 33.87 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.291 0.478 . . . . 63.24 112.291 -174.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.5 p -118.41 160.97 20.75 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.846 -0.616 . . . . 74.31 110.805 178.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.655 HG13 HD13 ' A' ' 67' ' ' LEU . 18.3 m -121.39 152.43 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.044 0.45 . . . . 74.34 111.175 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 78' ' ' ARG . 13.1 pt-20 -137.61 145.47 42.8 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.207 -0.451 . . . . 53.43 110.404 177.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.521 ' HB ' ' HD2' ' A' ' 107' ' ' PRO . 20.8 m -89.7 128.19 41.86 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.535 0.684 . . . . 73.45 112.377 -176.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 78' ' ' ARG . 47.6 mt -99.85 -1.88 36.35 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.866 -0.606 . . . . 72.5 111.27 178.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.868 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 14.8 t70 -77.39 -55.87 1.26 Allowed Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 109.514 -0.55 . . . . 72.45 109.514 175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.868 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -87.24 72.66 3.07 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 122.22 1.947 . . . . 75.33 108.692 156.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.416 ' C ' HD13 ' A' ' 108' ' ' LEU . 3.5 tm? -40.55 116.99 0.76 Allowed 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.67 -1.15 . . . . 72.14 113.34 -166.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.531 ' HG2' ' HD2' ' A' ' 110' ' ' HIS . 33.1 tt0 -90.02 -52.2 5.08 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.517 -0.765 . . . . 73.23 110.681 174.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.531 ' HD2' ' HG2' ' A' ' 109' ' ' GLU . 26.4 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.788 -0.625 . . . . 64.14 112.101 176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 110.323 -0.251 . . . . 72.23 110.323 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 2' ' ' LYS . 50.4 pttt -118.02 87.66 29.12 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.536 0.569 . . . . 64.42 112.536 177.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.65 102.83 1.63 Allowed 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 122.291 1.994 . . . . 72.23 111.126 169.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -79.31 137.9 37.52 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.173 0.511 . . . . 75.23 111.804 -174.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 90.4 m-70 -134.13 -4.46 2.74 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 116.068 -0.515 . . . . 53.45 111.886 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.684 ' HA ' ' HE ' ' A' ' 6' ' ' ARG . 1.1 mmp_? -117.44 -68.28 0.93 Allowed 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.189 0.44 . . . . 74.2 112.189 -174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 53.0 ttp -83.64 112.63 20.2 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.944 0.402 . . . . 63.34 111.735 -176.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -88.44 173.7 8.55 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.453 0.644 . . . . 73.33 112.624 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.2 p -103.73 177.57 4.8 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.69 -0.686 . . . . 73.13 111.424 -179.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 25.6 mt -63.36 -32.68 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 120.742 0.305 . . . . 74.51 111.751 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.582 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.5 t -59.73 -28.39 67.3 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.964 0.412 . . . . 75.43 111.843 175.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -85.76 -4.49 59.18 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.298 0.481 . . . . 65.33 112.298 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.6 mt -74.75 142.99 44.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.064 0.459 . . . . 70.03 112.119 -178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -152.63 152.89 32.32 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.371 -0.377 . . . . 61.42 110.931 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 122.73 15.01 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.332 0.587 . . . . 73.12 112.46 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.3 -16.23 55.51 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.976 -0.556 . . . . 53.3 112.855 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -83.52 135.07 34.79 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.91 0.386 . . . . 74.55 111.988 -178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -112.05 109.55 19.35 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.958 0.409 . . . . 63.01 110.982 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.4 t -151.52 153.67 32.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 116.329 -0.396 . . . . 54.04 111.433 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.47 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 27.1 Cg_endo -63.04 143.46 90.81 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.208 1.939 . . . . 64.43 112.043 170.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -124.21 156.97 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.152 0.501 . . . . 64.24 111.976 -176.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 83.7 m -132.95 146.52 51.85 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.207 -0.452 . . . . 74.32 111.045 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 176.94 152.55 9.93 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.596 -0.811 . . . . 63.13 113.644 177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HG2' HG13 ' A' ' 76' ' ' VAL . 92.5 mtt180 -89.11 124.19 34.09 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 122.536 -0.391 . . . . 64.14 110.493 177.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -62.24 126.26 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.214 0.45 . . . . 72.22 112.214 -174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.501 ' HG2' ' HG2' ' A' ' 27' ' ' LYS . 56.4 ttp -100.41 -57.34 2.14 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.297 -0.41 . . . . 74.21 110.533 175.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HG2' ' A' ' 26' ' ' MET . 1.4 mmmp? -133.88 143.95 48.59 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.802 0.334 . . . . 73.32 111.253 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 HG13 ' A' ' 47' ' ' VAL . 75.4 mt -121.2 128.86 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 120.723 0.297 . . . . 72.22 110.845 175.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.8 m -102.12 143.45 31.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.032 0.444 . . . . 64.05 111.509 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 43.2 m -64.57 152.79 88.77 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.063 -0.517 . . . . 52.23 111.442 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.7 142.35 88.99 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 122.749 2.3 . . . . 44.31 113.599 -179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 53.1 ttt180 -102.78 122.32 44.25 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.758 -0.655 . . . . 75.02 110.027 174.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.3 m -87.53 129.94 34.91 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.162 0.431 . . . . 73.11 112.162 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.424 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 49.6 p90 -136.99 149.98 47.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.342 -0.39 . . . . 74.03 110.783 178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.8 m -85.35 108.43 17.82 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.971 0.415 . . . . 73.33 111.715 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.3 t -108.69 151.37 26.27 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.035 0.445 . . . . 45.53 112.164 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.766 ' H ' ' HD3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -83.28 3.77 29.93 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.347 -0.388 . . . . 64.2 111.968 179.847 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 tppp? -66.36 -27.7 68.08 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-O 120.965 0.412 . . . . 65.34 111.53 176.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.82 -15.46 21.5 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.049 -0.596 . . . . 63.5 112.932 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.0 mtt-85 -85.7 161.84 19.03 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.799 0.333 . . . . 74.3 111.222 176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -59.07 -27.71 65.79 Favored 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 111.993 0.368 . . . . 71.22 111.993 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 34' ' ' PHE . . . 82.06 113.54 0.42 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.332 -0.461 . . . . 73.15 114.053 174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.508 ' H ' ' HB ' ' A' ' 62' ' ' THR . 85.0 mttt -154.25 149.71 27.26 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.789 0.435 . . . . 60.13 111.88 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -141.44 133.64 27.9 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.117 -0.492 . . . . 62.34 110.622 173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.87 139.78 51.06 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.817 0.341 . . . . 75.43 111.814 -178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.506 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 32.4 m-80 -106.04 111.14 23.65 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.911 0.386 . . . . 72.53 111.479 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.558 HG13 HG12 ' A' ' 28' ' ' ILE . 92.9 t -107.26 119.18 56.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 120.992 0.425 . . . . 74.44 110.968 176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 42.2 mm -93.8 108.7 20.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 CA-C-O 121.117 0.484 . . . . 71.53 111.444 -177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.416 HG21 HD11 ' A' ' 77' ' ' ILE . 35.8 pt -106.5 158.81 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.237 -0.438 . . . . 72.34 111.395 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -129.7 126.59 38.64 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.981 0.419 . . . . 54.21 111.273 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.448 ' HB3' HD12 ' A' ' 10' ' ' ILE . 34.0 t70 -116.06 168.24 10.27 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.039 0.447 . . . . 62.21 111.027 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.75 -11.9 20.59 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.38 0.511 . . . . 74.15 112.38 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 70.0 p -119.37 7.96 11.31 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.903 0.705 . . . . 65.02 112.903 -178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.95 168.99 11.86 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 120.474 -0.87 . . . . 74.22 113.186 -177.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -101.11 165.7 11.17 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.386 -0.479 . . . . 74.04 110.607 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 10' ' ' ILE . 39.9 tp -151.08 145.96 25.84 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.059 0.457 . . . . 52.41 111.871 -178.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.506 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 15.5 ttm180 -97.96 106.99 19.37 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.269 -0.423 . . . . 74.2 111.095 174.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.22 117.08 22.69 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 122.206 -0.309 . . . . 70.24 111.108 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.92 109.42 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 121.128 0.49 . . . . 65.11 111.732 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.401 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 25.6 m-85 -93.46 104.25 16.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.142 0.496 . . . . 71.41 111.227 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -76.18 162.34 28.05 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.872 -0.604 . . . . 54.02 111.936 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.508 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.9 t -39.42 -26.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.762 1.023 . . . . 73.51 113.762 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 36.3 mm-40 -73.76 -45.26 52.88 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.391 0.615 . . . . 74.22 110.913 175.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -91.37 3.61 54.47 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.347 0.869 . . . . 73.13 113.347 -174.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 41.0 mm -53.59 -27.98 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-O 121.385 0.612 . . . . 65.4 110.512 174.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 54.9 pttt -54.76 -29.07 53.03 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.649 -0.705 . . . . 62.23 112.734 175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.633 HD13 HG13 ' A' ' 102' ' ' VAL . 75.7 mt -81.26 -22.18 38.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.479 0.548 . . . . 74.23 112.479 -174.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -59.57 -28.98 67.62 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.415 0.524 . . . . 74.1 112.415 -177.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.6 ptpt -80.42 -12.33 59.58 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.472 0.545 . . . . 74.33 112.472 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -75.16 -55.15 6.01 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.376 0.509 . . . . 74.24 112.376 -174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -104.71 177.66 4.78 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.787 0.327 . . . . 74.32 111.834 -176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -127.65 170.95 12.11 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.935 0.397 . . . . 70.04 111.079 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -73.29 97.94 2.57 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.006 0.431 . . . . 73.12 110.87 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 139.9 -18.46 2.96 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.942 -0.646 . . . . 72.43 113.695 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -79.66 171.84 14.6 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.237 0.542 . . . . 72.13 112.01 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 HG13 ' HG2' ' A' ' 24' ' ' ARG . 21.3 t -100.22 125.13 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 116.344 -0.389 . . . . 62.4 110.491 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 49' ' ' ILE . 43.5 pt -124.08 164.63 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.069 0.937 . . . . 70.31 113.038 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttt180 -142.64 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.608 -1.178 . . . . 74.05 109.408 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.523 HG12 HG12 ' A' ' 102' ' ' VAL . 31.0 mt -99.44 128.56 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.747 0.308 . . . . 74.22 111.025 -175.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 84.1 tttt -100.41 126.93 46.85 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.3 0.482 . . . . 75.32 112.3 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 63.18 90.59 0.08 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.515 -0.766 . . . . 52.11 112.841 177.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.0 m -136.07 162.36 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-O 120.815 0.341 . . . . 75.24 111.687 176.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -103.22 118.83 37.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.463 -0.335 . . . . 72.22 111.482 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 40.5 mm -88.02 120.4 36.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 111.681 0.252 . . . . 51.02 111.681 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.43 ' HB2' ' CG ' ' A' ' 93' ' ' GLU . 39.2 mmt180 -91.36 -19.07 23.3 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 120.801 0.334 . . . . 73.11 111.511 175.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 97.08 -15.22 62.85 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 114.795 0.678 . . . . 74.4 114.795 174.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 55.18 58.94 11.44 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 117.67 0.735 . . . . 60.41 113.237 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -64.89 98.23 0.27 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.039 0.447 . . . . 71.11 111.592 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 132.51 -12.65 5.17 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.447 -0.406 . . . . 74.21 113.498 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -167.0 -118.29 0.43 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 120.98 -0.629 . . . . 22.1 112.983 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.6 mtt180 -88.25 149.12 24.01 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.199 0.523 . . . . 72.45 111.471 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.443 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 38.6 mttm -73.72 168.63 18.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.733 -0.667 . . . . 61.44 111.782 -175.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.43 ' CG ' ' HB2' ' A' ' 85' ' ' ARG . 15.7 pt-20 -142.61 148.64 37.79 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 116.119 -0.491 . . . . 63.51 111.544 -174.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.76 119.57 20.49 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.795 -0.639 . . . . 71.22 110.836 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -92.36 128.65 38.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.933 0.397 . . . . 65.44 111.504 -177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.9 149.86 23.84 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 121.373 0.606 . . . . 53.41 111.441 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 54.8 mtm -112.35 161.06 27.91 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 115.839 -0.618 . . . . 52.53 110.79 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 94.2 Cg_exo -43.26 -38.78 8.24 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.924 2.416 . . . . 74.55 114.607 -177.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -87.89 -10.39 50.83 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 112.799 0.666 . . . . 73.14 112.799 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.5 m -69.7 118.8 13.01 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.031 0.382 . . . . 74.43 112.031 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 54.9 p -105.75 166.04 10.75 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.924 0.392 . . . . 64.11 111.525 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.633 HG13 HD13 ' A' ' 67' ' ' LEU . 33.0 m -127.77 136.02 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 121.137 0.494 . . . . 54.12 111.775 178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.7 pt-20 -124.59 154.1 41.18 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.253 -0.43 . . . . 62.54 110.594 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.2 m -96.88 140.75 16.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.331 0.586 . . . . 74.23 112.202 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.622 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 80.1 mt -111.52 -178.22 3.39 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.131 -0.486 . . . . 42.24 111.507 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 70.59 -76.93 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.281 0 CA-C-O 118.579 -0.724 . . . . 62.05 111.038 -170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.622 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 32.9 Cg_exo -63.94 78.05 0.16 Allowed 'Trans proline' 0 C--N 1.364 1.376 0 CA-C-N 122.236 1.834 . . . . 75.5 110.349 155.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.19 118.36 6.74 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.999 0.74 . . . . 72.0 112.999 -169.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -78.88 -20.08 50.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.558 -0.746 . . . . 72.2 111.745 174.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 119.049 -0.501 . . . . 74.21 111.379 179.411 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 mmt . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 120.849 0.357 . . . . 63.2 111.626 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -78.83 116.65 61.43 Favored Pre-proline 0 CA--C 1.544 0.735 0 CA-C-N 116.425 -0.352 . . . . 73.44 110.809 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.9 147.53 49.86 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.607 2.204 . . . . 72.33 113.94 -173.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -104.3 -39.65 6.4 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.907 -0.588 . . . . 71.34 110.973 173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -159.0 105.53 1.77 Allowed 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.203 -0.453 . . . . 75.25 111.901 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -96.0 34.76 1.5 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.82 0.819 . . . . 71.34 110.522 176.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 41.9 ttm -149.01 22.91 0.96 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.67 0.748 . . . . 71.41 109.686 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.3 p-10 -78.85 92.69 4.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.746 0.784 . . . . 62.25 112.088 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.492 HG21 HG21 ' A' ' 53' ' ' THR . 9.3 t -76.55 -169.62 1.29 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.467 -0.788 . . . . 72.05 110.594 172.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.517 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 56.5 mt -50.49 -29.03 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 112.694 0.628 . . . . 61.03 112.694 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.57 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 26.5 t -54.67 -37.38 65.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.104 0.779 . . . . 71.11 113.104 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -125.98 33.2 5.11 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.096 0.776 . . . . 62.32 113.096 -172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 85.7 mt -78.14 106.5 10.07 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.959 0.409 . . . . 74.51 111.049 175.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -93.59 139.58 30.61 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.017 0.436 . . . . 61.1 111.582 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -59.87 128.07 35.07 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.16 0.505 . . . . 74.11 111.5 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.74 -5.58 66.86 Favored Glycine 0 CA--C 1.531 1.045 0 CA-C-N 116.352 -0.386 . . . . 74.14 113.301 -177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.24 148.1 24.51 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 112.235 0.457 . . . . 72.21 112.235 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -111.09 108.53 18.26 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 121.135 0.493 . . . . 73.33 110.522 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 12.9 t -152.24 150.84 26.36 Favored Pre-proline 0 N--CA 1.47 0.564 0 CA-C-N 116.399 -0.364 . . . . 62.25 111.233 -177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.17 140.75 54.81 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.439 2.093 . . . . 64.11 111.908 171.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.41 148.0 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 122.054 -0.403 . . . . 64.1 111.575 -176.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.8 m -125.83 145.78 50.08 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.631 -0.259 . . . . 74.45 111.579 -177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.1 153.0 15.77 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.902 -0.666 . . . . 74.42 113.195 176.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 44.7 mtp85 -86.51 119.06 26.36 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 122.626 -0.337 . . . . 70.33 110.167 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.85 112.13 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.258 0.551 . . . . 70.25 112.39 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.7 ttp -94.4 -52.07 4.5 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.118 -0.492 . . . . 34.42 110.976 177.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -129.76 143.63 50.91 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.072 0.397 . . . . 73.43 112.072 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 70.2 mt -125.85 116.54 46.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 116.291 -0.413 . . . . 73.55 110.574 173.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.4 m -102.96 138.99 39.1 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.051 0.453 . . . . 71.44 111.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.4 p -55.07 148.39 29.54 Favored Pre-proline 0 N--CA 1.475 0.79 0 N-CA-C 113.361 0.874 . . . . 75.43 113.361 -174.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.701 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . 39.0 Cg_endo -64.34 119.24 6.23 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.961 2.441 . . . . 72.42 112.921 175.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.3 ttt180 -94.33 124.61 38.46 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 122.776 0.43 . . . . 75.22 111.161 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.7 m -83.09 149.66 26.77 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 116.305 -0.407 . . . . 52.21 111.754 -176.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -151.4 168.37 25.06 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.906 0.384 . . . . 73.04 111.29 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.4 m -85.41 115.97 23.46 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.154 0.502 . . . . 74.32 111.672 178.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.5 t -107.7 -170.11 1.64 Allowed 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.961 -0.563 . . . . 65.35 110.763 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.4 mmm180 -48.77 -72.01 0.06 Allowed 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.163 0.431 . . . . 64.32 112.163 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.81 167.66 12.89 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.319 0.488 . . . . 71.14 112.319 177.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.37 -66.2 2.65 Favored Glycine 0 CA--C 1.524 0.644 0 CA-C-N 116.156 -0.475 . . . . 55.42 113.679 173.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -85.33 146.86 26.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.946 0.403 . . . . 74.01 111.243 -178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -73.49 -16.33 61.3 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.899 0.703 . . . . 74.23 112.899 -174.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 66.18 105.7 0.01 OUTLIER Glycine 0 CA--C 1.53 0.999 0 C-N-CA 121.327 -0.464 . . . . 53.01 113.826 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.701 ' HE2' ' HB2' ' A' ' 31' ' ' PRO . 47.9 mtpt -138.14 155.07 49.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.071 -0.664 . . . . 74.13 111.762 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -140.02 143.48 36.44 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.007 -0.542 . . . . 61.23 110.766 176.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.35 151.34 47.74 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 122.135 -0.353 . . . . 70.11 111.537 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 38.2 m-80 -121.92 111.75 17.46 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.024 0.44 . . . . 63.54 111.741 -178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.22 119.42 59.16 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.144 -0.48 . . . . 63.11 110.489 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.0 mm -93.17 109.23 21.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.118 0.485 . . . . 70.12 111.214 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.9 pt -106.87 142.97 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-N 116.032 -0.531 . . . . 74.14 111.389 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.48 130.7 52.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 65.33 111.393 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.91 162.28 27.11 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 120.952 0.406 . . . . 74.31 110.709 177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.82 -17.01 32.76 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.403 0.52 . . . . 73.4 112.403 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.57 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.1 p -100.72 -6.94 24.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.171 0.434 . . . . 55.43 112.171 178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 151.89 168.03 15.77 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 120.752 -0.737 . . . . 53.12 113.759 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 39.0 mt-10 -103.7 153.23 20.89 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 122.581 -0.364 . . . . 70.02 110.93 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.4 tp -142.19 143.23 32.84 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.996 0.427 . . . . 71.01 111.739 -177.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 93' ' ' GLU . 49.8 ttp180 -95.12 105.0 16.89 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.985 0.421 . . . . 64.31 110.743 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.41 121.26 28.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 120.799 0.333 . . . . 72.01 111.488 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.28 106.7 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.127 0.489 . . . . 64.34 111.825 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.536 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 24.0 m-85 -93.26 104.21 16.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.178 0.513 . . . . 65.15 111.145 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -72.74 161.15 31.11 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.998 -0.546 . . . . 73.24 111.339 176.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.502 ' HA ' HG12 ' A' ' 65' ' ' ILE . 4.9 t -41.38 -34.44 0.53 Allowed 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 113.602 0.964 . . . . 73.23 113.602 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -67.99 -28.12 67.16 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.293 0.479 . . . . 72.43 112.293 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -106.27 5.62 29.92 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.298 0.851 . . . . 71.25 113.298 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.502 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.3 mm -56.97 -32.52 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-O 120.978 0.418 . . . . 74.21 111.562 179.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 19.3 pttm -56.78 -18.7 13.64 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.55 0.574 . . . . 74.4 112.55 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.616 HD13 HG13 ' A' ' 102' ' ' VAL . 90.6 mt -82.33 -24.38 34.61 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.694 0.283 . . . . 72.24 111.644 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.3 mt -65.33 -17.13 64.27 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.62 0.6 . . . . 75.33 112.62 -177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 21.7 pttp -87.55 -7.81 57.09 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.154 -0.341 . . . . 53.22 111.85 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.2 mtpt -76.41 -63.86 1.24 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.184 0.516 . . . . 53.41 111.527 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -91.96 159.24 15.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.573 0.701 . . . . 62.22 112.494 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.21 163.91 12.93 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.472 -0.786 . . . . 75.32 110.734 177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -71.7 76.4 0.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.472 0.653 . . . . 74.01 110.132 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 160.66 -8.68 0.12 Allowed Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.762 -0.654 . . . . 23.32 113.795 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -94.96 -178.19 4.41 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 117.447 0.624 . . . . 73.13 111.155 176.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 39.5 t -113.08 139.01 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 O-C-N 122.296 -0.253 . . . . 65.34 110.711 177.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.2 pt -133.93 150.86 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 121.596 0.713 . . . . 75.14 112.704 -177.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -123.2 111.5 16.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.343 -0.844 . . . . 74.35 109.538 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.4 mt -87.22 124.93 40.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 72.44 110.971 -177.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -99.3 138.61 36.15 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 111.974 0.361 . . . . 61.13 111.974 -175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 55.7 m-20 63.86 76.58 0.35 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.768 -0.651 . . . . 45.31 112.722 177.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 157.73 34.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.169 0.509 . . . . 62.34 111.801 177.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -108.88 128.1 54.62 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.121 -0.491 . . . . 74.44 110.93 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.494 HG13 ' HB3' ' A' ' 13' ' ' LEU . 51.9 mm -80.59 109.6 15.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.066 -0.516 . . . . 75.41 110.122 178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 28.3 mmm180 -76.23 -53.4 8.3 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.137 0.421 . . . . 60.43 112.137 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.88 -52.53 0.19 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 119.43 -1.367 . . . . 74.31 115.477 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 53.84 45.46 70.07 Favored Glycine 0 CA--C 1.526 0.723 0 CA-C-N 117.633 0.717 . . . . 63.1 111.718 -167.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -50.66 118.44 3.09 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 121.191 0.52 . . . . 73.24 112.233 -172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.92 -49.47 0.86 Allowed Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.019 -0.537 . . . . 73.34 112.958 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -139.3 -105.71 0.66 Allowed Glycine 0 CA--C 1.524 0.647 0 C-N-CA 120.679 -0.772 . . . . 75.24 113.591 -176.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.447 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 51.7 mtm180 -88.77 123.25 33.0 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.062 0.458 . . . . 72.53 111.58 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.628 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 55.4 mttm -61.55 179.24 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.511 -0.768 . . . . 70.13 112.719 -178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 57' ' ' ARG . 14.6 pt-20 -141.91 142.35 33.04 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.843 -0.617 . . . . 74.22 111.589 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -117.16 112.93 21.53 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.155 -0.475 . . . . 71.22 111.208 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.21 131.38 38.36 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.938 0.399 . . . . 64.43 111.089 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.0 167.71 13.47 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.629 0.728 . . . . 71.3 112.304 -176.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -125.18 161.6 48.78 Favored Pre-proline 0 CA--C 1.542 0.641 0 CA-C-N 115.313 -0.858 . . . . 72.32 110.259 -178.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -51.26 -24.18 14.91 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 122.297 1.998 . . . . 64.02 113.707 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -98.82 2.36 46.71 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.0 m -85.42 135.13 33.99 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.183 0.516 . . . . 72.11 112.184 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 57.7 p -128.05 154.63 45.46 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.933 -0.576 . . . . 65.34 111.175 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.616 HG13 HD13 ' A' ' 67' ' ' LEU . 29.6 m -118.79 135.56 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 120.938 0.399 . . . . 64.11 111.691 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -114.69 137.62 51.69 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.256 -0.429 . . . . 74.35 109.945 175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.779 HG22 ' HG3' ' A' ' 109' ' ' GLU . 20.2 m -84.59 126.87 40.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 CA-C-O 121.481 0.658 . . . . 74.55 111.666 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.491 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 78.4 mt -103.52 177.86 4.72 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.908 -0.587 . . . . 75.32 110.518 176.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.677 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 18.3 t70 86.21 -65.1 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 124.111 0.965 . . . . 73.23 109.07 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 15.4 Cg_exo -75.29 -149.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 121.263 1.309 . . . . 64.02 109.798 149.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -167.27 124.33 1.2 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.659 -0.651 . . . . 65.23 111.601 175.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.779 ' HG3' HG22 ' A' ' 104' ' ' VAL . 45.9 mt-10 -78.46 -52.33 8.7 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 112.264 0.468 . . . . 73.13 112.264 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 . . . . . 0 C--O 1.253 1.277 0 N-CA-C 112.95 0.722 . . . . 64.51 112.95 -175.463 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' SD ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 110.236 -0.283 . . . . 71.33 110.236 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' O ' ' SD ' ' A' ' 1' ' ' MET . 3.5 mptp? -71.64 121.71 85.17 Favored Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 111.786 0.291 . . . . 74.04 111.786 -176.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.6 98.58 0.24 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.643 2.229 . . . . 72.12 112.904 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -61.85 128.88 38.29 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 116.187 -0.461 . . . . 71.4 111.65 -178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.84 130.78 5.04 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.533 -0.303 . . . . 73.42 111.488 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.666 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 2.8 mmp_? -101.47 76.85 1.72 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.429 0.633 . . . . 72.22 111.176 172.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.64 90.66 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.909 -1.042 . . . . 75.44 109.654 179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -114.73 135.59 53.99 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.967 0.413 . . . . 74.31 111.196 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.0 t -72.9 167.6 20.66 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.381 -0.372 . . . . 75.34 111.387 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 54.0 mt -56.28 -39.75 61.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.51 0.559 . . . . 63.44 112.51 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 40.3 t -61.68 -23.83 66.36 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.54 0.57 . . . . 75.13 112.54 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -106.33 7.03 31.06 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.805 0.669 . . . . 64.23 112.805 -175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 82.2 mt -67.86 121.26 15.64 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.39 0.614 . . . . 75.14 112.032 -178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -105.48 148.19 27.48 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.57 -0.741 . . . . 73.11 110.474 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -60.11 122.05 13.43 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.118 0.485 . . . . 73.34 110.952 175.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.12 -5.91 59.53 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.352 -0.451 . . . . 74.22 113.073 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.72 124.17 24.77 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.197 0.443 . . . . 60.13 112.197 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -102.39 107.96 19.14 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.775 -0.454 . . . . 73.12 109.775 174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t -152.5 154.64 32.08 Favored Pre-proline 0 N--CA 1.472 0.637 0 CA-C-N 116.244 -0.434 . . . . 65.01 111.926 -174.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 54.8 Cg_endo -71.1 139.59 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 121.959 1.773 . . . . 73.42 111.42 165.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.6 m -124.58 148.64 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 112.208 0.448 . . . . 74.22 112.208 -176.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.5 m -122.92 138.86 54.55 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.102 -0.499 . . . . 72.22 110.603 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -164.79 152.17 21.63 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.575 -0.821 . . . . 44.24 113.492 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.441 ' HG2' HG22 ' A' ' 76' ' ' VAL . 22.1 mtm180 -85.84 117.83 24.94 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 122.763 -0.257 . . . . 50.03 110.759 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 51.7 t -62.02 110.85 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.009 0.433 . . . . 54.43 111.565 -176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.45 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 54.9 ttp -100.43 -49.95 4.07 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.056 -0.52 . . . . 61.02 111.584 -178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 26' ' ' MET . 42.9 mmtm -133.24 143.36 49.07 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.458 -0.337 . . . . 74.2 111.125 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.551 HG12 HG13 ' A' ' 47' ' ' VAL . 65.1 mt -127.36 124.1 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-O 120.765 0.317 . . . . 53.2 111.662 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 71.0 m -93.73 155.03 17.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.7 0.286 . . . . 72.53 110.845 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.5 m -72.98 151.09 90.56 Favored Pre-proline 0 N--CA 1.471 0.581 0 CA-C-O 120.848 0.356 . . . . 63.13 111.609 -178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.74 129.97 12.14 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.719 2.279 . . . . 42.21 113.342 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -94.63 131.7 40.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.783 0.325 . . . . 73.43 110.913 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 52.8 m -95.74 124.24 39.67 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.975 0.416 . . . . 73.21 111.403 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -121.14 175.81 5.91 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.238 -0.437 . . . . 72.31 109.827 175.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.8 m -106.12 128.24 53.75 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.355 -0.216 . . . . 73.41 111.434 176.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 41' ' ' GLU . 14.5 p -83.28 172.77 12.21 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.443 0.639 . . . . 74.04 111.77 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -103.8 14.69 30.4 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.998 -0.546 . . . . 53.2 110.667 172.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 55.3 tptt -107.76 -69.12 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.14 0.422 . . . . 75.24 112.14 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.29 -55.81 0.02 OUTLIER Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.188 -1.006 . . . . 74.13 114.072 -176.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 34.2 mtm105 -85.43 162.94 18.78 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.072 0.397 . . . . 75.03 112.072 -177.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.559 ' HG3' ' H ' ' A' ' 42' ' ' GLY . 9.4 pt-20 -43.18 -68.92 0.16 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 115.788 -0.642 . . . . 73.34 112.711 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' H ' ' HG3' ' A' ' 41' ' ' GLU . . . 102.95 135.6 8.78 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 121.305 -0.474 . . . . 41.43 113.179 -169.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.466 ' H ' ' HB ' ' A' ' 62' ' ' THR . 41.2 mttp -148.76 158.18 43.97 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.031 0.532 . . . . 72.02 111.434 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.459 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -148.28 142.23 25.85 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.883 -0.599 . . . . 65.31 110.705 174.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -136.63 148.79 47.64 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.735 0.302 . . . . 63.15 111.635 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -113.4 111.48 22.04 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.947 0.403 . . . . 72.03 111.498 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.551 HG13 HG12 ' A' ' 28' ' ' ILE . 67.3 t -110.71 122.84 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-O 120.897 0.38 . . . . 73.13 110.772 176.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 50.5 mm -92.47 109.64 21.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.148 0.499 . . . . 63.51 111.474 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.2 pt -106.5 138.05 33.97 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.968 -0.56 . . . . 74.5 110.925 178.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -124.79 134.7 52.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.037 0.446 . . . . 61.3 112.006 -176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -128.01 163.2 25.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.131 -0.486 . . . . 71.43 110.475 175.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -63.89 -10.98 23.83 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.519 0.563 . . . . 72.55 112.519 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 39.2 p -94.72 -23.99 17.32 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.157 -0.339 . . . . 70.42 111.699 174.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.14 168.25 29.04 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.922 -0.656 . . . . 52.05 113.523 -176.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 42.9 mt-10 -105.83 148.95 26.96 Favored 'General case' 0 CA--C 1.544 0.747 0 O-C-N 122.648 -0.325 . . . . 75.33 111.244 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -143.0 146.06 33.52 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.176 0.512 . . . . 65.02 112.0 -175.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 -101.53 107.99 19.43 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.856 0.36 . . . . 73.34 111.137 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.05 121.86 29.26 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.711 0.291 . . . . 52.24 111.468 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -97.55 108.6 21.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.933 0.397 . . . . 74.12 111.737 -178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -92.44 105.09 17.34 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.228 0.537 . . . . 75.13 111.437 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -79.87 163.05 24.66 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.719 -0.673 . . . . 74.12 111.48 176.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.466 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.9 t -38.24 -47.73 1.22 Allowed 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 114.324 1.231 . . . . 71.34 114.324 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -62.44 -31.28 71.97 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.042 0.449 . . . . 65.14 111.993 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -94.24 -5.7 46.27 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.807 0.669 . . . . 74.22 112.807 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.6 mm -57.06 -35.38 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 CA-C-O 120.908 0.385 . . . . 74.14 111.402 177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 23.1 pttp -59.48 -15.9 20.65 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.51 0.559 . . . . 61.53 112.51 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.623 HD13 HG13 ' A' ' 102' ' ' VAL . 84.0 mt -81.64 -21.14 38.4 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 111.955 0.354 . . . . 72.0 111.955 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.8 mt -62.91 -20.76 65.48 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 112.738 0.644 . . . . 71.43 112.738 -176.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.508 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.4 OUTLIER -77.26 -18.46 57.59 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.215 0.45 . . . . 71.52 112.215 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -75.67 -32.32 60.1 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.947 0.404 . . . . 65.51 112.072 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -129.46 164.22 24.17 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.201 0.524 . . . . 75.34 111.688 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -133.56 169.59 16.77 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.2 -0.455 . . . . 63.32 110.699 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -62.95 100.53 0.21 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.232 0.539 . . . . 51.43 110.516 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.8 -33.86 1.83 Allowed Glycine 0 CA--C 1.527 0.796 0 CA-C-N 115.972 -0.558 . . . . 71.42 112.617 -175.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -70.86 178.54 3.09 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.461 0.648 . . . . 74.14 111.962 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 105' ' ' LEU . 35.1 t -121.78 137.99 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.887 -0.597 . . . . 54.44 109.689 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.6 pt -134.26 145.83 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 N-CA-C 113.11 0.781 . . . . 50.43 113.11 -175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -111.68 112.47 24.19 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.665 -0.698 . . . . 75.21 110.114 170.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.605 HG12 HG12 ' A' ' 102' ' ' VAL . 37.8 mt -94.46 127.97 46.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.333 -0.394 . . . . 55.51 110.596 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 58.7 tttm -92.37 128.26 38.16 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.929 0.395 . . . . 63.21 112.061 -175.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 57.86 91.36 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.21 0.819 . . . . 71.1 113.21 175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG22 ' O ' ' A' ' 19' ' ' THR . 27.6 m -131.62 160.46 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 120.92 0.391 . . . . 73.24 111.228 175.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -102.78 118.06 36.01 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.963 0.411 . . . . 64.45 111.487 179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 45.3 mm -81.22 119.73 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.525 -0.307 . . . . 72.44 110.254 175.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 85' ' ' ARG . 4.2 mmp_? -91.63 -73.5 0.54 Allowed 'General case' 0 N--CA 1.472 0.627 0 O-C-N 122.133 -0.355 . . . . 73.34 111.25 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 156.26 83.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.452 -0.88 . . . . 64.13 113.795 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.469 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -72.44 114.16 4.78 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.165 -0.54 . . . . 40.2 112.426 175.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -69.96 105.74 2.95 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.47 0.652 . . . . 74.52 111.851 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 130.91 40.8 0.23 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-N 116.111 -0.495 . . . . 62.51 113.244 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.95 -58.55 4.29 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 121.465 -0.398 . . . . 54.2 113.243 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.46 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 99.2 mtt180 -72.45 89.76 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.944 0.402 . . . . 74.23 111.715 179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 53.3 mttp -65.45 -173.46 0.14 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.375 0.607 . . . . 71.32 112.559 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 139.02 41.13 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.271 -0.422 . . . . 64.31 111.359 -173.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.33 115.0 23.24 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.985 -0.552 . . . . 72.31 111.189 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.66 125.21 37.18 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.141 0.496 . . . . 70.52 111.455 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -82.68 155.78 24.17 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.703 0.763 . . . . 63.33 112.002 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.553 ' SD ' ' NH2' ' A' ' 99' ' ' ARG . 35.6 mtt -113.95 162.24 23.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.201 -0.909 . . . . 70.33 110.318 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.79 -7.93 8.48 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 122.107 1.871 . . . . 54.12 112.243 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.553 ' NH2' ' SD ' ' A' ' 97' ' ' MET . 64.1 mtm-85 -100.79 -11.55 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.128 -0.487 . . . . 71.04 111.801 178.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.5 m -75.68 136.42 40.39 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.628 0.603 . . . . 41.15 112.628 -173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.7 p -118.25 159.62 23.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.051 -0.522 . . . . 55.44 110.95 178.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.623 HG13 HD13 ' A' ' 67' ' ' LEU . 30.3 m -130.22 146.36 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 CA-C-O 120.978 0.418 . . . . 64.4 111.81 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.18 145.5 34.22 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 120.826 0.346 . . . . 51.04 110.944 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 76' ' ' VAL . 23.0 m -84.48 122.24 37.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.561 0.696 . . . . 75.34 112.698 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.676 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 88.0 mt -110.13 173.61 6.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.858 -0.61 . . . . 74.31 110.996 177.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 0.8 OUTLIER 81.84 -62.07 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.197 0 C-N-CA 124.336 1.054 . . . . 54.42 111.237 -169.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 53.7 Cg_exo -59.39 67.81 0.06 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 CA-C-N 121.057 1.413 . . . . 74.41 109.04 148.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -65.56 129.61 40.38 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 114.802 -1.09 . . . . 62.1 113.291 -160.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -108.73 -58.76 1.97 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.528 -0.76 . . . . 75.25 110.593 173.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 . . . . . 0 C--O 1.252 1.189 0 CA-C-O 118.928 -0.558 . . . . 74.5 111.883 178.03 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.796 0.331 . . . . 54.22 111.085 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -109.72 131.66 21.8 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 116.675 -0.239 . . . . 74.33 111.084 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.0 -173.05 0.19 Allowed 'Trans proline' 0 CA--C 1.547 1.166 0 C-N-CA 122.894 2.396 . . . . 64.31 114.156 -177.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -97.51 2.67 50.43 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.24 0.83 . . . . 53.25 113.24 -172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -81.85 122.6 27.93 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.254 0.55 . . . . 74.44 111.871 -176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 6' ' ' ARG . 10.0 tpt180 -154.13 107.56 2.92 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.762 -0.654 . . . . 74.14 111.143 -174.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.1 mtt 56.06 29.16 14.0 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 111.898 0.333 . . . . 73.15 111.898 176.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 43.6 m-20 -64.32 139.22 58.74 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.015 0.436 . . . . 35.3 111.667 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.8 p -62.62 161.25 12.49 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.051 -0.522 . . . . 72.12 111.182 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.558 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 57.2 mt -54.57 -34.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 N-CA-C 112.493 0.553 . . . . 72.44 112.493 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.526 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.2 t -61.15 -36.98 81.25 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-O 121.061 0.458 . . . . 62.12 111.449 175.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 30.6 mmtp -87.42 -5.89 58.66 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.796 0.665 . . . . 61.55 112.796 -176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.558 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 65.9 mt -61.26 123.83 18.84 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.337 0.589 . . . . 63.41 111.914 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -106.91 123.57 48.36 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.501 -0.772 . . . . 75.54 110.937 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -58.72 127.11 30.55 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.034 0.445 . . . . 73.3 111.055 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.34 -18.7 50.68 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.302 -0.475 . . . . 62.15 112.452 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.28 156.68 20.83 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.149 0.499 . . . . 63.43 111.97 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' OE2' ' HE1' ' A' ' 97' ' ' MET . 45.2 tt0 -122.17 108.23 13.07 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.019 0.438 . . . . 74.04 110.829 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.5 t -152.4 150.94 26.32 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 116.391 -0.368 . . . . 75.32 111.48 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 29.6 Cg_endo -64.12 147.11 91.51 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 122.061 1.84 . . . . 41.55 112.196 169.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -123.83 168.92 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 CA-C-O 121.022 0.439 . . . . 62.4 112.075 -176.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.7 m -145.21 141.99 29.16 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.592 -0.276 . . . . 74.3 111.408 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.76 164.88 31.86 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 121.276 -0.487 . . . . 72.13 112.885 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.673 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.9 mtp180 -85.88 131.11 34.37 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.278 -0.542 . . . . 73.52 111.65 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -66.43 106.38 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 120.782 0.325 . . . . 72.32 110.902 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.518 ' O ' ' HD2' ' A' ' 27' ' ' LYS . 48.0 ttp -95.14 -42.75 8.43 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.544 0.211 . . . . 74.35 111.298 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 26' ' ' MET . 2.1 mmmp? -133.49 133.51 42.32 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.831 0.348 . . . . 62.35 111.926 -178.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.6 mt -116.67 120.17 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.756 0.312 . . . . 74.25 110.896 174.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.7 m -109.68 141.47 42.2 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.777 0.323 . . . . 62.42 111.284 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.6 m -66.23 153.41 92.4 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 112.417 0.525 . . . . 75.3 112.417 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -64.05 137.15 55.79 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.096 2.53 . . . . 74.42 113.487 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -101.98 121.34 41.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 109.617 -0.512 . . . . 72.55 109.617 173.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.9 m -87.51 145.21 26.35 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 111.775 0.287 . . . . 62.42 111.775 -174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -144.3 164.49 30.63 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.917 0.389 . . . . 74.31 111.4 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 34.0 m -84.8 124.65 31.82 Favored 'General case' 0 N--CA 1.47 0.549 0 O-C-N 122.226 -0.296 . . . . 65.42 111.627 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.4 p -102.6 147.09 27.22 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 120.764 0.316 . . . . 73.31 111.264 177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 86.6 mtt180 -69.08 -22.19 64.02 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.137 0.494 . . . . 72.41 110.935 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -72.07 -26.73 62.29 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.152 -0.476 . . . . 61.24 111.752 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.22 4.1 50.67 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.175 -0.536 . . . . 63.4 113.573 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -92.37 161.15 14.78 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.393 -0.475 . . . . 73.2 111.631 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -44.17 -52.16 7.56 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.464 0.913 . . . . 72.53 113.464 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.88 115.49 0.02 OUTLIER Glycine 0 CA--C 1.532 1.124 0 C-N-CA 121.098 -0.572 . . . . 64.24 113.362 -178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.482 ' N ' ' HB ' ' A' ' 62' ' ' THR . 93.5 mttt -147.51 151.55 36.54 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 121.874 -0.78 . . . . 74.51 111.752 -176.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.2 pp -138.02 128.43 26.3 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.099 -0.5 . . . . 74.24 110.391 171.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -119.04 148.65 42.79 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.163 -0.335 . . . . 35.51 111.447 -177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.424 ' OD1' ' HD3' ' A' ' 57' ' ' ARG . 38.5 m-80 -113.0 111.48 22.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.914 0.388 . . . . 73.1 111.718 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.3 t -113.32 117.48 55.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 116.435 -0.348 . . . . 74.33 110.41 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.9 mm -92.38 112.57 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 121.019 0.438 . . . . 50.01 111.347 -176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 36.0 pt -106.92 146.23 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 CA-C-N 116.027 -0.533 . . . . 74.03 110.938 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -127.57 123.85 36.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.08 0.467 . . . . 63.24 112.03 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -109.23 162.34 14.39 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.119 -0.491 . . . . 71.13 109.921 175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -64.11 -15.94 60.74 Favored 'General case' 0 CA--C 1.544 0.741 0 O-C-N 121.802 -0.562 . . . . 63.25 112.16 -177.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 38.5 p -97.07 -15.6 20.92 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.631 0.604 . . . . 74.14 112.631 178.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 167.18 167.81 28.43 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.478 -0.867 . . . . 23.23 113.673 -176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 43.7 mt-10 -107.37 149.39 27.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.849 0.357 . . . . 75.53 111.599 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 94' ' ' ALA . 35.9 tp -140.59 150.38 43.55 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.29 0.567 . . . . 44.21 112.292 -176.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.424 ' HD3' ' OD1' ' A' ' 46' ' ' ASN . 26.8 ttm-85 -103.83 108.76 20.22 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.085 -0.507 . . . . 74.03 111.299 176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.36 121.53 27.28 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 122.073 -0.392 . . . . 75.51 111.44 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.8 t -98.99 105.86 18.01 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.036 0.446 . . . . 64.14 111.578 -179.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.526 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 32.3 m-85 -93.28 105.03 17.15 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.122 0.487 . . . . 74.44 111.648 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -73.36 161.65 30.22 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.035 -0.53 . . . . 74.11 111.445 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.482 ' HB ' ' N ' ' A' ' 43' ' ' LYS . 6.6 t -43.93 -32.97 1.24 Allowed 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 113.223 0.823 . . . . 72.13 113.223 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 27.6 mm-40 -73.98 -26.17 60.32 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-O 120.838 0.352 . . . . 53.13 111.91 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -100.21 -3.11 32.25 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 112.579 0.585 . . . . 62.4 112.579 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.477 HG12 ' HA ' ' A' ' 62' ' ' THR . 42.0 mm -53.47 -35.28 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-O 120.863 0.363 . . . . 74.53 111.681 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.442 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.6 pttm -56.64 -20.73 22.79 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.787 0.662 . . . . 61.03 112.787 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD13 HG13 ' A' ' 102' ' ' VAL . 86.1 mt -80.29 -23.37 40.75 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.316 0.488 . . . . 64.54 112.316 -178.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.41 -26.42 65.14 Favored 'General case' 0 N--CA 1.475 0.793 0 N-CA-C 112.668 0.618 . . . . 72.21 112.668 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 7.2 ptpp? -74.07 -13.2 60.8 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.718 0.636 . . . . 60.34 112.718 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -77.11 -45.92 25.3 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 112.651 0.611 . . . . 54.14 112.651 -174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -112.07 166.3 11.36 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 112.14 0.422 . . . . 72.12 112.14 -174.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -122.33 164.97 17.01 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.121 0.486 . . . . 75.44 111.51 177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.0 92.62 0.53 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.175 0.512 . . . . 61.32 110.949 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 149.0 -28.91 1.25 Allowed Glycine 0 CA--C 1.528 0.867 0 CA-C-N 116.076 -0.511 . . . . 65.13 112.896 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -74.57 174.18 9.37 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.224 0.535 . . . . 74.01 111.665 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.673 HG22 ' HG2' ' A' ' 24' ' ' ARG . 5.0 t -105.33 140.32 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.446 -0.343 . . . . 65.11 110.111 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.6 pt -134.52 149.28 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.6 0.715 . . . . 72.32 112.596 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 41.6 ttm180 -120.34 111.48 17.82 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.122 -0.945 . . . . 74.21 109.46 171.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.428 HG23 HG12 ' A' ' 102' ' ' VAL . 33.4 mt -90.41 124.18 42.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 CA-C-O 120.867 0.365 . . . . 72.44 110.757 -177.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 32.9 ttmt -97.63 120.1 37.39 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.796 0.332 . . . . 74.01 111.872 -172.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 69.95 93.03 0.08 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.572 -0.74 . . . . 72.24 112.403 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.1 m -140.03 162.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.094 0.473 . . . . 70.22 111.272 174.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -102.86 118.32 36.56 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.281 -0.418 . . . . 73.24 110.582 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.479 HD12 HD13 ' A' ' 13' ' ' LEU . 47.1 mm -80.84 128.26 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.971 0.415 . . . . 73.54 111.093 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.518 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 29.6 mmm180 -124.1 171.34 9.86 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.164 0.507 . . . . 71.53 111.197 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -95.04 102.25 2.83 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 115.829 -0.623 . . . . 71.04 114.173 -173.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -81.67 93.31 1.57 Allowed Glycine 0 CA--C 1.526 0.746 0 C-N-CA 121.176 -0.535 . . . . 71.14 112.215 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -55.0 -27.2 42.38 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.166 0.432 . . . . 72.51 112.166 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -83.87 57.35 5.05 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.207 -0.52 . . . . 62.43 112.792 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.8 -85.27 0.66 Allowed Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.353 -0.451 . . . . 70.31 113.334 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 95.6 mtt180 -68.08 125.25 25.75 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.965 0.357 . . . . 64.32 111.965 -177.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.476 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 63.8 mttm -68.17 -176.21 0.69 Allowed 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.899 0.38 . . . . 61.54 110.804 175.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.518 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.4 pt-20 -139.64 149.35 43.65 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.025 -0.422 . . . . 73.14 111.109 -179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.41 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -126.43 119.34 26.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.436 -0.347 . . . . 55.14 111.058 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 54.2 m-70 -92.01 123.62 35.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.978 0.418 . . . . 61.41 111.433 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -80.5 178.82 8.07 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.224 0.535 . . . . 74.12 111.938 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.406 ' HE1' ' OE2' ' A' ' 18' ' ' GLU . 32.2 mtt -132.05 150.69 76.81 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.103 -0.499 . . . . 74.1 110.397 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.74 -34.38 15.53 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.397 2.065 . . . . 64.15 113.484 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 66.7 mtp180 -93.41 -17.22 23.74 Favored 'General case' 0 CA--C 1.543 0.681 0 N-CA-C 113.26 0.837 . . . . 72.35 113.26 -179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 83.6 p -72.26 139.17 47.94 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.243 0.545 . . . . 73.32 112.029 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 70.2 p -119.01 174.87 6.05 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 115.896 -0.593 . . . . 71.52 111.668 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.432 HG13 HD13 ' A' ' 67' ' ' LEU . 34.5 m -130.67 136.58 57.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 120.873 0.368 . . . . 70.4 111.672 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.497 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.7 pt-20 -114.46 144.96 42.49 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.343 -0.39 . . . . 74.02 110.144 176.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 36.0 m -98.49 138.15 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 121.707 0.765 . . . . 62.42 112.796 -173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.682 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 63.8 mt -111.76 166.41 11.21 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.422 -0.808 . . . . 74.31 110.018 174.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.5 ' HB3' ' CD ' ' A' ' 107' ' ' PRO . 21.1 t70 87.61 -67.96 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.125 0 C-N-CA 124.28 1.032 . . . . 63.13 109.504 -166.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.682 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 46.2 Cg_endo -71.38 75.28 1.94 Allowed 'Trans proline' 0 C--N 1.366 1.453 0 CA-C-N 121.12 1.436 . . . . 53.03 109.762 156.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -52.87 108.15 0.29 Allowed 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.55 -0.75 . . . . 75.35 112.608 -167.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -90.07 -61.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 116.041 -0.527 . . . . 62.21 110.988 172.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 112.36 0.504 . . . . 70.34 112.36 -174.088 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.616 0.246 . . . . 73.4 111.183 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -81.72 141.66 48.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.777 -0.192 . . . . 65.53 111.221 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -52.67 123.41 12.87 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.721 2.281 . . . . 73.11 112.905 176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -63.07 138.1 58.45 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.434 0.635 . . . . 72.41 112.351 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -116.3 128.52 55.63 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 74.4 110.889 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -169.67 118.83 0.63 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.828 -0.624 . . . . 72.03 110.634 -175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' MET . 5.5 tpt 65.2 20.5 11.95 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 112.177 0.436 . . . . 73.32 112.177 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -86.52 129.36 34.89 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 121.691 -0.631 . . . . 43.04 111.185 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.2 p -91.1 -177.82 5.0 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.811 0.671 . . . . 75.45 112.811 -175.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.462 HD13 ' HB2' ' A' ' 56' ' ' LEU . 58.5 mt -58.46 -28.33 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 N-CA-C 112.765 0.654 . . . . 55.13 112.765 -176.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.573 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.0 t -71.87 -35.49 69.8 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 121.125 0.488 . . . . 42.51 111.315 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -77.71 -27.71 50.7 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.339 -0.392 . . . . 71.43 111.823 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 80.3 mt -48.2 116.94 1.72 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.322 0.582 . . . . 75.02 112.182 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -104.69 139.67 39.17 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.71 -0.677 . . . . 42.52 111.562 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -59.89 134.59 57.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.141 0.496 . . . . 65.34 111.476 177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.56 -6.97 83.04 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.161 -0.542 . . . . 72.33 113.224 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.02 138.87 31.07 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.447 0.536 . . . . 33.44 112.447 -178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -99.37 109.58 22.16 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.195 -0.457 . . . . 73.41 109.793 173.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 82' ' ' VAL . 10.6 t -151.75 154.54 33.14 Favored Pre-proline 0 N--CA 1.472 0.665 0 N-CA-C 112.013 0.375 . . . . 72.31 112.013 -174.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -70.79 140.77 39.5 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.397 2.065 . . . . 74.24 111.74 167.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 33.7 m -122.63 147.77 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 121.013 0.435 . . . . 63.43 111.436 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 m -122.94 142.31 50.96 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.432 -0.349 . . . . 71.51 111.355 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.476 ' HA3' ' HB ' ' A' ' 49' ' ' ILE . . . -172.96 148.93 10.82 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.666 -0.778 . . . . 64.5 113.885 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.9 mtp180 -90.15 117.72 29.13 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 109.885 -0.413 . . . . 72.21 109.885 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.54 123.51 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 112.401 0.519 . . . . 74.24 112.401 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 59.1 ttp -109.17 -45.99 3.66 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.118 -0.492 . . . . 70.34 111.226 178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.18 142.55 48.68 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.351 -0.386 . . . . 64.34 110.854 -177.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.473 HG12 HG13 ' A' ' 47' ' ' VAL . 44.6 mt -132.57 130.8 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 121.07 0.462 . . . . 64.35 111.274 175.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.0 m -108.42 136.43 48.06 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.247 -0.433 . . . . 63.43 111.143 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 49.4 m -57.0 154.8 17.75 Favored Pre-proline 0 N--CA 1.474 0.734 0 N-CA-C 112.511 0.56 . . . . 31.21 112.511 -179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.48 ' HB3' HD12 ' A' ' 65' ' ' ILE . 18.9 Cg_endo -58.2 123.82 14.5 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.738 2.292 . . . . 71.2 113.423 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -94.55 126.31 39.75 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.81 -0.632 . . . . 64.51 110.658 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.9 m -89.24 145.95 25.06 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.449 0.537 . . . . 62.34 112.449 -172.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -148.22 156.73 42.91 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.318 -0.401 . . . . 74.42 110.571 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 95.5 m -85.08 118.61 24.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.038 0.447 . . . . 65.21 111.982 -176.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -89.44 147.55 23.96 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 116.323 -0.399 . . . . 73.31 110.952 176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 37' ' ' ARG . 5.7 tpm_? -73.82 -26.25 60.51 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.916 0.389 . . . . 75.13 111.071 177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -44.42 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.439 -0.346 . . . . 72.21 111.804 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.46 16.92 1.45 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.542 -0.837 . . . . 41.44 114.662 177.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -100.49 158.46 15.9 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 117.59 0.695 . . . . 71.31 110.784 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.2 -31.9 70.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.218 0.451 . . . . 64.43 112.218 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.87 116.8 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 N-CA-C 114.226 0.45 . . . . 70.03 114.226 174.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -146.1 150.97 36.94 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 122.251 -0.558 . . . . 75.22 112.385 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 60' ' ' PHE . 4.3 pp -141.66 134.76 29.13 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.632 -0.713 . . . . 73.44 110.31 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.21 140.96 49.02 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.949 -0.47 . . . . 64.23 111.606 -177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -104.68 111.15 23.74 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.006 0.431 . . . . 74.3 111.506 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.473 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -110.95 121.33 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-N 116.354 -0.384 . . . . 64.32 110.911 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.2 mm -92.59 107.22 18.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.124 0.488 . . . . 75.31 111.028 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' HB ' ' HA3' ' A' ' 23' ' ' GLY . 29.1 pt -106.12 143.53 16.93 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.029 -0.532 . . . . 63.51 110.67 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -120.61 130.45 54.17 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.811 0.671 . . . . 72.42 112.811 -174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -120.09 162.24 19.62 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.038 -0.528 . . . . 72.25 110.169 174.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -62.93 -17.29 61.68 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.638 0.607 . . . . 75.05 112.638 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 55.2 p -97.57 -16.69 19.94 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 112.199 0.444 . . . . 75.44 112.199 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 166.25 167.42 26.87 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 120.582 -0.818 . . . . 50.14 113.614 -177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 29.6 mt-10 -104.07 150.53 24.21 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.712 0.291 . . . . 70.54 110.818 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.462 ' HB2' HD13 ' A' ' 10' ' ' ILE . 27.4 tp -135.02 143.74 46.94 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 120.895 0.378 . . . . 71.34 111.891 -174.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -98.46 102.48 14.23 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.879 0.371 . . . . 72.45 110.956 175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.28 126.51 32.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.787 0.327 . . . . 63.01 111.255 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -107.3 110.2 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.16 0.505 . . . . 64.1 111.8 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 21.0 m-85 -91.75 104.43 16.88 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.114 0.483 . . . . 71.22 111.11 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -73.92 164.37 26.71 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 115.754 -0.657 . . . . 75.4 111.952 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.6 t -37.01 -45.17 0.56 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.491 1.293 . . . . 74.34 114.491 -176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.426 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . 16.3 mm-40 -72.03 -20.8 61.64 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.945 -0.472 . . . . 70.15 112.048 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -101.69 -2.26 30.7 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 112.771 0.656 . . . . 73.13 112.771 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 31' ' ' PRO . 38.5 mm -54.49 -38.77 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 121.107 0.48 . . . . 61.41 111.835 -179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 24.7 pttm -61.11 -17.12 50.98 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.833 0.679 . . . . 74.33 112.833 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 85.0 mt -75.47 -22.17 57.48 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 122.007 -0.433 . . . . 72.3 111.832 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.4 mt -62.16 -26.35 68.28 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.413 0.523 . . . . 54.23 112.413 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 17.7 ptpt -76.94 -15.81 59.55 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 111.935 0.346 . . . . 72.35 111.935 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -73.03 -40.29 65.26 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.972 0.415 . . . . 75.42 111.71 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -121.01 165.4 15.32 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.255 -0.429 . . . . 74.52 111.395 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -126.12 159.84 31.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.093 0.473 . . . . 63.52 111.682 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -60.41 94.11 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.238 0.542 . . . . 73.22 111.402 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 147.01 -32.24 1.42 Allowed Glycine 0 CA--C 1.525 0.672 0 CA-C-N 115.833 -0.621 . . . . 65.4 112.405 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.13 176.09 4.09 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.245 0.545 . . . . 72.11 111.74 178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 47.6 t -114.03 136.25 51.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 O-C-N 122.147 -0.346 . . . . 73.41 110.686 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.0 pt -137.74 157.48 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-O 121.705 0.764 . . . . 51.04 112.714 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.3 ttm180 -128.52 115.49 18.21 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.205 -0.907 . . . . 74.21 109.52 172.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.476 HG12 HG12 ' A' ' 102' ' ' VAL . 42.7 mt -91.26 126.7 43.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 120.813 0.339 . . . . 73.21 110.984 -176.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -98.98 135.88 39.76 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.033 0.383 . . . . 74.14 112.033 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 67.24 79.42 0.23 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.661 0.615 . . . . 74.14 112.661 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 19' ' ' THR . 33.4 m -136.17 158.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.985 -0.447 . . . . 74.22 111.391 175.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -106.37 126.53 52.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.113 0.482 . . . . 61.51 111.361 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.7 mm -80.86 115.03 22.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.652 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -85.52 -72.5 0.48 Allowed 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.298 -0.251 . . . . 73.41 111.14 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 140.55 89.57 0.16 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.601 -0.809 . . . . 53.13 113.751 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.93 108.25 2.48 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.004 -0.617 . . . . 33.53 112.21 176.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 21.3 p90 -62.37 96.48 0.08 Allowed 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 121.256 0.55 . . . . 74.4 112.138 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 146.59 39.03 0.05 OUTLIER Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.187 -0.53 . . . . 65.45 113.449 178.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.26 -69.84 3.26 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.398 -0.429 . . . . 52.33 113.071 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.62 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 74.9 mtm180 -67.99 101.09 1.06 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.168 0.509 . . . . 65.22 111.356 177.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 13' ' ' LEU . 38.2 mtmm -75.7 -170.62 1.34 Allowed 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.916 -0.584 . . . . 63.44 111.852 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.35 148.0 37.21 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.836 0.351 . . . . 75.31 111.599 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -129.93 125.09 34.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 116.183 -0.462 . . . . 71.1 111.098 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -103.19 132.83 49.15 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.122 0.487 . . . . 62.12 111.831 -177.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.2 mp -85.61 173.86 9.85 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.717 0.77 . . . . 60.14 112.689 -175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 41.7 mtt -130.02 160.46 65.15 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 115.117 -0.947 . . . . 75.54 110.462 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.21 -33.04 34.62 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.278 1.985 . . . . 74.22 113.442 175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -91.68 4.58 52.41 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.661 0.615 . . . . 72.1 112.661 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 27.4 m -79.75 140.98 36.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.483 . . . . 65.21 112.223 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 60.1 p -126.18 166.64 16.69 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.983 -0.553 . . . . 71.43 111.343 178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.476 HG12 HG12 ' A' ' 79' ' ' ILE . 35.8 m -129.23 137.12 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 120.983 0.42 . . . . 73.42 111.592 178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.493 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.0 pt-20 -118.6 144.61 46.01 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.229 -0.441 . . . . 73.0 110.953 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 18.5 m -91.17 140.24 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 CA-C-O 121.173 0.511 . . . . 75.14 111.88 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.655 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 87.3 mt -122.35 171.37 9.1 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.969 -0.56 . . . . 71.3 111.428 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 105' ' ' LEU . 2.3 m-20 77.35 -71.61 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 124.092 0.957 . . . . 74.3 110.889 -169.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.655 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 50.2 Cg_exo -59.68 77.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.365 1.415 0 CA-C-N 121.633 1.619 . . . . 74.43 109.888 154.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD13 ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -63.72 103.34 0.54 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.327 -0.851 . . . . 72.34 112.933 -165.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -98.76 -7.0 28.32 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.591 -0.731 . . . . 51.55 111.774 174.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.575 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.33 0 N-CA-C 112.404 0.52 . . . . 74.31 112.404 -177.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.744 0.306 . . . . 75.43 111.033 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.561 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 0.5 OUTLIER -149.25 88.08 5.15 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 120.859 0.362 . . . . 52.31 111.381 177.494 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -64.77 120.44 7.71 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.433 2.089 . . . . 71.31 111.638 174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -76.82 73.04 3.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.507 0.67 . . . . 63.54 110.453 -179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -86.56 85.57 7.31 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.856 -0.611 . . . . 73.25 111.69 -174.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -106.34 123.16 47.63 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 120.977 0.418 . . . . 75.12 111.627 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.2 mtm -128.13 83.52 2.17 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.228 -0.442 . . . . 62.53 109.997 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' HB2' ' CG ' ' A' ' 12' ' ' LYS . 38.8 m-20 -100.86 -171.49 2.01 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.528 0.68 . . . . 64.44 112.462 -176.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.1 p -79.8 -153.83 0.08 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 115.581 -0.736 . . . . 75.2 111.532 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.55 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 61.2 mt -52.52 -21.53 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 N-CA-C 113.356 0.873 . . . . 55.53 113.356 -174.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 34.1 t -60.67 -35.11 75.44 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.102 0.779 . . . . 63.41 113.102 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' CG ' ' HB2' ' A' ' 8' ' ' ASP . 40.3 mmtm -98.8 12.04 36.86 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.111 0.782 . . . . 75.3 113.111 -174.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 13.4 mt -90.88 96.71 10.77 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.798 -0.564 . . . . 73.02 112.427 -171.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -95.3 148.43 22.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.129 -0.487 . . . . 65.35 111.293 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -60.78 136.14 57.98 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.99 0.424 . . . . 74.32 111.437 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.22 59.83 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.279 -0.419 . . . . 35.1 113.015 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.9 150.5 27.72 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.332 0.587 . . . . 60.04 112.566 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -118.43 109.37 16.16 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.833 -0.621 . . . . 60.3 110.577 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.3 t -152.27 155.96 33.44 Favored Pre-proline 0 N--CA 1.472 0.669 0 CA-C-N 116.447 -0.342 . . . . 65.03 111.28 -177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.416 ' HD2' ' OG1' ' A' ' 19' ' ' THR . 38.9 Cg_endo -67.3 150.26 81.29 Favored 'Trans proline' 0 CA--C 1.543 0.967 0 C-N-CA 122.11 1.873 . . . . 73.12 112.109 169.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.01 159.7 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 121.218 0.532 . . . . 75.24 111.83 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.5 m -145.66 140.57 27.4 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.381 -0.372 . . . . 74.44 111.25 178.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -172.6 160.83 32.11 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 120.89 -0.672 . . . . 63.2 113.395 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.425 ' HG2' HG22 ' A' ' 76' ' ' VAL . 44.7 mtp85 -94.47 124.93 38.8 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 122.573 -0.369 . . . . 70.01 110.465 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.05 125.17 21.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 N-CA-C 112.46 0.541 . . . . 70.33 112.46 -175.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 60.2 ttp -99.85 -57.3 2.17 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.144 -0.48 . . . . 54.24 110.735 176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 26' ' ' MET . 44.7 mmtm -134.37 147.99 50.61 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 116.301 -0.409 . . . . 74.32 110.817 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 HG13 ' A' ' 47' ' ' VAL . 67.0 mt -122.11 122.36 66.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-O 121.042 0.449 . . . . 75.35 111.771 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.2 t -92.76 147.36 22.93 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.267 -0.424 . . . . 75.21 110.843 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.6 m -68.11 156.61 89.43 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 112.306 0.484 . . . . 72.2 112.306 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.58 131.84 25.56 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.544 2.162 . . . . 72.45 113.113 178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -93.8 120.68 34.38 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.01 -0.541 . . . . 74.32 110.234 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.9 m -84.89 138.09 32.74 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.627 0.603 . . . . 72.11 112.627 -173.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -147.48 173.12 12.96 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.525 -0.761 . . . . 73.42 109.937 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 94.7 m -106.24 113.64 27.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.916 -0.49 . . . . 70.15 111.604 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.1 t -80.81 -178.89 7.02 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.117 -0.492 . . . . 71.15 111.494 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.1 mmm180 -84.52 -5.28 59.28 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.704 0.288 . . . . 75.23 111.626 -178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -119.37 174.76 6.17 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.688 0.28 . . . . 74.4 111.233 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.67 55.26 3.77 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 114.812 0.685 . . . . 53.43 114.812 -173.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 90.7 mtm-85 -128.37 152.9 47.63 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.301 -0.529 . . . . 71.3 111.364 174.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -62.88 -23.88 67.55 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.9 0.704 . . . . 75.43 112.9 -174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.66 108.59 0.02 OUTLIER Glycine 0 CA--C 1.533 1.177 0 N-CA-C 114.378 0.511 . . . . 74.43 114.378 174.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.518 ' H ' ' HB ' ' A' ' 62' ' ' THR . 45.1 mttp -146.08 150.32 35.71 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 122.358 -0.495 . . . . 73.23 111.844 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.463 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -132.78 132.32 42.1 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.988 -0.551 . . . . 70.34 109.833 172.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -117.52 137.4 52.58 Favored 'General case' 0 N--CA 1.467 0.417 0 O-C-N 121.998 -0.439 . . . . 72.43 111.779 -174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -105.79 110.25 22.48 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.079 0.466 . . . . 75.34 111.38 -179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.477 HG13 HG12 ' A' ' 28' ' ' ILE . 63.5 t -103.09 127.02 57.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.287 -0.415 . . . . 63.52 110.779 177.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.15 104.04 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 121.016 0.436 . . . . 72.43 110.996 -178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 33.1 pt -105.78 143.2 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.325 -0.398 . . . . 60.24 110.772 178.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -128.18 150.8 49.85 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.319 0.58 . . . . 65.34 111.984 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -154.21 165.96 34.62 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.513 -0.767 . . . . 74.22 110.11 176.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -63.75 -13.19 41.51 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.842 0.353 . . . . 74.43 111.899 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.419 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 81.3 p -90.73 -18.31 25.23 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 112.103 0.409 . . . . 70.44 112.103 176.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 152.89 169.1 17.72 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.036 -0.602 . . . . 63.02 113.274 -176.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.591 ' HB2' ' HG2' ' A' ' 91' ' ' ARG . 2.2 mp0 -106.22 133.51 50.8 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 122.393 -0.475 . . . . 43.0 110.502 174.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.7 tp -123.44 154.43 39.08 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 120.938 0.399 . . . . 71.21 111.462 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -105.99 110.11 22.28 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.591 -0.277 . . . . 74.14 110.703 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.4 117.66 23.76 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.638 0.256 . . . . 72.05 111.101 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 95' ' ' HIS . 52.8 t -98.22 106.23 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 121.137 0.494 . . . . 72.44 111.788 -178.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -92.29 105.15 17.41 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.145 0.497 . . . . 74.54 111.092 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -74.48 163.0 28.27 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.942 -0.572 . . . . 73.34 112.165 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.518 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 7.0 t -38.71 -30.87 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.336 1.236 . . . . 72.44 114.336 -178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.503 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 30.0 mm-40 -80.24 -29.47 38.45 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.238 0.542 . . . . 63.12 111.657 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -93.17 -1.75 56.0 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.495 0.554 . . . . 70.12 112.495 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.4 mm -54.83 -35.57 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 CA-C-O 120.929 0.395 . . . . 74.03 111.607 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 63' ' ' GLU . 24.7 pttm -59.05 -22.12 60.21 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.189 0.441 . . . . 74.24 112.189 178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.504 HD13 HG13 ' A' ' 102' ' ' VAL . 88.9 mt -80.29 -22.9 41.13 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 111.935 0.346 . . . . 73.33 111.935 -177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.55 -22.99 62.48 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.621 0.6 . . . . 71.22 112.621 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -7.51 59.1 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.372 0.508 . . . . 73.14 112.372 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -77.79 -38.02 47.53 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.12 0.486 . . . . 54.13 111.853 -179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -117.57 159.48 22.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.196 0.522 . . . . 72.23 111.71 -176.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -117.78 170.15 9.02 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.995 -0.548 . . . . 75.31 110.814 176.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -68.45 82.34 0.26 Allowed 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.262 0.553 . . . . 74.34 110.731 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.46 -25.27 0.52 Allowed Glycine 0 CA--C 1.527 0.813 0 CA-C-N 115.973 -0.558 . . . . 31.41 113.12 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -72.48 174.99 6.66 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.373 0.606 . . . . 64.2 112.085 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.425 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -105.95 129.01 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 CA-C-N 115.977 -0.556 . . . . 70.12 110.041 176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.94 146.0 23.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 121.776 0.798 . . . . 64.21 112.333 -177.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HD2' HD11 ' A' ' 105' ' ' LEU . 63.4 ttt180 -127.15 111.96 14.59 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.161 -0.927 . . . . 74.43 109.683 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 102' ' ' VAL . 31.7 mt -105.56 138.56 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-O 120.577 0.227 . . . . 65.01 111.109 -175.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -114.27 135.58 53.91 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.037 0.446 . . . . 60.42 111.774 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 63.2 85.56 0.13 Allowed 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 115.442 -0.799 . . . . 61.42 112.587 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 96' ' ' LEU . 26.1 m -139.92 162.64 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 CA-C-O 120.979 0.419 . . . . 74.11 111.672 176.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.401 -0.363 . . . . 74.22 111.512 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 41.5 mm -85.74 112.93 23.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.586 -0.279 . . . . 73.03 110.581 176.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -85.38 -74.54 0.4 Allowed 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.142 -0.349 . . . . 75.11 111.915 -178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 151.3 89.96 0.08 OUTLIER Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.276 -0.964 . . . . 53.55 113.65 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.483 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -82.93 105.84 2.7 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 121.308 -0.472 . . . . 73.3 112.336 175.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -60.06 118.43 6.29 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.021 0.438 . . . . 73.44 111.735 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 120.71 39.19 0.62 Allowed Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.261 -0.495 . . . . 51.22 113.078 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.8 -61.27 4.54 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.452 -0.404 . . . . 53.32 113.444 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.591 ' HG2' ' HB2' ' A' ' 55' ' ' GLU . 23.1 mtm180 -75.24 89.54 2.55 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.136 0.493 . . . . 72.05 112.026 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.483 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 59.6 mttp -63.76 -176.88 0.2 Allowed 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.791 -0.64 . . . . 74.21 112.61 177.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.22 138.03 34.76 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.217 -0.447 . . . . 74.34 111.529 -173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.14 120.18 36.95 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.057 -0.52 . . . . 71.05 111.104 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 59' ' ' VAL . 20.8 m-70 -94.69 128.8 41.62 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.063 0.459 . . . . 64.31 111.917 -176.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.2 mp -86.03 163.06 18.17 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.806 -0.633 . . . . 74.14 111.804 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 38.6 mtt -118.2 159.56 42.78 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.771 -0.65 . . . . 74.42 110.373 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.503 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 88.2 Cg_exo -47.42 -36.79 24.33 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.554 2.169 . . . . 63.04 113.735 176.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -84.24 -11.87 55.74 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.45 0.537 . . . . 73.41 112.45 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 38.7 m -71.14 133.46 46.22 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.075 0.464 . . . . 74.11 112.145 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.6 p -118.82 161.2 20.55 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.0 -0.545 . . . . 64.32 111.206 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.66 HG12 HG12 ' A' ' 79' ' ' ILE . 18.5 m -127.61 136.75 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.105 0.479 . . . . 71.52 111.397 178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.482 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.3 pt-20 -122.37 143.31 49.73 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.446 -0.343 . . . . 72.44 110.92 176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 27.4 m -86.08 134.03 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.122 0.487 . . . . 74.4 111.672 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD11 ' HD2' ' A' ' 78' ' ' ARG . 81.2 mt -109.39 -172.4 2.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.342 -0.39 . . . . 51.33 111.786 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.764 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 7.7 t70 99.65 -58.7 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.089 0 C-N-CA 125.4 1.48 . . . . 71.22 110.326 -175.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 72.2 Cg_endo -96.32 96.84 0.09 OUTLIER 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.21 1.94 . . . . 70.01 111.205 160.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -68.84 109.36 3.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.482 0.919 . . . . 64.44 113.482 -171.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -97.13 -11.62 24.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.149 -0.932 . . . . 72.21 111.662 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 . . . . . 0 C--O 1.252 1.218 0 CA-C-O 118.922 -0.561 . . . . 74.04 112.002 -179.21 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.3 pmm? . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.001 0.429 . . . . 65.24 111.428 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -172.56 93.1 0.39 Allowed Pre-proline 0 N--CA 1.474 0.751 0 N-CA-C 112.145 0.424 . . . . 74.1 112.145 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -84.52 105.69 1.06 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.429 2.086 . . . . 71.25 112.031 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.52 -39.13 20.84 Favored 'General case' 0 CA--C 1.544 0.728 0 N-CA-C 112.501 0.556 . . . . 54.33 112.501 -174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -94.03 151.05 19.8 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.133 0.492 . . . . 74.11 111.823 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -107.21 -12.84 15.29 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.964 -0.562 . . . . 74.13 111.458 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.738 ' SD ' ' HG2' ' A' ' 20' ' ' PRO . 12.5 mmt -100.25 116.71 32.87 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 111.859 0.318 . . . . 72.21 111.859 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -131.04 -174.9 3.51 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 112.53 0.567 . . . . 73.01 112.53 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 10' ' ' ILE . 5.3 m -117.12 172.38 7.32 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 116.078 -0.51 . . . . 42.52 111.084 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.627 ' H ' HG22 ' A' ' 9' ' ' THR . 51.4 mt -48.02 -44.08 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 113.917 1.08 . . . . 73.23 113.917 -172.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.595 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 48.0 t -55.8 -29.56 59.91 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.75 0.648 . . . . 73.02 112.75 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -101.9 10.65 39.59 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.602 0.593 . . . . 64.0 112.602 -175.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.491 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 79.9 mt -75.39 87.66 2.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.108 0.48 . . . . 75.53 111.93 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -84.13 145.99 28.12 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.729 0.3 . . . . 60.44 111.238 178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -62.28 137.77 58.31 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.979 0.418 . . . . 73.3 111.386 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.47 -6.29 77.59 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.36 -0.448 . . . . 71.13 113.188 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.19 155.67 18.86 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.169 0.509 . . . . 52.24 111.746 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -121.39 109.75 15.25 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.49 0.662 . . . . 73.21 111.098 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 t -152.2 148.35 21.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 CA-C-N 115.512 -0.767 . . . . 52.44 110.798 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.738 ' HG2' ' SD ' ' A' ' 7' ' ' MET . 51.0 Cg_exo -58.39 149.03 76.84 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 121.678 1.585 . . . . 64.53 111.702 169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.47 148.11 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-O 121.19 0.519 . . . . 63.55 111.278 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 m -125.63 146.88 49.52 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.139 -0.482 . . . . 63.24 111.085 -176.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.61 152.91 10.46 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.477 -0.868 . . . . 60.33 113.719 177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.55 ' HG2' HG22 ' A' ' 76' ' ' VAL . 62.5 mtt180 -90.38 125.11 35.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 72.5 111.052 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 28' ' ' ILE . 59.1 t -68.24 107.27 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 120.923 0.392 . . . . 75.02 111.932 -175.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.8 ttp -93.51 -46.89 7.1 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.035 0.445 . . . . 73.51 110.556 176.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 33.6 mmtp -133.66 144.85 49.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.143 -0.481 . . . . 73.24 111.166 -178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 47' ' ' VAL . 68.1 mt -129.0 123.33 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 120.936 0.398 . . . . 74.14 110.924 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.8 t -88.16 133.86 33.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.954 0.407 . . . . 70.31 110.626 175.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 36.1 m -60.99 149.36 81.86 Favored Pre-proline 0 N--CA 1.473 0.721 0 CA-C-N 115.891 -0.595 . . . . 71.22 111.662 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -52.56 116.54 2.93 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.691 2.261 . . . . 51.4 112.666 -177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -95.04 121.04 36.26 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.751 -0.659 . . . . 72.31 110.625 -175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.4 m -89.18 130.99 35.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 111.981 0.363 . . . . 61.51 111.981 -173.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -133.61 157.97 44.38 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.881 0.372 . . . . 52.0 111.304 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 54.6 m -85.52 105.93 16.47 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 121.045 0.45 . . . . 74.5 111.0 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.4 t -91.39 -171.59 2.99 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 116.317 -0.402 . . . . 63.2 111.339 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 37' ' ' ARG . 7.4 tpt180 -75.35 44.8 0.27 Allowed 'General case' 0 CA--C 1.551 1.005 0 CA-C-O 121.246 0.546 . . . . 63.05 111.238 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp 63.45 -165.02 0.24 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.202 0.601 . . . . 64.01 111.58 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.0 -62.39 4.22 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 120.637 -0.792 . . . . 22.41 112.217 -175.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -115.92 161.5 18.73 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.999 0.428 . . . . 74.55 111.088 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -61.93 -39.88 93.59 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.204 -0.453 . . . . 74.42 111.412 174.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.5 107.16 2.51 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.465 -0.398 . . . . 24.32 114.036 177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.435 ' H ' ' HB ' ' A' ' 62' ' ' THR . 40.4 mttp -144.31 152.54 40.9 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.153 0.502 . . . . 64.12 112.35 175.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -143.25 146.33 33.53 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.541 -0.754 . . . . 61.33 110.153 172.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -123.13 129.84 51.97 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 122.05 -0.406 . . . . 70.33 111.856 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -99.64 111.05 23.43 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.855 0.36 . . . . 64.35 111.082 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 28' ' ' ILE . 73.3 t -107.87 125.32 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-O 121.033 0.444 . . . . 52.15 111.319 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.504 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 49.1 mm -95.7 103.96 15.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 CA-C-O 121.041 0.448 . . . . 40.03 111.397 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.439 HD11 HD23 ' A' ' 56' ' ' LEU . 25.0 pt -106.91 138.73 31.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.285 -0.416 . . . . 75.01 110.985 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -121.14 132.97 55.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.032 0.444 . . . . 50.31 111.84 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' HB3' HD12 ' A' ' 10' ' ' ILE . 33.8 t70 -136.24 166.6 23.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.195 -0.457 . . . . 63.13 110.589 176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.02 -27.97 65.96 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.807 0.337 . . . . 51.44 111.79 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.595 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 47.9 p -90.93 1.04 57.34 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.38 0.511 . . . . 72.53 112.38 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.98 167.77 12.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.681 -0.771 . . . . 63.11 114.039 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -103.84 137.11 42.31 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 122.579 -0.365 . . . . 73.54 110.362 172.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.439 HD23 HD11 ' A' ' 49' ' ' ILE . 34.0 tp -124.13 141.71 51.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.947 0.403 . . . . 72.43 112.065 -174.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -96.48 101.07 12.64 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.293 -0.412 . . . . 75.02 110.505 173.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.02 129.89 34.9 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.547 -0.297 . . . . 73.35 111.352 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.4 t -110.49 107.21 22.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-O 121.19 0.519 . . . . 63.04 111.623 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 11.2 m-85 -92.54 104.28 16.6 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.141 -0.481 . . . . 71.23 110.497 176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -71.6 161.44 31.01 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.188 -0.46 . . . . 75.41 111.634 178.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.435 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 8.7 t -39.08 -30.54 0.05 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.911 1.078 . . . . 73.32 113.911 -178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.7 mm-40 -67.57 -43.82 79.7 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.391 0.615 . . . . 74.32 111.254 177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -92.19 -2.34 56.59 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.268 0.84 . . . . 71.11 113.268 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.3 mm -52.94 -33.62 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 121.289 0.566 . . . . 71.22 111.653 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -63.95 -16.95 62.71 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 112.645 0.609 . . . . 55.34 112.645 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.6 mt -82.54 -21.36 35.4 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.386 0.513 . . . . 63.3 112.386 -178.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -57.64 -32.8 67.63 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.4 0.518 . . . . 44.13 112.4 -176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -80.13 -5.8 56.62 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.863 0.69 . . . . 74.41 112.863 -178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -73.86 -19.22 60.79 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.093 0.473 . . . . 74.32 110.962 176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -140.11 178.53 7.21 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.864 -0.607 . . . . 73.22 111.221 177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.9 mtt180 -127.31 171.61 11.34 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 121.221 0.534 . . . . 71.43 111.128 176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -72.48 115.48 11.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.282 -0.417 . . . . 73.11 110.55 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.02 -2.94 19.28 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 121.046 -0.597 . . . . 53.51 113.11 -176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -95.82 163.71 13.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.252 0.549 . . . . 63.4 111.579 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.5 t -96.52 118.31 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-N 116.165 -0.471 . . . . 22.53 111.152 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.6 pt -122.99 173.17 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.791 0.805 . . . . 72.33 112.555 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 64.3 ttt180 -150.26 116.54 5.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.964 -1.016 . . . . 73.43 109.819 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.421 HG12 HG12 ' A' ' 102' ' ' VAL . 41.6 mt -92.67 126.32 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 120.741 0.305 . . . . 71.32 110.9 -177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 57.1 tttm -100.31 141.73 32.76 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.528 0.566 . . . . 72.54 112.528 -173.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 55.78 79.63 0.16 Allowed 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.397 -0.819 . . . . 72.22 112.561 175.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.7 m -137.8 171.95 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-O 121.093 0.473 . . . . 65.2 111.89 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -114.2 135.32 54.18 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.204 0.526 . . . . 73.43 111.674 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG13 ' HB3' ' A' ' 13' ' ' LEU . 45.1 mm -94.33 125.21 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.022 -0.535 . . . . 54.12 110.918 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.414 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 30.5 mmm180 -99.39 4.76 46.4 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 112.3 0.482 . . . . 74.25 112.3 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 97.7 -36.83 3.72 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.224 0.85 . . . . 74.22 115.224 171.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 56.18 91.38 0.01 OUTLIER Glycine 0 CA--C 1.529 0.922 0 CA-C-N 117.552 0.676 . . . . 52.03 112.678 -172.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -71.69 89.41 1.01 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.273 0.559 . . . . 71.31 111.031 -175.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.48 51.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.795 0 CA-C-N 115.976 -0.556 . . . . 73.44 112.858 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.76 -62.55 3.89 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 121.174 -0.536 . . . . 75.35 113.803 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -80.56 100.09 8.42 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.004 0.431 . . . . 74.44 111.73 -176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.59 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 57.7 mttp -61.28 173.89 0.79 Allowed 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 112.912 0.708 . . . . 73.42 112.912 178.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 14.1 pt-20 -141.99 148.66 38.92 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.91 -0.586 . . . . 75.02 111.051 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -130.24 125.63 35.33 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.739 0.304 . . . . 71.4 111.571 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 33.8 m-70 -103.94 134.27 47.51 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.108 0.48 . . . . 63.34 111.535 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.0 mp -87.89 175.33 7.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.46 0.648 . . . . 71.22 112.088 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.462 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 38.2 mtt -129.52 164.02 42.64 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-N 115.635 -0.711 . . . . 63.54 110.257 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 13.6 Cg_endo -55.86 -16.62 16.27 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.624 2.216 . . . . 65.15 113.523 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 63.2 mtp85 -111.88 4.34 18.22 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.783 0.66 . . . . 73.33 112.783 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 m -78.21 131.74 37.28 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 122.151 -0.343 . . . . 65.23 111.601 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 80.9 p -117.67 162.44 18.03 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.006 0.431 . . . . 73.45 111.755 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.421 HG12 HG12 ' A' ' 79' ' ' ILE . 31.5 m -119.64 132.03 70.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-O 121.012 0.434 . . . . 74.22 111.628 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 11.0 pt-20 -114.72 147.2 40.02 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.685 0.279 . . . . 54.21 110.614 176.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 24.7 m -93.84 136.22 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-O 120.947 0.403 . . . . 73.33 111.113 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.493 ' HB2' HG12 ' A' ' 76' ' ' VAL . 44.3 mt -102.51 -153.35 0.46 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.324 -0.398 . . . . 64.21 111.766 -177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 6.0 m-20 68.11 158.04 0.14 Allowed Pre-proline 0 N--CA 1.472 0.659 0 N-CA-C 108.464 -0.939 . . . . 61.15 108.464 -166.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.564 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 9.7 Cg_exo 0.73 82.6 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.317 0 C-N-CA 123.421 2.747 . . . . 73.23 113.269 -152.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -40.67 128.69 2.56 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.842 -1.527 . . . . 52.23 114.328 -161.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -81.74 -38.1 26.24 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.234 -0.894 . . . . 62.25 111.776 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 . . . . . 0 C--O 1.253 1.25 0 CA-C-O 118.791 -0.623 . . . . 70.21 112.004 -179.073 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 tpp . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 120.645 0.26 . . . . 74.41 111.651 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' NZ ' ' HB2' ' A' ' 2' ' ' LYS . 9.1 mtmp? -111.28 110.03 56.26 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.043 0.386 . . . . 64.02 112.043 -174.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -88.43 116.97 0.95 Allowed 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 122.767 2.311 . . . . 74.54 113.029 176.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -78.34 17.55 0.63 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.431 0.53 . . . . 64.54 112.431 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -87.62 105.83 17.61 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.047 0.451 . . . . 73.41 111.539 -178.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -81.78 -177.15 6.44 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.204 0.526 . . . . 72.52 111.848 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 20.9 ptp -150.41 98.46 2.66 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.918 -0.583 . . . . 71.43 110.912 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.82 -158.61 0.68 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.006 0.373 . . . . 54.24 112.006 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.411 HG21 HG21 ' A' ' 53' ' ' THR . 7.9 t -124.65 179.69 4.86 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 120.879 0.371 . . . . 64.41 111.734 -176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.581 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 44.3 mt -54.11 -31.71 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 113.24 0.83 . . . . 72.24 113.24 -172.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.552 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 87.0 p -65.19 -32.93 74.86 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.247 0.462 . . . . 42.43 112.247 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm -93.23 -19.12 21.73 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.969 0.729 . . . . 65.54 112.969 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 71.0 mt -45.8 110.15 0.23 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.417 0.627 . . . . 71.21 112.225 -176.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -100.04 141.31 33.03 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.734 -0.666 . . . . 75.51 112.325 -174.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -59.84 91.12 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 CA-C-O 121.678 0.751 . . . . 74.34 112.277 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 123.99 3.05 8.4 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-N 115.761 -0.654 . . . . 55.52 113.369 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.39 140.34 29.94 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.485 -0.421 . . . . 75.22 111.867 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 33.3 tt0 -104.52 108.47 19.92 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.981 0.42 . . . . 74.41 110.522 176.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.0 t -152.21 151.8 28.28 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 112.042 0.386 . . . . 71.55 112.042 -175.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 43.4 Cg_endo -68.8 143.08 54.36 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.443 2.095 . . . . 75.34 112.892 171.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.4 m -124.36 163.42 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.152 0.501 . . . . 72.01 111.699 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.5 m -145.26 143.3 30.16 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.203 -0.311 . . . . 71.01 111.104 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.46 164.1 34.98 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 120.817 -0.706 . . . . 64.13 113.555 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.9 mtm180 -81.2 118.57 22.69 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 122.725 -0.279 . . . . 72.41 110.779 178.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.0 t -66.14 109.06 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 120.787 0.327 . . . . 71.33 110.685 176.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.448 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 42.8 ttp -106.29 -43.44 4.79 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.781 0.289 . . . . 71.05 111.781 -178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HD3' ' O ' ' A' ' 26' ' ' MET . 38.2 mmtm -130.41 136.47 49.08 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.827 0.346 . . . . 74.0 111.533 177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -124.05 116.72 48.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.818 0.342 . . . . 52.22 111.238 175.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -86.91 119.38 27.06 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 110.248 -0.279 . . . . 71.33 110.248 173.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 39.7 m -53.64 145.02 31.47 Favored Pre-proline 0 N--CA 1.473 0.719 0 CA-C-N 116.618 -0.265 . . . . 72.34 111.46 -178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -51.24 121.57 8.59 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 123.136 2.557 . . . . 74.53 113.589 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 24.1 ttt180 -93.54 124.14 37.33 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.775 -0.648 . . . . 73.42 110.116 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.1 m -95.33 143.52 26.63 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.956 0.724 . . . . 75.25 112.956 -170.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -139.42 174.75 10.19 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.245 -0.889 . . . . 64.51 109.19 174.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 86.2 m -100.69 108.75 20.69 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 121.721 -0.612 . . . . 70.24 111.627 177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.7 t -78.08 -172.04 2.58 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.371 -0.377 . . . . 74.11 111.592 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -53.72 -66.55 0.37 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.043 0.757 . . . . 74.42 113.043 -175.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -167.57 148.85 5.5 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.296 0.569 . . . . 62.44 112.401 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 92.0 -64.67 2.35 Favored Glycine 0 C--N 1.337 0.588 0 CA-C-N 116.069 -0.514 . . . . 30.14 112.596 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 23.0 mtm180 -84.58 161.51 20.14 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.889 0.376 . . . . 73.04 111.154 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.465 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 20.4 pt-20 -76.39 -56.71 4.38 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.644 -0.253 . . . . 72.4 110.862 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 97.76 106.93 2.53 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 121.464 -0.398 . . . . 44.12 113.417 -174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' H ' ' CB ' ' A' ' 62' ' ' THR . 48.2 mttp -126.87 163.49 23.5 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.226 0.536 . . . . 70.54 111.77 173.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -148.81 140.89 23.91 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.064 -0.516 . . . . 71.41 110.396 171.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -130.23 151.51 50.67 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.89 0.376 . . . . 53.14 111.775 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -126.12 115.74 20.27 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.13 0.491 . . . . 75.04 111.281 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 90.6 t -109.98 129.39 65.03 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 116.144 -0.48 . . . . 41.4 111.047 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.415 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.3 mm -93.16 107.1 18.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 CA-C-O 121.03 0.443 . . . . 71.53 110.994 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.7 pt -106.65 140.07 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-N 116.081 -0.509 . . . . 73.01 110.755 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.86 123.47 44.79 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.056 0.455 . . . . 72.22 112.111 -177.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -106.0 175.1 5.61 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.011 -0.541 . . . . 64.21 110.141 176.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -75.22 -9.29 58.41 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 122.14 -0.35 . . . . 72.42 111.673 177.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 11' ' ' SER . 63.5 p -105.26 -11.2 16.62 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.661 0.615 . . . . 71.21 112.661 177.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 156.78 168.95 20.18 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.755 -0.736 . . . . 64.14 113.477 -176.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.636 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 45.5 mt-10 -102.4 144.39 30.93 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.896 0.379 . . . . 64.11 110.85 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 94' ' ' ALA . 38.4 tp -132.8 140.98 48.26 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.508 -0.315 . . . . 75.41 111.313 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ttp-105 -95.03 106.32 18.31 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.038 0.447 . . . . 74.34 110.661 176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.39 113.01 20.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.364 -0.38 . . . . 52.52 111.37 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.0 t -92.3 108.56 20.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 121.098 0.475 . . . . 75.14 111.77 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.473 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 38.9 m-85 -92.8 104.89 17.11 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.139 0.495 . . . . 74.44 110.816 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -73.36 162.1 29.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.887 -0.597 . . . . 72.34 112.573 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.447 ' CB ' ' H ' ' A' ' 43' ' ' LYS . 7.1 t -42.03 -31.87 0.39 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 114.271 1.211 . . . . 43.41 114.271 -176.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -89.68 -13.5 36.81 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 112.264 0.468 . . . . 72.3 112.264 -178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -104.66 4.71 32.92 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.269 0.47 . . . . 43.42 112.269 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 48.6 mm -58.43 -33.39 47.79 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 121.11 0.481 . . . . 72.32 111.035 178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 20.3 pttm -58.29 -16.66 15.06 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.559 0.577 . . . . 62.24 112.559 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.609 HD13 HG13 ' A' ' 102' ' ' VAL . 83.6 mt -80.32 -23.15 40.83 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.16 -0.338 . . . . 75.22 111.727 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.9 mt -62.03 -42.7 99.45 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.751 0.31 . . . . 75.15 111.819 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 22.8 pttp -65.92 -6.72 13.3 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.654 0.612 . . . . 72.02 112.654 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -83.69 -26.48 29.77 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 112.059 0.392 . . . . 62.54 112.059 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -135.05 171.37 14.53 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.056 0.455 . . . . 75.23 111.5 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 72' ' ' ARG . 44.8 mtt180 -130.76 169.31 15.86 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.929 0.395 . . . . 75.25 111.102 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -67.21 93.44 0.31 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.123 0.487 . . . . 62.4 111.583 -176.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 150.5 -34.18 0.98 Allowed Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.149 -0.478 . . . . 64.45 112.931 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -68.9 158.6 34.23 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.553 0.575 . . . . 72.31 112.553 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 51.9 t -95.54 113.68 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.247 -0.433 . . . . 65.3 110.522 175.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.513 HG22 HG12 ' A' ' 104' ' ' VAL . 45.5 pt -109.25 157.28 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 121.726 0.774 . . . . 74.35 112.813 -175.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.56 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -124.42 109.76 13.7 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.027 -0.988 . . . . 65.34 109.306 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 35.0 mt -90.3 121.55 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 110.004 -0.369 . . . . 75.01 110.004 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 30.5 tttt -101.25 121.65 42.26 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.707 0.632 . . . . 60.43 112.707 -165.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 56.14 86.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.252 -0.885 . . . . 74.34 112.976 179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 17.0 m -132.26 172.9 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.07 0.462 . . . . 64.03 112.204 178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -102.97 117.87 35.57 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.099 -0.5 . . . . 75.54 111.819 -176.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.408 HD12 HD13 ' A' ' 13' ' ' LEU . 49.9 mm -84.18 116.24 27.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.742 0.306 . . . . 73.34 110.784 177.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 13.9 mmm180 -93.36 -37.47 11.99 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.763 0.316 . . . . 64.05 111.152 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 60.0 61.96 6.59 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.273 -0.489 . . . . 73.43 113.278 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.429 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . -71.14 140.21 30.71 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.156 -0.545 . . . . 52.22 113.406 -177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -61.17 96.94 0.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.134 0.492 . . . . 74.44 111.445 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.02 46.66 0.16 Allowed Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.79 -0.641 . . . . 75.35 112.341 176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.66 -77.46 0.64 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.416 -0.421 . . . . 71.33 112.799 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.636 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 48.8 mtm180 -93.77 139.88 30.31 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 120.987 0.423 . . . . 74.01 111.301 -179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.49 -177.39 4.69 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.452 0.644 . . . . 75.42 112.323 -175.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 87' ' ' GLY . 10.8 pt-20 -146.15 145.7 30.58 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.074 -0.512 . . . . 71.35 111.815 -176.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.461 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -119.38 137.7 53.56 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.937 -0.574 . . . . 71.11 110.934 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.3 m-70 -112.17 129.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.209 0.528 . . . . 72.01 111.503 -176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.37 143.01 27.07 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.681 -0.69 . . . . 63.22 111.473 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.1 mtm -105.1 160.59 25.48 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-N 115.86 -0.609 . . . . 75.14 110.515 178.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.3 -21.54 17.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.274 1.982 . . . . 62.34 112.826 177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -89.26 -15.2 34.11 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.393 -0.367 . . . . 60.45 111.823 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -74.71 142.97 44.36 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.153 0.501 . . . . 65.03 112.057 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.1 p -131.75 169.35 16.33 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.923 -0.58 . . . . 65.31 110.68 177.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.609 HG13 HD13 ' A' ' 67' ' ' LEU . 25.4 m -130.39 134.79 61.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-O 121.411 0.624 . . . . 54.34 111.919 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.56 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 8.9 pt-20 -118.03 132.97 56.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.182 -0.463 . . . . 63.3 110.389 175.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.513 HG12 HG22 ' A' ' 77' ' ' ILE . 23.4 m -87.13 120.57 36.66 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.159 0.504 . . . . 71.21 111.729 -175.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.9 mt -85.49 -15.6 42.32 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.593 0.59 . . . . 71.34 112.593 -176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.837 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 26.8 t70 -71.21 -58.65 3.81 Favored Pre-proline 0 CA--C 1.554 1.121 0 C-N-CA 121.111 -0.236 . . . . 64.41 110.874 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.837 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 14.1 Cg_exo -72.18 -18.81 26.7 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 121.859 1.706 . . . . 53.54 111.07 167.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.0 tm? 72.08 111.49 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.868 -1.06 . . . . 74.4 113.305 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.42 -70.58 0.53 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.593 -0.73 . . . . 73.24 110.339 168.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 118.78 -0.628 . . . . 75.32 111.305 175.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.711 0.291 . . . . 63.22 111.178 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -94.86 114.88 64.63 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.558 -0.292 . . . . 72.42 111.069 178.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.81 138.0 68.29 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.667 2.245 . . . . 72.22 113.038 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -76.75 66.66 2.71 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.186 0.439 . . . . 73.03 112.186 -175.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -171.36 131.48 0.75 Allowed 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.575 -0.284 . . . . 74.14 111.128 178.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.39 57.92 1.38 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.412 0.625 . . . . 64.55 111.708 176.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 45.4 ttp -173.4 58.04 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.798 0.809 . . . . 72.51 109.474 176.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 1.8 m-20 -86.38 164.37 17.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.467 -0.788 . . . . 73.03 112.3 -174.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 53' ' ' THR . 10.0 t -99.28 -178.93 4.07 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.88 -0.6 . . . . 61.12 111.298 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.6 mt -60.3 -38.55 77.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 112.752 0.649 . . . . 74.42 112.752 -173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.423 ' HB3' ' HB ' ' A' ' 53' ' ' THR . 47.7 p -67.02 -6.86 18.75 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 112.725 0.639 . . . . 73.41 112.725 178.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 2.8 mmmp? -105.75 -1.68 24.13 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.227 0.455 . . . . 70.42 112.227 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 80.0 mt -73.9 131.44 41.48 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.086 0.469 . . . . 71.54 111.92 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.08 139.85 53.64 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.282 0.563 . . . . 75.33 111.174 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.545 ' HB3' ' HA3' ' A' ' 86' ' ' GLY . 9.0 pt-20 -63.53 119.79 10.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.728 -0.669 . . . . 44.51 112.757 -174.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.87 -20.8 26.26 Favored Glycine 0 CA--C 1.526 0.725 0 CA-C-N 115.917 -0.583 . . . . 50.45 113.058 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.05 146.98 29.38 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.326 0.584 . . . . 74.25 112.559 -175.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.64 109.11 21.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.048 -0.524 . . . . 71.04 110.412 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.4 t -151.86 150.87 27.09 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.482 -0.326 . . . . 65.34 111.579 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -71.76 157.2 55.88 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.299 2.0 . . . . 63.45 112.268 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.6 m -129.99 138.22 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 CA-C-O 121.05 0.452 . . . . 61.02 111.554 179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 99.8 m -123.74 131.25 53.56 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.749 0.309 . . . . 74.43 111.065 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.31 172.96 42.44 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 120.888 -0.672 . . . . 53.53 113.289 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HG2' HG22 ' A' ' 76' ' ' VAL . 52.2 mtm180 -98.28 126.36 43.74 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 122.471 -0.429 . . . . 73.34 110.788 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.538 ' HA ' HG22 ' A' ' 49' ' ' ILE . 48.0 t -62.19 125.94 19.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.798 0.333 . . . . 64.34 111.306 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.5 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 55.6 ttp -111.31 -62.71 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.692 0.282 . . . . 64.23 110.829 176.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 26' ' ' MET . 72.9 mmtt -129.36 128.28 42.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.737 0.303 . . . . 70.52 110.966 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 HG23 HG22 ' A' ' 47' ' ' VAL . 67.0 mt -105.76 106.22 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 120.738 0.304 . . . . 45.13 111.386 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.8 m -73.7 130.44 40.0 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.723 0.297 . . . . 74.43 110.851 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 60.7 p -56.73 147.68 50.99 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 112.886 0.699 . . . . 72.32 112.886 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.9 125.3 17.32 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.899 2.399 . . . . 62.52 113.01 176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -94.3 122.3 36.71 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.138 -0.483 . . . . 71.31 110.397 176.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.3 m -88.73 143.45 26.91 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.263 -0.426 . . . . 71.44 111.541 -176.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -145.4 158.54 43.81 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.142 0.496 . . . . 60.34 112.014 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 56.1 m -86.33 105.52 16.74 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 116.213 -0.449 . . . . 63.14 111.212 178.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.9 t -96.85 173.59 7.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 121.3 0.572 . . . . 73.11 111.732 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -97.39 0.43 47.82 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.307 0.575 . . . . 64.0 110.68 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.428 ' NZ ' ' HB3' ' A' ' 38' ' ' LYS . 6.0 mtpm? -94.52 13.42 24.06 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 112.992 0.738 . . . . 62.42 112.992 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 81.05 -28.19 2.94 Favored Glycine 0 CA--C 1.534 1.232 0 N-CA-C 115.087 0.795 . . . . 70.11 115.087 172.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -85.05 160.77 19.93 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.807 -0.82 . . . . 75.22 112.004 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -48.37 -39.43 22.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.413 0.894 . . . . 71.25 113.413 -175.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.25 110.24 0.12 Allowed Glycine 0 CA--C 1.529 0.946 0 C-N-CA 121.017 -0.611 . . . . 73.1 113.675 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.471 ' H ' ' HB ' ' A' ' 62' ' ' THR . 82.1 mttt -147.33 149.52 32.98 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.954 0.407 . . . . 62.23 111.539 -179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -140.15 129.82 24.38 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.958 -0.565 . . . . 72.4 110.485 174.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.494 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.72 158.26 25.9 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.141 -0.35 . . . . 71.14 111.353 -178.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -127.65 111.0 13.23 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.974 0.416 . . . . 72.12 111.045 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.498 HG22 HG23 ' A' ' 28' ' ' ILE . 64.5 t -103.34 118.85 51.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 120.975 0.417 . . . . 72.43 110.812 177.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.2 mm -92.57 104.69 15.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.222 0.534 . . . . 74.2 110.723 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG22 ' HA ' ' A' ' 25' ' ' VAL . 33.5 pt -106.38 136.7 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.946 -0.57 . . . . 73.4 110.896 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.31 122.28 41.51 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.658 0.742 . . . . 45.2 111.98 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.55 168.5 9.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.225 -0.898 . . . . 61.5 110.014 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -52.0 -35.13 45.61 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.086 0.469 . . . . 62.15 111.293 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 9' ' ' THR . 33.8 p -90.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.188 0.81 . . . . 60.33 113.188 -175.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.79 167.01 11.59 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.869 -0.682 . . . . 21.23 113.433 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -113.26 137.47 51.43 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 122.524 -0.398 . . . . 63.22 111.694 178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 tp -122.84 157.49 32.37 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.161 -0.472 . . . . 64.31 111.871 -173.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -102.25 112.04 24.57 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.969 0.414 . . . . 73.42 111.138 174.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -96.43 125.44 40.93 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.754 0.312 . . . . 75.54 111.557 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.5 t -98.85 108.42 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 121.055 0.455 . . . . 73.11 111.731 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.494 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 16.8 m-85 -94.3 104.3 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.164 0.507 . . . . 65.1 111.467 178.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -72.98 162.14 29.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.0 -0.545 . . . . 74.32 111.611 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.471 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 6.0 t -39.33 -38.02 0.49 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 114.255 1.206 . . . . 74.13 114.255 -177.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -71.79 -28.35 63.55 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.154 0.502 . . . . 74.31 111.924 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -96.45 -1.29 47.71 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.44 0.533 . . . . 74.32 112.44 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.452 HG12 ' HA ' ' A' ' 62' ' ' THR . 44.8 mm -56.73 -35.5 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.129 0.49 . . . . 72.31 111.094 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 61.8 pttt -53.24 -28.04 25.24 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.992 -0.549 . . . . 75.52 112.046 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 102' ' ' VAL . 80.0 mt -74.3 -28.03 60.99 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 111.797 0.295 . . . . 71.1 111.797 -177.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 98.3 mt -58.77 -27.91 65.43 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.614 0.598 . . . . 71.34 112.614 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 18.5 ptpt -87.13 -6.71 58.56 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.145 0.424 . . . . 73.41 112.145 -179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -75.81 -19.19 59.15 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.862 0.363 . . . . 72.14 111.697 178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -138.13 174.88 10.09 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.055 0.455 . . . . 75.35 111.447 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtp-105 -120.69 171.73 8.38 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.444 0.64 . . . . 74.03 111.466 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -77.44 86.01 3.82 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.794 -0.639 . . . . 74.24 110.927 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.33 -19.71 0.93 Allowed Glycine 0 CA--C 1.531 1.063 0 C-N-CA 120.88 -0.676 . . . . 64.45 113.724 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -81.19 171.84 14.39 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 117.096 0.448 . . . . 70.43 112.076 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG22 ' HG2' ' A' ' 24' ' ' ARG . 40.1 t -97.81 128.52 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 116.572 -0.285 . . . . 73.33 110.777 177.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.531 HG22 HG12 ' A' ' 104' ' ' VAL . 47.5 pt -130.09 156.56 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-O 121.65 0.738 . . . . 54.34 112.683 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.491 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 71.9 ttt180 -119.24 110.83 17.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.464 -0.789 . . . . 74.23 110.005 172.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -89.72 105.39 16.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.095 0.474 . . . . 72.12 109.82 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -96.22 135.45 38.02 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.487 0.551 . . . . 70.51 112.487 -168.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 63.9 83.59 0.16 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.508 -0.769 . . . . 73.04 112.346 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 96' ' ' LEU . 17.1 m -139.6 173.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 121.343 0.592 . . . . 74.21 112.445 178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -108.16 120.68 43.04 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.948 -0.569 . . . . 75.12 111.428 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.463 HD13 ' HB2' ' A' ' 94' ' ' ALA . 41.3 mm -81.3 109.12 15.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 110.008 -0.367 . . . . 72.21 110.008 173.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -75.89 -49.29 18.3 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.058 0.456 . . . . 64.41 110.956 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.733 ' HA2' ' HB3' ' A' ' 92' ' ' LYS . . . 58.47 65.05 3.77 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 115.991 -0.549 . . . . 62.43 114.169 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.43 -32.55 3.65 Favored Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.928 -0.654 . . . . 53.14 112.593 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -82.48 131.54 35.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.927 0.394 . . . . 75.14 111.67 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.53 82.07 0.21 Allowed Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.149 -0.548 . . . . 55.14 112.562 176.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 142.74 -109.77 0.58 Allowed Glycine 0 CA--C 1.524 0.626 0 N-CA-C 112.032 -0.427 . . . . 64.23 112.032 -178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 77.8 mtm180 -72.56 87.22 1.2 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.153 0.501 . . . . 74.11 110.773 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.733 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 76.6 mttt -66.9 179.68 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.841 -0.618 . . . . 73.44 111.548 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -131.0 149.45 52.61 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.255 0.55 . . . . 60.21 112.449 -176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.463 ' HB2' HD13 ' A' ' 84' ' ' ILE . . . -121.33 132.46 54.79 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.642 -0.708 . . . . 75.14 110.953 178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -104.94 133.96 48.85 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.178 0.514 . . . . 74.32 111.685 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.467 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.8 mp -87.51 156.37 19.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.636 -0.711 . . . . 65.2 111.111 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.426 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 31.6 mtt -104.43 160.69 25.21 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.136 -0.484 . . . . 53.44 110.395 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 11.8 Cg_endo -54.65 -18.06 14.67 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.575 2.183 . . . . 72.41 113.905 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 75.9 mtt-85 -111.38 -1.48 15.96 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.106 0.41 . . . . 73.23 112.106 179.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.469 ' O ' HD11 ' A' ' 67' ' ' LEU . 49.2 m -70.81 136.02 48.49 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.096 0.474 . . . . 74.01 111.912 -177.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 78.5 p -124.83 161.57 26.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 116.117 -0.492 . . . . 72.03 111.771 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 67' ' ' LEU . 31.1 m -118.71 136.25 56.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-N 116.385 -0.37 . . . . 71.1 111.348 177.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.0 pt-20 -114.28 123.05 48.58 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.131 0.491 . . . . 71.13 110.309 176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 77' ' ' ILE . 35.6 m -79.27 123.67 36.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.224 -0.444 . . . . 60.33 111.76 -175.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 78.4 mt -80.7 -169.18 2.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.804 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.528 ' CG ' ' HD2' ' A' ' 107' ' ' PRO . 10.6 t70 70.52 140.39 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.931 0 N-CA-C 108.348 -0.982 . . . . 73.15 108.348 -172.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.528 ' HD2' ' CG ' ' A' ' 106' ' ' ASP . 21.3 Cg_exo -3.48 81.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.368 1.577 0 C-N-CA 124.536 3.491 . . . . 72.22 114.752 -161.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.772 HD13 ' H ' ' A' ' 110' ' ' HIS . 2.0 tm? -63.14 140.06 58.84 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.084 -1.416 . . . . 73.23 111.943 -168.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -41.64 -46.52 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.074 0.768 . . . . 74.11 113.074 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.772 ' H ' HD13 ' A' ' 108' ' ' LEU . 23.5 m170 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.799 -0.619 . . . . 72.4 111.342 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.837 0.351 . . . . 71.44 111.267 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -143.02 96.98 5.83 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 120.829 0.347 . . . . 70.0 111.054 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -87.52 131.48 2.91 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.759 2.306 . . . . 73.42 113.548 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.12 156.03 24.93 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.536 -0.302 . . . . 72.32 110.809 177.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -134.01 101.27 4.99 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.902 0.382 . . . . 60.25 111.992 -175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -154.32 80.3 1.11 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 116.359 -0.382 . . . . 73.12 110.433 174.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -172.65 31.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.48 0.657 . . . . 74.0 110.733 -176.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 3.3 m-20 -70.01 161.94 29.1 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 114.208 1.188 . . . . 52.42 114.208 -170.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.7 p -104.5 178.83 4.45 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.169 -0.923 . . . . 73.41 111.07 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 51' ' ' ASP . 54.9 mt -58.8 -41.03 81.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 112.2 0.444 . . . . 74.23 112.2 -176.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.451 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 46.3 t -59.96 -33.68 72.26 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.167 0.508 . . . . 73.11 111.541 175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 31.3 mmmt -79.62 -25.18 41.51 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.54 0.57 . . . . 72.41 112.54 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.6 mt -56.88 102.67 0.09 Allowed 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 112.276 0.473 . . . . 74.54 112.276 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -91.94 152.03 20.23 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.993 0.425 . . . . 74.04 111.158 177.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -60.85 140.21 57.73 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.109 0.48 . . . . 71.43 111.805 177.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.69 3.74 90.28 Favored Glycine 0 CA--C 1.529 0.925 0 CA-C-N 116.282 -0.417 . . . . 75.13 113.546 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.72 143.75 26.19 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.352 -0.499 . . . . 74.43 111.954 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -110.27 108.68 18.86 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 121.23 0.538 . . . . 74.35 110.807 175.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.8 t -153.03 154.68 31.3 Favored Pre-proline 0 N--CA 1.473 0.695 0 CA-C-N 116.088 -0.505 . . . . 65.02 111.58 -177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.68 144.26 65.24 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.005 1.804 . . . . 71.54 111.867 168.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.491 HG22 ' HB ' ' A' ' 79' ' ' ILE . 22.8 m -124.17 159.65 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 120.952 0.406 . . . . 71.34 111.794 -176.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.448 HG23 HD12 ' A' ' 105' ' ' LEU . 88.7 m -134.61 146.61 49.75 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.418 -0.356 . . . . 71.44 111.822 -176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.98 155.57 16.46 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.119 -0.562 . . . . 74.14 113.228 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HE ' HG21 ' A' ' 76' ' ' VAL . 18.5 mtp180 -89.88 127.07 35.93 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 122.381 -0.482 . . . . 71.33 110.068 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.3 t -67.21 125.52 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 121.056 0.455 . . . . 53.25 112.134 -174.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.0 ttp -113.0 -55.42 2.53 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.225 -0.443 . . . . 71.52 111.26 177.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -128.71 140.37 51.77 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 120.815 0.34 . . . . 53.12 111.561 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.457 HG23 HG22 ' A' ' 47' ' ' VAL . 64.4 mt -124.12 119.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 120.737 0.303 . . . . 63.04 111.199 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.1 t -91.36 145.12 24.9 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.693 0.282 . . . . 53.33 110.889 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 91.6 p -65.11 146.01 99.0 Favored Pre-proline 0 N--CA 1.473 0.718 0 N-CA-C 112.264 0.468 . . . . 72.13 112.264 -176.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -49.81 118.02 3.48 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 123.099 2.533 . . . . 41.12 112.615 175.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.8 ttt180 -93.49 117.8 30.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.214 -0.448 . . . . 73.34 110.424 -178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.2 m -83.03 138.99 33.51 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.251 -0.431 . . . . 60.14 112.146 -172.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -144.47 157.08 44.41 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.362 -0.381 . . . . 75.51 110.396 178.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.8 m -85.48 112.75 21.19 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.285 0.564 . . . . 74.14 111.657 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 11.1 t -89.75 -171.1 3.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.863 -0.608 . . . . 72.15 111.187 178.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 37' ' ' ARG . 43.7 mtt-85 -56.35 -59.25 5.24 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.819 0.342 . . . . 74.54 111.572 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.7 ptpp? -178.11 156.45 1.02 Allowed 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.155 -0.475 . . . . 73.05 111.189 177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.22 -72.55 0.2 Allowed Glycine 0 CA--C 1.524 0.598 0 C-N-CA 121.321 -0.466 . . . . 52.51 113.127 175.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 71.6 mtm-85 -104.34 155.31 18.88 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.016 0.436 . . . . 70.02 111.348 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -67.51 -11.37 57.8 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.542 0.941 . . . . 75.04 113.542 -173.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.03 122.36 0.08 OUTLIER Glycine 0 CA--C 1.531 1.055 0 C-N-CA 121.432 -0.413 . . . . 54.24 113.916 176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.464 ' H ' ' HB ' ' A' ' 62' ' ' THR . 67.9 mttm -153.61 152.1 30.48 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 122.358 -0.496 . . . . 63.21 111.569 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -145.09 133.23 21.52 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.103 -0.498 . . . . 55.01 110.206 172.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.513 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -118.83 151.64 37.7 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.985 -0.447 . . . . 71.23 111.704 -176.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -119.01 111.53 18.43 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.941 0.4 . . . . 63.14 111.492 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG22 HG23 ' A' ' 28' ' ' ILE . 97.3 t -109.41 124.23 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.965 0.412 . . . . 74.31 110.805 176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 mm -93.6 109.54 22.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.507 0 CA-C-O 120.914 0.388 . . . . 74.35 111.348 -178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 31.1 pt -106.45 142.35 19.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.157 -0.474 . . . . 53.51 111.121 178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.64 133.43 55.65 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.418 0.525 . . . . 74.23 112.418 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.524 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.5 t70 -136.11 163.49 30.21 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.046 -0.525 . . . . 72.23 110.76 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -61.55 -20.36 63.17 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.451 0.537 . . . . 52.12 112.451 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 41.5 p -94.23 -0.86 54.84 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.177 0.436 . . . . 53.45 112.177 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.71 166.85 11.01 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 121.311 -0.471 . . . . 12.21 113.489 179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.529 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 1.8 mp0 -103.9 139.45 39.04 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 122.469 -0.43 . . . . 71.12 111.001 175.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 tp -120.73 140.49 51.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.548 -0.296 . . . . 74.23 111.54 -174.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -92.96 108.31 19.9 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.942 0.401 . . . . 74.52 110.838 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.46 122.31 31.02 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.524 -0.307 . . . . 44.53 111.582 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.0 t -101.89 106.58 19.97 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.145 0.498 . . . . 64.4 111.554 -178.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.6 m-85 -92.79 104.28 16.55 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.083 0.468 . . . . 61.3 111.031 178.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -73.73 162.25 29.36 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.274 -0.421 . . . . 62.24 111.706 178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.52 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.2 t -42.11 -30.15 0.28 Allowed 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.07 0.767 . . . . 72.54 113.07 178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -68.1 -35.28 77.89 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.167 0.508 . . . . 72.21 111.421 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.484 ' HB3' HD12 ' A' ' 67' ' ' LEU . 9.9 m120 -107.19 5.45 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.414 0.894 . . . . 74.3 113.414 -174.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.52 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.6 mm -53.75 -38.63 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.066 0.46 . . . . 73.24 111.873 177.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -56.79 -17.03 7.71 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.629 0.603 . . . . 64.5 112.629 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD13 HG13 ' A' ' 102' ' ' VAL . 79.2 mt -79.9 -24.49 41.11 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.221 0.452 . . . . 61.04 112.221 -178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.1 mt -58.47 -39.66 80.54 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 112.142 0.423 . . . . 70.03 112.142 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -71.83 -11.53 60.85 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.87 0.693 . . . . 73.52 112.87 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -71.01 -36.08 72.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.096 0.406 . . . . 65.43 112.096 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -118.19 168.68 10.36 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.166 0.508 . . . . 72.31 112.086 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -108.71 158.24 17.8 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.152 -0.476 . . . . 72.43 110.756 176.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -69.89 89.35 0.58 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.269 0.557 . . . . 61.35 110.476 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.57 -22.26 1.34 Allowed Glycine 0 CA--C 1.527 0.817 0 CA-C-N 115.915 -0.584 . . . . 44.35 112.673 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -76.36 -179.59 5.23 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.325 0.583 . . . . 61.22 111.383 177.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.421 HG21 ' HE ' ' A' ' 24' ' ' ARG . 42.5 t -112.78 135.82 51.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 122.162 -0.336 . . . . 73.14 110.712 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.5 pt -128.82 164.05 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.884 0.85 . . . . 44.54 112.597 -176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -137.3 111.52 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.704 -1.134 . . . . 54.03 109.522 177.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 21' ' ' VAL . 44.9 mt -89.48 125.25 42.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 120.895 0.378 . . . . 62.34 110.815 -176.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -94.2 117.83 30.69 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 112.865 0.691 . . . . 74.34 112.865 -169.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 56.49 86.48 0.07 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.529 0.937 . . . . 64.45 113.529 174.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 94' ' ' ALA . 19.4 m -130.01 173.12 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-O 120.98 0.419 . . . . 72.43 112.049 177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -104.95 119.71 39.68 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.919 0.39 . . . . 73.21 111.295 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.424 HD11 HG11 ' A' ' 21' ' ' VAL . 48.5 mm -84.87 113.39 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.331 -0.395 . . . . 74.23 111.189 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.515 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 24.5 mmm180 -81.02 -42.48 21.05 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.866 0.365 . . . . 65.1 111.045 176.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 59.41 50.11 71.32 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 114.198 0.439 . . . . 64.21 114.198 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.68 66.49 0.14 Allowed Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.243 -0.979 . . . . 41.14 114.044 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -126.27 89.38 3.0 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.053 0.454 . . . . 75.1 110.476 176.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.36 -49.08 3.24 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.052 -0.594 . . . . 65.43 113.209 -177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.83 -43.71 0.03 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 121.232 -0.509 . . . . 60.43 112.91 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.529 ' NH1' ' HB2' ' A' ' 55' ' ' GLU . 88.7 mtt180 -88.78 172.28 9.34 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.661 0.743 . . . . 71.34 112.684 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 93.3 mttt -87.65 168.92 12.59 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.513 -0.767 . . . . 74.0 112.153 -175.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 16.7 pt-20 -151.42 147.3 26.71 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.713 -0.676 . . . . 71.32 111.498 -175.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 82' ' ' VAL . . . -119.41 117.83 29.54 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.326 -0.397 . . . . 70.31 111.159 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -93.43 122.24 35.64 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.945 0.403 . . . . 74.14 111.244 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.47 137.57 33.83 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.311 0.577 . . . . 62.33 111.616 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.489 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 49.8 mtm -104.05 165.75 12.86 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.832 -0.622 . . . . 74.33 110.565 177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.2 Cg_endo -51.0 -23.78 12.79 Favored 'Trans proline' 0 CA--C 1.548 1.208 0 C-N-CA 122.59 2.194 . . . . 74.04 113.971 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -88.16 -21.02 24.84 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.073 0.397 . . . . 72.11 112.073 178.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 39.0 m -66.14 117.22 8.14 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.618 0.599 . . . . 64.45 112.618 -174.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 68.6 p -110.21 168.72 9.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.14 -0.482 . . . . 54.54 111.128 176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.496 HG13 HD13 ' A' ' 67' ' ' LEU . 32.7 m -130.3 134.09 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.167 0.508 . . . . 72.24 112.128 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -118.41 147.38 43.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.9 -0.591 . . . . 75.0 109.867 175.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.8 m -88.52 134.98 26.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.135 0.493 . . . . 73.51 111.776 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.561 HD22 HD21 ' A' ' 108' ' ' LEU . 36.5 mt -99.76 -172.27 2.21 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.419 -0.355 . . . . 55.44 111.301 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.589 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.0 OUTLIER 64.73 155.78 0.12 Allowed Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 108.618 -0.882 . . . . 74.33 108.618 -166.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.589 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 6.3 Cg_exo -1.54 79.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 123.717 2.945 . . . . 75.21 113.669 -156.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.561 HD21 HD22 ' A' ' 105' ' ' LEU . 0.3 OUTLIER -50.64 133.72 25.26 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.907 -1.497 . . . . 72.4 114.772 -162.158 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.88 -61.78 2.37 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.068 -0.969 . . . . 73.24 110.621 170.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.255 1.363 0 CA-C-O 118.53 -0.748 . . . . 72.43 111.29 176.486 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 111.581 0.215 . . . . 72.33 111.581 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' H ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -142.46 105.79 5.51 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-O 121.237 0.541 . . . . 73.32 110.761 177.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -89.76 114.23 0.57 Allowed 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.459 2.106 . . . . 73.12 113.302 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -82.85 113.73 20.68 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.248 0.547 . . . . 51.51 111.08 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -101.62 145.72 28.68 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 115.916 -0.584 . . . . 65.13 112.194 -173.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.537 ' NH1' ' HD3' ' A' ' 20' ' ' PRO . 17.7 tpt85 72.52 26.03 2.6 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.411 0.684 . . . . 71.13 112.318 173.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.52 100.06 0.92 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.639 -0.504 . . . . 73.12 109.639 175.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -118.92 141.21 48.86 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.179 0.437 . . . . 62.05 112.179 -173.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.426 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 77.3 p -77.69 169.83 17.63 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.495 -0.32 . . . . 74.44 110.908 175.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HD12 ' O ' ' A' ' 54' ' ' GLY . 29.2 mt -56.7 -32.51 37.97 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 N-CA-C 112.9 0.704 . . . . 74.23 112.9 -174.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.607 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 36.4 t -74.95 -31.51 61.51 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.115 0.483 . . . . 74.24 111.403 174.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 28.7 mmmt -77.28 -15.34 59.48 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.078 0.399 . . . . 75.5 112.078 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 9' ' ' THR . 79.5 mt -65.25 89.39 0.09 Allowed 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.096 0.474 . . . . 74.02 111.104 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -83.74 145.57 28.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.109 -0.496 . . . . 64.42 111.572 -177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -58.68 129.82 43.91 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.262 0.554 . . . . 70.11 111.672 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 84.64 0.9 89.27 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 121.272 -0.489 . . . . 63.23 113.639 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.2 146.1 24.24 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.073 0.464 . . . . 40.42 111.919 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -108.06 108.41 19.5 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.248 0.547 . . . . 71.4 110.988 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.435 ' OG1' ' HD2' ' A' ' 20' ' ' PRO . 9.4 t -153.01 151.72 26.73 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 115.951 -0.568 . . . . 73.0 110.719 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' HD3' ' NH1' ' A' ' 6' ' ' ARG . 56.1 Cg_endo -69.38 150.55 70.67 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.059 1.84 . . . . 73.12 112.271 175.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' HB ' ' A' ' 79' ' ' ILE . 19.7 m -122.9 153.9 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 121.148 0.499 . . . . 50.35 111.713 -176.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.9 m -144.6 143.45 30.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 116.382 -0.372 . . . . 63.41 111.32 -178.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 177.91 161.4 26.05 Favored Glycine 0 CA--C 1.527 0.798 0 C-N-CA 120.947 -0.644 . . . . 63.5 113.216 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.593 ' HG2' HG22 ' A' ' 76' ' ' VAL . 42.6 mtt-85 -83.93 122.64 29.01 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 122.474 -0.427 . . . . 73.21 110.947 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.84 119.21 6.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 120.985 0.422 . . . . 75.43 112.033 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 50.6 ttp -94.54 -57.18 2.55 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.451 -0.34 . . . . 72.12 110.81 175.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 mmmp? -130.04 143.8 50.99 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-O 120.655 0.264 . . . . 72.33 111.425 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -120.59 112.38 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 120.921 0.391 . . . . 73.3 111.509 177.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB2' ' HB2' ' A' ' 46' ' ' ASN . 68.3 m -88.37 125.01 34.49 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.408 -0.36 . . . . 74.33 111.267 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.5 m -55.96 152.37 21.11 Favored Pre-proline 0 N--CA 1.473 0.714 0 N-CA-C 112.895 0.702 . . . . 71.03 112.895 -176.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.82 135.7 57.5 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.781 2.321 . . . . 53.23 113.385 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 31.1 ttm180 -103.27 128.4 50.31 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.54 -0.3 . . . . 73.42 110.263 174.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 25.8 m -89.12 143.09 27.09 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.675 0.274 . . . . 71.21 111.413 -177.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -152.03 165.43 34.7 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 120.96 0.41 . . . . 71.33 111.201 -179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 98.2 m -85.14 133.31 34.21 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.937 0.398 . . . . 71.41 111.486 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.588 HG21 ' HB2' ' A' ' 40' ' ' ARG . 47.2 p -92.12 178.33 5.9 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.211 0.529 . . . . 74.41 112.111 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -92.12 9.58 32.9 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.49 0.552 . . . . 71.15 112.49 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -142.31 -69.08 0.36 Allowed 'General case' 0 CA--C 1.539 0.524 0 O-C-N 122.082 -0.386 . . . . 73.14 111.894 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 175.29 40.33 0.05 OUTLIER Glycine 0 CA--C 1.528 0.847 0 C-N-CA 119.739 -1.219 . . . . 74.23 114.691 -178.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.588 ' HB2' HG21 ' A' ' 36' ' ' THR . 46.7 mtp85 -111.04 161.72 15.6 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 122.386 -0.479 . . . . 75.44 110.073 175.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -68.56 -25.06 64.71 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 120.751 -0.38 . . . . 71.2 111.432 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 66.79 107.73 0.01 OUTLIER Glycine 0 CA--C 1.527 0.837 0 CA-C-N 116.397 -0.365 . . . . 64.25 114.01 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' ARG . 79.3 mttt -146.93 150.17 34.67 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.197 -0.59 . . . . 54.42 112.073 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.471 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.5 pp -144.11 135.4 25.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.545 -0.752 . . . . 60.04 110.473 176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.581 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.01 155.94 40.66 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 122.049 -0.407 . . . . 71.41 111.258 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HB2' ' HB2' ' A' ' 29' ' ' SER . 28.9 m-80 -124.32 111.62 16.02 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.499 -0.318 . . . . 64.31 111.271 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 71.3 t -110.97 121.65 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 120.862 0.363 . . . . 70.32 110.958 177.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 48.8 mm -92.91 106.51 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-O 120.989 0.423 . . . . 43.11 110.981 -178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.4 pt -106.77 141.35 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.27 -0.423 . . . . 53.53 110.618 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' GLU . . . -118.21 136.57 53.57 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.844 0.683 . . . . 71.25 112.844 -174.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -126.0 167.57 15.13 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.14 -0.936 . . . . 73.1 109.853 175.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -56.97 -19.92 20.83 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.238 0.458 . . . . 75.34 112.238 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.607 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 52.1 p -102.02 11.66 38.11 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.728 0.64 . . . . 73.34 112.728 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 126.1 168.7 12.69 Favored Glycine 0 CA--C 1.524 0.652 0 C-N-CA 120.942 -0.647 . . . . 74.11 112.777 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 50' ' ' ALA . 0.9 OUTLIER -103.24 160.19 14.89 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.147 0.498 . . . . 64.22 111.533 176.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.8 tp -132.51 145.36 51.1 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.203 -0.453 . . . . 62.15 111.637 -170.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.457 HH21 ' CD ' ' A' ' 93' ' ' GLU . 46.7 ttp180 -94.83 100.64 12.49 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.889 0.376 . . . . 62.31 110.965 175.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.67 118.19 25.02 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.537 -0.301 . . . . 61.11 111.3 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 55.9 t -96.77 108.89 22.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.074 0.464 . . . . 65.02 111.885 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 17.3 m-85 -92.92 104.58 16.81 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.141 0.496 . . . . 62.35 111.085 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -76.45 161.9 28.28 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.025 -0.534 . . . . 74.14 111.514 177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.421 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 3.3 t -38.7 -37.37 0.33 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.631 0.975 . . . . 72.02 113.631 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -63.6 -35.1 79.4 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.008 0.433 . . . . 73.4 111.95 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.43 ' HB3' HD12 ' A' ' 67' ' ' LEU . 14.8 m120 -106.24 4.18 28.55 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 113.442 0.904 . . . . 74.15 113.442 -174.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 62' ' ' THR . 39.7 mm -54.08 -34.68 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 121.162 0.506 . . . . 40.44 111.551 177.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -59.91 -16.88 33.07 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.718 0.636 . . . . 70.31 112.718 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD13 HG13 ' A' ' 102' ' ' VAL . 94.2 mt -81.31 -23.28 37.95 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 111.914 0.339 . . . . 71.44 111.914 -179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.56 -35.34 72.2 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.346 0.498 . . . . 72.22 112.346 -177.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -73.78 -14.08 61.05 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.379 0.511 . . . . 71.3 112.379 -177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -70.8 -34.52 71.85 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.488 0.551 . . . . 61.0 112.488 -178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -122.5 170.42 10.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.218 0.533 . . . . 74.2 112.232 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -117.58 162.09 18.56 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.898 -0.592 . . . . 74.23 111.061 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.81 89.54 0.27 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.071 0.462 . . . . 72.4 110.633 176.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 145.81 -13.84 1.74 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-N 116.147 -0.478 . . . . 71.34 112.99 -177.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -85.43 167.48 15.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.135 0.493 . . . . 75.5 111.313 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 24' ' ' ARG . 15.9 t -100.02 126.45 53.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.507 -0.315 . . . . 70.24 110.724 179.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.7 pt -125.14 146.23 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 121.764 0.792 . . . . 64.54 112.935 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -115.4 112.77 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.087 -0.96 . . . . 73.14 110.052 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.5 HG12 HG12 ' A' ' 102' ' ' VAL . 34.9 mt -90.75 116.99 33.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 120.869 0.366 . . . . 73.1 110.323 178.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 80' ' ' LYS . 35.2 ttmt -93.66 129.29 40.02 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.327 -0.397 . . . . 71.43 111.843 -172.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.69 88.93 0.1 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.97 0.73 . . . . 70.13 112.97 178.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 18.5 m -140.41 170.27 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.985 0.421 . . . . 74.42 111.533 176.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -116.89 127.1 53.93 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.881 0.372 . . . . 62.34 111.423 177.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.427 HG22 ' H ' ' A' ' 86' ' ' GLY . 43.2 mm -83.63 121.11 35.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.398 -0.365 . . . . 73.32 111.288 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.441 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 26.5 mmm180 -97.78 7.99 45.47 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.379 0.511 . . . . 73.3 112.379 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' H ' HG22 ' A' ' 84' ' ' ILE . . . 85.78 -26.76 5.74 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 114.539 0.576 . . . . 62.3 114.539 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.515 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.33 64.29 3.86 Favored Glycine 0 CA--C 1.527 0.786 0 CA-C-N 117.386 0.593 . . . . 65.14 112.939 -177.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -50.51 107.35 0.16 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.111 0.481 . . . . 64.33 112.073 -176.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.15 -39.86 1.63 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 121.273 -0.489 . . . . 24.55 113.221 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.4 -67.99 0.1 Allowed Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.87 -0.681 . . . . 64.24 113.298 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 58.2 mtt180 -79.45 112.11 16.38 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 122.787 -0.243 . . . . 71.25 111.343 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.515 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 9.6 mtmp? -58.11 155.48 11.06 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.073 0.463 . . . . 74.44 111.212 174.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 57' ' ' ARG . 16.2 pt-20 -133.76 146.87 51.13 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.195 0.521 . . . . 65.11 112.136 -174.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -122.97 116.23 23.22 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.875 -0.602 . . . . 71.45 110.686 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.96 131.34 38.04 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.898 0.38 . . . . 73.42 111.272 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.1 mp -88.82 160.25 17.34 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.527 0.679 . . . . 64.34 112.364 -177.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.43 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 59.1 mtm -126.76 162.78 45.16 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 115.384 -0.826 . . . . 60.43 110.43 179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 9.4 Cg_endo -49.66 -34.47 35.05 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 122.61 2.206 . . . . 43.43 113.264 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -89.48 10.42 22.81 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.138 0.421 . . . . 75.22 112.138 -178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.2 m -90.03 133.78 34.63 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.911 0.386 . . . . 74.45 111.229 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 64.8 p -126.71 154.33 44.26 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.377 -0.374 . . . . 50.31 111.22 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.5 HG12 HG12 ' A' ' 79' ' ' ILE . 35.2 m -118.45 128.64 75.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.228 0.537 . . . . 74.01 111.779 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -120.37 129.06 53.78 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.21 -0.45 . . . . 74.01 110.792 176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 29.9 m -78.66 142.7 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.416 0.627 . . . . 73.5 112.501 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.492 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 86.2 mt -123.49 -175.13 3.13 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.909 -0.587 . . . . 72.24 111.598 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 27.9 t70 80.04 -74.39 0.0 OUTLIER Pre-proline 0 CA--C 1.558 1.286 0 C-N-CA 124.38 1.072 . . . . 73.11 110.343 -174.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 10.6 Cg_exo -75.76 93.88 1.0 Allowed 'Trans proline' 0 C--N 1.368 1.591 0 CA-C-N 121.812 1.683 . . . . 74.03 109.882 156.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.54 92.25 0.14 Allowed 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.358 0.873 . . . . 54.34 113.358 -170.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -68.22 -25.34 65.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.705 -1.134 . . . . 73.21 111.637 173.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.142 0 N-CA-C 112.857 0.688 . . . . 74.33 112.857 -173.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 pmm? . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 120.958 0.408 . . . . 73.43 111.512 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -163.44 82.5 1.46 Allowed Pre-proline 0 CA--C 1.544 0.745 0 N-CA-C 109.85 -0.426 . . . . 73.31 109.85 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -90.98 121.54 0.73 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.262 2.642 . . . . 75.33 112.814 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -79.07 81.09 5.37 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.229 0.538 . . . . 72.44 111.42 178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -154.95 72.66 0.85 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.87 -0.605 . . . . 65.2 110.887 173.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -92.57 -158.87 0.62 Allowed 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.073 -0.714 . . . . 74.15 109.073 170.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.498 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . 18.1 ptm -91.13 87.33 6.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.484 -0.562 . . . . 63.23 109.484 168.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -53.55 136.35 38.66 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.627 -0.715 . . . . 74.13 112.238 -177.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 t -69.36 167.39 16.61 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.217 -0.447 . . . . 75.42 111.013 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.464 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 27.4 mt -57.66 -28.38 32.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 112.588 0.588 . . . . 71.32 112.588 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.535 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 71.5 m -68.05 -38.15 82.13 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.947 0.403 . . . . 72.3 111.471 172.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 28.2 mmmt -91.07 -5.89 54.57 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.296 0.85 . . . . 74.13 113.296 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 55.3 mt -55.72 105.44 0.18 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.574 0.702 . . . . 65.21 111.504 178.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -99.23 134.52 41.98 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.309 -0.859 . . . . 73.55 111.7 -175.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -60.11 139.86 57.25 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.145 0.498 . . . . 71.02 111.778 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.57 -13.6 57.88 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.27 -0.491 . . . . 53.22 113.122 -177.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.93 131.62 34.25 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.035 0.445 . . . . 70.3 112.094 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -92.63 111.65 23.32 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.264 -0.426 . . . . 73.42 110.446 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.7 t -150.72 148.58 23.74 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.46 -0.337 . . . . 75.23 111.617 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HG2' ' HB3' ' A' ' 7' ' ' MET . 53.0 Cg_endo -70.1 143.03 47.99 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.065 1.844 . . . . 33.24 111.537 169.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.98 152.2 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 121.084 0.469 . . . . 73.5 111.782 -176.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' OG1' ' HG3' ' A' ' 78' ' ' ARG . 78.0 m -127.79 140.57 51.96 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.279 -0.418 . . . . 73.45 110.78 178.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.8 153.35 22.57 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.681 -0.771 . . . . 74.21 113.46 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG2' HG22 ' A' ' 76' ' ' VAL . 72.0 mtt-85 -86.06 116.24 24.15 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 122.269 0.228 . . . . 54.43 110.549 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.9 t -64.21 110.29 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-O 121.032 0.444 . . . . 72.14 112.146 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 48.6 ttp -106.9 -38.44 6.06 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.569 -0.287 . . . . 61.14 111.744 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 34.2 mmtp -128.1 127.08 42.42 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.659 0.266 . . . . 73.13 111.665 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.9 mt -120.09 116.24 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.954 0.407 . . . . 71.25 111.172 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.9 m -95.46 138.27 33.37 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.409 -0.36 . . . . 52.31 110.767 175.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 71.1 p -61.07 150.24 79.35 Favored Pre-proline 0 N--CA 1.472 0.632 0 N-CA-C 112.176 0.436 . . . . 64.12 112.176 -176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -59.82 118.02 4.84 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.582 2.188 . . . . 63.34 112.469 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 -93.9 127.43 39.65 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.542 -0.299 . . . . 73.23 110.477 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 2.6 m -90.14 141.41 28.72 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.484 -0.325 . . . . 73.12 111.494 -175.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -146.8 146.62 30.31 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.895 0.379 . . . . 72.33 111.419 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 64.3 m -84.57 106.88 16.47 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.276 0.56 . . . . 62.45 112.159 -174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 t -97.61 149.09 22.63 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.156 -0.475 . . . . 70.23 111.156 173.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 60.4 mtm180 -80.27 1.65 27.71 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.489 -0.323 . . . . 70.41 111.861 -179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -73.66 -43.53 59.18 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.179 0.437 . . . . 75.01 112.179 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 147.03 -32.77 1.4 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.475 -0.869 . . . . 65.43 113.809 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -84.03 160.77 20.91 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 117.091 0.446 . . . . 72.33 111.181 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.402 ' OE1' ' HE3' ' A' ' 43' ' ' LYS . 13.0 pt-20 -69.41 -13.23 62.25 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.987 0.736 . . . . 63.41 112.987 -174.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 70.18 123.49 0.04 OUTLIER Glycine 0 CA--C 1.531 1.08 0 C-N-CA 121.506 -0.378 . . . . 51.14 114.037 175.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' H ' ' HB ' ' A' ' 62' ' ' THR . 80.2 mttt -147.76 148.64 31.17 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 122.242 -0.563 . . . . 61.14 111.355 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.6 pp -146.38 137.28 24.25 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.138 -0.483 . . . . 73.13 110.596 173.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.529 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -126.27 137.8 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.895 0.379 . . . . 61.23 111.328 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -105.89 110.93 23.38 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.84 0.353 . . . . 71.4 111.053 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.9 t -112.84 116.63 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.923 0.392 . . . . 64.14 110.732 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.583 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 48.8 mm -92.89 111.13 24.07 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-O 121.179 0.514 . . . . 61.05 111.058 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 26.3 pt -106.41 143.5 17.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.77 -0.65 . . . . 75.13 110.771 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.27 124.99 49.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.188 0.518 . . . . 65.34 112.151 -175.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' HD12 ' A' ' 10' ' ' ILE . 31.7 t70 -110.74 167.62 10.09 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.76 -0.655 . . . . 74.13 110.172 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.03 -32.04 53.14 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.106 0.41 . . . . 55.23 112.106 178.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.535 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 30.5 p -97.12 0.19 48.07 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.54 0.941 . . . . 61.11 113.54 -174.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.85 170.29 17.72 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.108 -1.044 . . . . 52.44 113.855 -177.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.416 ' HB2' ' HD2' ' A' ' 91' ' ' ARG . 53.0 mt-10 -100.98 151.34 21.9 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.93 0.395 . . . . 75.43 110.804 175.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 tp -128.97 143.47 50.88 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.127 0.489 . . . . 75.41 111.39 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -94.21 100.29 12.39 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.033 -0.531 . . . . 74.31 110.615 177.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.31 112.07 21.06 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.74 0.305 . . . . 73.02 111.078 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.6 t -95.19 107.61 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.078 0.466 . . . . 73.33 111.668 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.529 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 20.4 m-85 -92.14 104.23 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.127 0.489 . . . . 72.1 110.835 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -77.38 161.5 27.97 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.075 -0.511 . . . . 63.12 111.49 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 4.8 t -38.55 -33.31 0.1 Allowed 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.565 0.95 . . . . 61.03 113.565 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -63.48 -43.84 96.13 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 121.112 0.482 . . . . 61.53 111.561 178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -95.91 3.37 53.64 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.694 0.998 . . . . 44.41 113.694 -172.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.5 mm -54.26 -31.77 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.119 0.485 . . . . 64.13 111.553 178.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.76 -16.27 26.4 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 112.927 0.714 . . . . 62.51 112.927 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.546 HD13 HG13 ' A' ' 102' ' ' VAL . 97.7 mt -87.11 -22.66 25.24 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.314 0.487 . . . . 75.23 112.314 -178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.7 mt -58.84 -30.74 67.91 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.93 0.395 . . . . 73.24 112.024 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 17.0 ptpt -72.3 -6.36 42.62 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 113.038 0.755 . . . . 71.42 113.038 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -80.31 -47.85 13.9 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.725 0.639 . . . . 63.42 112.725 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -109.85 165.92 11.33 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.106 0.78 . . . . 72.12 113.106 -171.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -109.82 166.08 11.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.488 -0.778 . . . . 72.01 110.67 176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -73.58 77.15 1.48 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.392 0.615 . . . . 63.14 110.182 176.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 162.94 -23.47 0.19 Allowed Glycine 0 CA--C 1.529 0.927 0 CA-C-N 115.848 -0.614 . . . . 75.04 113.27 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -75.37 157.72 33.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 117.253 0.526 . . . . 70.43 111.429 177.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.498 HG22 ' HG2' ' A' ' 24' ' ' ARG . 43.0 t -91.36 121.98 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 110.133 -0.321 . . . . 70.11 110.133 173.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.3 pt -114.29 154.37 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.722 0.773 . . . . 75.34 112.466 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.528 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 55.4 ttt180 -125.12 110.84 14.61 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.1 -0.955 . . . . 53.22 109.478 175.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 33.7 mt -92.27 123.97 44.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.891 0.377 . . . . 74.14 110.869 -176.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.08 126.36 38.14 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.443 0.535 . . . . 71.01 112.443 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 60.18 87.05 0.09 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.573 -0.74 . . . . 61.23 112.928 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 96' ' ' LEU . 29.9 m -131.81 159.84 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.221 0.534 . . . . 64.12 111.627 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.92 120.31 40.4 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.145 -0.48 . . . . 74.44 110.643 177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.7 mm -80.32 125.13 38.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 73.03 110.98 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 14.6 mmm-85 -101.92 -31.75 10.54 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.16 -0.338 . . . . 52.33 111.462 174.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 78.75 94.52 0.29 Allowed Glycine 0 CA--C 1.526 0.734 0 C-N-CA 120.882 -0.675 . . . . 42.33 113.454 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -62.37 120.73 22.99 Favored Glycine 0 CA--C 1.524 0.623 0 C-N-CA 121.117 -0.563 . . . . 64.1 112.392 173.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -60.04 -33.89 72.64 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 122.673 -0.31 . . . . 72.14 111.716 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.31 70.76 1.84 Allowed Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.954 -0.641 . . . . 61.32 113.59 -178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.7 -77.36 1.27 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 113.929 0.332 . . . . 35.4 113.929 176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' HD2' ' HB2' ' A' ' 55' ' ' GLU . 89.4 mtm180 -86.62 135.38 33.44 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 121.074 0.464 . . . . 73.32 112.195 -174.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HA ' ' H ' ' A' ' 87' ' ' GLY . 52.3 mttp -72.34 -176.05 1.74 Allowed 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.379 0.609 . . . . 60.52 112.37 -176.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -148.64 147.42 28.93 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.252 -0.431 . . . . 54.21 111.349 -177.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.21 129.14 41.28 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.304 -179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -101.79 130.31 48.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.007 0.432 . . . . 64.43 111.259 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.419 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -84.14 164.26 19.28 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.357 0.599 . . . . 61.11 112.009 -177.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 30.3 mtt -120.62 157.4 54.34 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.716 -0.675 . . . . 61.13 110.391 -178.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.25 -35.27 15.15 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.726 2.284 . . . . 55.43 113.993 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.27 -10.13 39.56 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.734 0.642 . . . . 64.22 112.734 -177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.408 ' O ' HD11 ' A' ' 67' ' ' LEU . 40.8 m -62.68 123.51 18.6 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.91 0.386 . . . . 62.43 112.015 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 79.4 p -109.1 155.99 20.33 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.378 -0.374 . . . . 71.12 111.099 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.546 HG13 HD13 ' A' ' 67' ' ' LEU . 34.3 m -118.22 127.96 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 CA-C-O 121.144 0.497 . . . . 52.32 111.525 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 9.6 pt-20 -115.09 134.55 55.07 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.101 -0.499 . . . . 54.43 110.554 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.09 136.94 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 112.721 0.637 . . . . 73.31 112.721 -175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.685 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 76.6 mt -115.75 164.7 13.98 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.624 -0.716 . . . . 74.53 110.214 175.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.494 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 31.6 t70 91.42 -60.79 0.0 OUTLIER Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.62 1.168 . . . . 65.13 109.415 -168.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.685 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 38.3 Cg_endo -69.73 -138.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.252 0 N-CA-C 109.047 -1.174 . . . . 75.44 109.047 149.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.401 ' H ' ' HB2' ' A' ' 107' ' ' PRO . 0.1 OUTLIER -173.46 138.78 0.71 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 118.821 0.737 . . . . 75.11 111.972 171.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -74.56 -53.08 10.12 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.181 0.515 . . . . 71.22 110.871 172.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 . . . . . 0 C--O 1.252 1.207 0 CA-C-O 118.534 -0.746 . . . . 75.2 112.08 176.008 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptm . . . . . 0 N--CA 1.493 1.721 0 N-CA-C 112.151 0.426 . . . . 72.44 112.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -120.72 159.62 47.81 Favored Pre-proline 0 N--CA 1.473 0.693 0 O-C-N 122.207 -0.308 . . . . 44.02 110.636 178.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -52.85 92.32 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.332 2.022 . . . . 51.24 113.465 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -89.86 107.94 19.41 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.369 0.605 . . . . 74.13 111.289 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -140.55 103.98 4.65 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.918 -0.583 . . . . 73.33 111.972 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' A' ' 6' ' ' ARG . 2.9 mmp_? -145.12 -179.43 6.62 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.238 -0.437 . . . . 71.34 111.055 177.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 85.2 mmm -87.07 134.84 33.46 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.243 0.544 . . . . 62.12 112.015 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -76.52 126.96 31.92 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.708 0.766 . . . . 73.55 112.895 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.2 p -133.94 161.42 34.85 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.488 -0.778 . . . . 72.4 109.093 171.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.518 HD12 ' O ' ' A' ' 54' ' ' GLY . 35.3 mt -67.3 -22.09 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 CA-C-O 121.084 0.469 . . . . 62.32 111.264 178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.599 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 47.4 t -77.82 -9.91 59.28 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.921 0.391 . . . . 45.2 111.383 172.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -106.36 -8.94 16.97 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 111.958 0.355 . . . . 71.12 111.958 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.517 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 81.0 mt -71.73 96.31 1.59 Allowed 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.05 0.453 . . . . 74.34 111.783 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -91.71 132.88 36.06 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 116.242 -0.435 . . . . 64.21 110.832 175.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.59 121.66 16.87 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.566 0.698 . . . . 71.41 111.364 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.38 -11.53 28.49 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.621 -0.718 . . . . 55.14 111.887 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.17 141.84 28.09 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.987 0.422 . . . . 70.23 111.806 178.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -98.9 108.99 21.81 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.175 0.512 . . . . 74.44 110.442 174.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 t -152.35 155.01 32.77 Favored Pre-proline 0 N--CA 1.469 0.516 0 CA-C-N 116.37 -0.377 . . . . 65.42 111.438 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 22.5 Cg_exo -64.63 151.31 86.12 Favored 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 122.114 1.876 . . . . 53.4 111.3 167.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG22 ' HB ' ' A' ' 79' ' ' ILE . 31.0 m -124.65 156.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 120.817 0.341 . . . . 71.33 111.679 -178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.4 m -136.31 145.95 46.06 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.425 0.528 . . . . 75.23 112.425 -174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.96 155.59 9.86 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 121.056 -0.592 . . . . 71.13 113.738 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HG2' HG22 ' A' ' 76' ' ' VAL . 86.3 mtt180 -79.72 135.77 36.61 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 122.528 -0.395 . . . . 75.13 111.126 176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.6 t -68.1 106.79 1.08 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.207 0.527 . . . . 70.23 111.08 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.423 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 52.0 ttp -96.64 -56.61 2.54 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.09 -0.505 . . . . 71.21 111.125 -178.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 26' ' ' MET . 73.5 mmtt -131.99 139.7 48.71 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 116.534 -0.303 . . . . 73.44 110.882 -178.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.8 mt -120.61 128.62 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-O 121.043 0.449 . . . . 71.51 111.726 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.2 m -97.42 132.22 43.33 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.494 -0.321 . . . . 72.43 110.607 174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.8 m -55.87 148.04 39.98 Favored Pre-proline 0 N--CA 1.474 0.732 0 N-CA-C 112.015 0.376 . . . . 70.01 112.015 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.73 133.68 46.47 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.497 2.131 . . . . 72.33 112.866 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -94.03 120.71 34.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 63.51 110.09 177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 15.7 m -82.68 121.33 26.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.637 -0.256 . . . . 71.23 111.086 -177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -122.98 153.41 39.81 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.836 0.351 . . . . 74.35 111.298 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 61.3 m -84.94 122.94 29.93 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.016 0.436 . . . . 65.1 111.41 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 4.0 t -108.48 168.45 9.31 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.013 0.435 . . . . 75.34 111.038 176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' ARG . 2.4 mpt_? -102.05 5.21 40.44 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 111.767 0.284 . . . . 72.54 111.767 -176.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -90.93 -53.06 4.55 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 112.399 0.518 . . . . 73.4 112.399 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 159.9 -19.3 0.24 Allowed Glycine 0 CA--C 1.534 1.225 0 C-N-CA 120.033 -1.079 . . . . 64.31 114.991 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 49.1 mtt180 -85.59 160.79 19.54 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 117.656 0.728 . . . . 71.44 111.345 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.89 -22.23 63.24 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.374 0.509 . . . . 72.43 112.374 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 33' ' ' THR . . . 74.74 123.54 0.12 Allowed Glycine 0 CA--C 1.534 1.274 0 N-CA-C 114.769 0.668 . . . . 23.43 114.769 173.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.463 ' H ' ' HB ' ' A' ' 62' ' ' THR . 49.2 mttp -150.99 152.79 34.04 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.036 0.446 . . . . 71.3 112.088 176.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.3 pp -143.15 137.11 28.84 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.801 -0.636 . . . . 74.02 110.301 172.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -119.2 133.89 55.51 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 112.124 0.416 . . . . 74.34 112.124 -176.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -99.48 111.42 23.77 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.892 0.377 . . . . 74.54 111.443 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.5 t -108.03 122.16 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-O 120.881 0.372 . . . . 72.53 111.227 178.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.3 mm -93.53 111.01 24.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.135 0.493 . . . . 74.04 111.117 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.6 pt -106.25 144.12 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 CA-C-N 116.127 -0.488 . . . . 75.22 111.501 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -119.72 124.84 47.2 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.001 0.429 . . . . 65.3 111.719 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -119.63 166.33 13.31 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.148 -0.478 . . . . 75.04 110.361 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -58.61 -20.59 48.66 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.259 0.466 . . . . 74.54 112.259 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.599 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 77.6 p -103.44 7.78 37.97 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.907 0.706 . . . . 52.51 112.907 -178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.518 ' O ' HD12 ' A' ' 10' ' ' ILE . . . 137.34 169.63 11.69 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.513 -0.851 . . . . 74.34 113.49 -178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -102.97 158.77 16.06 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 122.333 -0.51 . . . . 74.43 110.969 174.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.1 tp -140.42 152.69 45.91 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.388 -0.369 . . . . 62.52 111.533 -178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' A' ' 57' ' ' ARG . 37.4 ttp-105 -106.6 110.59 22.83 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.874 0.369 . . . . 71.23 111.201 175.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -94.21 136.83 34.07 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.726 0.298 . . . . 51.45 111.609 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 54.4 t -110.14 108.51 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.044 0.45 . . . . 53.44 111.677 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -92.73 104.91 17.13 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.032 0.444 . . . . 54.03 110.958 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.7 m95 -72.11 161.2 31.22 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.982 -0.554 . . . . 73.02 112.084 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.463 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 2.2 t -38.07 -38.31 0.32 Allowed 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.956 1.095 . . . . 70.05 113.956 -178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -67.89 -37.45 81.77 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.214 0.531 . . . . 73.12 111.46 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -85.39 -7.63 58.85 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.855 0.687 . . . . 74.33 112.855 -175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.4 mm -53.14 -32.78 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 CA-C-O 121.072 0.463 . . . . 50.22 111.971 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -65.44 -18.95 65.71 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 112.599 0.592 . . . . 72.14 112.599 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 92.0 mt -85.59 -17.05 37.33 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.991 0.367 . . . . 71.25 111.991 -178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 96.5 mt -56.93 -29.84 63.47 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.18 0.437 . . . . 63.15 112.18 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -67.72 -21.2 65.31 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.194 0.442 . . . . 75.11 112.194 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.444 ' HE2' ' HB3' ' A' ' 70' ' ' LYS . 45.3 mtpt -67.48 -29.35 68.77 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.895 0.379 . . . . 71.15 111.861 -178.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -134.08 160.45 37.75 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.493 0.663 . . . . 73.31 111.839 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.2 mtm180 -124.16 165.68 17.15 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.459 -0.791 . . . . 75.44 111.224 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.32 88.55 0.46 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.115 0.483 . . . . 63.44 109.891 176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.51 2.09 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.873 -0.603 . . . . 73.34 112.809 -174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -84.08 -176.41 6.25 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.082 0.468 . . . . 72.31 111.423 176.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.514 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.8 t -121.26 131.91 71.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 122.268 -0.27 . . . . 74.21 110.76 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.39 164.35 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-O 121.945 0.879 . . . . 75.14 113.358 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.617 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 34.3 ttt180 -141.8 118.77 11.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.62 -1.173 . . . . 71.45 109.135 172.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.498 HG12 HG12 ' A' ' 102' ' ' VAL . 47.4 mt -93.84 127.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.796 0.331 . . . . 70.45 111.245 -174.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.519 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 23.3 ttmm -95.38 132.01 40.87 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 112.858 0.688 . . . . 54.12 112.858 -172.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 56.47 86.9 0.06 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.517 -0.765 . . . . 75.51 112.999 176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 96' ' ' LEU . 19.0 m -137.37 166.42 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.221 0.534 . . . . 74.21 111.777 177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -103.08 119.11 38.26 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.139 -0.482 . . . . 74.24 111.367 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 43.4 mm -80.26 109.73 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 116.555 -0.293 . . . . 72.42 110.372 177.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.534 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 3.5 mmp_? -85.98 -52.89 5.42 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.089 0.471 . . . . 74.1 111.092 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 92' ' ' LYS . . . 93.27 104.13 1.65 Allowed Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.153 -0.546 . . . . 44.55 113.689 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 92' ' ' LYS . . . -56.79 118.9 13.02 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 120.977 -0.63 . . . . 72.2 111.735 173.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -54.71 112.79 1.1 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.205 0.446 . . . . 73.24 112.205 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 78.13 11.06 85.73 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 114.413 0.525 . . . . 61.43 114.413 175.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -143.51 -146.75 4.6 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.968 -0.634 . . . . 72.45 112.719 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.4 mtm180 -74.18 145.49 44.17 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.365 0.602 . . . . 74.21 110.853 177.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.412 ' HA ' ' HA2' ' A' ' 86' ' ' GLY . 65.4 mttm -81.09 174.32 11.7 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.498 0.666 . . . . 71.45 112.054 -173.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.534 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 11.1 pt-20 -141.75 146.28 35.8 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.962 -0.563 . . . . 55.23 111.224 -175.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.45 117.49 24.53 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.407 -0.361 . . . . 52.54 111.446 -177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.0 m-70 -92.79 129.66 38.65 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.888 0.375 . . . . 75.3 111.357 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.526 ' HA ' HG12 ' A' ' 82' ' ' VAL . 10.1 mp -82.31 167.89 18.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.612 0.72 . . . . 72.12 112.063 -178.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.53 ' HB3' ' HD2' ' A' ' 98' ' ' PRO . 39.5 mtt -121.97 165.6 19.82 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 115.387 -0.824 . . . . 51.54 109.988 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 97' ' ' MET . 10.7 Cg_endo -52.63 -25.17 25.1 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.344 2.029 . . . . 73.43 113.582 179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -112.56 11.63 19.74 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.91 0.707 . . . . 74.24 112.91 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.9 m -80.09 111.64 16.65 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 122.104 -0.373 . . . . 31.4 111.062 177.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 77.4 p -100.81 164.91 11.63 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.179 0.514 . . . . 73.43 111.631 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.498 HG12 HG12 ' A' ' 79' ' ' ILE . 27.5 m -118.48 133.01 66.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 121.09 0.472 . . . . 64.41 111.637 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.617 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 10.2 pt-20 -114.26 130.55 56.64 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 116.012 -0.54 . . . . 74.21 110.64 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.9 m -80.71 136.64 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-O 121.185 0.517 . . . . 61.02 111.77 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.517 HD22 HD11 ' A' ' 108' ' ' LEU . 58.9 mt -105.53 -172.01 2.02 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.24 -0.436 . . . . 73.33 111.432 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.668 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 1.3 m-20 65.03 161.31 0.12 Allowed Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 108.758 -0.83 . . . . 75.23 108.758 -167.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.668 ' HD2' ' HB3' ' A' ' 106' ' ' ASP . 11.2 Cg_exo 0.3 81.27 0.0 OUTLIER 'Trans proline' 0 C--N 1.365 1.434 0 C-N-CA 123.342 2.695 . . . . 63.4 113.185 -153.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.517 HD11 HD22 ' A' ' 105' ' ' LEU . 4.1 mm? -57.98 128.82 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 115.566 1.691 . . . . 63.11 115.566 -159.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -70.58 -22.13 62.61 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.17 -1.377 . . . . 62.53 111.084 169.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.402 -0.809 . . . . 74.44 111.354 -178.311 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.812 0.339 . . . . 72.34 110.777 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 1.0 OUTLIER -118.82 148.44 44.48 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-O 120.573 0.225 . . . . 74.52 111.204 -177.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.99 56.01 2.41 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 122.543 2.162 . . . . 61.42 111.049 168.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -77.89 107.68 10.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.932 -1.031 . . . . 62.44 112.339 -170.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 42.8 p-80 -167.43 130.83 1.75 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.972 -0.558 . . . . 74.52 110.831 174.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 38.3 ttt85 -173.92 151.91 1.86 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.546 -0.297 . . . . 73.22 110.664 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 71.9 mtm -55.09 99.82 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.507 0.558 . . . . 61.41 112.507 -175.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.416 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 1.2 p30 -83.98 153.77 23.69 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.934 -0.576 . . . . 73.5 112.164 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -134.27 -163.87 1.43 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.942 -0.572 . . . . 63.23 111.611 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.53 HD12 ' HB3' ' A' ' 51' ' ' ASP . 48.3 mt -55.29 -40.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 N-CA-C 112.815 0.672 . . . . 74.53 112.815 -174.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 53' ' ' THR . 45.1 t -68.88 -15.54 63.52 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.294 0.479 . . . . 65.24 112.294 178.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 8' ' ' ASP . 72.2 mmtt -103.32 -3.02 26.15 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 120.732 0.301 . . . . 64.44 111.79 -175.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.53 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 76.5 mt -71.79 110.1 6.1 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.447 0.536 . . . . 74.44 112.447 -174.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -96.99 147.86 23.56 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.724 0.297 . . . . 75.51 110.619 172.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.21 138.74 58.59 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.119 0.485 . . . . 70.53 111.242 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.34 -11.1 73.12 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.351 -0.452 . . . . 73.41 113.147 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.52 153.7 23.13 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.049 0.452 . . . . 42.45 111.658 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -122.37 108.48 13.27 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.376 -0.375 . . . . 63.22 110.837 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 9.9 t -153.78 154.8 30.7 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 111.907 0.336 . . . . 74.45 111.907 -177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.498 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . 44.5 Cg_endo -68.68 145.96 65.25 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 122.424 2.083 . . . . 74.12 112.857 169.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.68 157.01 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.88 0.372 . . . . 63.22 111.117 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.2 m -133.89 138.78 45.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.713 -0.221 . . . . 44.25 111.524 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.96 163.76 31.09 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.821 -0.704 . . . . 41.1 113.257 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.546 ' HG2' HG22 ' A' ' 76' ' ' VAL . 24.6 mtp-105 -89.14 139.3 30.61 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 122.295 -0.533 . . . . 75.25 110.973 177.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 46.4 t -72.77 134.5 29.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 120.799 0.333 . . . . 71.34 111.472 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 57.6 ttp -115.17 -62.33 1.62 Allowed 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 120.802 0.334 . . . . 73.1 111.026 175.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -127.63 125.88 41.01 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.873 0.368 . . . . 72.42 111.635 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.412 HG12 HG13 ' A' ' 47' ' ' VAL . 63.5 mt -106.64 113.59 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.109 0.48 . . . . 61.15 111.066 176.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.7 m -77.96 145.61 35.95 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.436 -0.347 . . . . 75.43 110.594 177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -64.21 150.15 93.04 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 112.151 0.426 . . . . 61.31 112.151 -175.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -63.25 119.29 6.3 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 122.781 2.321 . . . . 24.12 112.726 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -94.14 120.66 34.7 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 116.116 -0.493 . . . . 63.15 110.871 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.4 m -89.43 124.08 34.15 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.038 0.384 . . . . 73.32 112.038 -176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -119.59 174.42 6.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.852 0.461 . . . . 75.31 110.207 174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.3 m -101.62 120.85 40.97 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 122.158 -0.338 . . . . 70.44 111.839 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 13.9 t -107.39 173.35 6.36 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 120.913 0.387 . . . . 54.23 110.77 172.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -89.15 -31.72 17.83 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 113.319 0.859 . . . . 74.35 113.319 -171.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.1 137.69 49.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.545 0.943 . . . . 73.22 113.545 -170.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.98 -72.24 1.1 Allowed Glycine 0 CA--C 1.524 0.632 0 CA-C-N 115.624 -0.716 . . . . 23.43 114.409 170.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -95.54 162.79 13.49 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.913 0.708 . . . . 64.12 112.913 -172.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.533 ' CD ' ' HZ3' ' A' ' 43' ' ' LYS . 14.8 pt-20 -64.28 -54.46 32.92 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 115.27 -0.877 . . . . 73.12 111.214 171.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.48 ' N ' ' HG3' ' A' ' 41' ' ' GLU . . . 120.04 117.06 2.59 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-N 116.359 -0.382 . . . . 75.34 113.026 -176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 40.0 mttp -149.82 154.06 37.79 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 122.216 -0.579 . . . . 73.12 112.21 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.3 pp -150.79 154.2 36.88 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.554 -0.748 . . . . 65.5 110.333 173.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -138.26 144.31 40.46 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.982 -0.449 . . . . 75.41 111.992 -179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -106.78 111.29 23.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.915 0.388 . . . . 72.51 111.542 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG13 HG12 ' A' ' 28' ' ' ILE . 98.3 t -106.65 122.46 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 CA-C-O 121.051 0.453 . . . . 74.33 110.973 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.6 mm -93.51 107.27 18.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-N 116.31 -0.404 . . . . 71.32 111.417 -179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 pt -106.65 153.43 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 121.017 0.437 . . . . 73.43 111.196 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.87 132.73 40.69 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.956 0.408 . . . . 52.42 111.483 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 10' ' ' ILE . 35.0 t70 -131.32 164.86 24.71 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.671 177.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.37 -26.82 61.62 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 111.836 0.31 . . . . 62.52 111.836 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 11' ' ' SER . 43.7 p -92.18 0.41 57.46 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.517 0.562 . . . . 70.23 112.517 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.85 168.3 11.22 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 120.371 -0.919 . . . . 62.31 113.854 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -103.15 149.78 24.3 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.77 0.319 . . . . 70.31 110.573 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 tp -139.12 137.91 36.56 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.802 0.334 . . . . 71.43 111.53 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 34.8 ttp180 -94.69 108.67 20.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.004 0.431 . . . . 73.45 110.666 171.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -92.99 125.3 37.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.422 -0.353 . . . . 62.34 111.671 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.35 110.52 26.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.11 0.481 . . . . 61.21 111.569 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.93 104.95 17.32 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.114 -0.494 . . . . 71.52 110.733 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -73.85 161.87 29.71 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.173 -0.467 . . . . 73.15 111.772 178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.478 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 10.0 t -38.58 -37.02 0.29 Allowed 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 114.256 1.206 . . . . 75.53 114.256 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.401 ' HG3' ' HG3' ' A' ' 98' ' ' PRO . 78.4 mm-40 -69.57 -40.75 76.58 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.077 0.465 . . . . 75.14 111.435 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -82.29 -10.99 58.9 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.921 0.711 . . . . 74.52 112.921 -176.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 47.0 mm -52.47 -35.34 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-O 121.088 0.471 . . . . 62.54 111.401 178.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.457 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 62.9 pttt -61.22 -22.62 64.95 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 112.253 0.464 . . . . 71.42 112.253 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.411 ' HB3' HG22 ' A' ' 102' ' ' VAL . 90.5 mt -76.07 -22.55 55.5 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.262 0.467 . . . . 74.31 112.262 -177.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.82 -19.97 60.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.809 0.67 . . . . 61.51 112.809 -176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 9.9 ptpp? -79.16 -15.37 58.21 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.57 0.582 . . . . 74.13 112.57 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -67.03 -51.57 53.2 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 122.069 -0.394 . . . . 75.15 111.994 -177.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -108.7 179.88 4.06 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.981 0.42 . . . . 73.44 111.81 -175.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 72' ' ' ARG . 38.3 mtt180 -120.42 163.69 17.5 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.017 0.437 . . . . 73.24 110.769 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -67.53 86.52 0.19 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.293 0.568 . . . . 75.13 111.127 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 149.96 -14.3 1.01 Allowed Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.981 -0.554 . . . . 63.31 113.369 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -79.49 171.07 15.66 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.346 0.593 . . . . 73.02 112.431 -179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG22 ' HG2' ' A' ' 24' ' ' ARG . 21.2 t -96.3 108.44 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-N 115.913 -0.585 . . . . 73.14 111.002 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.525 HG22 HG12 ' A' ' 104' ' ' VAL . 42.3 pt -109.86 146.63 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 121.607 0.717 . . . . 65.12 112.563 -177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -117.12 111.36 19.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.642 -0.708 . . . . 74.33 109.519 170.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 56.6 mt -88.06 119.48 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.988 0.423 . . . . 74.13 110.055 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.498 ' HA ' ' HB3' ' A' ' 20' ' ' PRO . 16.2 tttt -96.25 122.59 39.27 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.136 0.791 . . . . 50.21 113.136 -164.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 87.76 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.918 0.887 . . . . 72.24 112.981 176.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' A' ' 96' ' ' LEU . 21.9 m -132.62 167.8 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 116.246 -0.433 . . . . 73.32 111.787 178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -103.14 126.0 50.11 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 120.89 0.376 . . . . 55.33 111.764 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 13' ' ' LEU . 33.0 mm -86.63 123.54 39.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.441 -0.345 . . . . 71.42 111.437 -178.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 23.3 mmt85 -87.66 -22.65 24.56 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.702 0.286 . . . . 73.15 111.506 178.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 101.22 -14.01 58.43 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.409 -0.424 . . . . 72.54 113.639 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.566 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 61.6 -138.97 46.83 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.371 -0.442 . . . . 63.41 113.517 -177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -139.07 99.5 3.78 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.241 0.46 . . . . 74.11 112.241 178.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 43.11 56.27 4.64 Favored Glycine 0 CA--C 1.532 1.141 0 N-CA-C 115.0 0.76 . . . . 22.32 115.0 170.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 147.64 -74.95 0.28 Allowed Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.966 -0.635 . . . . 75.44 112.66 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 21.9 mtp180 -94.78 124.43 38.82 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 122.443 -0.445 . . . . 72.33 110.961 177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.566 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 36.3 mtmm -92.85 176.09 6.56 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.004 -0.544 . . . . 63.11 111.306 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 12.6 pt-20 -145.14 154.3 42.3 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.791 0.329 . . . . 63.14 111.206 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.69 130.43 34.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.172 -0.467 . . . . 62.41 111.488 -177.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -99.44 134.56 42.13 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.899 0.38 . . . . 74.12 111.582 -178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.9 mp -88.36 155.86 19.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 121.556 0.693 . . . . 71.23 112.011 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 26.9 mtt -110.65 158.97 34.03 Favored Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 115.471 -0.786 . . . . 73.43 110.304 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.401 ' HG3' ' HG3' ' A' ' 63' ' ' GLU . 89.3 Cg_exo -48.8 -29.97 16.08 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 122.292 1.995 . . . . 53.31 112.934 175.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -91.32 -15.85 28.43 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.126 -0.488 . . . . 73.21 112.121 -178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 49.5 m -64.29 134.84 55.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.144 0.497 . . . . 74.22 111.722 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 50.9 p -115.19 159.91 20.36 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.864 -0.607 . . . . 75.02 111.009 178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 67' ' ' LEU . 32.0 m -118.36 121.59 67.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.595 0.712 . . . . 74.24 110.438 173.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 109' ' ' GLU . 9.7 pt-20 -120.2 116.14 25.03 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.605 -0.725 . . . . 65.31 111.433 -176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.525 HG12 HG22 ' A' ' 77' ' ' ILE . 29.4 m -75.07 139.58 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 121.061 0.458 . . . . 71.01 111.628 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -102.33 -3.3 27.37 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.557 0.577 . . . . 74.23 112.557 -176.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.816 ' HB3' ' HD3' ' A' ' 107' ' ' PRO . 33.3 t70 -75.88 -53.11 2.48 Favored Pre-proline 0 CA--C 1.55 0.951 0 N-CA-C 110.47 -0.196 . . . . 74.43 110.47 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.816 ' HD3' ' HB3' ' A' ' 106' ' ' ASP . 1.9 Cg_endo -84.93 -12.63 7.08 Favored 'Trans proline' 0 C--N 1.361 1.217 0 C-N-CA 122.312 2.008 . . . . 55.23 111.368 165.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 68.45 112.79 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.454 0.702 . . . . 63.42 111.764 178.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.631 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 5.7 mm-40 -94.1 -59.98 1.84 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.897 -0.592 . . . . 72.25 112.277 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.416 ' HD2' ' HB3' ' A' ' 109' ' ' GLU . 18.7 m-70 . . . . . 0 C--O 1.255 1.359 0 CA-C-O 118.985 -0.531 . . . . 73.22 112.206 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 112.167 0.432 . . . . 74.11 112.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -125.68 86.8 56.88 Favored Pre-proline 0 N--CA 1.471 0.58 0 O-C-N 121.958 -0.464 . . . . 63.15 111.215 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -84.75 91.35 0.77 Allowed 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.348 2.032 . . . . 75.13 112.643 177.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 4' ' ' GLU . 0.5 OUTLIER -70.15 83.71 0.53 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.759 0.79 . . . . 52.54 111.4 -179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -74.69 109.19 7.96 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.771 -0.65 . . . . 71.12 111.542 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 6' ' ' ARG . 16.4 mtm180 -117.87 -178.28 3.45 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.09 -0.504 . . . . 63.32 110.693 177.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 94.6 mmm -115.88 60.82 0.71 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.142 0.496 . . . . 62.04 109.908 174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.736 ' HB2' HG21 ' A' ' 19' ' ' THR . 59.7 m-20 -71.56 110.02 5.87 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.114 -0.494 . . . . 74.33 111.676 -174.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 52.3 p -71.58 175.61 5.45 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.162 -0.472 . . . . 43.21 110.176 174.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.56 ' HA ' ' HG ' ' A' ' 13' ' ' LEU . 51.9 mt -58.06 -21.73 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-O 121.277 0.56 . . . . 71.42 111.275 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -71.83 -32.44 67.54 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.938 -0.574 . . . . 75.34 112.0 175.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -109.69 13.58 23.7 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 113.741 1.015 . . . . 74.44 113.741 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 83.2 mt -66.49 88.68 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 65.41 111.849 177.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -81.42 140.52 34.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.109 -0.496 . . . . 74.52 111.131 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.68 131.21 38.73 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.29 0.567 . . . . 64.33 111.657 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.56 -17.87 58.21 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 116.279 -0.419 . . . . 51.02 113.819 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.46 152.2 37.95 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.812 0.671 . . . . 45.34 112.812 -175.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 34.2 tt0 -117.71 109.56 16.77 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.905 -0.589 . . . . 70.15 110.291 175.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.736 HG21 ' HB2' ' A' ' 8' ' ' ASP . 5.3 t -150.88 152.78 32.42 Favored Pre-proline 0 N--CA 1.474 0.752 0 CA-C-N 116.213 -0.448 . . . . 73.12 111.264 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.74 141.05 36.74 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.07 1.847 . . . . 74.12 111.997 171.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.5 m -122.94 141.46 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.07 0.462 . . . . 65.12 111.805 -176.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.8 m -121.02 141.99 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.297 -0.411 . . . . 65.22 110.813 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -170.13 156.71 27.59 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 120.503 -0.856 . . . . 73.44 113.707 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HG2' HG22 ' A' ' 76' ' ' VAL . 41.3 mtm-85 -94.74 117.92 30.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 122.414 0.285 . . . . 74.25 110.5 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 49' ' ' ILE . 58.6 t -62.73 125.58 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.566 0.58 . . . . 75.43 112.566 -173.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 54.2 ttp -110.13 -54.9 2.52 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.092 -0.504 . . . . 70.04 111.283 177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -126.97 133.13 50.65 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.407 -0.361 . . . . 73.24 111.364 -177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.406 HG12 HG13 ' A' ' 47' ' ' VAL . 55.8 mt -119.65 116.28 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.968 0.413 . . . . 73.44 111.196 173.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.3 m -84.01 121.34 27.26 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.301 -0.409 . . . . 63.44 110.564 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 m -51.22 151.27 5.13 Favored Pre-proline 0 N--CA 1.476 0.868 0 N-CA-C 112.357 0.503 . . . . 64.55 112.357 -177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.39 122.31 11.31 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.584 2.189 . . . . 64.13 112.994 -179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -94.47 123.93 38.19 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 116.309 -0.405 . . . . 72.52 110.306 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 m -91.09 122.68 33.94 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.162 0.506 . . . . 63.34 111.899 -176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -117.57 175.0 5.84 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.947 -0.57 . . . . 74.52 110.741 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 89.9 m -94.06 105.44 17.45 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.787 0.327 . . . . 74.43 111.551 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 14.2 t -81.86 -171.65 3.48 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 111.964 0.357 . . . . 73.3 111.964 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -60.05 -65.2 0.72 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 122.866 0.466 . . . . 74.52 112.229 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -162.36 150.12 14.17 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 112.541 0.571 . . . . 72.35 112.541 -177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.78 -67.51 3.2 Favored Glycine 0 CA--C 1.523 0.585 0 CA-C-N 116.362 -0.381 . . . . 62.33 113.115 175.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -85.95 161.94 18.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.098 0.475 . . . . 62.31 111.674 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -72.46 -60.89 2.01 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 115.925 -0.58 . . . . 72.14 111.014 172.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.75 119.54 4.14 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 121.589 -0.339 . . . . 72.54 113.119 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.496 ' H ' ' HB ' ' A' ' 62' ' ' THR . 46.1 mttp -136.76 154.2 50.63 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.323 -0.516 . . . . 71.2 112.354 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 pp -140.42 150.06 43.39 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.523 -0.762 . . . . 75.12 110.211 173.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -136.4 154.77 50.71 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.0 -0.438 . . . . 72.33 111.763 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -126.4 111.84 14.94 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.898 0.38 . . . . 73.41 111.227 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG13 HG12 ' A' ' 28' ' ' ILE . 97.8 t -108.12 119.04 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 120.912 0.386 . . . . 63.13 110.961 177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.8 mm -93.0 104.82 16.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 121.194 0.521 . . . . 64.54 111.076 -179.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG22 HG22 ' A' ' 25' ' ' VAL . 34.3 pt -106.44 137.69 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-N 116.076 -0.511 . . . . 74.42 110.808 179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -122.89 123.29 40.64 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.327 0.584 . . . . 71.33 112.301 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -108.84 168.53 9.28 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.564 -0.744 . . . . 74.51 110.072 174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -65.23 -21.78 66.79 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.059 0.392 . . . . 72.32 112.059 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.4 p -86.97 -11.75 49.57 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 111.86 0.319 . . . . 70.0 111.86 176.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.67 167.98 13.75 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.254 -0.498 . . . . 75.25 112.692 -177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.89 154.72 28.17 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-O 121.292 0.567 . . . . 75.14 112.143 178.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.0 tp -136.01 150.08 49.08 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.037 -0.529 . . . . 62.54 112.13 -172.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -93.97 105.59 17.59 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.001 -0.545 . . . . 64.45 110.658 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -89.24 120.52 30.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.605 0.241 . . . . 70.53 111.475 179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.4 t -97.31 107.29 19.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-O 121.102 0.477 . . . . 62.43 111.86 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.559 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 26.9 m-85 -93.44 104.87 16.99 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.322 -0.399 . . . . 54.33 111.536 178.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -76.82 163.04 27.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 122.564 0.345 . . . . 71.34 111.578 176.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.496 ' HB ' ' H ' ' A' ' 43' ' ' LYS . 9.0 t -44.33 -28.56 0.55 Allowed 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 113.859 1.059 . . . . 61.14 113.859 -178.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.475 ' O ' ' HE3' ' A' ' 66' ' ' LYS . 6.1 mm-40 -75.81 -27.72 58.05 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.042 -0.411 . . . . 72.13 112.008 177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 18.5 m120 -95.62 -5.97 41.24 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.943 0.72 . . . . 75.41 112.943 -178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 62' ' ' THR . 48.4 mm -55.23 -33.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 CA-C-O 121.063 0.459 . . . . 73.1 111.518 178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 63' ' ' GLU . 23.1 pttp -59.04 -17.41 25.27 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.486 0.55 . . . . 61.33 112.486 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD13 HG13 ' A' ' 102' ' ' VAL . 95.4 mt -83.99 -23.89 30.82 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 111.819 0.303 . . . . 73.31 111.819 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 92.7 mt -61.36 -37.29 82.81 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 112.245 0.461 . . . . 72.24 112.245 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -63.59 -16.12 60.0 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.256 0.465 . . . . 74.21 112.256 -178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -74.54 -26.36 59.92 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.26 0.467 . . . . 72.33 112.26 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -140.13 175.92 9.19 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.011 0.434 . . . . 62.13 111.638 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.2 mtp85 -136.21 174.44 10.61 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.325 0.583 . . . . 71.54 111.777 177.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -68.53 104.36 1.92 Allowed 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.014 -0.539 . . . . 61.13 111.273 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 134.59 -19.36 4.01 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 116.075 -0.511 . . . . 60.14 112.646 -178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -79.64 162.02 25.53 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 121.365 0.602 . . . . 73.13 112.242 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.497 HG22 ' HG2' ' A' ' 24' ' ' ARG . 38.7 t -96.77 119.62 45.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.049 -0.523 . . . . 71.23 110.366 176.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.515 HG22 HG12 ' A' ' 104' ' ' VAL . 42.8 pt -121.86 157.85 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.637 0.732 . . . . 71.52 112.853 -176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.557 ' HB3' ' HG3' ' A' ' 103' ' ' GLU . 42.5 ttt-85 -133.55 111.95 11.09 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.115 -0.948 . . . . 71.24 109.711 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.538 HG12 HG12 ' A' ' 102' ' ' VAL . 43.9 mt -94.5 119.51 42.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 120.711 0.291 . . . . 65.41 111.348 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -95.48 135.07 37.6 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.885 0.374 . . . . 74.42 111.797 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 69.71 85.84 0.13 Allowed 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 115.607 -0.724 . . . . 72.14 112.703 178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 18' ' ' GLU . 28.0 m -140.17 159.62 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 120.892 0.377 . . . . 72.43 111.182 175.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -112.11 125.92 54.63 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 120.997 0.427 . . . . 72.34 110.961 176.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mm -80.95 121.68 34.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-N 116.156 -0.475 . . . . 71.45 111.357 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.517 ' HB2' ' HG3' ' A' ' 93' ' ' GLU . 31.7 mmm180 -92.63 -17.47 24.3 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.63 0.252 . . . . 74.52 111.488 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.8 61.45 4.96 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.344 -0.455 . . . . 34.12 113.703 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 93' ' ' GLU . . . -55.59 123.76 31.33 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.381 -0.438 . . . . 40.21 113.087 177.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -71.12 134.83 47.3 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.017 0.437 . . . . 70.05 111.394 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 131.75 -4.98 5.45 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.231 -0.509 . . . . 72.33 113.066 -178.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 118.81 -81.56 0.33 Allowed Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.663 -0.303 . . . . 61.34 112.783 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -72.37 110.49 6.83 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.021 0.439 . . . . 75.51 110.681 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -67.39 -176.2 0.56 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.15 0.796 . . . . 62.11 113.15 -172.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.517 ' HG3' ' HB2' ' A' ' 85' ' ' ARG . 15.6 pt-20 -137.11 148.44 46.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.624 -0.716 . . . . 63.41 110.821 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -134.67 131.76 38.1 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.392 -0.367 . . . . 74.15 111.24 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -102.56 132.16 48.82 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.251 0.548 . . . . 73.04 111.262 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.415 ' HB3' ' ND2' ' A' ' 64' ' ' ASN . 10.0 mp -88.25 163.99 15.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.541 -0.754 . . . . 72.44 111.698 -177.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 34.9 mtt -114.65 154.67 46.71 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-N 115.82 -0.627 . . . . 73.45 110.583 -178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -53.29 -27.61 39.39 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.429 2.086 . . . . 64.32 112.936 178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -89.26 -15.5 33.43 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.512 0.56 . . . . 73.54 112.512 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.1 m -60.03 148.73 34.51 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 112.685 0.624 . . . . 72.32 112.685 -175.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 61.4 p -129.0 154.26 46.79 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.88 -0.6 . . . . 54.11 111.166 179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.538 HG12 HG12 ' A' ' 79' ' ' ILE . 31.9 m -119.9 130.51 74.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-O 121.116 0.484 . . . . 62.02 111.448 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 78' ' ' ARG . 7.9 pt-20 -114.61 137.14 52.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.205 -0.452 . . . . 73.04 110.473 178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.515 HG12 HG22 ' A' ' 77' ' ' ILE . 28.1 m -100.69 141.53 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 121.435 0.636 . . . . 70.01 112.533 -174.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.661 ' O ' ' HD2' ' A' ' 107' ' ' PRO . 51.8 mt -104.16 158.27 16.55 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 73.34 110.679 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.47 ' HB3' ' HD2' ' A' ' 107' ' ' PRO . 36.4 t70 89.06 -64.44 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.154 0 C-N-CA 125.0 1.32 . . . . 63.34 110.893 -168.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 105' ' ' LEU . 19.4 Cg_endo -64.64 70.35 0.24 Allowed 'Trans proline' 0 C--N 1.364 1.385 0 CA-C-N 121.082 1.422 . . . . 73.42 109.494 155.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 110' ' ' HIS . 1.8 tm? -42.27 103.7 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 114.494 -1.23 . . . . 73.04 114.192 -161.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -112.63 73.34 0.81 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.633 -0.712 . . . . 63.13 109.473 164.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.521 ' H ' HD13 ' A' ' 108' ' ' LEU . 22.0 m-70 . . . . . 0 C--O 1.254 1.324 0 CA-C-O 118.501 -0.762 . . . . 65.24 112.591 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 120.999 0.428 . . . . 73.44 111.598 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -171.61 83.74 0.48 Allowed Pre-proline 0 CA--C 1.543 0.675 0 CA-C-N 116.297 -0.411 . . . . 74.41 110.13 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.53 90.48 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.764 2.309 . . . . 52.01 113.282 -178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -101.52 101.15 11.67 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.039 0.447 . . . . 73.22 111.815 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -133.65 171.65 13.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 116.091 -0.504 . . . . 75.25 110.66 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 6' ' ' ARG . 50.8 mtm180 64.25 23.32 13.07 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.935 0.398 . . . . 72.03 110.972 -171.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.487 ' HG3' ' HG2' ' A' ' 20' ' ' PRO . 46.7 ttm -104.26 105.94 16.27 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.212 -0.449 . . . . 54.42 111.447 -178.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 12' ' ' LYS . 3.2 p-10 -136.89 157.66 46.23 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.345 0.593 . . . . 74.22 111.549 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' ILE . 11.4 m -94.97 173.52 7.54 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.184 -0.462 . . . . 74.4 111.43 -175.071 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' THR . 58.7 mt -42.44 -44.32 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 115.104 1.52 . . . . 73.33 115.104 -170.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.548 ' OG ' ' HB ' ' A' ' 53' ' ' THR . 68.1 m -58.19 -34.36 70.27 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 121.714 -0.616 . . . . 72.44 112.453 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 8' ' ' ASP . 31.7 mmmt -96.23 -2.68 45.64 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.065 0.765 . . . . 55.42 113.065 -172.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' A' ' 10' ' ' ILE . 74.5 mt -55.35 106.42 0.24 Allowed 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 112.129 0.418 . . . . 74.41 112.129 -177.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' HB2' ' A' ' 17' ' ' ALA . 35.2 tt0 -82.96 136.23 34.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.977 0.417 . . . . 73.03 111.144 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -62.87 89.85 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 121.665 0.745 . . . . 73.55 111.391 177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 127.87 0.65 6.53 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.511 -0.768 . . . . 73.34 112.919 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.515 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . . . -89.17 162.62 15.83 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.32 0.581 . . . . 74.04 112.522 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -123.83 109.37 13.55 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.889 -0.596 . . . . 73.33 110.309 175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.6 t -151.7 151.65 28.86 Favored Pre-proline 0 N--CA 1.472 0.642 0 N-CA-C 112.175 0.435 . . . . 72.45 112.175 -175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . 60.5 Cg_endo -74.36 138.71 25.11 Favored 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 122.455 2.103 . . . . 55.23 112.37 169.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.92 135.17 63.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-O 121.088 0.47 . . . . 64.33 111.491 -176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.3 m -107.55 151.8 25.11 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.514 -0.312 . . . . 45.23 110.948 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 179.26 155.95 16.23 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 120.106 -1.045 . . . . 72.53 114.132 176.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.549 ' HG2' HG22 ' A' ' 76' ' ' VAL . 81.2 mtm180 -81.5 117.87 22.26 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 122.597 0.359 . . . . 75.3 110.758 175.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.52 114.57 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 121.136 0.493 . . . . 74.24 111.368 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -96.87 -59.82 1.72 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.137 -0.483 . . . . 54.24 110.756 177.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -127.55 140.46 52.11 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.364 -0.38 . . . . 75.1 111.287 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG23 HG22 ' A' ' 47' ' ' VAL . 66.1 mt -119.73 102.37 12.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.922 0.391 . . . . 74.2 110.62 173.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.7 m -73.14 113.2 9.93 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 110.088 -0.338 . . . . 51.32 110.088 176.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.6 m -53.52 144.79 31.21 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 116.329 -0.396 . . . . 61.53 112.065 -173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -51.62 127.85 24.1 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.572 2.848 . . . . 71.15 114.349 -175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -94.06 125.52 38.74 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.936 -0.575 . . . . 74.35 110.154 172.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.6 m -91.51 136.75 32.89 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.97 0.414 . . . . 75.45 111.633 -177.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -135.73 148.96 49.03 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 116.26 -0.427 . . . . 72.52 110.239 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 92.6 m -85.11 112.01 20.28 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.09 0.471 . . . . 63.4 111.415 -178.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 5.4 t -95.77 169.27 10.13 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.832 -0.622 . . . . 73.2 111.976 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -78.29 -9.16 59.12 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.88 -0.6 . . . . 74.1 111.841 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -93.66 165.24 12.81 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.233 -0.439 . . . . 71.21 110.609 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -71.92 7.96 6.81 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 121.227 -0.511 . . . . 74.24 113.817 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -87.54 156.78 19.36 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.463 -0.433 . . . . 74.43 111.252 177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -61.91 -45.75 92.37 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.55 0.574 . . . . 72.23 112.55 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.78 106.37 0.63 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.291 -0.48 . . . . 31.43 112.903 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -148.98 153.38 37.85 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 122.362 -0.493 . . . . 73.11 112.001 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 44' ' ' LEU . 4.4 pp -142.9 136.49 28.68 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.702 -0.681 . . . . 64.3 110.567 173.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 60' ' ' PHE . . . -129.61 140.34 51.2 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.796 0.331 . . . . 63.2 111.778 -178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -103.87 110.54 22.71 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.794 0.33 . . . . 74.13 111.139 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.516 HG22 HG23 ' A' ' 28' ' ' ILE . 98.1 t -110.67 119.17 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 120.983 0.421 . . . . 72.14 110.719 177.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 35.5 mm -96.98 112.42 28.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 120.881 0.372 . . . . 74.24 111.719 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.6 pt -111.48 138.83 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 116.308 -0.406 . . . . 61.04 111.073 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -118.42 122.85 43.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.204 0.526 . . . . 61.2 112.045 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -114.68 172.47 7.02 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.851 -0.613 . . . . 64.1 110.81 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -58.14 -26.26 62.46 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.795 0.331 . . . . 74.05 111.801 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.548 ' HB ' ' OG ' ' A' ' 11' ' ' SER . 62.1 p -96.86 9.82 40.74 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.819 0.674 . . . . 73.02 112.819 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.75 169.37 12.85 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.792 -0.718 . . . . 44.15 113.028 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -103.56 153.14 20.9 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.203 0.525 . . . . 75.11 111.666 174.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 94' ' ' ALA . 32.7 tp -135.19 152.48 51.62 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.175 -0.466 . . . . 74.04 111.68 -174.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.2 ttm180 -101.14 107.71 19.2 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.095 0.474 . . . . 72.22 111.314 176.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -88.85 132.4 34.68 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.443 -0.344 . . . . 52.35 111.238 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.4 t -105.38 106.85 21.29 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.093 0.473 . . . . 54.2 111.569 -179.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.544 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 18.4 m-85 -92.95 104.56 16.78 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.25 0.547 . . . . 74.13 111.197 178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -76.77 162.81 27.37 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.708 -0.678 . . . . 72.31 111.517 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 5.7 t -39.25 -35.47 0.25 Allowed 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.513 0.931 . . . . 63.51 113.513 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -72.89 -29.32 63.08 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.191 0.519 . . . . 62.33 112.065 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.491 ' ND2' ' HB3' ' A' ' 96' ' ' LEU . 16.9 m120 -97.29 -2.73 41.95 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.805 0.669 . . . . 64.14 112.805 -178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.416 HG23 HD12 ' A' ' 68' ' ' LEU . 50.7 mm -57.74 -32.92 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.1 0.476 . . . . 54.42 110.798 176.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -60.26 -16.3 32.68 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 116.273 -0.421 . . . . 65.03 112.064 176.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 75.6 mt -87.94 -24.88 23.46 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.727 0.269 . . . . 60.14 111.727 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.416 HD12 HG23 ' A' ' 65' ' ' ILE . 89.2 mt -57.34 -30.77 65.09 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.196 0.443 . . . . 74.2 112.196 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.526 ' HB3' ' NZ ' ' A' ' 69' ' ' LYS . 0.3 OUTLIER -80.11 -8.81 59.59 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.406 0.521 . . . . 72.4 112.406 -178.476 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -74.44 -23.65 58.95 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.941 0.401 . . . . 63.14 111.57 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -135.81 172.13 13.46 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.117 -0.492 . . . . 73.31 110.874 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -127.1 166.52 17.48 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.162 0.505 . . . . 72.24 111.232 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.58 82.77 0.27 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.329 0.585 . . . . 71.44 111.722 -174.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.7 -12.55 0.75 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 121.156 -0.545 . . . . 64.44 113.878 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -82.92 171.83 13.45 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 117.355 0.578 . . . . 74.21 111.609 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.549 HG22 ' HG2' ' A' ' 24' ' ' ARG . 23.0 t -101.39 133.08 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 O-C-N 122.236 -0.29 . . . . 72.32 110.402 175.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.4 pt -135.01 155.35 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-O 121.222 0.534 . . . . 74.01 112.023 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -123.27 115.62 22.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.828 -0.624 . . . . 72.41 110.144 171.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG12 HG12 ' A' ' 102' ' ' VAL . 48.4 mt -93.86 123.2 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.16 -0.473 . . . . 75.43 111.168 -178.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.497 ' HG3' ' HB3' ' A' ' 20' ' ' PRO . 28.4 ttpp -115.33 157.29 24.04 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.887 0.375 . . . . 75.03 111.943 -175.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 100' ' ' SER . 24.0 m-20 72.77 39.56 0.66 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 115.735 -0.666 . . . . 73.44 112.158 175.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.565 HG12 ' HA ' ' A' ' 96' ' ' LEU . 31.7 m -121.83 161.63 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.547 0.573 . . . . 71.45 112.547 -176.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.1 136.89 50.9 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.983 0.42 . . . . 64.33 111.603 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 49.9 mm -92.6 119.04 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 116.012 -0.54 . . . . 73.14 110.681 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -83.91 -65.85 0.96 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.238 0.458 . . . . 72.44 112.238 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.47 ' O ' ' HG2' ' A' ' 92' ' ' LYS . . . 178.62 -39.41 0.08 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 120.091 -1.052 . . . . 34.33 114.017 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.574 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 79.26 111.79 0.23 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.105 -0.569 . . . . 72.42 113.278 -176.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -65.02 109.11 2.02 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.219 0.533 . . . . 75.23 111.594 178.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 107.85 -48.17 0.97 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 121.205 -0.521 . . . . 63.42 113.071 179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 170.41 -40.8 0.19 Allowed Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.683 -0.77 . . . . 42.11 113.443 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -71.9 97.43 1.83 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.028 0.442 . . . . 75.11 110.699 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.574 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 97.1 mttt -59.27 163.86 3.58 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 121.597 0.713 . . . . 51.12 112.538 -177.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -127.42 137.72 52.8 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.68 -0.691 . . . . 74.04 111.269 -171.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.422 ' HB2' HD21 ' A' ' 56' ' ' LEU . . . -112.89 111.61 22.49 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.247 -0.433 . . . . 54.15 110.927 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -92.6 121.41 34.01 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.326 0.584 . . . . 72.25 111.704 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.565 ' HA ' HG12 ' A' ' 82' ' ' VAL . 9.7 mp -84.93 148.09 26.41 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.504 -0.771 . . . . 65.33 111.39 -178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 37.4 mtt -108.2 161.18 24.29 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.725 -0.67 . . . . 54.45 110.258 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -53.03 -22.8 19.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 0 C-N-CA 122.275 1.983 . . . . 62.43 112.959 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 60.1 mtt85 -102.91 3.8 36.86 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.976 0.361 . . . . 41.3 111.976 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 81' ' ' ASP . 52.1 m -77.62 152.55 33.84 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.909 0.385 . . . . 72.24 111.423 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 32.8 p -134.67 149.3 50.5 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.977 0.418 . . . . 54.54 111.994 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.46 HG12 HG12 ' A' ' 79' ' ' ILE . 30.4 m -123.4 148.63 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 CA-C-N 116.222 -0.444 . . . . 74.44 111.067 178.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -135.77 138.5 42.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 62.44 111.611 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 30.6 m -84.37 135.24 25.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 CA-C-O 120.962 0.41 . . . . 74.55 111.443 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.9 mt -136.79 178.43 7.08 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.696 0.76 . . . . 63.01 112.983 -171.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 107' ' ' PRO . 3.4 m-20 60.14 58.91 4.35 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 115.787 1.773 . . . . 75.21 115.787 168.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 106' ' ' ASP . 76.6 Cg_endo -103.09 20.38 0.16 Allowed 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.361 2.707 . . . . 71.21 110.044 157.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -133.35 135.13 44.56 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.114 -0.948 . . . . 53.33 111.288 -166.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -66.5 -60.7 2.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.094 0.776 . . . . 73.21 113.094 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 . . . . . 0 C--O 1.252 1.217 0 N-CA-C 114.062 1.134 . . . . 74.22 114.062 -171.09 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.495 0.188 . . . . 72.52 111.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.605 ' HD3' ' SD ' ' A' ' 7' ' ' MET . 28.3 mtpp 65.24 114.75 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 122.9 0.48 . . . . 63.34 111.969 -177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -45.84 115.87 1.21 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.542 2.828 . . . . 62.31 114.91 -174.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 58.35 67.07 0.98 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.186 -0.915 . . . . 74.41 112.888 174.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -149.1 150.21 32.36 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.098 -0.501 . . . . 71.42 110.566 174.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -78.57 74.61 5.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.62 0.724 . . . . 73.15 111.502 176.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.605 ' SD ' ' HD3' ' A' ' 2' ' ' LYS . 80.9 mtp -126.85 40.32 3.75 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.101 -0.954 . . . . 51.15 108.896 173.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 62.5 m-20 -62.1 133.92 55.91 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.382 -1.281 . . . . 71.53 113.196 -171.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 76.7 p -89.4 -178.17 5.53 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.595 -0.73 . . . . 75.13 111.476 176.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 65.3 mt -55.0 -36.93 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 N-CA-C 112.93 0.715 . . . . 74.1 112.93 -174.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.9 t -61.89 -34.79 76.67 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.111 0.481 . . . . 75.14 111.73 176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 8' ' ' ASP . 72.3 mmtt -84.17 -29.53 26.56 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.235 0.457 . . . . 72.23 112.235 -177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 89.5 mt -50.1 134.73 21.74 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.085 0.772 . . . . 45.55 113.085 -174.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -127.63 140.3 52.18 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.678 -0.692 . . . . 75.04 111.296 178.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -62.57 128.04 34.13 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.128 0.489 . . . . 75.13 111.333 177.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.89 55.01 Favored Glycine 0 CA--C 1.528 0.886 0 C-N-CA 121.323 -0.465 . . . . 65.44 112.991 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -95.38 144.07 26.22 Favored 'General case' 0 CA--C 1.541 0.611 0 O-C-N 122.501 -0.411 . . . . 31.4 112.041 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -106.2 108.44 19.95 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.032 0.444 . . . . 73.45 110.289 175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 5.9 t -152.09 150.54 25.92 Favored Pre-proline 0 N--CA 1.472 0.664 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.321 -176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.66 153.31 69.55 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.452 2.101 . . . . 75.32 112.329 173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.1 m -126.68 148.75 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 CA-C-O 121.061 0.458 . . . . 64.42 111.932 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.3 m -132.71 145.51 51.09 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.248 -0.433 . . . . 64.22 111.048 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 170.43 178.51 41.27 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.876 -0.678 . . . . 73.34 113.435 178.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.568 ' HG2' HG22 ' A' ' 76' ' ' VAL . 66.5 mtp180 -92.29 141.51 28.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 122.426 -0.455 . . . . 65.41 111.948 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 74' ' ' GLY . 44.2 t -78.66 112.3 16.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.506 -0.315 . . . . 65.35 110.706 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 49.7 ttp -97.07 -54.65 3.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.845 0.355 . . . . 53.21 111.273 -179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' HB2' ' HB ' ' A' ' 48' ' ' ILE . 41.0 mmtm -129.78 145.76 51.55 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.58 -0.282 . . . . 64.1 110.82 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.534 HG12 HG13 ' A' ' 47' ' ' VAL . 63.3 mt -126.72 126.38 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.559 0.218 . . . . 75.41 111.153 175.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.7 m -96.59 149.4 21.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 120.773 0.321 . . . . 64.5 111.215 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.2 m -67.44 152.61 96.04 Favored Pre-proline 0 N--CA 1.473 0.725 0 CA-C-O 120.825 0.345 . . . . 65.44 111.869 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.16 124.46 9.54 Favored 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 122.828 2.352 . . . . 73.34 113.627 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 32' ' ' ARG . 46.0 ttt-85 -93.99 141.03 28.99 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.534 0.334 . . . . 73.12 111.192 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HA ' ' HG2' ' A' ' 43' ' ' LYS . 6.4 m -93.58 138.69 31.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.589 -0.278 . . . . 62.31 110.736 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.518 ' HE1' ' HB ' ' A' ' 36' ' ' THR . 32.9 p90 -131.04 173.44 11.0 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.139 0.495 . . . . 61.21 111.723 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 90.1 m -95.08 108.22 20.3 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.996 0.427 . . . . 52.54 111.889 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.518 ' HB ' ' HE1' ' A' ' 34' ' ' PHE . 10.5 t -116.63 -179.3 3.64 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.306 -0.407 . . . . 71.41 110.596 174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.416 ' HD3' ' N ' ' A' ' 37' ' ' ARG . 0.3 OUTLIER -63.3 133.1 53.6 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.901 -0.407 . . . . 75.32 109.901 176.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 38' ' ' LYS . 3.2 mptp? -71.5 79.31 0.78 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.501 0.926 . . . . 75.1 113.501 -166.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.15 -45.67 0.18 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 109.348 -1.501 . . . . 50.44 109.348 168.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 92.8 mtm-85 -124.05 158.67 31.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.829 -0.685 . . . . 75.12 109.749 167.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -62.43 -46.28 89.27 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.775 0.657 . . . . 72.44 112.775 -173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.78 115.99 2.35 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 120.901 -0.666 . . . . 43.12 113.759 -177.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.488 ' N ' ' HB ' ' A' ' 62' ' ' THR . 33.2 mttp -146.69 162.12 39.15 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.162 0.585 . . . . 71.31 111.109 178.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 44' ' ' LEU . 4.3 pp -148.8 147.42 28.76 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.094 -0.503 . . . . 72.55 110.607 176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.61 147.68 45.21 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.756 0.312 . . . . 72.53 111.437 -179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -115.28 111.68 21.27 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.384 0.611 . . . . 55.3 111.55 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG13 HG12 ' A' ' 28' ' ' ILE . 94.8 t -102.87 123.72 56.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 115.997 -0.547 . . . . 74.42 110.531 176.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 27' ' ' LYS . 45.4 mm -92.57 106.53 17.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 121.22 0.533 . . . . 75.01 111.06 -177.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 32.5 pt -105.88 149.43 9.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.953 -0.567 . . . . 53.05 110.593 179.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -133.83 146.03 50.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 72.01 111.665 -177.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -141.95 166.41 24.8 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.697 -0.683 . . . . 72.43 110.257 176.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -63.41 -8.7 9.69 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 111.924 0.342 . . . . 74.41 111.924 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 52.3 p -107.76 5.94 27.11 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.758 0.651 . . . . 74.51 112.758 178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.37 169.35 11.56 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 120.579 -0.82 . . . . 72.41 113.763 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' CD ' HH12 ' A' ' 91' ' ' ARG . 41.5 mt-10 -103.39 155.13 18.71 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 122.72 -0.282 . . . . 75.11 110.818 175.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.4 tp -145.08 144.46 30.97 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.86 0.362 . . . . 72.33 111.93 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -98.66 105.85 18.05 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 120.836 0.351 . . . . 75.12 111.032 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.12 119.0 24.46 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.762 0.315 . . . . 54.44 111.46 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 52.8 t -95.73 104.89 16.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.137 0.494 . . . . 72.33 111.758 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -92.86 105.36 17.5 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.239 -0.437 . . . . 73.45 111.398 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -73.08 159.99 32.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.467 -0.333 . . . . 71.31 111.262 176.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.506 ' HA ' HG12 ' A' ' 65' ' ' ILE . 5.9 t -44.8 -36.08 3.05 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.606 0.965 . . . . 74.13 113.606 -175.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.431 ' OE2' HG23 ' A' ' 62' ' ' THR . 27.9 mm-40 -63.19 -41.55 99.2 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.206 0.527 . . . . 65.04 110.796 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -88.22 -2.9 58.88 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.031 0.752 . . . . 54.32 113.031 -176.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.506 HG12 ' HA ' ' A' ' 62' ' ' THR . 36.1 mm -55.17 -29.37 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 121.349 0.595 . . . . 73.13 110.908 175.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.444 ' O ' ' HG2' ' A' ' 69' ' ' LYS . 0.1 OUTLIER -57.35 -19.88 25.58 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 115.654 -0.703 . . . . 75.34 112.396 177.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.497 HD13 HG13 ' A' ' 102' ' ' VAL . 82.1 mt -82.63 -21.76 34.96 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.084 0.401 . . . . 73.54 112.084 -176.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.6 -18.36 63.83 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.376 0.51 . . . . 64.42 112.376 -177.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -82.89 -13.42 56.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.872 0.368 . . . . 62.53 111.916 179.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -79.19 -56.94 3.99 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.005 0.431 . . . . 73.31 112.114 -174.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -101.07 170.48 8.24 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 120.949 0.404 . . . . 74.41 111.507 -178.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.54 157.44 33.64 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 121.251 0.548 . . . . 65.52 111.43 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.96 96.24 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.004 -0.544 . . . . 74.13 111.332 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 25' ' ' VAL . . . 143.25 -21.82 2.25 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 116.132 -0.486 . . . . 71.21 113.661 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -77.99 169.13 18.79 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.9 0.704 . . . . 71.14 112.9 -176.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' ARG . 10.9 t -99.3 111.09 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-N 115.826 -0.625 . . . . 72.53 110.45 176.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 46.0 pt -118.86 163.08 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-O 121.686 0.755 . . . . 73.14 112.537 -175.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' HB2' HD11 ' A' ' 105' ' ' LEU . 56.3 ttp180 -128.1 121.7 30.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.394 -0.821 . . . . 74.43 110.224 172.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.435 HG12 HG12 ' A' ' 102' ' ' VAL . 33.1 mt -96.81 110.32 24.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.022 0.439 . . . . 71.12 109.94 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 100' ' ' SER . 88.0 tttt -92.26 134.65 34.69 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.333 -0.394 . . . . 62.1 111.49 -173.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 65.47 87.01 0.12 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.307 0.643 . . . . 64.2 112.408 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.3 m -140.59 168.23 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 121.159 0.504 . . . . 62.22 112.167 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -117.83 119.28 34.41 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.238 -0.437 . . . . 64.03 111.656 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 42.6 mm -81.09 111.3 17.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-O 120.794 0.33 . . . . 75.32 110.478 177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 85' ' ' ARG . 12.5 mmm180 -90.57 -27.32 19.21 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.367 0.506 . . . . 70.31 112.367 -176.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.89 -29.76 3.48 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 120.169 -1.015 . . . . 53.34 114.915 173.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 92' ' ' LYS . . . 63.48 92.38 0.02 OUTLIER Glycine 0 CA--C 1.526 0.778 0 CA-C-N 117.299 0.55 . . . . 71.3 112.873 -176.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -60.19 112.51 1.94 Allowed 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.158 0.429 . . . . 50.13 112.158 -176.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 93.8 44.31 3.66 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 121.139 -0.553 . . . . 60.43 114.48 176.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 109.52 -76.19 0.22 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 120.886 -0.673 . . . . 24.34 114.456 173.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.451 ' O ' ' HA3' ' A' ' 87' ' ' GLY . 73.8 mtp85 -77.14 107.67 9.69 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.45 -0.441 . . . . 73.5 112.124 -172.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.526 ' HA ' ' HA3' ' A' ' 87' ' ' GLY . 59.4 mttp -61.58 170.23 2.0 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.629 -0.714 . . . . 63.45 112.862 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -142.11 152.36 43.19 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.741 -0.663 . . . . 74.32 111.743 -174.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -132.55 117.57 18.14 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.323 -0.399 . . . . 72.12 111.449 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -92.65 135.44 34.09 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 111.942 0.349 . . . . 64.23 111.942 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 9.7 mp -88.09 -177.24 5.68 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.314 0.578 . . . . 71.24 111.924 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 40.0 mtt -137.32 152.42 73.32 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 116.254 -0.43 . . . . 74.22 110.631 -175.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -53.35 -15.26 5.46 Favored 'Trans proline' 0 CA--C 1.55 1.28 0 C-N-CA 122.792 2.328 . . . . 70.04 114.523 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -112.23 -8.26 13.98 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.934 0.716 . . . . 61.32 112.934 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.565 ' HB2' ' O ' ' A' ' 80' ' ' LYS . 80.1 p -87.54 137.28 32.47 Favored 'General case' 0 N--CA 1.471 0.618 0 O-C-N 121.873 -0.517 . . . . 61.12 111.554 -176.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 73.3 p -125.42 171.97 10.03 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.261 0.553 . . . . 61.5 112.303 -175.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.497 HG13 HD13 ' A' ' 67' ' ' LEU . 25.7 m -118.74 154.48 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 115.776 -0.647 . . . . 64.2 111.148 178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.3 153.94 44.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.742 0.306 . . . . 71.02 111.698 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.5 m -95.48 129.67 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.007 0.432 . . . . 54.23 110.974 176.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' A' ' 78' ' ' ARG . 84.0 mt -104.46 -68.05 0.87 Allowed 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.916 0.71 . . . . 71.35 112.916 -174.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' N ' ' CD ' ' A' ' 107' ' ' PRO . 10.0 m-20 -91.77 -6.66 0.11 Allowed Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 115.857 1.799 . . . . 51.44 115.857 -172.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' CD ' ' N ' ' A' ' 106' ' ' ASP . 26.0 Cg_exo -66.91 53.6 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.444 0 CA-C-N 121.509 1.575 . . . . 72.13 110.924 164.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.486 HD13 ' N ' ' A' ' 110' ' ' HIS . 3.2 tm? -107.78 136.25 47.84 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.284 -0.871 . . . . 54.53 111.356 -164.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -85.3 -42.34 14.71 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 113.028 0.751 . . . . 75.3 113.028 -177.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.486 ' N ' HD13 ' A' ' 108' ' ' LEU . 13.8 m-70 . . . . . 0 C--O 1.252 1.206 0 N-CA-C 112.603 0.594 . . . . 75.31 112.603 -172.947 . . . . . . . . 1 1 . 1 stop_ save_